id	sid	tid	token	lemma	pos
ihlr-16498	1	1	joanna	joanna	PROPN
ihlr-16498	1	2	sax	sax	PROPN
ihlr-16498	1	3	joanna	joanna	PROPN
ihlr-16498	1	4	sax	sax	PROPN
ihlr-16498	1	5	focuses	focus	VERB
ihlr-16498	1	6	her	her	PRON
ihlr-16498	1	7	legal	legal	ADJ
ihlr-16498	1	8	research	research	NOUN
ihlr-16498	1	9	on	on	ADP
ihlr-16498	1	10	policy	policy	NOUN
ihlr-16498	1	11	issues	issue	NOUN
ihlr-16498	1	12	surrounding	surround	VERB
ihlr-16498	1	13	health	health	NOUN
ihlr-16498	1	14	law	law	NOUN
ihlr-16498	1	15	and	and	CCONJ
ihlr-16498	1	16	biomedical	biomedical	ADJ
ihlr-16498	1	17	research	research	NOUN
ihlr-16498	1	18	.	.	PUNCT
ihlr-16498	2	1	she	she	PRON
ihlr-16498	2	2	received	receive	VERB
ihlr-16498	2	3	a	a	DET
ihlr-16498	2	4	ph.d	ph.d	NOUN
ihlr-16498	2	5	.	.	PUNCT
ihlr-16498	3	1	in	in	ADP
ihlr-16498	3	2	cell	cell	NOUN
ihlr-16498	3	3	and	and	CCONJ
ihlr-16498	3	4	molecular	molecular	ADJ
ihlr-16498	3	5	biology	biology	NOUN
ihlr-16498	3	6	from	from	ADP
ihlr-16498	3	7	the	the	DET
ihlr-16498	3	8	university	university	PROPN
ihlr-16498	3	9	of	of	ADP
ihlr-16498	3	10	pennsylvania	pennsylvania	PROPN
ihlr-16498	3	11	school	school	PROPN
ihlr-16498	3	12	of	of	ADP
ihlr-16498	3	13	medicine	medicine	NOUN
ihlr-16498	3	14	in	in	ADP
ihlr-16498	3	15	2003	2003	NUM
ihlr-16498	3	16	.	.	PUNCT
ihlr-16498	4	1	in	in	ADP
ihlr-16498	4	2	2006	2006	NUM
ihlr-16498	4	3	,	,	PUNCT
ihlr-16498	4	4	she	she	PRON
ihlr-16498	4	5	received	receive	VERB
ihlr-16498	4	6	a	a	DET
ihlr-16498	4	7	j.d	j.d	PROPN
ihlr-16498	4	8	.	.	PROPN
ihlr-16498	4	9	from	from	ADP
ihlr-16498	4	10	the	the	DET
ihlr-16498	4	11	university	university	PROPN
ihlr-16498	4	12	of	of	ADP
ihlr-16498	4	13	pennsylvania	pennsylvania	PROPN
ihlr-16498	4	14	law	law	PROPN
ihlr-16498	4	15	school	school	NOUN
ihlr-16498	4	16	.	.	PUNCT
ihlr-16498	5	1	joanna	joanna	PROPN
ihlr-16498	5	2	sax	sax	PROPN
ihlr-16498	5	3	is	be	AUX
ihlr-16498	5	4	a	a	DET
ihlr-16498	5	5	first	first	ADJ
ihlr-16498	5	6	year	year	NOUN
ihlr-16498	5	7	associate	associate	NOUN
ihlr-16498	5	8	at	at	ADP
ihlr-16498	5	9	a	a	DET
ihlr-16498	5	10	law	law	NOUN
ihlr-16498	5	11	firm	firm	NOUN
ihlr-16498	5	12	in	in	ADP
ihlr-16498	5	13	san	san	PROPN
ihlr-16498	5	14	francisco	francisco	PROPN
ihlr-16498	5	15	,	,	PUNCT
ihlr-16498	5	16	california	california	PROPN
ihlr-16498	5	17	.	.	PUNCT
ihlr-16498	6	1	reforming	reform	VERB
ihlr-16498	6	2	fda	fda	PROPN
ihlr-16498	6	3	policy	policy	NOUN
ihlr-16498	6	4	for	for	ADP
ihlr-16498	6	5	pediatric	pediatric	ADJ
ihlr-16498	6	6	testing	testing	NOUN
ihlr-16498	6	7	:	:	PUNCT
ihlr-16498	6	8	challenges	challenge	NOUN
ihlr-16498	6	9	and	and	CCONJ
ihlr-16498	6	10	changes	change	NOUN
ihlr-16498	6	11	in	in	ADP
ihlr-16498	6	12	thew	thew	PROPN
ihlr-16498	6	13	ake	ake	NOUN
ihlr-16498	6	14	of	of	ADP
ihlr-16498	6	15	studies	study	NOUN
ihlr-16498	6	16	using	use	VERB
ihlr-16498	6	17	antidepressant	antidepressant	ADJ
ihlr-16498	6	18	drugs	drug	NOUN
ihlr-16498	6	19	joanna	joanna	PROPN
ihlr-16498	6	20	k.	k.	PROPN
ihlr-16498	6	21	sax	sax	PROPN
ihlr-16498	7	1	•	•	NOUN
ihlr-16498	7	2	table	table	NOUN
ihlr-16498	7	3	of	of	ADP
ihlr-16498	7	4	contents	content	NOUN
ihlr-16498	7	5	l.	l.	PROPN
ihlr-16498	7	6	introduction	introduction	NOUN
ihlr-16498	7	7	.................................................................................	.................................................................................	PUNCT
ihlr-16498	8	1	62	62	NUM
ihlr-16498	8	2	ii	ii	NOUN
ihlr-16498	8	3	.	.	PUNCT
ihlr-16498	8	4	historical	historical	ADJ
ihlr-16498	8	5	treatment	treatment	NOUN
ihlr-16498	8	6	of	of	ADP
ihlr-16498	8	7	children	child	NOUN
ihlr-16498	8	8	in	in	ADP
ihlr-16498	8	9	drug	drug	NOUN
ihlr-16498	8	10	testing	testing	NOUN
ihlr-16498	8	11	impacts	impact	VERB
ihlr-16498	8	12	regulatory	regulatory	ADJ
ihlr-16498	8	13	reform	reform	NOUN
ihlr-16498	8	14	................................................................	................................................................	PUNCT
ihlr-16498	8	15	65	65	NUM
ihlr-16498	8	16	iii	iii	NOUN
ihlr-16498	8	17	.	.	PUNCT
ihlr-16498	8	18	legislative	legislative	ADJ
ihlr-16498	8	19	history	history	NOUN
ihlr-16498	8	20	of	of	ADP
ihlr-16498	8	21	the	the	DET
ihlr-16498	8	22	acts	act	NOUN
ihlr-16498	8	23	designed	design	VERB
ihlr-16498	8	24	to	to	PART
ihlr-16498	8	25	protect	protect	VERB
ihlr-16498	8	26	children	child	NOUN
ihlr-16498	8	27	in	in	ADP
ihlr-16498	8	28	the	the	DET
ihlr-16498	8	29	testing	testing	NOUN
ihlr-16498	8	30	and	and	CCONJ
ihlr-16498	8	31	use	use	NOUN
ihlr-16498	8	32	of	of	ADP
ihlr-16498	8	33	fda	fda	PROPN
ihlr-16498	8	34	approved	approve	VERB
ihlr-16498	8	35	drugs	drug	NOUN
ihlr-16498	8	36	............................................................................	............................................................................	PUNCT
ihlr-16498	9	1	66	66	NUM
ihlr-16498	9	2	a.	a.	NOUN
ihlr-16498	9	3	patent	patent	NOUN
ihlr-16498	9	4	exclusivity	exclusivity	NOUN
ihlr-16498	9	5	for	for	ADP
ihlr-16498	9	6	voluntarily	voluntarily	ADV
ihlr-16498	9	7	conducting	conduct	VERB
ihlr-16498	9	8	pediatric	pediatric	ADJ
ihlr-16498	9	9	trials	trial	NOUN
ihlr-16498	9	10	..........................................................................	..........................................................................	PUNCT
ihlr-16498	9	11	66	66	NUM
ihlr-16498	9	12	b.	b.	NOUN
ihlr-16498	9	13	the	the	DET
ihlr-16498	9	14	fda	fda	PROPN
ihlr-16498	9	15	required	require	VERB
ihlr-16498	9	16	pediatric	pediatric	ADJ
ihlr-16498	9	17	testing	testing	NOUN
ihlr-16498	9	18	under	under	ADP
ihlr-16498	9	19	the	the	DET
ihlr-16498	9	20	1998	1998	NUM
ihlr-16498	9	21	final	final	ADJ
ihlr-16498	9	22	rule	rule	NOUN
ihlr-16498	9	23	....................................................................	....................................................................	PUNCT
ihlr-16498	9	24	67	67	NUM
ihlr-16498	9	25	c.	c.	NOUN
ihlr-16498	9	26	pediatric	pediatric	ADJ
ihlr-16498	9	27	testing	testing	NOUN
ihlr-16498	9	28	of	of	ADP
ihlr-16498	9	29	both	both	DET
ihlr-16498	9	30	patented	patented	ADJ
ihlr-16498	9	31	and	and	CCONJ
ihlr-16498	9	32	off	off	ADP
ihlr-16498	9	33	-	-	PUNCT
ihlr-16498	9	34	patent	patent	NOUN
ihlr-16498	9	35	drugs	drug	NOUN
ihlr-16498	9	36	is	be	AUX
ihlr-16498	9	37	permitted	permit	VERB
ihlr-16498	9	38	under	under	ADP
ihlr-16498	9	39	the	the	DET
ihlr-16498	9	40	best	good	ADJ
ihlr-16498	9	41	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	9	42	for	for	ADP
ihlr-16498	9	43	children	child	NOUN
ihlr-16498	9	44	act	act	VERB
ihlr-16498	9	45	.........................................................................	.........................................................................	PUNCT
ihlr-16498	9	46	68	68	NUM
ihlr-16498	9	47	d.	d.	NOUN
ihlr-16498	9	48	the	the	DET
ihlr-16498	9	49	pediatric	pediatric	PROPN
ihlr-16498	9	50	research	research	PROPN
ihlr-16498	9	51	equity	equity	PROPN
ihlr-16498	9	52	act	act	PROPN
ihlr-16498	9	53	essentially	essentially	ADV
ihlr-16498	9	54	codified	codify	VERB
ihlr-16498	9	55	the	the	DET
ihlr-16498	9	56	1998	1998	NUM
ihlr-16498	9	57	final	final	ADJ
ihlr-16498	9	58	rule	rule	NOUN
ihlr-16498	9	59	.....................................................	.....................................................	PUNCT
ihlr-16498	10	1	70	70	NUM
ihlr-16498	10	2	iv	iv	NOUN
ihlr-16498	10	3	.	.	PUNCT
ihlr-16498	11	1	the	the	DET
ihlr-16498	11	2	antidepressant	antidepressant	ADJ
ihlr-16498	11	3	story	story	NOUN
ihlr-16498	11	4	is	be	AUX
ihlr-16498	11	5	a	a	DET
ihlr-16498	11	6	model	model	NOUN
ihlr-16498	11	7	for	for	ADP
ihlr-16498	11	8	the	the	DET
ihlr-16498	11	9	deficiencies	deficiency	NOUN
ihlr-16498	11	10	in	in	ADP
ihlr-16498	11	11	the	the	DET
ihlr-16498	11	12	current	current	ADJ
ihlr-16498	11	13	legislation	legislation	NOUN
ihlr-16498	11	14	.................................	.................................	PUNCT
ihlr-16498	12	1	71	71	NUM
ihlr-16498	12	2	a.	a.	NOUN
ihlr-16498	12	3	the	the	PRON
ihlr-16498	12	4	for	for	ADP
ihlr-16498	12	5	est	est	X
ihlr-16498	12	6	laboratories	laboratory	NOUN
ihlr-16498	12	7	clinical	clinical	ADJ
ihlr-16498	12	8	studies	study	NOUN
ihlr-16498	12	9	demonstrate	demonstrate	VERB
ihlr-16498	12	10	conflicting	conflicting	ADJ
ihlr-16498	12	11	clinical	clinical	ADJ
ihlr-16498	12	12	results	result	NOUN
ihlr-16498	12	13	........................................................	........................................................	PUNCT
ihlr-16498	12	14	72	72	NUM
ihlr-16498	12	15	b.	b.	NOUN
ihlr-16498	12	16	anecdotal	anecdotal	ADJ
ihlr-16498	12	17	reports	report	NOUN
ihlr-16498	12	18	regarding	regard	VERB
ihlr-16498	12	19	selective	selective	ADJ
ihlr-16498	12	20	serotonin	serotonin	NOUN
ihlr-16498	12	21	re	re	NOUN
ihlr-16498	12	22	-	-	ADJ
ihlr-16498	12	23	uptake	uptake	ADJ
ihlr-16498	12	24	inhibitors	inhibitor	NOUN
ihlr-16498	12	25	caused	cause	VERB
ihlr-16498	12	26	the	the	DET
ihlr-16498	12	27	british	british	PROPN
ihlr-16498	12	28	medical	medical	PROPN
ihlr-16498	12	29	health	health	PROPN
ihlr-16498	12	30	regulatory	regulatory	ADJ
ihlr-16498	12	31	agency	agency	NOUN
ihlr-16498	12	32	to	to	PART
ihlr-16498	12	33	ban	ban	VERB
ihlr-16498	12	34	the	the	DET
ihlr-16498	12	35	use	use	NOUN
ihlr-16498	12	36	of	of	ADP
ihlr-16498	12	37	this	this	DET
ihlr-16498	12	38	class	class	NOUN
ihlr-16498	12	39	of	of	ADP
ihlr-16498	12	40	antidepressant	antidepressant	ADJ
ihlr-16498	12	41	drugs	drug	NOUN
ihlr-16498	12	42	in	in	ADP
ihlr-16498	12	43	children	child	NOUN
ihlr-16498	12	44	................................	................................	PUNCT
ihlr-16498	13	1	73	73	NUM
ihlr-16498	13	2	c.	c.	NOUN
ihlr-16498	13	3	the	the	DET
ihlr-16498	13	4	eli	eli	PROPN
ihlr-16498	13	5	lilly	lilly	PROPN
ihlr-16498	13	6	clinical	clinical	ADJ
ihlr-16498	13	7	studies	study	NOUN
ihlr-16498	13	8	showed	show	VERB
ihlr-16498	13	9	that	that	SCONJ
ihlr-16498	13	10	the	the	DET
ihlr-16498	13	11	fda	fda	PROPN
ihlr-16498	13	12	and	and	CCONJ
ihlr-16498	13	13	researchers	researcher	NOUN
ihlr-16498	13	14	must	must	AUX
ihlr-16498	13	15	be	be	AUX
ihlr-16498	13	16	attentive	attentive	ADJ
ihlr-16498	13	17	when	when	SCONJ
ihlr-16498	13	18	taking	take	VERB
ihlr-16498	13	19	adolescents	adolescent	NOUN
ihlr-16498	13	20	off	off	ADP
ihlr-16498	13	21	antidepressants	antidepressant	NOUN
ihlr-16498	13	22	................................................	................................................	PUNCT
ihlr-16498	13	23	74	74	NUM
ihlr-16498	13	24	d.	d.	PROPN
ihlr-16498	13	25	committee	committee	PROPN
ihlr-16498	13	26	hearings	hearing	NOUN
ihlr-16498	13	27	addressed	address	VERB
ihlr-16498	13	28	antidepressant	antidepressant	ADJ
ihlr-16498	13	29	clinical	clinical	ADJ
ihlr-16498	13	30	studies	study	NOUN
ihlr-16498	13	31	in	in	ADP
ihlr-16498	13	32	pediatric	pediatric	ADJ
ihlr-16498	13	33	populations	population	NOUN
ihlr-16498	13	34	..................................	..................................	PUNCT
ihlr-16498	14	1	74	74	NUM
ihlr-16498	14	2	v.	v.	ADP
ihlr-16498	14	3	policy	policy	NOUN
ihlr-16498	14	4	recommendations	recommendation	NOUN
ihlr-16498	14	5	to	to	PART
ihlr-16498	14	6	address	address	VERB
ihlr-16498	14	7	the	the	DET
ihlr-16498	14	8	difficulties	difficulty	NOUN
ihlr-16498	14	9	associated	associate	VERB
ihlr-16498	14	10	with	with	ADP
ihlr-16498	14	11	pediatric	pediatric	ADJ
ihlr-16498	14	12	studies	study	NOUN
ihlr-16498	14	13	...........................................	...........................................	PUNCT
ihlr-16498	15	1	76	76	NUM
ihlr-16498	15	2	*	*	PUNCT
ihlr-16498	15	3	j.d	j.d	PROPN
ihlr-16498	15	4	.	.	PROPN
ihlr-16498	15	5	,	,	PUNCT
ihlr-16498	15	6	2006	2006	NUM
ihlr-16498	15	7	,	,	PUNCT
ihlr-16498	15	8	university	university	NOUN
ihlr-16498	15	9	ofpennsylvania	ofpennsylvania	NOUN
ihlr-16498	15	10	law	law	PROPN
ihlr-16498	15	11	school	school	PROPN
ihlr-16498	15	12	,	,	PUNCT
ihlr-16498	15	13	philadelphia	philadelphia	PROPN
ihlr-16498	15	14	,	,	PUNCT
ihlr-16498	15	15	pennsylvania	pennsylvania	PROPN
ihlr-16498	15	16	;	;	PUNCT
ihlr-16498	15	17	ph.d	ph.d	PROPN
ihlr-16498	15	18	.	.	PROPN
ihlr-16498	15	19	,	,	PUNCT
ihlr-16498	15	20	2003	2003	NUM
ihlr-16498	15	21	,	,	PUNCT
ihlr-16498	15	22	cell	cell	NOUN
ihlr-16498	15	23	and	and	CCONJ
ihlr-16498	15	24	molecular	molecular	ADJ
ihlr-16498	15	25	biology	biology	NOUN
ihlr-16498	15	26	,	,	PUNCT
ihlr-16498	15	27	university	university	NOUN
ihlr-16498	15	28	of	of	ADP
ihlr-16498	15	29	pennsylvania	pennsylvania	PROPN
ihlr-16498	15	30	school	school	PROPN
ihlr-16498	15	31	of	of	ADP
ihlr-16498	15	32	medicine	medicine	NOUN
ihlr-16498	15	33	,	,	PUNCT
ihlr-16498	15	34	philadelphia	philadelphia	PROPN
ihlr-16498	15	35	,	,	PUNCT
ihlr-16498	15	36	pennsylvania	pennsylvania	PROPN
ihlr-16498	15	37	;	;	PUNCT
ihlr-16498	15	38	b.s	b.s	PROPN
ihlr-16498	15	39	.	.	PROPN
ihlr-16498	15	40	,	,	PUNCT
ihlr-16498	15	41	1997	1997	NUM
ihlr-16498	15	42	,	,	PUNCT
ihlr-16498	15	43	zoology	zoology	NOUN
ihlr-16498	15	44	,	,	PUNCT
ihlr-16498	15	45	university	university	NOUN
ihlr-16498	15	46	ofwisconsin	ofwisconsin	NOUN
ihlr-16498	15	47	,	,	PUNCT
ihlr-16498	15	48	madison	madison	PROPN
ihlr-16498	15	49	,	,	PUNCT
ihlr-16498	15	50	wisconsin	wisconsin	PROPN
ihlr-16498	15	51	.	.	PUNCT
ihlr-16498	16	1	the	the	DET
ihlr-16498	16	2	author	author	NOUN
ihlr-16498	16	3	wishes	wish	VERB
ihlr-16498	16	4	to	to	PART
ihlr-16498	16	5	thank	thank	VERB
ihlr-16498	16	6	professor	professor	NOUN
ihlr-16498	16	7	theodore	theodore	NOUN
ihlr-16498	16	8	ruger	ruger	NOUN
ihlr-16498	16	9	for	for	ADP
ihlr-16498	16	10	invaluable	invaluable	ADJ
ihlr-16498	16	11	comments	comment	NOUN
ihlr-16498	16	12	and	and	CCONJ
ihlr-16498	16	13	criticisms	criticism	NOUN
ihlr-16498	16	14	.	.	PUNCT
ihlr-16498	17	1	62	62	NUM
ihlr-16498	17	2	indiana	indiana	PROPN
ihlr-16498	17	3	heal	heal	PROPN
ihlr-16498	17	4	til	til	PROPN
ihlr-16498	17	5	law	law	NOUN
ihlr-16498	17	6	review	review	NOUN
ihlr-16498	17	7	[	[	X
ihlr-16498	17	8	vol	vol	NOUN
ihlr-16498	17	9	.	.	PUNCT
ihlr-16498	17	10	4:59	4:59	NUM
ihlr-16498	17	11	a.	a.	NOUN
ihlr-16498	17	12	public	public	ADJ
ihlr-16498	17	13	databases	database	NOUN
ihlr-16498	17	14	that	that	PRON
ihlr-16498	17	15	disclose	disclose	VERB
ihlr-16498	17	16	medical	medical	ADJ
ihlr-16498	17	17	device	device	NOUN
ihlr-16498	17	18	and	and	CCONJ
ihlr-16498	17	19	drug	drug	NOUN
ihlr-16498	17	20	tests	test	NOUN
ihlr-16498	17	21	by	by	ADP
ihlr-16498	17	22	reporting	report	VERB
ihlr-16498	17	23	inconclusive	inconclusive	ADJ
ihlr-16498	17	24	or	or	CCONJ
ihlr-16498	17	25	negative	negative	ADJ
ihlr-16498	17	26	clinical	clinical	ADJ
ihlr-16498	17	27	trials	trial	NOUN
ihlr-16498	17	28	.....	.....	PUNCT
ihlr-16498	17	29	76	76	NUM
ihlr-16498	17	30	b.	b.	NOUN
ihlr-16498	17	31	changes	change	NOUN
ihlr-16498	17	32	should	should	AUX
ihlr-16498	17	33	be	be	AUX
ihlr-16498	17	34	made	make	VERB
ihlr-16498	17	35	to	to	ADP
ihlr-16498	17	36	the	the	DET
ihlr-16498	17	37	exclusivity	exclusivity	NOUN
ihlr-16498	17	38	provision	provision	NOUN
ihlr-16498	17	39	..............	..............	PUNCT
ihlr-16498	18	1	78	78	NUM
ihlr-16498	18	2	c.	c.	NOUN
ihlr-16498	18	3	the	the	DET
ihlr-16498	18	4	new	new	ADJ
ihlr-16498	18	5	policy	policy	NOUN
ihlr-16498	18	6	should	should	AUX
ihlr-16498	18	7	address	address	VERB
ihlr-16498	18	8	labeling	labeling	NOUN
ihlr-16498	18	9	changes	change	NOUN
ihlr-16498	18	10	...................	...................	PUNCT
ihlr-16498	19	1	80	80	NUM
ihlr-16498	19	2	d.	d.	NOUN
ihlr-16498	19	3	the	the	DET
ihlr-16498	19	4	fda	fda	PROPN
ihlr-16498	19	5	should	should	AUX
ihlr-16498	19	6	implement	implement	VERB
ihlr-16498	19	7	additional	additional	ADJ
ihlr-16498	19	8	post	post	ADJ
ihlr-16498	19	9	-	-	ADJ
ihlr-16498	19	10	approval	approval	ADJ
ihlr-16498	19	11	surveillance	surveillance	NOUN
ihlr-16498	19	12	mechanisms	mechanism	NOUN
ihlr-16498	19	13	...........................................................	...........................................................	PUNCT
ihlr-16498	19	14	82	82	NUM
ihlr-16498	19	15	vi	vi	NOUN
ihlr-16498	19	16	.	.	PUNCT
ihlr-16498	19	17	conclusion	conclusion	NOUN
ihlr-16498	19	18	.....................................................................................	.....................................................................................	PUNCT
ihlr-16498	19	19	83	83	NUM
ihlr-16498	19	20	i.	i.	NOUN
ihlr-16498	19	21	introduction	introduction	NOUN
ihlr-16498	19	22	many	many	ADJ
ihlr-16498	19	23	physicians	physician	NOUN
ihlr-16498	19	24	"	"	PUNCT
ihlr-16498	19	25	dose	dose	VERB
ihlr-16498	19	26	down	down	ADP
ihlr-16498	19	27	"	"	PUNCT
ihlr-16498	19	28	a	a	DET
ihlr-16498	19	29	drug	drug	NOUN
ihlr-16498	19	30	approved	approve	VERB
ihlr-16498	19	31	by	by	ADP
ihlr-16498	19	32	the	the	DET
ihlr-16498	19	33	food	food	NOUN
ihlr-16498	19	34	and	and	CCONJ
ihlr-16498	19	35	drug	drug	PROPN
ihlr-16498	19	36	administration	administration	NOUN
ihlr-16498	19	37	(	(	PUNCT
ihlr-16498	19	38	"	"	PUNCT
ihlr-16498	19	39	fda	fda	PROPN
ihlr-16498	19	40	"	"	PUNCT
ihlr-16498	19	41	)	)	PUNCT
ihlr-16498	19	42	when	when	SCONJ
ihlr-16498	19	43	prescribing	prescribe	VERB
ihlr-16498	19	44	it	it	PRON
ihlr-16498	19	45	for	for	SCONJ
ihlr-16498	19	46	children	child	NOUN
ihlr-16498	19	47	to	to	PART
ihlr-16498	19	48	account	account	VERB
ihlr-16498	19	49	for	for	ADP
ihlr-16498	19	50	their	their	PRON
ihlr-16498	19	51	lower	low	ADJ
ihlr-16498	19	52	body	body	NOUN
ihlr-16498	19	53	weight	weight	NOUN
ihlr-16498	19	54	.	.	PUNCT
ihlr-16498	20	1	children	child	NOUN
ihlr-16498	20	2	,	,	PUNCT
ihlr-16498	20	3	however	however	ADV
ihlr-16498	20	4	,	,	PUNCT
ihlr-16498	20	5	may	may	AUX
ihlr-16498	20	6	react	react	VERB
ihlr-16498	20	7	differently	differently	ADV
ihlr-16498	20	8	to	to	ADP
ihlr-16498	20	9	drugs	drug	NOUN
ihlr-16498	20	10	than	than	ADP
ihlr-16498	20	11	adults	adult	NOUN
ihlr-16498	20	12	for	for	ADP
ihlr-16498	20	13	a	a	DET
ihlr-16498	20	14	variety	variety	NOUN
ihlr-16498	20	15	of	of	ADP
ihlr-16498	20	16	reasons	reason	NOUN
ihlr-16498	20	17	including	include	VERB
ihlr-16498	20	18	kidney	kidney	NOUN
ihlr-16498	20	19	and	and	CCONJ
ihlr-16498	20	20	liver	liver	NOUN
ihlr-16498	20	21	development	development	NOUN
ihlr-16498	20	22	.	.	PUNCT
ihlr-16498	21	1	the	the	DET
ihlr-16498	21	2	practice	practice	NOUN
ihlr-16498	21	3	of"dosing	of"dose	VERB
ihlr-16498	21	4	down	down	ADP
ihlr-16498	21	5	"	"	PUNCT
ihlr-16498	21	6	may	may	AUX
ihlr-16498	21	7	not	not	PART
ihlr-16498	21	8	always	always	ADV
ihlr-16498	21	9	account	account	VERB
ihlr-16498	21	10	for	for	ADP
ihlr-16498	21	11	these	these	DET
ihlr-16498	21	12	physiological	physiological	ADJ
ihlr-16498	21	13	dif­	dif­	NOUN
ihlr-16498	21	14	ferences.1	ferences.1	NOUN
ihlr-16498	21	15	indeed	indeed	ADV
ihlr-16498	21	16	,	,	PUNCT
ihlr-16498	21	17	some	some	DET
ihlr-16498	21	18	physicians	physician	NOUN
ihlr-16498	21	19	may	may	AUX
ihlr-16498	21	20	worry	worry	VERB
ihlr-16498	21	21	about	about	ADP
ihlr-16498	21	22	adverse	adverse	ADJ
ihlr-16498	21	23	side	side	NOUN
ihlr-16498	21	24	effects	effect	NOUN
ihlr-16498	21	25	when	when	SCONJ
ihlr-16498	21	26	"	"	PUNCT
ihlr-16498	21	27	dosing	dose	VERB
ihlr-16498	21	28	down	down	ADP
ihlr-16498	21	29	"	"	PUNCT
ihlr-16498	21	30	and	and	CCONJ
ihlr-16498	21	31	may	may	AUX
ihlr-16498	21	32	opt	opt	VERB
ihlr-16498	21	33	to	to	PART
ihlr-16498	21	34	prescribe	prescribe	VERB
ihlr-16498	21	35	less	less	ADV
ihlr-16498	21	36	effective	effective	ADJ
ihlr-16498	21	37	medication	medication	NOUN
ihlr-16498	21	38	that	that	PRON
ihlr-16498	21	39	is	be	AUX
ihlr-16498	21	40	known	know	VERB
ihlr-16498	21	41	not	not	PART
ihlr-16498	21	42	to	to	PART
ihlr-16498	21	43	have	have	VERB
ihlr-16498	21	44	serious	serious	ADJ
ihlr-16498	21	45	adverse	adverse	ADJ
ihlr-16498	21	46	effects	effect	NOUN
ihlr-16498	21	47	in	in	ADP
ihlr-16498	21	48	children	child	NOUN
ihlr-16498	21	49	.	.	PUNCT
ihlr-16498	22	1	the	the	DET
ihlr-16498	22	2	dilemma	dilemma	NOUN
ihlr-16498	22	3	presents	present	VERB
ihlr-16498	22	4	physi­	physi­	PROPN
ihlr-16498	22	5	cians	cian	NOUN
ihlr-16498	22	6	with	with	ADP
ihlr-16498	22	7	a	a	DET
ihlr-16498	22	8	choice	choice	NOUN
ihlr-16498	22	9	,	,	PUNCT
ihlr-16498	22	10	on	on	ADP
ihlr-16498	22	11	the	the	DET
ihlr-16498	22	12	one	one	NUM
ihlr-16498	22	13	hand	hand	NOUN
ihlr-16498	22	14	,	,	PUNCT
ihlr-16498	22	15	to	to	PART
ihlr-16498	22	16	prescribe	prescribe	VERB
ihlr-16498	22	17	a	a	DET
ihlr-16498	22	18	potentially	potentially	ADV
ihlr-16498	22	19	more	more	ADV
ihlr-16498	22	20	effective	effective	ADJ
ihlr-16498	22	21	medication	medication	NOUN
ihlr-16498	22	22	and	and	CCONJ
ihlr-16498	22	23	risk	risk	NOUN
ihlr-16498	22	24	adverse	adverse	ADJ
ihlr-16498	22	25	side	side	NOUN
ihlr-16498	22	26	effects	effect	NOUN
ihlr-16498	22	27	because	because	SCONJ
ihlr-16498	22	28	it	it	PRON
ihlr-16498	22	29	bas	bas	AUX
ihlr-16498	22	30	not	not	PART
ihlr-16498	22	31	been	be	AUX
ihlr-16498	22	32	tested	test	VERB
ihlr-16498	22	33	in	in	ADP
ihlr-16498	22	34	pedi­	pedi­	NOUN
ihlr-16498	22	35	atric	atric	ADJ
ihlr-16498	22	36	populations	population	NOUN
ihlr-16498	22	37	,	,	PUNCT
ihlr-16498	22	38	or	or	CCONJ
ihlr-16498	22	39	,	,	PUNCT
ihlr-16498	22	40	on	on	ADP
ihlr-16498	22	41	the	the	DET
ihlr-16498	22	42	other	other	ADJ
ihlr-16498	22	43	hand	hand	NOUN
ihlr-16498	22	44	,	,	PUNCT
ihlr-16498	22	45	to	to	PART
ihlr-16498	22	46	use	use	VERB
ihlr-16498	22	47	an	an	DET
ihlr-16498	22	48	older	old	ADJ
ihlr-16498	22	49	and	and	CCONJ
ihlr-16498	22	50	perhaps	perhaps	ADV
ihlr-16498	22	51	less	less	ADJ
ihlr-16498	22	52	effec­	effec­	X
ihlr-16498	22	53	tive	tive	NOUN
ihlr-16498	22	54	drug	drug	NOUN
ihlr-16498	22	55	.	.	PUNCT
ihlr-16498	23	1	recognizing	recognize	VERB
ihlr-16498	23	2	the	the	DET
ihlr-16498	23	3	problem	problem	NOUN
ihlr-16498	23	4	of	of	ADP
ihlr-16498	23	5	safe	safe	ADJ
ihlr-16498	23	6	and	and	CCONJ
ihlr-16498	23	7	effective	effective	ADJ
ihlr-16498	23	8	drug	drug	NOUN
ihlr-16498	23	9	use	use	NOUN
ihlr-16498	23	10	in	in	ADP
ihlr-16498	23	11	children	child	NOUN
ihlr-16498	23	12	,	,	PUNCT
ihlr-16498	23	13	congress	congress	PROPN
ihlr-16498	23	14	and	and	CCONJ
ihlr-16498	23	15	the	the	DET
ihlr-16498	23	16	food	food	NOUN
ihlr-16498	23	17	and	and	CCONJ
ihlr-16498	23	18	drug	drug	PROPN
ihlr-16498	23	19	administration	administration	PROPN
ihlr-16498	23	20	(	(	PUNCT
ihlr-16498	23	21	fda	fda	PROPN
ihlr-16498	23	22	)	)	PUNCT
ihlr-16498	23	23	have	have	AUX
ihlr-16498	23	24	enacted	enact	VERB
ihlr-16498	23	25	statutes	statute	NOUN
ihlr-16498	23	26	and	and	CCONJ
ihlr-16498	23	27	regulations	regulation	NOUN
ihlr-16498	23	28	respectively	respectively	ADV
ihlr-16498	23	29	,	,	PUNCT
ihlr-16498	23	30	which	which	PRON
ihlr-16498	23	31	only	only	ADV
ihlr-16498	23	32	begin	begin	VERB
ihlr-16498	23	33	to	to	PART
ihlr-16498	23	34	address	address	VERB
ihlr-16498	23	35	the	the	DET
ihlr-16498	23	36	plethora	plethora	NOUN
ihlr-16498	23	37	of	of	ADP
ihlr-16498	23	38	prob­	prob­	NOUN
ihlr-16498	23	39	lems	lem	NOUN
ihlr-16498	23	40	associated	associate	VERB
ihlr-16498	23	41	with	with	ADP
ihlr-16498	23	42	prescribing	prescribe	VERB
ihlr-16498	23	43	drugs	drug	NOUN
ihlr-16498	23	44	to	to	ADP
ihlr-16498	23	45	pediatric	pediatric	ADJ
ihlr-16498	23	46	populations	population	NOUN
ihlr-16498	23	47	.	.	PUNCT
ihlr-16498	24	1	it	it	PRON
ihlr-16498	24	2	was	be	AUX
ihlr-16498	24	3	not	not	PART
ihlr-16498	24	4	until	until	ADP
ihlr-16498	24	5	the	the	DET
ihlr-16498	24	6	past	past	ADJ
ihlr-16498	24	7	decade	decade	NOUN
ihlr-16498	24	8	that	that	PRON
ihlr-16498	24	9	congress	congress	PROPN
ihlr-16498	24	10	significantly	significantly	ADV
ihlr-16498	24	11	recognized	recognize	VERB
ihlr-16498	24	12	the	the	DET
ihlr-16498	24	13	need	need	NOUN
ihlr-16498	24	14	for	for	ADP
ihlr-16498	24	15	drug	drug	NOUN
ihlr-16498	24	16	testing	testing	NOUN
ihlr-16498	24	17	in	in	ADP
ihlr-16498	24	18	pediatric	pediatric	ADJ
ihlr-16498	24	19	populations	population	NOUN
ihlr-16498	24	20	.	.	PUNCT
ihlr-16498	25	1	the	the	DET
ihlr-16498	25	2	first	first	ADJ
ihlr-16498	25	3	in	in	ADP
ihlr-16498	25	4	the	the	DET
ihlr-16498	25	5	line	line	NOUN
ihlr-16498	25	6	of	of	ADP
ihlr-16498	25	7	these	these	DET
ihlr-16498	25	8	leg­	leg­	NOUN
ihlr-16498	25	9	islative	islative	ADJ
ihlr-16498	25	10	schemes	scheme	NOUN
ihlr-16498	25	11	was	be	AUX
ihlr-16498	25	12	the	the	DET
ihlr-16498	25	13	food	food	NOUN
ihlr-16498	25	14	and	and	CCONJ
ihlr-16498	25	15	drug	drug	PROPN
ihlr-16498	25	16	administration	administration	PROPN
ihlr-16498	25	17	modernization	modernization	PROPN
ihlr-16498	25	18	act	act	NOUN
ihlr-16498	25	19	of	of	ADP
ihlr-16498	25	20	1997	1997	NUM
ihlr-16498	25	21	(	(	PUNCT
ihlr-16498	25	22	"	"	PUNCT
ihlr-16498	25	23	fdama	fdama	NOUN
ihlr-16498	25	24	"	"	PUNCT
ihlr-16498	25	25	)	)	PUNCT
ihlr-16498	25	26	,	,	PUNCT
ihlr-16498	25	27	which	which	PRON
ihlr-16498	25	28	included	include	VERB
ihlr-16498	25	29	a	a	DET
ihlr-16498	25	30	pediatric	pediatric	ADJ
ihlr-16498	25	31	drug	drug	NOUN
ihlr-16498	25	32	exclusivity	exclusivity	NOUN
ihlr-16498	25	33	provision	provision	NOUN
ihlr-16498	25	34	to	to	PART
ihlr-16498	25	35	encourage	encourage	VERB
ihlr-16498	25	36	drug	drug	NOUN
ihlr-16498	25	37	testing	testing	NOUN
ihlr-16498	25	38	in	in	ADP
ihlr-16498	25	39	children	child	NOUN
ihlr-16498	25	40	.	.	PUNCT
ihlr-16498	26	1	2	2	NUM
ihlr-16498	26	2	although	although	SCONJ
ihlr-16498	26	3	drug	drug	NOUN
ihlr-16498	26	4	companies	company	NOUN
ihlr-16498	26	5	were	be	AUX
ihlr-16498	26	6	not	not	PART
ihlr-16498	26	7	re­	re­	AUX
ihlr-16498	26	8	quired	quire	VERB
ihlr-16498	26	9	to	to	PART
ihlr-16498	26	10	conduct	conduct	VERB
ihlr-16498	26	11	clinical	clinical	ADJ
ihlr-16498	26	12	trials	trial	NOUN
ihlr-16498	26	13	in	in	ADP
ihlr-16498	26	14	children	child	NOUN
ihlr-16498	26	15	,	,	PUNCT
ihlr-16498	26	16	the	the	DET
ihlr-16498	26	17	fdama	fdama	NOUN
ihlr-16498	26	18	encouraged	encourage	VERB
ihlr-16498	26	19	such	such	ADJ
ihlr-16498	26	20	drug	drug	NOUN
ihlr-16498	26	21	testing	testing	NOUN
ihlr-16498	26	22	by	by	ADP
ihlr-16498	26	23	offering	offer	VERB
ihlr-16498	26	24	a	a	DET
ihlr-16498	26	25	six	six	NUM
ihlr-16498	26	26	-	-	PUNCT
ihlr-16498	26	27	month	month	NOUN
ihlr-16498	26	28	patent	patent	NOUN
ihlr-16498	26	29	extension	extension	NOUN
ihlr-16498	26	30	period.3	period.3	NOUN
ihlr-16498	26	31	with	with	ADP
ihlr-16498	26	32	the	the	DET
ihlr-16498	26	33	impending	impending	ADJ
ihlr-16498	26	34	2002	2002	NUM
ihlr-16498	26	35	sunset	sunset	NOUN
ihlr-16498	26	36	provision	provision	NOUN
ihlr-16498	26	37	of	of	ADP
ihlr-16498	26	38	the	the	DET
ihlr-16498	26	39	fdama	fdama	NOUN
ihlr-16498	26	40	,	,	PUNCT
ihlr-16498	26	41	congress	congress	PROPN
ihlr-16498	26	42	passed	pass	VERB
ihlr-16498	26	43	the	the	DET
ihlr-16498	26	44	best	good	ADJ
ihlr-16498	26	45	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	26	46	for	for	ADP
ihlr-16498	26	47	children	child	NOUN
ihlr-16498	26	48	act	act	NOUN
ihlr-16498	26	49	(	(	PUNCT
ihlr-16498	26	50	"	"	PUNCT
ihlr-16498	26	51	bpcn').4	bpcn').4	VERB
ihlr-16498	26	52	the	the	DET
ihlr-16498	26	53	bpca	bpca	PROPN
ihlr-16498	26	54	also	also	ADV
ihlr-16498	26	55	1	1	NUM
ihlr-16498	26	56	jerome	jerome	PROPN
ihlr-16498	26	57	groopman	groopman	NOUN
ihlr-16498	26	58	,	,	PUNCT
ihlr-16498	26	59	the	the	DET
ihlr-16498	26	60	pediatric	pediatric	ADJ
ihlr-16498	26	61	gap	gap	NOUN
ihlr-16498	26	62	:	:	PUNCT
ihlr-16498	26	63	why	why	SCONJ
ihlr-16498	26	64	have	have	AUX
ihlr-16498	26	65	most	most	ADJ
ihlr-16498	26	66	medications	medication	NOUN
ihlr-16498	26	67	never	never	ADV
ihlr-16498	26	68	been	be	AUX
ihlr-16498	26	69	properly	properly	ADV
ihlr-16498	26	70	tested	test	VERB
ihlr-16498	26	71	on	on	ADP
ihlr-16498	26	72	kids	kid	NOUN
ihlr-16498	26	73	?	?	PUNCT
ihlr-16498	26	74	,	,	PUNCT
ihlr-16498	26	75	the	the	DET
ihlr-16498	26	76	new	new	ADJ
ihlr-16498	26	77	yorker	yorker	PROPN
ihlr-16498	26	78	,	,	PUNCT
ihlr-16498	26	79	jan	jan	PROPN
ihlr-16498	26	80	.	.	PROPN
ihlr-16498	26	81	10	10	NUM
ihlr-16498	26	82	,	,	PUNCT
ihlr-16498	26	83	2005	2005	NUM
ihlr-16498	26	84	,	,	PUNCT
ihlr-16498	26	85	at	at	ADP
ihlr-16498	26	86	32	32	NUM
ihlr-16498	26	87	,	,	PUNCT
ihlr-16498	26	88	32	32	NUM
ihlr-16498	26	89	-	-	SYM
ihlr-16498	26	90	35	35	NUM
ihlr-16498	26	91	(	(	PUNCT
ihlr-16498	26	92	describing	describe	VERB
ihlr-16498	26	93	the	the	DET
ihlr-16498	26	94	myriad	myriad	NOUN
ihlr-16498	26	95	of	of	ADP
ihlr-16498	26	96	problems	problem	NOUN
ihlr-16498	26	97	associated	associate	VERB
ihlr-16498	26	98	with	with	ADP
ihlr-16498	26	99	administering	administer	VERB
ihlr-16498	26	100	drugs	drug	NOUN
ihlr-16498	26	101	to	to	ADP
ihlr-16498	26	102	pediatric	pediatric	ADJ
ihlr-16498	26	103	patients	patient	NOUN
ihlr-16498	26	104	)	)	PUNCT
ihlr-16498	26	105	.	.	PUNCT
ihlr-16498	27	1	2	2	NUM
ihlr-16498	27	2	food	food	NOUN
ihlr-16498	27	3	and	and	CCONJ
ihlr-16498	27	4	drug	drug	PROPN
ihlr-16498	27	5	administration	administration	PROPN
ihlr-16498	27	6	modernization	modernization	PROPN
ihlr-16498	27	7	act	act	NOUN
ihlr-16498	27	8	of	of	ADP
ihlr-16498	27	9	1997	1997	NUM
ihlr-16498	27	10	,	,	PUNCT
ihlr-16498	27	11	pub	pub	NOUN
ihlr-16498	27	12	.	.	PUNCT
ihlr-16498	28	1	l.	l.	PROPN
ihlr-16498	28	2	no	no	INTJ
ihlr-16498	28	3	.	.	PROPN
ihlr-16498	29	1	105	105	NUM
ihlr-16498	29	2	-	-	SYM
ihlr-16498	29	3	115	115	NUM
ihlr-16498	29	4	,	,	PUNCT
ihlr-16498	29	5	§	§	PROPN
ihlr-16498	29	6	111	111	NUM
ihlr-16498	29	7	,	,	PUNCT
ihlr-16498	29	8	111	111	NUM
ihlr-16498	29	9	stat	stat	NOUN
ihlr-16498	29	10	.	.	PUNCT
ihlr-16498	30	1	2296,2305	2296,2305	NUM
ihlr-16498	30	2	-	-	SYM
ihlr-16498	30	3	09	09	NUM
ihlr-16498	30	4	(	(	PUNCT
ihlr-16498	30	5	1997	1997	NUM
ihlr-16498	30	6	)	)	PUNCT
ihlr-16498	31	1	(	(	PUNCT
ihlr-16498	31	2	codified	codify	VERB
ihlr-16498	31	3	as	as	SCONJ
ihlr-16498	31	4	amended	amend	VERB
ihlr-16498	31	5	at	at	ADP
ihlr-16498	31	6	21	21	NUM
ihlr-16498	31	7	u.s.c	u.s.c	ADJ
ihlr-16498	31	8	.	.	PUNCT
ihlr-16498	32	1	§	§	PROPN
ihlr-16498	32	2	355a	355a	PROPN
ihlr-16498	32	3	)	)	PUNCT
ihlr-16498	32	4	,	,	PUNCT
ihlr-16498	32	5	amended	amend	VERB
ihlr-16498	32	6	by	by	ADP
ihlr-16498	32	7	best	good	ADJ
ihlr-16498	32	8	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	32	9	for	for	ADP
ihlr-16498	32	10	children	child	NOUN
ihlr-16498	32	11	act	act	NOUN
ihlr-16498	32	12	,	,	PUNCT
ihlr-16498	32	13	pub	pub	NOUN
ihlr-16498	32	14	.	.	PUNCT
ihlr-16498	33	1	l.	l.	PROPN
ihlr-16498	33	2	no	no	INTJ
ihlr-16498	33	3	.	.	PUNCT
ihlr-16498	34	1	107	107	NUM
ihlr-16498	34	2	-	-	SYM
ihlr-16498	34	3	109	109	NUM
ihlr-16498	34	4	,	,	PUNCT
ihlr-16498	34	5	115	115	NUM
ihlr-16498	34	6	stat	stat	NOUN
ihlr-16498	34	7	.	.	PUNCT
ihlr-16498	35	1	1408	1408	NUM
ihlr-16498	35	2	(	(	PUNCT
ihlr-16498	35	3	2002	2002	NUM
ihlr-16498	35	4	)	)	PUNCT
ihlr-16498	35	5	(	(	PUNCT
ihlr-16498	35	6	codified	codify	VERB
ihlr-16498	35	7	in	in	ADP
ihlr-16498	35	8	scattered	scatter	VERB
ihlr-16498	35	9	sections	section	NOUN
ihlr-16498	35	10	of21	of21	PROPN
ihlr-16498	35	11	u.s.c	u.s.c	NOUN
ihlr-16498	35	12	.	.	PUNCT
ihlr-16498	36	1	and	and	CCONJ
ihlr-16498	36	2	42	42	NUM
ihlr-16498	36	3	u.s.c	u.s.c	ADJ
ihlr-16498	36	4	.	.	PUNCT
ihlr-16498	36	5	)	)	PUNCT
ihlr-16498	36	6	.	.	PUNCT
ihlr-16498	37	1	3	3	NUM
ihlr-16498	37	2	21	21	NUM
ihlr-16498	37	3	u.s.c	u.s.c	NOUN
ihlr-16498	37	4	.	.	PUNCT
ihlr-16498	38	1	§	§	PROPN
ihlr-16498	38	2	355a(b	355a(b	PROPN
ihlr-16498	38	3	)	)	PUNCT
ihlr-16498	38	4	(	(	PUNCT
ihlr-16498	38	5	2000	2000	NUM
ihlr-16498	38	6	&	&	CCONJ
ihlr-16498	38	7	supp	supp	PROPN
ihlr-16498	38	8	.	.	PUNCT
ihlr-16498	39	1	iv	iv	NUM
ihlr-16498	39	2	2004	2004	NUM
ihlr-16498	39	3	)	)	PUNCT
ihlr-16498	39	4	.	.	PUNCT
ihlr-16498	40	1	4	4	NUM
ihlr-16498	40	2	best	good	ADJ
ihlr-16498	40	3	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	40	4	for	for	ADP
ihlr-16498	40	5	children	child	NOUN
ihlr-16498	40	6	act	act	NOUN
ihlr-16498	40	7	,	,	PUNCT
ihlr-16498	40	8	pub	pub	NOUN
ihlr-16498	40	9	.	.	PUNCT
ihlr-16498	41	1	l.	l.	PROPN
ihlr-16498	41	2	no	no	INTJ
ihlr-16498	41	3	.	.	PUNCT
ihlr-16498	42	1	107	107	NUM
ihlr-16498	42	2	-	-	SYM
ihlr-16498	42	3	109,115	109,115	NUM
ihlr-16498	42	4	stat	stat	NOUN
ihlr-16498	42	5	.	.	PUNCT
ihlr-16498	43	1	1408	1408	NUM
ihlr-16498	43	2	(	(	PUNCT
ihlr-16498	43	3	2002	2002	NUM
ihlr-16498	43	4	)	)	PUNCT
ihlr-16498	43	5	(	(	PUNCT
ihlr-16498	43	6	codified	codify	VERB
ihlr-16498	43	7	in	in	ADP
ihlr-16498	43	8	scattered	scatter	VERB
ihlr-16498	43	9	sections	section	NOUN
ihlr-16498	43	10	of21	of21	PROPN
ihlr-16498	43	11	u.s.c	u.s.c	ADJ
ihlr-16498	43	12	.	.	PUNCT
ihlr-16498	44	1	and42	and42	ADJ
ihlr-16498	44	2	u.s.c	u.s.c	ADJ
ihlr-16498	44	3	.	.	PUNCT
ihlr-16498	44	4	)	)	PUNCT
ihlr-16498	44	5	.	.	PUNCT
ihlr-16498	45	1	2007	2007	NUM
ihlr-16498	45	2	]	]	PUNCT
ihlr-16498	45	3	reforming	reform	VERB
ihlr-16498	45	4	fda	fda	PROPN
ihlr-16498	45	5	poucy	poucy	PROPN
ihlr-16498	45	6	for	for	ADP
ihlr-16498	45	7	pediatric	pediatric	ADJ
ihlr-16498	45	8	testing	testing	NOUN
ihlr-16498	45	9	63	63	NUM
ihlr-16498	45	10	grants	grant	NOUN
ihlr-16498	45	11	the	the	DET
ihlr-16498	45	12	six	six	NUM
ihlr-16498	45	13	-	-	PUNCT
ihlr-16498	45	14	month	month	NOUN
ihlr-16498	45	15	patent	patent	NOUN
ihlr-16498	45	16	exclusivity	exclusivity	NOUN
ihlr-16498	45	17	extension	extension	NOUN
ihlr-16498	45	18	but	but	CCONJ
ihlr-16498	45	19	goes	go	VERB
ihlr-16498	45	20	one	one	NUM
ihlr-16498	45	21	step	step	NOUN
ihlr-16498	45	22	further	far	ADV
ihlr-16498	45	23	.	.	PUNCT
ihlr-16498	46	1	5	5	NUM
ihlr-16498	46	2	if	if	SCONJ
ihlr-16498	46	3	the	the	DET
ihlr-16498	46	4	fda	fda	PROPN
ihlr-16498	46	5	determines	determine	VERB
ihlr-16498	46	6	more	more	ADJ
ihlr-16498	46	7	information	information	NOUN
ihlr-16498	46	8	is	be	AUX
ihlr-16498	46	9	needed	need	VERB
ihlr-16498	46	10	about	about	ADP
ihlr-16498	46	11	a	a	DET
ihlr-16498	46	12	particular	particular	ADJ
ihlr-16498	46	13	drug	drug	NOUN
ihlr-16498	46	14	,	,	PUNCT
ihlr-16498	46	15	it	it	PRON
ihlr-16498	46	16	can	can	AUX
ihlr-16498	46	17	refer	refer	VERB
ihlr-16498	46	18	the	the	DET
ihlr-16498	46	19	drug	drug	NOUN
ihlr-16498	46	20	to	to	ADP
ihlr-16498	46	21	the	the	DET
ihlr-16498	46	22	national	national	PROPN
ihlr-16498	46	23	institutes	institutes	PROPN
ihlr-16498	46	24	of	of	ADP
ihlr-16498	46	25	health	health	PROPN
ihlr-16498	46	26	(	(	PUNCT
ihlr-16498	46	27	''	''	PUNCT
ihlr-16498	46	28	nlll	nlll	ADJ
ihlr-16498	46	29	''	''	PUNCT
ihlr-16498	46	30	)	)	PUNCT
ihlr-16498	46	31	and	and	CCONJ
ihlr-16498	46	32	authorize	authorize	VERB
ihlr-16498	46	33	the	the	DET
ihlr-16498	46	34	nih	nih	PROPN
ihlr-16498	46	35	to	to	PART
ihlr-16498	46	36	collect	collect	VERB
ihlr-16498	46	37	funds	fund	NOUN
ihlr-16498	46	38	and	and	CCONJ
ihlr-16498	46	39	award	award	NOUN
ihlr-16498	46	40	research	research	NOUN
ihlr-16498	46	41	grants	grant	NOUN
ihlr-16498	46	42	to	to	ADP
ihlr-16498	46	43	third	third	ADJ
ihlr-16498	46	44	parties	party	NOUN
ihlr-16498	46	45	to	to	PART
ihlr-16498	46	46	test	test	VERB
ihlr-16498	46	47	the	the	DET
ihlr-16498	46	48	drug.6	drug.6	NOUN
ihlr-16498	46	49	the	the	DET
ihlr-16498	46	50	bpca	bpca	PROPN
ihlr-16498	46	51	also	also	ADV
ihlr-16498	46	52	establishes	establish	VERB
ihlr-16498	46	53	a	a	DET
ihlr-16498	46	54	public	public	ADJ
ihlr-16498	46	55	fund	fund	NOUN
ihlr-16498	46	56	that	that	PRON
ihlr-16498	46	57	the	the	DET
ihlr-16498	46	58	fda	fda	PROPN
ihlr-16498	46	59	can	can	AUX
ihlr-16498	46	60	use	use	VERB
ihlr-16498	46	61	to	to	PART
ihlr-16498	46	62	pay	pay	VERB
ihlr-16498	46	63	a	a	DET
ihlr-16498	46	64	third	third	ADJ
ihlr-16498	46	65	party	party	NOUN
ihlr-16498	46	66	directly	directly	ADV
ihlr-16498	46	67	to	to	PART
ihlr-16498	46	68	conduct	conduct	VERB
ihlr-16498	46	69	the	the	DET
ihlr-16498	46	70	appropriate	appropriate	ADJ
ihlr-16498	46	71	tests	test	NOUN
ihlr-16498	46	72	.	.	PUNCT
ihlr-16498	47	1	7	7	NUM
ihlr-16498	47	2	the	the	DET
ihlr-16498	47	3	results	result	NOUN
ihlr-16498	47	4	of	of	ADP
ihlr-16498	47	5	these	these	DET
ihlr-16498	47	6	tests	test	NOUN
ihlr-16498	47	7	must	must	AUX
ihlr-16498	47	8	then	then	ADV
ihlr-16498	47	9	be	be	AUX
ihlr-16498	47	10	reported	report	VERB
ihlr-16498	47	11	back	back	ADV
ihlr-16498	47	12	to	to	ADP
ihlr-16498	47	13	the	the	DET
ihlr-16498	47	14	fda	fda	PROPN
ihlr-16498	47	15	.	.	PROPN
ihlr-16498	47	16	8	8	NUM
ihlr-16498	47	17	the	the	DET
ihlr-16498	47	18	bpca	bpca	PROPN
ihlr-16498	47	19	,	,	PUNCT
ihlr-16498	47	20	however	however	ADV
ihlr-16498	47	21	,	,	PUNCT
ihlr-16498	47	22	sunsets	sunset	NOUN
ihlr-16498	47	23	in	in	ADP
ihlr-16498	47	24	2007.9	2007.9	NUM
ihlr-16498	47	25	on	on	ADP
ihlr-16498	47	26	the	the	DET
ihlr-16498	47	27	heels	heel	NOUN
ihlr-16498	47	28	of	of	ADP
ihlr-16498	47	29	the	the	DET
ihlr-16498	47	30	fdama	fdama	NOUN
ihlr-16498	47	31	,	,	PUNCT
ihlr-16498	47	32	the	the	DET
ihlr-16498	47	33	fda	fda	PROPN
ihlr-16498	47	34	promulgated	promulgate	VERB
ihlr-16498	47	35	the	the	DET
ihlr-16498	47	36	1998	1998	NUM
ihlr-16498	47	37	"	"	PUNCT
ihlr-16498	47	38	pediatric	pediatric	ADJ
ihlr-16498	47	39	rule	rule	NOUN
ihlr-16498	47	40	,	,	PUNCT
ihlr-16498	47	41	"	"	PUNCT
ihlr-16498	47	42	which	which	PRON
ihlr-16498	47	43	allowed	allow	VERB
ihlr-16498	47	44	the	the	DET
ihlr-16498	47	45	fda	fda	PROPN
ihlr-16498	47	46	to	to	PART
ihlr-16498	47	47	require	require	VERB
ihlr-16498	47	48	pediatric	pediatric	ADJ
ihlr-16498	47	49	testing	testing	NOUN
ihlr-16498	47	50	on	on	ADP
ihlr-16498	47	51	already	already	ADV
ihlr-16498	47	52	marketed	market	VERB
ihlr-16498	47	53	drugs	drug	NOUN
ihlr-16498	47	54	and	and	CCONJ
ihlr-16498	47	55	require	require	VERB
ihlr-16498	47	56	pediatric	pediatric	ADJ
ihlr-16498	47	57	testing	testing	NOUN
ihlr-16498	47	58	and	and	CCONJ
ihlr-16498	47	59	labeling	labeling	NOUN
ihlr-16498	47	60	of	of	ADP
ihlr-16498	47	61	new	new	ADJ
ihlr-16498	47	62	drugs.10	drugs.10	PROPN
ihlr-16498	47	63	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	47	64	companies	company	NOUN
ihlr-16498	47	65	,	,	PUNCT
ihlr-16498	47	66	however	however	ADV
ihlr-16498	47	67	,	,	PUNCT
ihlr-16498	47	68	could	could	AUX
ihlr-16498	47	69	request	request	VERB
ihlr-16498	47	70	a	a	DET
ihlr-16498	47	71	full	full	ADJ
ihlr-16498	47	72	or	or	CCONJ
ihlr-16498	47	73	partial	partial	ADJ
ihlr-16498	47	74	waiver	waiver	NOUN
ihlr-16498	47	75	of	of	ADP
ihlr-16498	47	76	this	this	DET
ihlr-16498	47	77	requirement	requirement	NOUN
ihlr-16498	47	78	11	11	NUM
ihlr-16498	47	79	in	in	ADP
ihlr-16498	47	80	october	october	PROPN
ihlr-16498	47	81	2002	2002	NUM
ihlr-16498	47	82	,	,	PUNCT
ihlr-16498	47	83	a	a	DET
ihlr-16498	47	84	united	united	PROPN
ihlr-16498	47	85	states	states	PROPN
ihlr-16498	47	86	district	district	NOUN
ihlr-16498	47	87	court	court	NOUN
ihlr-16498	47	88	for	for	ADP
ihlr-16498	47	89	the	the	DET
ihlr-16498	47	90	district	district	PROPN
ihlr-16498	47	91	of	of	ADP
ihlr-16498	47	92	columbia	columbia	PROPN
ihlr-16498	47	93	struck	strike	VERB
ihlr-16498	47	94	down	down	ADP
ihlr-16498	47	95	the	the	DET
ihlr-16498	47	96	1998	1998	NUM
ihlr-16498	47	97	pediatric	pediatric	ADJ
ihlr-16498	47	98	rule	rule	NOUN
ihlr-16498	47	99	as	as	ADP
ihlr-16498	47	100	incompatible	incompatible	ADJ
ihlr-16498	47	101	with	with	ADP
ihlr-16498	47	102	the	the	DET
ihlr-16498	47	103	bpca	bpca	PROPN
ihlr-16498	47	104	and	and	CCONJ
ihlr-16498	47	105	ex­	ex­	NOUN
ihlr-16498	47	106	ceeding	ceede	VERB
ihlr-16498	47	107	the	the	DET
ihlr-16498	47	108	authority	authority	NOUN
ihlr-16498	47	109	of	of	ADP
ihlr-16498	47	110	the	the	DET
ihlr-16498	47	111	fda	fda	PROPN
ihlr-16498	47	112	under	under	ADP
ihlr-16498	47	113	the	the	DET
ihlr-16498	47	114	food	food	NOUN
ihlr-16498	47	115	drug	drug	NOUN
ihlr-16498	47	116	and	and	CCONJ
ihlr-16498	47	117	cosmetic	cosmetic	ADJ
ihlr-16498	47	118	act	act	NOUN
ihlr-16498	47	119	(	(	PUNCT
ihlr-16498	47	120	"	"	PUNCT
ihlr-16498	47	121	fdca'').12	fdca'').12	NOUN
ihlr-16498	47	122	shortly	shortly	ADV
ihlr-16498	47	123	after	after	ADP
ihlr-16498	47	124	the	the	DET
ihlr-16498	47	125	court	court	NOUN
ihlr-16498	47	126	's	's	PART
ihlr-16498	47	127	decision	decision	NOUN
ihlr-16498	47	128	,	,	PUNCT
ihlr-16498	47	129	congress	congress	PROPN
ihlr-16498	47	130	passed	pass	VERB
ihlr-16498	47	131	the	the	DET
ihlr-16498	47	132	pediatric	pediatric	ADJ
ihlr-16498	47	133	research	research	PROPN
ihlr-16498	47	134	equity	equity	PROPN
ihlr-16498	47	135	act	act	PROPN
ihlr-16498	47	136	of2003	of2003	PROPN
ihlr-16498	47	137	(	(	PUNCT
ihlr-16498	47	138	"	"	PUNCT
ihlr-16498	47	139	prea").13	prea").13	PROPN
ihlr-16498	47	140	the	the	DET
ihlr-16498	47	141	prea	prea	PROPN
ihlr-16498	47	142	codified	codify	VERB
ihlr-16498	47	143	the	the	DET
ihlr-16498	47	144	"	"	PUNCT
ihlr-16498	47	145	pediatric	pediatric	ADJ
ihlr-16498	47	146	rule	rule	NOUN
ihlr-16498	47	147	,	,	PUNCT
ihlr-16498	47	148	"	"	PUNCT
ihlr-16498	47	149	and	and	CCONJ
ihlr-16498	47	150	it	it	PRON
ihlr-16498	47	151	will	will	AUX
ihlr-16498	47	152	sunset	sunset	VERB
ihlr-16498	47	153	in	in	ADP
ihlr-16498	47	154	2007.14	2007.14	NUM
ihlr-16498	47	155	the	the	DET
ihlr-16498	47	156	importance	importance	NOUN
ihlr-16498	47	157	of	of	ADP
ihlr-16498	47	158	regulated	regulated	ADJ
ihlr-16498	47	159	pediatric	pediatric	ADJ
ihlr-16498	47	160	clinical	clinical	ADJ
ihlr-16498	47	161	trials	trial	NOUN
ihlr-16498	47	162	is	be	AUX
ihlr-16498	47	163	underscored	underscore	VERB
ihlr-16498	47	164	by	by	ADP
ihlr-16498	47	165	medical	medical	ADJ
ihlr-16498	47	166	discoveries	discovery	NOUN
ihlr-16498	47	167	that	that	PRON
ihlr-16498	47	168	adults	adult	NOUN
ihlr-16498	47	169	and	and	CCONJ
ihlr-16498	47	170	children	child	NOUN
ihlr-16498	47	171	react	react	VERB
ihlr-16498	47	172	differently	differently	ADV
ihlr-16498	47	173	to	to	ADP
ihlr-16498	47	174	certain	certain	ADJ
ihlr-16498	47	175	medica­	medica­	NOUN
ihlr-16498	47	176	tions	tion	NOUN
ihlr-16498	47	177	.	.	PUNCT
ihlr-16498	48	1	one	one	NUM
ihlr-16498	48	2	malady	malady	NOUN
ihlr-16498	48	3	present	present	ADJ
ihlr-16498	48	4	in	in	ADP
ihlr-16498	48	5	both	both	CCONJ
ihlr-16498	48	6	the	the	DET
ihlr-16498	48	7	pediatric	pediatric	ADJ
ihlr-16498	48	8	and	and	CCONJ
ihlr-16498	48	9	adult	adult	NOUN
ihlr-16498	48	10	population	population	NOUN
ihlr-16498	48	11	is	be	AUX
ihlr-16498	48	12	depres­	depres­	PROPN
ihlr-16498	48	13	sion	sion	NOUN
ihlr-16498	48	14	.	.	PUNCT
ihlr-16498	49	1	although	although	SCONJ
ihlr-16498	49	2	exact	exact	ADJ
ihlr-16498	49	3	biological	biological	ADJ
ihlr-16498	49	4	differences	difference	NOUN
ihlr-16498	49	5	between	between	ADP
ihlr-16498	49	6	adult	adult	NOUN
ihlr-16498	49	7	and	and	CCONJ
ihlr-16498	49	8	pediatric	pediatric	ADJ
ihlr-16498	49	9	depression	depression	NOUN
ihlr-16498	49	10	are	be	AUX
ihlr-16498	49	11	unclear	unclear	ADJ
ihlr-16498	49	12	,	,	PUNCT
ihlr-16498	49	13	some	some	DET
ihlr-16498	49	14	experts	expert	NOUN
ihlr-16498	49	15	believe	believe	VERB
ihlr-16498	49	16	they	they	PRON
ihlr-16498	49	17	are	be	AUX
ihlr-16498	49	18	not	not	PART
ihlr-16498	49	19	identical	identical	ADJ
ihlr-16498	49	20	and	and	CCONJ
ihlr-16498	49	21	therefore	therefore	ADV
ihlr-16498	49	22	antidepressant	antidepressant	ADJ
ihlr-16498	49	23	medications	medication	NOUN
ihlr-16498	49	24	may	may	AUX
ihlr-16498	49	25	work	work	VERB
ihlr-16498	49	26	differently	differently	ADV
ihlr-16498	49	27	in	in	ADP
ihlr-16498	49	28	a	a	DET
ihlr-16498	49	29	developing	develop	VERB
ihlr-16498	49	30	brain.15	brain.15	NOUN
ihlr-16498	49	31	for	for	ADP
ihlr-16498	49	32	example	example	NOUN
ihlr-16498	49	33	,	,	PUNCT
ihlr-16498	49	34	in	in	ADP
ihlr-16498	49	35	2003	2003	NUM
ihlr-16498	49	36	,	,	PUNCT
ihlr-16498	49	37	the	the	DET
ihlr-16498	49	38	british	british	ADJ
ihlr-16498	49	39	government	government	NOUN
ihlr-16498	49	40	concluded	conclude	VERB
ihlr-16498	49	41	that	that	SCONJ
ihlr-16498	49	42	seroxat	seroxat	NOUN
ihlr-16498	49	43	(	(	PUNCT
ihlr-16498	49	44	known	know	VERB
ihlr-16498	49	45	as	as	ADP
ihlr-16498	49	46	s	s	NOUN
ihlr-16498	49	47	21	21	NUM
ihlr-16498	49	48	u.s.c	u.s.c	ADJ
ihlr-16498	49	49	.	.	PUNCT
ihlr-16498	50	1	§	§	PROPN
ihlr-16498	50	2	355a(b	355a(b	PROPN
ihlr-16498	50	3	)	)	PUNCT
ihlr-16498	50	4	(	(	PUNCT
ihlr-16498	50	5	supp	supp	PROPN
ihlr-16498	50	6	.	.	PUNCT
ihlr-16498	51	1	iv	iv	NUM
ihlr-16498	51	2	2004	2004	NUM
ihlr-16498	51	3	)	)	PUNCT
ihlr-16498	51	4	.	.	PUNCT
ihlr-16498	52	1	6	6	NUM
ihlr-16498	52	2	42	42	NUM
ihlr-16498	52	3	u.s.c	u.s.c	ADJ
ihlr-16498	52	4	.	.	PUNCT
ihlr-16498	53	1	§	§	PROPN
ihlr-16498	53	2	284	284	NUM
ihlr-16498	53	3	m	m	VERB
ihlr-16498	53	4	(	(	PUNCT
ihlr-16498	53	5	a	a	NOUN
ihlr-16498	53	6	)	)	PUNCT
ihlr-16498	53	7	-(b	-(b	PUNCT
ihlr-16498	53	8	)	)	PUNCT
ihlr-16498	53	9	(	(	PUNCT
ihlr-16498	53	10	supp	supp	PROPN
ihlr-16498	53	11	.	.	PUNCT
ihlr-16498	54	1	m	m	PROPN
ihlr-16498	54	2	2003	2003	NUM
ihlr-16498	54	3	)	)	PUNCT
ihlr-16498	54	4	.	.	PUNCT
ihlr-16498	55	1	7	7	NUM
ihlr-16498	55	2	i	i	PROPN
ihlr-16498	55	3	d	d	PROPN
ihlr-16498	55	4	§	§	PROPN
ihlr-16498	55	5	§	§	PROPN
ihlr-16498	55	6	284m(cxl	284m(cxl	NUM
ihlr-16498	55	7	)	)	PUNCT
ihlr-16498	55	8	,	,	PUNCT
ihlr-16498	55	9	{	{	PUNCT
ihlr-16498	55	10	d	d	NOUN
ihlr-16498	55	11	)	)	PUNCT
ihlr-16498	55	12	.	.	PUNCT
ihlr-16498	56	1	8	8	NUM
ihlr-16498	56	2	i	i	NOUN
ihlr-16498	56	3	d	d	PROPN
ihlr-16498	56	4	§	§	PROPN
ihlr-16498	56	5	284m(cx6xa	284m(cx6xa	PROPN
ihlr-16498	56	6	)	)	PUNCT
ihlr-16498	56	7	.	.	PUNCT
ihlr-16498	57	1	9	9	NUM
ihlr-16498	57	2	21	21	NUM
ihlr-16498	57	3	u.s	u.s	PROPN
ihlr-16498	57	4	.	.	PROPN
ihlr-16498	57	5	c.	c.	PROPN
ihlr-16498	57	6	§	§	PROPN
ihlr-16498	57	7	355a(n	355a(n	PROPN
ihlr-16498	57	8	)	)	PUNCT
ihlr-16498	57	9	(	(	PUNCT
ihlr-16498	57	10	supp	supp	PROPN
ihlr-16498	57	11	.	.	PUNCT
ihlr-16498	58	1	iv	iv	NUM
ihlr-16498	58	2	2004	2004	NUM
ihlr-16498	58	3	)	)	PUNCT
ihlr-16498	58	4	(	(	PUNCT
ihlr-16498	58	5	sunset	sunset	NOUN
ihlr-16498	58	6	date	date	NOUN
ihlr-16498	58	7	is	be	AUX
ihlr-16498	58	8	oct	oct	PROPN
ihlr-16498	58	9	.	.	PROPN
ihlr-16498	58	10	1	1	NUM
ihlr-16498	58	11	,	,	PUNCT
ihlr-16498	58	12	2007	2007	NUM
ihlr-16498	58	13	)	)	PUNCT
ihlr-16498	58	14	.	.	PUNCT
ihlr-16498	59	1	10	10	NUM
ihlr-16498	59	2	regulations	regulation	NOUN
ihlr-16498	59	3	requiring	require	VERB
ihlr-16498	59	4	manufacturers	manufacturer	NOUN
ihlr-16498	59	5	to	to	PART
ihlr-16498	59	6	assess	assess	VERB
ihlr-16498	59	7	the	the	DET
ihlr-16498	59	8	safety	safety	NOUN
ihlr-16498	59	9	and	and	CCONJ
ihlr-16498	59	10	effectiveness	effectiveness	NOUN
ihlr-16498	59	11	ofnew	ofnew	ADJ
ihlr-16498	59	12	drugs	drug	NOUN
ihlr-16498	59	13	and	and	CCONJ
ihlr-16498	59	14	biological	biological	ADJ
ihlr-16498	59	15	products	product	NOUN
ihlr-16498	59	16	in	in	ADP
ihlr-16498	59	17	pediatric	pediatric	ADJ
ihlr-16498	59	18	patients	patient	NOUN
ihlr-16498	59	19	,	,	PUNCT
ihlr-16498	59	20	63	63	NUM
ihlr-16498	59	21	fed	feed	VERB
ihlr-16498	59	22	.	.	PUNCT
ihlr-16498	60	1	reg	reg	PROPN
ihlr-16498	60	2	.	.	PROPN
ihlr-16498	60	3	66,632	66,632	NUM
ihlr-16498	60	4	,	,	PUNCT
ihlr-16498	60	5	66,639	66,639	NUM
ihlr-16498	60	6	(	(	PUNCT
ihlr-16498	60	7	dec	dec	PROPN
ihlr-16498	60	8	.	.	PROPN
ihlr-16498	60	9	2	2	NUM
ihlr-16498	60	10	,	,	PUNCT
ihlr-16498	60	11	1998	1998	NUM
ihlr-16498	60	12	)	)	PUNCT
ihlr-16498	61	1	(	(	PUNCT
ihlr-16498	61	2	to	to	PART
ihlr-16498	61	3	be	be	AUX
ihlr-16498	61	4	codified	codify	VERB
ihlr-16498	61	5	at21	at21	PROPN
ihlr-16498	61	6	c.f.r	c.f.r	NOUN
ihlr-16498	61	7	pts	pt	NOUN
ihlr-16498	61	8	.	.	PROPN
ihlr-16498	62	1	201,312,314	201,312,314	NUM
ihlr-16498	62	2	,	,	PUNCT
ihlr-16498	62	3	and	and	CCONJ
ihlr-16498	62	4	601	601	NUM
ihlr-16498	62	5	)	)	PUNCT
ihlr-16498	62	6	.	.	PUNCT
ihlr-16498	63	1	11	11	NUM
ihlr-16498	63	2	21	21	NUM
ihlr-16498	63	3	c.f.r	c.f.r	NOUN
ihlr-16498	63	4	.	.	PUNCT
ihlr-16498	64	1	§	§	PROPN
ihlr-16498	64	2	§	§	PROPN
ihlr-16498	64	3	314.55(cx1)-(4	314.55(cx1)-(4	PROPN
ihlr-16498	64	4	)	)	PUNCT
ihlr-16498	64	5	,	,	PUNCT
ihlr-16498	64	6	601.27{cx1)-(4)(2006	601.27{cx1)-(4)(2006	NUM
ihlr-16498	64	7	)	)	PUNCT
ihlr-16498	64	8	.	.	PUNCT
ihlr-16498	65	1	see	see	VERB
ihlr-16498	65	2	also	also	ADV
ihlr-16498	65	3	ass'n	ass'n	PROPN
ihlr-16498	65	4	of	of	ADP
ihlr-16498	65	5	am	am	NOUN
ihlr-16498	65	6	.	.	PUNCT
ihlr-16498	65	7	,	,	PUNCT
ihlr-16498	65	8	phy­	phy­	PROPN
ihlr-16498	65	9	sicians	sician	NOUN
ihlr-16498	65	10	&	&	CCONJ
ihlr-16498	65	11	surgeons	surgeons	PROPN
ihlr-16498	65	12	,	,	PUNCT
ihlr-16498	65	13	inc	inc	PROPN
ihlr-16498	65	14	.	.	PROPN
ihlr-16498	66	1	v.	v.	PROPN
ihlr-16498	66	2	fda	fda	PROPN
ihlr-16498	66	3	,	,	PUNCT
ihlr-16498	66	4	226	226	NUM
ihlr-16498	66	5	f.	f.	PROPN
ihlr-16498	66	6	supp	supp	PROPN
ihlr-16498	66	7	.	.	PUNCT
ihlr-16498	67	1	2d	2d	PROPN
ihlr-16498	67	2	204	204	NUM
ihlr-16498	67	3	,	,	PUNCT
ihlr-16498	67	4	208	208	NUM
ihlr-16498	67	5	(	(	PUNCT
ihlr-16498	67	6	d.d.c	d.d.c	PROPN
ihlr-16498	67	7	.	.	PROPN
ihlr-16498	67	8	2002	2002	NUM
ihlr-16498	67	9	)	)	PUNCT
ihlr-16498	67	10	.	.	PUNCT
ihlr-16498	68	1	12	12	NUM
ihlr-16498	68	2	ass	ass	NOUN
ihlr-16498	68	3	'	'	CCONJ
ihlr-16498	68	4	n	n	NUM
ihlr-16498	68	5	of	of	ADP
ihlr-16498	68	6	am	am	PROPN
ihlr-16498	68	7	.	.	PUNCT
ihlr-16498	68	8	,	,	PUNCT
ihlr-16498	68	9	physicians	physician	NOUN
ihlr-16498	68	10	&	&	CCONJ
ihlr-16498	68	11	surgeons	surgeons	PROPN
ihlr-16498	68	12	,	,	PUNCT
ihlr-16498	68	13	inc	inc	PROPN
ihlr-16498	68	14	.	.	PROPN
ihlr-16498	68	15	,	,	PUNCT
ihlr-16498	68	16	226	226	NUM
ihlr-16498	68	17	f.	f.	PROPN
ihlr-16498	68	18	supp	supp	PROPN
ihlr-16498	68	19	.	.	PUNCT
ihlr-16498	69	1	2d	2d	NOUN
ihlr-16498	69	2	at	at	ADP
ihlr-16498	69	3	220	220	NUM
ihlr-16498	69	4	-	-	SYM
ihlr-16498	69	5	21	21	NUM
ihlr-16498	69	6	(	(	PUNCT
ihlr-16498	69	7	describing	describe	VERB
ihlr-16498	69	8	that	that	SCONJ
ihlr-16498	69	9	the	the	DET
ihlr-16498	69	10	"	"	PUNCT
ihlr-16498	69	11	pediatric	pediatric	ADJ
ihlr-16498	69	12	rule	rule	NOUN
ihlr-16498	69	13	"	"	PUNCT
ihlr-16498	69	14	was	be	AUX
ihlr-16498	69	15	neither	neither	CCONJ
ihlr-16498	69	16	accepted	accept	VERB
ihlr-16498	69	17	nor	nor	CCONJ
ihlr-16498	69	18	rejected	reject	VERB
ihlr-16498	69	19	by	by	ADP
ihlr-16498	69	20	congress	congress	PROPN
ihlr-16498	69	21	when	when	SCONJ
ihlr-16498	69	22	adopting	adopt	VERB
ihlr-16498	69	23	the	the	DET
ihlr-16498	69	24	bpca	bpca	NOUN
ihlr-16498	69	25	and	and	CCONJ
ihlr-16498	69	26	that	that	SCONJ
ihlr-16498	69	27	the	the	DET
ihlr-16498	69	28	"	"	PUNCT
ihlr-16498	69	29	pediatric	pediatric	ADJ
ihlr-16498	69	30	rule	rule	NOUN
ihlr-16498	69	31	"	"	PUNCT
ihlr-16498	69	32	exceeds	exceed	VERB
ihlr-16498	69	33	the	the	DET
ihlr-16498	69	34	fda	fda	PROPN
ihlr-16498	69	35	's	's	PART
ihlr-16498	69	36	statutory	statutory	ADJ
ihlr-16498	69	37	authority	authority	NOUN
ihlr-16498	69	38	)	)	PUNCT
ihlr-16498	69	39	.	.	PUNCT
ihlr-16498	70	1	13	13	NUM
ihlr-16498	70	2	pediatric	pediatric	ADJ
ihlr-16498	70	3	research	research	NOUN
ihlr-16498	70	4	equity	equity	PROPN
ihlr-16498	70	5	act	act	PROPN
ihlr-16498	70	6	of2003	of2003	PROPN
ihlr-16498	70	7	,	,	PUNCT
ihlr-16498	70	8	pub	pub	NOUN
ihlr-16498	70	9	.	.	PUNCT
ihlr-16498	71	1	l.	l.	PROPN
ihlr-16498	71	2	no	no	INTJ
ihlr-16498	71	3	.	.	PROPN
ihlr-16498	72	1	108	108	NUM
ihlr-16498	72	2	-	-	SYM
ihlr-16498	72	3	155	155	NUM
ihlr-16498	72	4	,	,	PUNCT
ihlr-16498	72	5	117	117	NUM
ihlr-16498	72	6	stat	stat	NOUN
ihlr-16498	72	7	1936	1936	NUM
ihlr-16498	72	8	(	(	PUNCT
ihlr-16498	72	9	codified	codify	VERB
ihlr-16498	72	10	as	as	SCONJ
ihlr-16498	72	11	amended	amend	VERB
ihlr-16498	72	12	at	at	ADP
ihlr-16498	72	13	21	21	NUM
ihlr-16498	72	14	u.s.c	u.s.c	ADJ
ihlr-16498	72	15	.	.	PUNCT
ihlr-16498	73	1	§	§	PROPN
ihlr-16498	73	2	355c	355c	PROPN
ihlr-16498	73	3	(	(	PUNCT
ihlr-16498	73	4	supp	supp	PROPN
ihlr-16498	73	5	.	.	PUNCT
ihlr-16498	74	1	iv	iv	NUM
ihlr-16498	74	2	2004	2004	NUM
ihlr-16498	74	3	)	)	PUNCT
ihlr-16498	74	4	)	)	PUNCT
ihlr-16498	74	5	.	.	PUNCT
ihlr-16498	75	1	14	14	NUM
ihlr-16498	75	2	/d	/d	PUNCT
ihlr-16498	75	3	.	.	PUNCT
ihlr-16498	76	1	;	;	PUNCT
ihlr-16498	76	2	groopman	groopman	NOUN
ihlr-16498	76	3	,	,	PUNCT
ihlr-16498	76	4	supra	supra	PROPN
ihlr-16498	76	5	note	note	NOUN
ihlr-16498	76	6	1	1	NUM
ihlr-16498	76	7	,	,	PUNCT
ihlr-16498	76	8	at	at	ADP
ihlr-16498	76	9	35	35	NUM
ihlr-16498	76	10	(	(	PUNCT
ihlr-16498	76	11	"	"	PUNCT
ihlr-16498	76	12	in	in	ADP
ihlr-16498	76	13	2003	2003	NUM
ihlr-16498	76	14	,	,	PUNCT
ihlr-16498	76	15	congress	congress	PROPN
ihlr-16498	76	16	passed	pass	VERB
ihlr-16498	76	17	legislation	legislation	NOUN
ihlr-16498	76	18	that	that	PRON
ihlr-16498	76	19	codi­	codi­	PROPN
ihlr-16498	76	20	fied	fie	VERB
ihlr-16498	76	21	what	what	PRON
ihlr-16498	76	22	is	be	AUX
ihlr-16498	76	23	known	know	VERB
ihlr-16498	76	24	as	as	ADP
ihlr-16498	76	25	the	the	DET
ihlr-16498	76	26	pediatric	pediatric	ADJ
ihlr-16498	76	27	rule	rule	NOUN
ihlr-16498	76	28	....	....	PUNCT
ihlr-16498	77	1	[	[	X
ihlr-16498	77	2	t]he	t]he	ADJ
ihlr-16498	77	3	reforms	reform	NOUN
ihlr-16498	77	4	include	include	VERB
ihlr-16498	77	5	a	a	DET
ihlr-16498	77	6	'	'	PUNCT
ihlr-16498	77	7	sunset	sunset	NOUN
ihlr-16498	77	8	clause	clause	NOUN
ihlr-16498	77	9	'	'	PUNCT
ihlr-16498	77	10	...	...	PUNCT
ihlr-16498	78	1	(	(	PUNCT
ihlr-16498	78	2	this	this	DET
ihlr-16498	78	3	clause	clause	NOUN
ihlr-16498	78	4	was	be	AUX
ihlr-16498	78	5	added	add	VERB
ihlr-16498	78	6	as	as	ADP
ihlr-16498	78	7	a	a	DET
ihlr-16498	78	8	result	result	NOUN
ihlr-16498	78	9	of	of	ADP
ihlr-16498	78	10	pressure	pressure	NOUN
ihlr-16498	78	11	from	from	ADP
ihlr-16498	78	12	drug	drug	NOUN
ihlr-16498	78	13	companies	company	NOUN
ihlr-16498	78	14	and	and	CCONJ
ihlr-16498	78	15	groups	group	NOUN
ihlr-16498	78	16	that	that	PRON
ihlr-16498	78	17	oppose	oppose	VERB
ihlr-16498	78	18	govern­	govern­	ADJ
ihlr-16498	78	19	ment	ment	ADJ
ihlr-16498	78	20	regulation	regulation	NOUN
ihlr-16498	78	21	.	.	PUNCT
ihlr-16498	78	22	)	)	PUNCT
ihlr-16498	79	1	"	"	PUNCT
ihlr-16498	79	2	)	)	PUNCT
ihlr-16498	79	3	.	.	PUNCT
ihlr-16498	80	1	15	15	NUM
ihlr-16498	80	2	groopman	groopman	NOUN
ihlr-16498	80	3	,	,	PUNCT
ihlr-16498	80	4	supra	supra	PROPN
ihlr-16498	80	5	note	note	NOUN
ihlr-16498	80	6	1	1	NUM
ihlr-16498	80	7	,	,	PUNCT
ihlr-16498	80	8	at	at	ADP
ihlr-16498	80	9	34	34	NUM
ihlr-16498	80	10	(	(	PUNCT
ihlr-16498	80	11	"	"	PUNCT
ihlr-16498	80	12	although	although	SCONJ
ihlr-16498	80	13	the	the	DET
ihlr-16498	80	14	precise	precise	ADJ
ihlr-16498	80	15	biological	biological	ADJ
ihlr-16498	80	16	differences	difference	NOUN
ihlr-16498	80	17	between	between	ADP
ihlr-16498	80	18	adult	adult	NOUN
ihlr-16498	80	19	depression	depression	NOUN
ihlr-16498	80	20	and	and	CCONJ
ihlr-16498	80	21	childhood	childhood	NOUN
ihlr-16498	80	22	depression	depression	NOUN
ihlr-16498	80	23	are	be	AUX
ihlr-16498	80	24	not	not	PART
ihlr-16498	80	25	yet	yet	ADV
ihlr-16498	80	26	known	know	VERB
ihlr-16498	80	27	,	,	PUNCT
ihlr-16498	80	28	there	there	PRON
ihlr-16498	80	29	is	be	VERB
ihlr-16498	80	30	reason	reason	NOUN
ihlr-16498	80	31	to	to	PART
ihlr-16498	80	32	believe	believe	VERB
ihlr-16498	80	33	that	that	SCONJ
ihlr-16498	80	34	the	the	DET
ihlr-16498	80	35	maladies	malady	NOUN
ihlr-16498	80	36	are	be	AUX
ihlr-16498	80	37	not	not	PART
ihlr-16498	80	38	identical	identical	ADJ
ihlr-16498	80	39	,	,	PUNCT
ihlr-16498	80	40	and	and	CCONJ
ihlr-16498	80	41	that	that	SCONJ
ihlr-16498	80	42	antidepressants	antidepressant	NOUN
ihlr-16498	80	43	may	may	AUX
ihlr-16498	80	44	work	work	VERB
ihlr-16498	80	45	differently	differently	ADV
ihlr-16498	80	46	on	on	ADP
ihlr-16498	80	47	a	a	DET
ihlr-16498	80	48	developing	develop	VERB
ihlr-16498	80	49	brain	brain	NOUN
ihlr-16498	80	50	.	.	PUNCT
ihlr-16498	81	1	"	"	PUNCT
ihlr-16498	81	2	)	)	PUNCT
ihlr-16498	81	3	.	.	PUNCT
ihlr-16498	82	1	64	64	NUM
ihlr-16498	82	2	indiana	indiana	PROPN
ihlr-16498	82	3	realm	realm	PROPN
ihlr-16498	82	4	law	law	PROPN
ihlr-16498	82	5	review	review	NOUN
ihlr-16498	82	6	[	[	X
ihlr-16498	82	7	vol	vol	NOUN
ihlr-16498	82	8	.	.	PUNCT
ihlr-16498	82	9	4:59	4:59	NUM
ihlr-16498	82	10	paxil	paxil	NOUN
ihlr-16498	82	11	in	in	ADP
ihlr-16498	82	12	the	the	DET
ihlr-16498	82	13	united	united	PROPN
ihlr-16498	82	14	states	states	PROPN
ihlr-16498	82	15	)	)	PUNCT
ihlr-16498	82	16	should	should	AUX
ihlr-16498	82	17	not	not	PART
ihlr-16498	82	18	be	be	AUX
ihlr-16498	82	19	prescribed	prescribe	VERB
ihlr-16498	82	20	to	to	ADP
ihlr-16498	82	21	children	child	NOUN
ihlr-16498	82	22	because	because	SCONJ
ihlr-16498	82	23	of	of	ADP
ihlr-16498	82	24	in­	in­	PRON
ihlr-16498	82	25	creased	creased	ADJ
ihlr-16498	82	26	suicidal	suicidal	ADJ
ihlr-16498	82	27	behavior	behavior	NOUN
ihlr-16498	82	28	and	and	CCONJ
ihlr-16498	82	29	withdrawal	withdrawal	PROPN
ihlr-16498	82	30	symptoms.16	symptoms.16	PROPN
ihlr-16498	82	31	the	the	DET
ihlr-16498	82	32	fda	fda	PROPN
ihlr-16498	82	33	followed	follow	VERB
ihlr-16498	82	34	suit	suit	NOUN
ihlr-16498	82	35	--but	--but	PUNCT
ihlr-16498	82	36	not	not	PART
ihlr-16498	82	37	until	until	ADP
ihlr-16498	82	38	ten	ten	NUM
ihlr-16498	82	39	months	month	NOUN
ihlr-16498	82	40	later.17	later.17	PROPN
ihlr-16498	82	41	eli	eli	PROPN
ihlr-16498	82	42	lilly	lilly	PROPN
ihlr-16498	82	43	recently	recently	ADV
ihlr-16498	82	44	received	receive	VERB
ihlr-16498	82	45	bad	bad	ADJ
ihlr-16498	82	46	press	press	NOUN
ihlr-16498	82	47	when	when	SCONJ
ihlr-16498	82	48	college	college	NOUN
ihlr-16498	82	49	student	student	PROPN
ihlr-16498	82	50	traci	traci	PROPN
ihlr-16498	82	51	johnson	johnson	PROPN
ihlr-16498	82	52	committed	commit	VERB
ihlr-16498	82	53	suicide	suicide	NOUN
ihlr-16498	82	54	after	after	ADP
ihlr-16498	82	55	moving	move	VERB
ihlr-16498	82	56	from	from	ADP
ihlr-16498	82	57	the	the	DET
ihlr-16498	82	58	antidepressant	antidepressant	ADJ
ihlr-16498	82	59	cymbalta	cymbalta	NOUN
ihlr-16498	82	60	to	to	ADP
ihlr-16498	82	61	a	a	DET
ihlr-16498	82	62	placebo	placebo	NOUN
ihlr-16498	82	63	during	during	ADP
ihlr-16498	82	64	a	a	DET
ihlr-16498	82	65	clinical	clinical	ADJ
ihlr-16498	82	66	trial	trial	NOUN
ihlr-16498	82	67	for	for	ADP
ihlr-16498	82	68	treatment	treatment	NOUN
ihlr-16498	82	69	of	of	ADP
ihlr-16498	82	70	depression	depression	NOUN
ihlr-16498	82	71	,	,	PUNCT
ihlr-16498	82	72	thus	thus	ADV
ihlr-16498	82	73	highlighting	highlight	VERB
ihlr-16498	82	74	the	the	DET
ihlr-16498	82	75	potential	potential	ADJ
ihlr-16498	82	76	problem	problem	NOUN
ihlr-16498	82	77	of	of	ADP
ihlr-16498	82	78	withdrawal	withdrawal	NOUN
ihlr-16498	82	79	from	from	ADP
ihlr-16498	82	80	a	a	DET
ihlr-16498	82	81	drug.18	drug.18	PROPN
ihlr-16498	82	82	although	although	SCONJ
ihlr-16498	82	83	the	the	DET
ihlr-16498	82	84	fda	fda	PROPN
ihlr-16498	82	85	cleared	clear	VERB
ihlr-16498	82	86	eli	eli	PROPN
ihlr-16498	82	87	lilly	lilly	PROPN
ihlr-16498	82	88	of	of	ADP
ihlr-16498	82	89	wrongdoing	wrongdoing	NOUN
ihlr-16498	82	90	,	,	PUNCT
ihlr-16498	82	91	19	19	NUM
ihlr-16498	82	92	this	this	DET
ihlr-16498	82	93	tragic	tragic	ADJ
ihlr-16498	82	94	episode	episode	NOUN
ihlr-16498	82	95	highlights	highlight	NOUN
ihlr-16498	82	96	some	some	DET
ihlr-16498	82	97	problems	problem	NOUN
ihlr-16498	82	98	associated	associate	VERB
ihlr-16498	82	99	with	with	ADP
ihlr-16498	82	100	pediatric	pediatric	ADJ
ihlr-16498	82	101	testing	testing	NOUN
ihlr-16498	82	102	.	.	PUNCT
ihlr-16498	83	1	indeed	indeed	ADV
ihlr-16498	83	2	,	,	PUNCT
ihlr-16498	83	3	at	at	ADP
ihlr-16498	83	4	about	about	ADV
ihlr-16498	83	5	the	the	DET
ihlr-16498	83	6	same	same	ADJ
ihlr-16498	83	7	time	time	NOUN
ihlr-16498	83	8	,	,	PUNCT
ihlr-16498	83	9	the	the	DET
ihlr-16498	83	10	fda	fda	PROPN
ihlr-16498	83	11	reported	report	VERB
ihlr-16498	83	12	the	the	DET
ihlr-16498	83	13	results	result	NOUN
ihlr-16498	83	14	of	of	ADP
ihlr-16498	83	15	a	a	DET
ihlr-16498	83	16	2004	2004	NUM
ihlr-16498	83	17	study	study	NOUN
ihlr-16498	83	18	indicating	indicate	VERB
ihlr-16498	83	19	that	that	SCONJ
ihlr-16498	83	20	twice	twice	ADV
ihlr-16498	83	21	as	as	ADV
ihlr-16498	83	22	many	many	ADJ
ihlr-16498	83	23	children	child	NOUN
ihlr-16498	83	24	taking	take	VERB
ihlr-16498	83	25	antidepressants	antidepressant	NOUN
ihlr-16498	83	26	had	have	VERB
ihlr-16498	83	27	suicidal	suicidal	ADJ
ihlr-16498	83	28	behavior	behavior	NOUN
ihlr-16498	83	29	compared	compare	VERB
ihlr-16498	83	30	to	to	ADP
ihlr-16498	83	31	children	child	NOUN
ihlr-16498	83	32	taking	take	VERB
ihlr-16498	83	33	placebos.20	placebos.20	NOUN
ihlr-16498	83	34	this	this	DET
ihlr-16498	83	35	study	study	NOUN
ihlr-16498	83	36	ex­	ex­	NOUN
ihlr-16498	83	37	emplifies	emplifie	VERB
ihlr-16498	83	38	the	the	DET
ihlr-16498	83	39	need	need	NOUN
ihlr-16498	83	40	for	for	ADP
ihlr-16498	83	41	heightened	heightened	ADJ
ihlr-16498	83	42	monitoring	monitoring	NOUN
ihlr-16498	83	43	of	of	ADP
ihlr-16498	83	44	children	child	NOUN
ihlr-16498	83	45	in	in	ADP
ihlr-16498	83	46	pediatric	pediatric	ADJ
ihlr-16498	83	47	studies­	studies­	NOUN
ihlr-16498	83	48	because	because	SCONJ
ihlr-16498	83	49	pediatric	pediatric	ADJ
ihlr-16498	83	50	populations	population	NOUN
ihlr-16498	83	51	may	may	AUX
ihlr-16498	83	52	react	react	VERB
ihlr-16498	83	53	differently	differently	ADV
ihlr-16498	83	54	than	than	ADP
ihlr-16498	83	55	adult	adult	NOUN
ihlr-16498	83	56	populations	population	NOUN
ihlr-16498	83	57	.	.	PUNCT
ihlr-16498	84	1	despite	despite	SCONJ
ihlr-16498	84	2	both	both	DET
ihlr-16498	84	3	fda	fda	PROPN
ihlr-16498	84	4	and	and	CCONJ
ihlr-16498	84	5	congressional	congressional	ADJ
ihlr-16498	84	6	attempts	attempt	NOUN
ihlr-16498	84	7	to	to	PART
ihlr-16498	84	8	address	address	VERB
ihlr-16498	84	9	the	the	DET
ihlr-16498	84	10	problems	problem	NOUN
ihlr-16498	84	11	of	of	ADP
ihlr-16498	84	12	prescription	prescription	NOUN
ihlr-16498	84	13	drug	drug	NOUN
ihlr-16498	84	14	use	use	NOUN
ihlr-16498	84	15	in	in	ADP
ihlr-16498	84	16	children	child	NOUN
ihlr-16498	84	17	,	,	PUNCT
ihlr-16498	84	18	several	several	ADJ
ihlr-16498	84	19	deficiencies	deficiency	NOUN
ihlr-16498	84	20	and	and	CCONJ
ihlr-16498	84	21	loopholes	loophole	NOUN
ihlr-16498	84	22	exist	exist	VERB
ihlr-16498	84	23	.	.	PUNCT
ihlr-16498	85	1	thus	thus	ADV
ihlr-16498	85	2	,	,	PUNCT
ihlr-16498	85	3	conducting	conduct	VERB
ihlr-16498	85	4	clinical	clinical	ADJ
ihlr-16498	85	5	trials	trial	NOUN
ihlr-16498	85	6	in	in	ADP
ihlr-16498	85	7	this	this	DET
ihlr-16498	85	8	vulnerable	vulnerable	ADJ
ihlr-16498	85	9	population	population	NOUN
ihlr-16498	85	10	must	must	AUX
ihlr-16498	85	11	be	be	AUX
ihlr-16498	85	12	highly	highly	ADV
ihlr-16498	85	13	regulated	regulate	VERB
ihlr-16498	85	14	.	.	PUNCT
ihlr-16498	86	1	part	part	NOUN
ihlr-16498	86	2	ii	ii	PROPN
ihlr-16498	86	3	briefly	briefly	NOUN
ihlr-16498	86	4	introduces	introduce	VERB
ihlr-16498	86	5	that	that	SCONJ
ihlr-16498	86	6	the	the	DET
ihlr-16498	86	7	historical	historical	ADJ
ihlr-16498	86	8	treatment	treatment	NOUN
ihlr-16498	86	9	of	of	ADP
ihlr-16498	86	10	children	child	NOUN
ihlr-16498	86	11	im­	im­	NOUN
ihlr-16498	86	12	pacts	pact	VERB
ihlr-16498	86	13	regulatory	regulatory	ADJ
ihlr-16498	86	14	reform	reform	NOUN
ihlr-16498	86	15	.	.	PUNCT
ihlr-16498	87	1	part	part	NOUN
ihlr-16498	87	2	m	m	PROPN
ihlr-16498	87	3	will	will	AUX
ihlr-16498	87	4	explain	explain	VERB
ihlr-16498	87	5	the	the	DET
ihlr-16498	87	6	evolution	evolution	NOUN
ihlr-16498	87	7	of	of	ADP
ihlr-16498	87	8	regulatory	regulatory	ADJ
ihlr-16498	87	9	and	and	CCONJ
ihlr-16498	87	10	legislative	legislative	ADJ
ihlr-16498	87	11	approaches	approach	NOUN
ihlr-16498	87	12	to	to	ADP
ihlr-16498	87	13	pediatric	pediatric	ADJ
ihlr-16498	87	14	drug	drug	NOUN
ihlr-16498	87	15	testing	testing	NOUN
ihlr-16498	87	16	,	,	PUNCT
ihlr-16498	87	17	highlighting	highlight	VERB
ihlr-16498	87	18	how	how	SCONJ
ihlr-16498	87	19	each	each	DET
ihlr-16498	87	20	new	new	ADJ
ihlr-16498	87	21	leg­	leg­	NOUN
ihlr-16498	87	22	islative	islative	PROPN
ihlr-16498	87	23	program	program	NOUN
ihlr-16498	87	24	contained	contain	VERB
ihlr-16498	87	25	special	special	ADJ
ihlr-16498	87	26	precautions	precaution	NOUN
ihlr-16498	87	27	to	to	PART
ihlr-16498	87	28	widen	widen	VERB
ihlr-16498	87	29	the	the	DET
ihlr-16498	87	30	number	number	NOUN
ihlr-16498	87	31	of	of	ADP
ihlr-16498	87	32	drugs	drug	NOUN
ihlr-16498	87	33	tested	test	VERB
ihlr-16498	87	34	in	in	ADP
ihlr-16498	87	35	children	child	NOUN
ihlr-16498	87	36	and	and	CCONJ
ihlr-16498	87	37	also	also	ADV
ihlr-16498	87	38	protected	protect	VERB
ihlr-16498	87	39	children	child	NOUN
ihlr-16498	87	40	as	as	ADP
ihlr-16498	87	41	participants	participant	NOUN
ihlr-16498	87	42	in	in	ADP
ihlr-16498	87	43	clinical	clinical	ADJ
ihlr-16498	87	44	trials	trial	NOUN
ihlr-16498	87	45	.	.	PUNCT
ihlr-16498	88	1	part	part	NOUN
ihlr-16498	88	2	n	n	CCONJ
ihlr-16498	88	3	,	,	PUNCT
ihlr-16498	88	4	however	however	ADV
ihlr-16498	88	5	,	,	PUNCT
ihlr-16498	88	6	demonstrates	demonstrate	VERB
ihlr-16498	88	7	how	how	SCONJ
ihlr-16498	88	8	these	these	DET
ihlr-16498	88	9	statutory	statutory	ADJ
ihlr-16498	88	10	and	and	CCONJ
ihlr-16498	88	11	regulatory	regulatory	ADJ
ihlr-16498	88	12	provisions	provision	NOUN
ihlr-16498	88	13	have	have	AUX
ihlr-16498	88	14	failed	fail	VERB
ihlr-16498	88	15	to	to	PART
ihlr-16498	88	16	address	address	VERB
ihlr-16498	88	17	the	the	DET
ihlr-16498	88	18	use	use	NOUN
ihlr-16498	88	19	of	of	ADP
ihlr-16498	88	20	antidepressant	antidepressant	ADJ
ihlr-16498	88	21	mediation	mediation	NOUN
ihlr-16498	88	22	in	in	ADP
ihlr-16498	88	23	pediatric	pediatric	ADJ
ihlr-16498	88	24	patients	patient	NOUN
ihlr-16498	88	25	.	.	PUNCT
ihlr-16498	89	1	in	in	ADP
ihlr-16498	89	2	response	response	NOUN
ihlr-16498	89	3	to	to	ADP
ihlr-16498	89	4	learning	learn	VERB
ihlr-16498	89	5	that	that	PRON
ihlr-16498	89	6	pediatric	pediatric	ADJ
ihlr-16498	89	7	populations	population	NOUN
ihlr-16498	89	8	may	may	AUX
ihlr-16498	89	9	be	be	AUX
ihlr-16498	89	10	at	at	ADP
ihlr-16498	89	11	risk	risk	NOUN
ihlr-16498	89	12	when	when	SCONJ
ihlr-16498	89	13	taking	take	VERB
ihlr-16498	89	14	antidepressant	antidepressant	ADJ
ihlr-16498	89	15	mediation	mediation	NOUN
ihlr-16498	89	16	,	,	PUNCT
ihlr-16498	89	17	congress	congress	PROPN
ihlr-16498	89	18	held	hold	VERB
ihlr-16498	89	19	hearings	hearing	NOUN
ihlr-16498	89	20	to	to	PART
ihlr-16498	89	21	determine	determine	VERB
ihlr-16498	89	22	whether	whether	SCONJ
ihlr-16498	89	23	the	the	DET
ihlr-16498	89	24	fda	fda	PROPN
ihlr-16498	89	25	and	and	CCONJ
ihlr-16498	89	26	drug	drug	NOUN
ihlr-16498	89	27	manufacturers	manufacturer	NOUN
ihlr-16498	89	28	were	be	AUX
ihlr-16498	89	29	conducting	conduct	VERB
ihlr-16498	89	30	and	and	CCONJ
ihlr-16498	89	31	publicizing	publicize	VERB
ihlr-16498	89	32	the	the	DET
ihlr-16498	89	33	results	result	NOUN
ihlr-16498	89	34	of	of	ADP
ihlr-16498	89	35	positive	positive	ADJ
ihlr-16498	89	36	,	,	PUNCT
ihlr-16498	89	37	negative	negative	ADJ
ihlr-16498	89	38	,	,	PUNCT
ihlr-16498	89	39	and	and	CCONJ
ihlr-16498	89	40	inconclusive	inconclusive	ADJ
ihlr-16498	89	41	clinical	clinical	ADJ
ihlr-16498	89	42	trials	trial	NOUN
ihlr-16498	89	43	.	.	PUNCT
ihlr-16498	90	1	as	as	SCONJ
ihlr-16498	90	2	the	the	DET
ihlr-16498	90	3	sunset	sunset	NOUN
ihlr-16498	90	4	date	date	NOUN
ihlr-16498	90	5	of	of	ADP
ihlr-16498	90	6	the	the	DET
ihlr-16498	90	7	current	current	ADJ
ihlr-16498	90	8	programs	program	NOUN
ihlr-16498	90	9	approaches	approach	VERB
ihlr-16498	90	10	,	,	PUNCT
ihlr-16498	90	11	new	new	ADJ
ihlr-16498	90	12	policy	policy	NOUN
ihlr-16498	90	13	changes	change	NOUN
ihlr-16498	90	14	are	be	AUX
ihlr-16498	90	15	proposed	propose	VERB
ihlr-16498	90	16	in	in	ADP
ihlr-16498	90	17	part	part	NOUN
ihlr-16498	90	18	v	v	NOUN
ihlr-16498	90	19	for	for	ADP
ihlr-16498	90	20	consideration	consideration	NOUN
ihlr-16498	90	21	as	as	SCONJ
ihlr-16498	90	22	the	the	DET
ihlr-16498	90	23	fda	fda	PROPN
ihlr-16498	90	24	moves	move	VERB
ihlr-16498	90	25	forward	forward	ADV
ihlr-16498	90	26	.	.	PUNCT
ihlr-16498	91	1	while	while	SCONJ
ihlr-16498	91	2	the	the	DET
ihlr-16498	91	3	recent	recent	ADJ
ihlr-16498	91	4	legislative	legislative	ADJ
ihlr-16498	91	5	schemes	scheme	NOUN
ihlr-16498	91	6	offer	offer	VERB
ihlr-16498	91	7	some	some	DET
ihlr-16498	91	8	protection	protection	NOUN
ihlr-16498	91	9	to	to	ADP
ihlr-16498	91	10	children	child	NOUN
ihlr-16498	91	11	as	as	ADP
ihlr-16498	91	12	clinical	clinical	ADJ
ihlr-16498	91	13	subjects	subject	NOUN
ihlr-16498	91	14	,	,	PUNCT
ihlr-16498	91	15	they	they	PRON
ihlr-16498	91	16	do	do	AUX
ihlr-16498	91	17	not	not	PART
ihlr-16498	91	18	provide	provide	VERB
ihlr-16498	91	19	enough	enough	ADJ
ihlr-16498	91	20	protection	protection	NOUN
ihlr-16498	91	21	once	once	SCONJ
ihlr-16498	91	22	the	the	DET
ihlr-16498	91	23	drug	drug	NOUN
ihlr-16498	91	24	is	be	AUX
ihlr-16498	91	25	on	on	ADP
ihlr-16498	91	26	the	the	DET
ihlr-16498	91	27	market	market	NOUN
ihlr-16498	91	28	.	.	PUNCT
ihlr-16498	92	1	legislative	legislative	ADJ
ihlr-16498	92	2	and	and	CCONJ
ihlr-16498	92	3	policy	policy	NOUN
ihlr-16498	92	4	re­	re­	NOUN
ihlr-16498	92	5	forms	form	NOUN
ihlr-16498	92	6	might	might	AUX
ihlr-16498	92	7	include	include	VERB
ihlr-16498	92	8	the	the	DET
ihlr-16498	92	9	following	follow	VERB
ihlr-16498	92	10	:	:	PUNCT
ihlr-16498	92	11	public	public	ADJ
ihlr-16498	92	12	disclosure	disclosure	NOUN
ihlr-16498	92	13	of	of	ADP
ihlr-16498	92	14	all	all	DET
ihlr-16498	92	15	clinical	clinical	ADJ
ihlr-16498	92	16	trials	trial	NOUN
ihlr-16498	92	17	,	,	PUNCT
ihlr-16498	92	18	16	16	NUM
ihlr-16498	92	19	/d	/d	PUNCT
ihlr-16498	92	20	.	.	PUNCT
ihlr-16498	93	1	at	at	ADP
ihlr-16498	93	2	35	35	NUM
ihlr-16498	93	3	(	(	PUNCT
ihlr-16498	93	4	describing	describe	VERB
ihlr-16498	93	5	that	that	PRON
ihlr-16498	93	6	in	in	ADP
ihlr-16498	93	7	the	the	DET
ihlr-16498	93	8	1980s	1980s	NUM
ihlr-16498	93	9	.	.	PUNCT
ihlr-16498	94	1	1990s	1990s	NUM
ihlr-16498	94	2	.	.	PUNCT
ihlr-16498	95	1	and	and	CCONJ
ihlr-16498	95	2	2000s	2000s	NUM
ihlr-16498	95	3	,	,	PUNCT
ihlr-16498	95	4	the	the	DET
ihlr-16498	95	5	british	british	ADJ
ihlr-16498	95	6	government	government	NOUN
ihlr-16498	95	7	monitored	monitor	VERB
ihlr-16498	95	8	reports	report	NOUN
ihlr-16498	95	9	of	of	ADP
ihlr-16498	95	10	selective	selective	ADJ
ihlr-16498	95	11	serotonin	serotonin	NOUN
ihlr-16498	95	12	re	re	NOUN
ihlr-16498	95	13	-	-	NOUN
ihlr-16498	95	14	uptake	uptake	ADJ
ihlr-16498	95	15	inhibitors	inhibitor	NOUN
ihlr-16498	95	16	and	and	CCONJ
ihlr-16498	95	17	ultimately	ultimately	ADV
ihlr-16498	95	18	concluded	conclude	VERB
ihlr-16498	95	19	they	they	PRON
ihlr-16498	95	20	were	be	AUX
ihlr-16498	95	21	not	not	PART
ihlr-16498	95	22	safe	safe	ADJ
ihlr-16498	95	23	for	for	ADP
ihlr-16498	95	24	use	use	NOUN
ihlr-16498	95	25	in	in	ADP
ihlr-16498	95	26	children	child	NOUN
ihlr-16498	95	27	)	)	PUNCT
ihlr-16498	95	28	.	.	PUNCT
ihlr-16498	96	1	17	17	NUM
ihlr-16498	96	2	e.g.	e.g.	X
ihlr-16498	96	3	,id	,id	PUNCT
ihlr-16498	96	4	18	18	NUM
ihlr-16498	96	5	/d	/d	PUNCT
ihlr-16498	96	6	.	.	PUNCT
ihlr-16498	97	1	at	at	ADP
ihlr-16498	97	2	34	34	NUM
ihlr-16498	97	3	(	(	PUNCT
ihlr-16498	97	4	"	"	PUNCT
ihlr-16498	97	5	indeed	indeed	ADV
ihlr-16498	97	6	,	,	PUNCT
ihlr-16498	97	7	eli	eli	PROPN
ihlr-16498	97	8	lilly	lilly	PROPN
ihlr-16498	97	9	and	and	CCONJ
ihlr-16498	97	10	company	company	NOUN
ihlr-16498	97	11	recently	recently	ADV
ihlr-16498	97	12	received	receive	VERB
ihlr-16498	97	13	a	a	DET
ihlr-16498	97	14	tremendous	tremendous	ADJ
ihlr-16498	97	15	amount	amount	NOUN
ihlr-16498	97	16	of	of	ADP
ihlr-16498	97	17	bad	bad	ADJ
ihlr-16498	97	18	press	press	NOUN
ihlr-16498	97	19	when	when	SCONJ
ihlr-16498	97	20	traci	traci	PROPN
ihlr-16498	97	21	johnson	johnson	PROPN
ihlr-16498	97	22	,	,	PUNCT
ihlr-16498	97	23	an	an	DET
ihlr-16498	97	24	indiana	indiana	PROPN
ihlr-16498	97	25	college	college	NOUN
ihlr-16498	97	26	student	student	NOUN
ihlr-16498	97	27	.	.	PUNCT
ihlr-16498	98	1	committed	commit	VERB
ihlr-16498	98	2	suicide	suicide	NOUN
ihlr-16498	98	3	during	during	ADP
ihlr-16498	98	4	a	a	DET
ihlr-16498	98	5	clinical	clinical	ADJ
ihlr-16498	98	6	trial	trial	NOUN
ihlr-16498	98	7	ofcymbalta	ofcymbalta	NOUN
ihlr-16498	98	8	,	,	PUNCT
ihlr-16498	98	9	an	an	DET
ihlr-16498	98	10	antidepressant	antidepressant	NOUN
ihlr-16498	98	11	.	.	PUNCT
ihlr-16498	98	12	"	"	PUNCT
ihlr-16498	98	13	)	)	PUNCT
ihlr-16498	98	14	.	.	PUNCT
ihlr-16498	99	1	19	19	NUM
ihlr-16498	99	2	e.g.	e.g.	ADV
ihlr-16498	99	3	,	,	PUNCT
ihlr-16498	99	4	i	i	PROPN
ihlr-16498	99	5	d.	d.	PROPN
ihlr-16498	99	6	;	;	PUNCT
ihlr-16498	99	7	u.s	u.s	PROPN
ihlr-16498	99	8	.	.	PROPN
ihlr-16498	99	9	finds	find	VERB
ihlr-16498	99	10	no	no	DET
ihlr-16498	99	11	link	link	NOUN
ihlr-16498	99	12	between	between	ADP
ihlr-16498	99	13	a	a	DET
ihlr-16498	99	14	suicide	suicide	NOUN
ihlr-16498	99	15	and	and	CCONJ
ihlr-16498	99	16	a	a	DET
ihlr-16498	99	17	lilly	lilly	ADJ
ihlr-16498	99	18	drug	drug	NOUN
ihlr-16498	99	19	,	,	PUNCT
ihlr-16498	99	20	n.y	n.y	PROPN
ihlr-16498	99	21	.	.	PROPN
ihlr-16498	99	22	times	times	PROPN
ihlr-16498	99	23	,	,	PUNCT
ihlr-16498	99	24	aug	aug	PROPN
ihlr-16498	99	25	.	.	PROPN
ihlr-16498	99	26	13	13	NUM
ihlr-16498	99	27	,	,	PUNCT
ihlr-16498	99	28	2004	2004	NUM
ihlr-16498	99	29	,	,	PUNCT
ihlr-16498	99	30	at	at	ADP
ihlr-16498	99	31	c4	c4	NOUN
ihlr-16498	99	32	.	.	PUNCT
ihlr-16498	100	1	20	20	NUM
ihlr-16498	100	2	groopman	groopman	NOUN
ihlr-16498	100	3	,	,	PUNCT
ihlr-16498	100	4	supra	supra	PROPN
ihlr-16498	100	5	note	note	NOUN
ihlr-16498	100	6	1	1	NUM
ihlr-16498	100	7	,	,	PUNCT
ihlr-16498	100	8	at	at	ADP
ihlr-16498	100	9	34	34	NUM
ihlr-16498	100	10	(	(	PUNCT
ihlr-16498	100	11	"	"	PUNCT
ihlr-16498	100	12	johnson	johnson	PROPN
ihlr-16498	100	13	's	's	PART
ihlr-16498	100	14	death	death	NOUN
ihlr-16498	100	15	occurred	occur	VERB
ihlr-16498	100	16	at	at	ADP
ihlr-16498	100	17	the	the	DET
ihlr-16498	100	18	same	same	ADJ
ihlr-16498	100	19	time	time	NOUN
ihlr-16498	100	20	that	that	SCONJ
ihlr-16498	100	21	the	the	DET
ihlr-16498	100	22	f.d.a	f.d.a	NOUN
ihlr-16498	100	23	.	.	PROPN
ihlr-16498	100	24	was	be	AUX
ihlr-16498	100	25	analyzing	analyze	VERB
ihlr-16498	100	26	a	a	DET
ihlr-16498	100	27	large	large	ADJ
ihlr-16498	100	28	set	set	NOUN
ihlr-16498	100	29	of	of	ADP
ihlr-16498	100	30	data	datum	NOUN
ihlr-16498	100	31	compiled	compile	VERB
ihlr-16498	100	32	from	from	ADP
ihlr-16498	100	33	multiple	multiple	ADJ
ihlr-16498	100	34	clinical	clinical	ADJ
ihlr-16498	100	35	trials	trial	NOUN
ihlr-16498	100	36	.	.	PUNCT
ihlr-16498	101	1	the	the	DET
ihlr-16498	101	2	results	result	NOUN
ihlr-16498	101	3	,	,	PUNCT
ihlr-16498	101	4	which	which	PRON
ihlr-16498	101	5	were	be	AUX
ihlr-16498	101	6	released	release	VERB
ihlr-16498	101	7	in	in	ADP
ihlr-16498	101	8	october	october	PROPN
ihlr-16498	101	9	,	,	PUNCT
ihlr-16498	101	10	indicated	indicate	VERB
ihlr-16498	101	11	that	that	SCONJ
ihlr-16498	101	12	twice	twice	ADV
ihlr-16498	101	13	as	as	ADV
ihlr-16498	101	14	many	many	ADJ
ihlr-16498	101	15	children	child	NOUN
ihlr-16498	101	16	taking	take	VERB
ihlr-16498	101	17	antidepressants	antidepressant	NOUN
ihlr-16498	101	18	in	in	ADP
ihlr-16498	101	19	clinical	clinical	ADJ
ihlr-16498	101	20	trials	trial	NOUN
ihlr-16498	101	21	considered	consider	VERB
ihlr-16498	101	22	or	or	CCONJ
ihlr-16498	101	23	attempted	attempt	VERB
ihlr-16498	101	24	suicide	suicide	NOUN
ihlr-16498	101	25	as	as	ADP
ihlr-16498	101	26	children	child	NOUN
ihlr-16498	101	27	taking	take	VERB
ihlr-16498	101	28	placebos	placebo	NOUN
ihlr-16498	101	29	.	.	PUNCT
ihlr-16498	101	30	"	"	PUNCT
ihlr-16498	101	31	)	)	PUNCT
ihlr-16498	101	32	.	.	PUNCT
ihlr-16498	102	1	2007	2007	NUM
ihlr-16498	102	2	]	]	PUNCT
ihlr-16498	102	3	reforming	reform	VERB
ihlr-16498	102	4	fda	fda	PROPN
ihlr-16498	102	5	policy	policy	NOUN
ihlr-16498	102	6	for	for	ADP
ihlr-16498	102	7	pediatric	pediatric	ADJ
ihlr-16498	102	8	testing	testing	NOUN
ihlr-16498	102	9	65	65	NUM
ihlr-16498	102	10	changes	change	NOUN
ihlr-16498	102	11	in	in	ADP
ihlr-16498	102	12	the	the	DET
ihlr-16498	102	13	exclusivity	exclusivity	NOUN
ihlr-16498	102	14	provision	provision	NOUN
ihlr-16498	102	15	,	,	PUNCT
ihlr-16498	102	16	labeling	labeling	NOUN
ihlr-16498	102	17	changes	change	NOUN
ihlr-16498	102	18	,	,	PUNCT
ihlr-16498	102	19	and	and	CCONJ
ihlr-16498	102	20	post	post	ADJ
ihlr-16498	102	21	-	-	ADJ
ihlr-16498	102	22	approval	approval	ADJ
ihlr-16498	102	23	drug	drug	NOUN
ihlr-16498	102	24	surveillance	surveillance	NOUN
ihlr-16498	102	25	.	.	PUNCT
ihlr-16498	103	1	ii	ii	X
ihlr-16498	103	2	.	.	PUNCT
ihlr-16498	103	3	historical	historical	ADJ
ihlr-16498	103	4	treatment	treatment	NOUN
ihlr-16498	103	5	of	of	ADP
ihlr-16498	103	6	children	child	NOUN
ihlr-16498	103	7	in	in	ADP
ihlr-16498	103	8	drug	drug	NOUN
ihlr-16498	103	9	testing	testing	NOUN
ihlr-16498	103	10	impacts	impact	VERB
ihlr-16498	103	11	regulatory	regulatory	ADJ
ihlr-16498	103	12	reform	reform	NOUN
ihlr-16498	103	13	historically	historically	ADV
ihlr-16498	103	14	,	,	PUNCT
ihlr-16498	103	15	children	child	NOUN
ihlr-16498	103	16	were	be	AUX
ihlr-16498	103	17	used	use	VERB
ihlr-16498	103	18	as	as	ADP
ihlr-16498	103	19	subjects	subject	NOUN
ihlr-16498	103	20	in	in	ADP
ihlr-16498	103	21	medical	medical	ADJ
ihlr-16498	103	22	experiments	experiment	NOUN
ihlr-16498	103	23	.	.	PUNCT
ihlr-16498	104	1	21	21	NUM
ihlr-16498	104	2	un­	un­	PUNCT
ihlr-16498	104	3	til	til	SCONJ
ihlr-16498	104	4	the	the	DET
ihlr-16498	104	5	later	later	ADJ
ihlr-16498	104	6	part	part	NOUN
ihlr-16498	104	7	of	of	ADP
ihlr-16498	104	8	the	the	DET
ihlr-16498	104	9	twentieth	twentieth	ADJ
ihlr-16498	104	10	century	century	NOUN
ihlr-16498	104	11	,	,	PUNCT
ihlr-16498	104	12	the	the	DET
ihlr-16498	104	13	government	government	NOUN
ihlr-16498	104	14	made	make	VERB
ihlr-16498	104	15	few	few	ADJ
ihlr-16498	104	16	efforts	effort	NOUN
ihlr-16498	104	17	to	to	PART
ihlr-16498	104	18	regulate	regulate	VERB
ihlr-16498	104	19	pediatric	pediatric	ADJ
ihlr-16498	104	20	testing	testing	NOUN
ihlr-16498	104	21	,	,	PUNCT
ihlr-16498	104	22	and	and	CCONJ
ihlr-16498	104	23	children	child	NOUN
ihlr-16498	104	24	were	be	AUX
ihlr-16498	104	25	often	often	ADV
ihlr-16498	104	26	forced	force	VERB
ihlr-16498	104	27	to	to	PART
ihlr-16498	104	28	participate	participate	VERB
ihlr-16498	104	29	in	in	ADP
ihlr-16498	104	30	dan­	dan­	ADJ
ihlr-16498	104	31	gerous	gerous	ADJ
ihlr-16498	104	32	tests	test	NOUN
ihlr-16498	104	33	.	.	PUNCT
ihlr-16498	105	1	22	22	NUM
ihlr-16498	105	2	in	in	ADP
ihlr-16498	105	3	addition	addition	NOUN
ihlr-16498	105	4	,	,	PUNCT
ihlr-16498	105	5	the	the	DET
ihlr-16498	105	6	testing	testing	NOUN
ihlr-16498	105	7	among	among	ADP
ihlr-16498	105	8	pediatric	pediatric	ADJ
ihlr-16498	105	9	populations	population	NOUN
ihlr-16498	105	10	usually	usually	ADV
ihlr-16498	105	11	fo­	fo­	PROPN
ihlr-16498	105	12	cused	cuse	VERB
ihlr-16498	105	13	on	on	ADP
ihlr-16498	105	14	understanding	understand	VERB
ihlr-16498	105	15	a	a	DET
ihlr-16498	105	16	disease	disease	NOUN
ihlr-16498	105	17	,	,	PUNCT
ihlr-16498	105	18	rather	rather	ADV
ihlr-16498	105	19	than	than	ADP
ihlr-16498	105	20	testing	test	VERB
ihlr-16498	105	21	new	new	ADJ
ihlr-16498	105	22	drugs	drug	NOUN
ihlr-16498	105	23	that	that	PRON
ihlr-16498	105	24	could	could	AUX
ihlr-16498	105	25	be	be	AUX
ihlr-16498	105	26	used	use	VERB
ihlr-16498	105	27	to	to	PART
ihlr-16498	105	28	treat	treat	VERB
ihlr-16498	105	29	it	it	PRON
ihlr-16498	105	30	.	.	PUNCT
ihlr-16498	106	1	children	child	NOUN
ihlr-16498	106	2	need	need	VERB
ihlr-16498	106	3	protection	protection	NOUN
ihlr-16498	106	4	from	from	ADP
ihlr-16498	106	5	medical	medical	ADJ
ihlr-16498	106	6	mistreatment	mistreatment	NOUN
ihlr-16498	106	7	.	.	PUNCT
ihlr-16498	107	1	this	this	DET
ihlr-16498	107	2	set	set	NOUN
ihlr-16498	107	3	of	of	ADP
ihlr-16498	107	4	ethical	ethical	ADJ
ihlr-16498	107	5	concerns	concern	NOUN
ihlr-16498	107	6	,	,	PUNCT
ihlr-16498	107	7	regarding	regard	VERB
ihlr-16498	107	8	the	the	DET
ihlr-16498	107	9	protection	protection	NOUN
ihlr-16498	107	10	of	of	ADP
ihlr-16498	107	11	children	child	NOUN
ihlr-16498	107	12	entering	enter	VERB
ihlr-16498	107	13	a	a	DET
ihlr-16498	107	14	clinical	clinical	ADJ
ihlr-16498	107	15	trial	trial	NOUN
ihlr-16498	107	16	,	,	PUNCT
ihlr-16498	107	17	includes	include	VERB
ihlr-16498	107	18	issues	issue	NOUN
ihlr-16498	107	19	such	such	ADJ
ihlr-16498	107	20	as	as	ADP
ihlr-16498	107	21	consent	consent	NOUN
ihlr-16498	107	22	,	,	PUNCT
ihlr-16498	107	23	protection	protection	NOUN
ihlr-16498	107	24	of	of	ADP
ihlr-16498	107	25	disabled	disabled	ADJ
ihlr-16498	107	26	children	child	NOUN
ihlr-16498	107	27	,	,	PUNCT
ihlr-16498	107	28	and	and	CCONJ
ihlr-16498	107	29	associated	associated	ADJ
ihlr-16498	107	30	health	health	NOUN
ihlr-16498	107	31	risks	risk	NOUN
ihlr-16498	107	32	.	.	PUNCT
ihlr-16498	108	1	a	a	DET
ihlr-16498	108	2	thorough	thorough	ADJ
ihlr-16498	108	3	discussion	discussion	NOUN
ihlr-16498	108	4	of	of	ADP
ihlr-16498	108	5	the	the	DET
ihlr-16498	108	6	ethical	ethical	ADJ
ihlr-16498	108	7	dilemmas	dilemma	NOUN
ihlr-16498	108	8	regarding	regard	VERB
ihlr-16498	108	9	children	child	NOUN
ihlr-16498	108	10	in	in	ADP
ihlr-16498	108	11	clinical	clinical	ADJ
ihlr-16498	108	12	trials	trial	NOUN
ihlr-16498	108	13	is	be	AUX
ihlr-16498	108	14	beyond	beyond	ADP
ihlr-16498	108	15	the	the	DET
ihlr-16498	108	16	scope	scope	NOUN
ihlr-16498	108	17	ofthis	ofthi	VERB
ihlr-16498	108	18	article	article	NOUN
ihlr-16498	108	19	,	,	PUNCT
ihlr-16498	108	20	but	but	CCONJ
ihlr-16498	108	21	a	a	DET
ihlr-16498	108	22	large	large	ADJ
ihlr-16498	108	23	body	body	NOUN
ihlr-16498	108	24	oflaw	oflaw	NOUN
ihlr-16498	108	25	review	review	PROPN
ihlr-16498	108	26	articles	article	NOUN
ihlr-16498	108	27	specifically	specifically	ADV
ihlr-16498	108	28	addresses	address	VERB
ihlr-16498	108	29	this	this	DET
ihlr-16498	108	30	difficult	difficult	ADJ
ihlr-16498	108	31	and	and	CCONJ
ihlr-16498	108	32	critical	critical	ADJ
ihlr-16498	108	33	area	area	NOUN
ihlr-16498	108	34	.	.	PUNCT
ihlr-16498	109	1	23	23	NUM
ihlr-16498	109	2	clinical	clinical	ADJ
ihlr-16498	109	3	trials	trial	NOUN
ihlr-16498	109	4	for	for	ADP
ihlr-16498	109	5	safe	safe	ADJ
ihlr-16498	109	6	and	and	CCONJ
ihlr-16498	109	7	effective	effective	ADJ
ihlr-16498	109	8	treatments	treatment	NOUN
ihlr-16498	109	9	of	of	ADP
ihlr-16498	109	10	childhood	childhood	NOUN
ihlr-16498	109	11	ailments	ailment	NOUN
ihlr-16498	109	12	need	need	VERB
ihlr-16498	109	13	to	to	PART
ihlr-16498	109	14	be	be	AUX
ihlr-16498	109	15	conducted	conduct	VERB
ihlr-16498	109	16	.	.	PUNCT
ihlr-16498	110	1	this	this	DET
ihlr-16498	110	2	article	article	NOUN
ihlr-16498	110	3	focuses	focus	VERB
ihlr-16498	110	4	on	on	ADP
ihlr-16498	110	5	this	this	DET
ihlr-16498	110	6	set	set	NOUN
ihlr-16498	110	7	of	of	ADP
ihlr-16498	110	8	issues	issue	NOUN
ihlr-16498	110	9	that	that	PRON
ihlr-16498	110	10	concerns	concern	VERB
ihlr-16498	110	11	the	the	DET
ihlr-16498	110	12	testing	testing	NOUN
ihlr-16498	110	13	of	of	ADP
ihlr-16498	110	14	pediatric	pediatric	ADJ
ihlr-16498	110	15	drugs	drug	NOUN
ihlr-16498	110	16	to	to	PART
ihlr-16498	110	17	determine	determine	VERB
ihlr-16498	110	18	whether	whether	SCONJ
ihlr-16498	110	19	they	they	PRON
ihlr-16498	110	20	are	be	AUX
ihlr-16498	110	21	safe	safe	ADJ
ihlr-16498	110	22	and	and	CCONJ
ihlr-16498	110	23	effective	effective	ADJ
ihlr-16498	110	24	for	for	ADP
ihlr-16498	110	25	pediatric	pediatric	ADJ
ihlr-16498	110	26	populations	population	NOUN
ihlr-16498	110	27	.	.	PUNCT
ihlr-16498	111	1	as	as	SCONJ
ihlr-16498	111	2	described	describe	VERB
ihlr-16498	111	3	above	above	ADV
ihlr-16498	111	4	,	,	PUNCT
ihlr-16498	111	5	because	because	SCONJ
ihlr-16498	111	6	relatively	relatively	ADV
ihlr-16498	111	7	few	few	ADJ
ihlr-16498	111	8	drugs	drug	NOUN
ihlr-16498	111	9	are	be	AUX
ihlr-16498	111	10	tested	test	VERB
ihlr-16498	111	11	on	on	ADP
ihlr-16498	111	12	pediatric	pediatric	ADJ
ihlr-16498	111	13	populations	population	NOUN
ihlr-16498	111	14	,	,	PUNCT
ihlr-16498	111	15	doctors	doctor	NOUN
ihlr-16498	111	16	tend	tend	VERB
ihlr-16498	111	17	to	to	PART
ihlr-16498	111	18	"	"	PUNCT
ihlr-16498	111	19	dose	dose	VERB
ihlr-16498	111	20	down	down	ADP
ihlr-16498	111	21	"	"	PUNCT
ihlr-16498	111	22	adult	adult	NOUN
ihlr-16498	111	23	dosages	dosage	NOUN
ihlr-16498	111	24	to	to	PART
ihlr-16498	111	25	account	account	VERB
ihlr-16498	111	26	for	for	ADP
ihlr-16498	111	27	the	the	DET
ihlr-16498	111	28	lower	low	ADJ
ihlr-16498	111	29	body	body	NOUN
ihlr-16498	111	30	weight	weight	NOUN
ihlr-16498	111	31	in	in	ADP
ihlr-16498	111	32	children	child	NOUN
ihlr-16498	111	33	.	.	PUNCT
ihlr-16498	112	1	children	child	NOUN
ihlr-16498	112	2	,	,	PUNCT
ihlr-16498	112	3	however	however	ADV
ihlr-16498	112	4	,	,	PUNCT
ihlr-16498	112	5	have	have	VERB
ihlr-16498	112	6	physiological	physiological	ADJ
ihlr-16498	112	7	differences	difference	NOUN
ihlr-16498	112	8	that	that	PRON
ihlr-16498	112	9	may	may	AUX
ihlr-16498	112	10	cause	cause	VERB
ihlr-16498	112	11	a	a	DET
ihlr-16498	112	12	drug	drug	NOUN
ihlr-16498	112	13	to	to	PART
ihlr-16498	112	14	metabolize	metabolize	VERB
ihlr-16498	112	15	differently	differently	ADV
ihlr-16498	112	16	.	.	PUNCT
ihlr-16498	113	1	gov­	gov­	PROPN
ihlr-16498	113	2	ernment	ernment	PROPN
ihlr-16498	113	3	regulations	regulation	NOUN
ihlr-16498	113	4	aimed	aim	VERB
ihlr-16498	113	5	at	at	ADP
ihlr-16498	113	6	promoting	promote	VERB
ihlr-16498	113	7	and	and	CCONJ
ihlr-16498	113	8	even	even	ADV
ihlr-16498	113	9	requiring	require	VERB
ihlr-16498	113	10	drug	drug	NOUN
ihlr-16498	113	11	testing	testing	NOUN
ihlr-16498	113	12	in	in	ADP
ihlr-16498	113	13	children	child	NOUN
ihlr-16498	113	14	are	be	AUX
ihlr-16498	113	15	necessary	necessary	ADJ
ihlr-16498	113	16	to	to	PART
ihlr-16498	113	17	ensure	ensure	VERB
ihlr-16498	113	18	the	the	DET
ihlr-16498	113	19	safe	safe	ADJ
ihlr-16498	113	20	and	and	CCONJ
ihlr-16498	113	21	effective	effective	ADJ
ihlr-16498	113	22	use	use	NOUN
ihlr-16498	113	23	of	of	ADP
ihlr-16498	113	24	drugs	drug	NOUN
ihlr-16498	113	25	in	in	ADP
ihlr-16498	113	26	pediatric	pediatric	ADJ
ihlr-16498	113	27	populations	population	NOUN
ihlr-16498	113	28	.	.	PUNCT
ihlr-16498	114	1	described	describe	VERB
ihlr-16498	114	2	below	below	ADV
ihlr-16498	114	3	are	be	AUX
ihlr-16498	114	4	the	the	DET
ihlr-16498	114	5	current	current	ADJ
ihlr-16498	114	6	legislative	legislative	ADJ
ihlr-16498	114	7	and	and	CCONJ
ihlr-16498	114	8	regulatory	regulatory	ADJ
ihlr-16498	114	9	schemes	scheme	NOUN
ihlr-16498	114	10	addressing	address	VERB
ihlr-16498	114	11	such	such	ADJ
ihlr-16498	114	12	drug	drug	NOUN
ihlr-16498	114	13	experimentation	experimentation	NOUN
ihlr-16498	114	14	in	in	ADP
ihlr-16498	114	15	pediatric	pediatric	ADJ
ihlr-16498	114	16	populations	population	NOUN
ihlr-16498	114	17	.	.	PUNCT
ihlr-16498	115	1	al­	al­	PROPN
ihlr-16498	115	2	though	though	SCONJ
ihlr-16498	115	3	these	these	DET
ihlr-16498	115	4	schemes	scheme	NOUN
ihlr-16498	115	5	are	be	AUX
ihlr-16498	115	6	a	a	DET
ihlr-16498	115	7	good	good	ADJ
ihlr-16498	115	8	starting	starting	NOUN
ihlr-16498	115	9	point	point	NOUN
ihlr-16498	115	10	to	to	PART
ihlr-16498	115	11	address	address	VERB
ihlr-16498	115	12	the	the	DET
ihlr-16498	115	13	problems	problem	NOUN
ihlr-16498	115	14	of	of	ADP
ihlr-16498	115	15	drug	drug	NOUN
ihlr-16498	115	16	testing	testing	NOUN
ihlr-16498	115	17	in	in	ADP
ihlr-16498	115	18	children	child	NOUN
ihlr-16498	115	19	,	,	PUNCT
ihlr-16498	115	20	they	they	PRON
ihlr-16498	115	21	do	do	AUX
ihlr-16498	115	22	not	not	PART
ihlr-16498	115	23	go	go	VERB
ihlr-16498	115	24	far	far	ADV
ihlr-16498	115	25	enough	enough	ADV
ihlr-16498	115	26	.	.	PUNCT
ihlr-16498	116	1	21	21	NUM
ihlr-16498	116	2	see	see	VERB
ihlr-16498	116	3	generally	generally	ADV
ihlr-16498	116	4	susan	susan	PROPN
ihlr-16498	116	5	e.	e.	PROPN
ihlr-16498	116	6	lederer	lederer	PROPN
ihlr-16498	116	7	&	&	CCONJ
ihlr-16498	116	8	michael	michael	PROPN
ihlr-16498	116	9	a.	a.	PROPN
ihlr-16498	116	10	grodin	grodin	PROPN
ihlr-16498	116	11	,	,	PUNCT
ihlr-16498	116	12	historical	historical	ADJ
ihlr-16498	116	13	overview	overview	NOUN
ihlr-16498	116	14	:	:	PUNCT
ihlr-16498	116	15	pediatric	pediatric	ADJ
ihlr-16498	116	16	experimentation	experimentation	NOUN
ihlr-16498	116	17	,	,	PUNCT
ihlr-16498	116	18	in	in	ADP
ihlr-16498	116	19	children	child	NOUN
ihlr-16498	116	20	as	as	ADP
ihlr-16498	116	21	research	research	NOUN
ihlr-16498	116	22	subjects	subject	NOUN
ihlr-16498	116	23	:	:	PUNCT
ihlr-16498	116	24	science	science	NOUN
ihlr-16498	116	25	,	,	PUNCT
ihlr-16498	116	26	elhics	elhic	NOUN
ihlr-16498	116	27	,	,	PUNCT
ihlr-16498	116	28	and	and	CCONJ
ihlr-16498	116	29	law	law	NOUN
ihlr-16498	116	30	3	3	NUM
ihlr-16498	116	31	,	,	PUNCT
ihlr-16498	116	32	3	3	NUM
ihlr-16498	116	33	-	-	SYM
ihlr-16498	116	34	20	20	NUM
ihlr-16498	116	35	(	(	PUNCT
ihlr-16498	116	36	mi­	mi­	PROPN
ihlr-16498	116	37	chael	chael	PROPN
ihlr-16498	116	38	a.	a.	PROPN
ihlr-16498	116	39	grodin	grodin	PROPN
ihlr-16498	116	40	&	&	CCONJ
ihlr-16498	116	41	leonard	leonard	PROPN
ihlr-16498	116	42	h.	h.	PROPN
ihlr-16498	116	43	glantz	glantz	PROPN
ihlr-16498	116	44	eds	eds	PROPN
ihlr-16498	116	45	.	.	PROPN
ihlr-16498	116	46	,	,	PUNCT
ihlr-16498	116	47	1994	1994	NUM
ihlr-16498	116	48	)	)	PUNCT
ihlr-16498	116	49	.	.	PUNCT
ihlr-16498	117	1	22	22	NUM
ihlr-16498	117	2	lauren	lauren	PROPN
ihlr-16498	117	3	hammer	hammer	PROPN
ihlr-16498	117	4	breslow	breslow	NOUN
ihlr-16498	117	5	,	,	PUNCT
ihlr-16498	117	6	note	note	NOUN
ihlr-16498	117	7	,	,	PUNCT
ihlr-16498	117	8	the	the	DET
ihlr-16498	117	9	best	good	ADJ
ihlr-16498	117	10	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	117	11	for	for	ADP
ihlr-16498	117	12	children	child	NOUN
ihlr-16498	117	13	act	act	VERB
ihlr-16498	117	14	of2002	of2002	ADV
ihlr-16498	117	15	:	:	PUNCT
ihlr-16498	117	16	the	the	DET
ihlr-16498	117	17	rise	rise	NOUN
ihlr-16498	117	18	of	of	ADP
ihlr-16498	117	19	the	the	DET
ihlr-16498	117	20	voluntary	voluntary	ADJ
ihlr-16498	117	21	incentive	incentive	NOUN
ihlr-16498	117	22	structure	structure	NOUN
ihlr-16498	117	23	and	and	CCONJ
ihlr-16498	117	24	congressional	congressional	ADJ
ihlr-16498	117	25	refusal	refusal	NOUN
ihlr-16498	117	26	to	to	PART
ihlr-16498	117	27	require	require	VERB
ihlr-16498	117	28	pediatric	pediatric	ADJ
ihlr-16498	117	29	testing	testing	NOUN
ihlr-16498	117	30	,	,	PUNCT
ihlr-16498	117	31	40	40	NUM
ihlr-16498	117	32	harv	harv	NOUN
ihlr-16498	117	33	.	.	PUNCT
ihlr-16498	118	1	j.	j.	PROPN
ihlr-16498	118	2	onlegis.133	onlegis.133	PROPN
ihlr-16498	118	3	,	,	PUNCT
ihlr-16498	118	4	135	135	NUM
ihlr-16498	118	5	-	-	SYM
ihlr-16498	118	6	41	41	NUM
ihlr-16498	118	7	(	(	PUNCT
ihlr-16498	118	8	2003	2003	NUM
ihlr-16498	118	9	)	)	PUNCT
ihlr-16498	118	10	;	;	PUNCT
ihlr-16498	118	11	lederer	lederer	PROPN
ihlr-16498	118	12	&	&	CCONJ
ihlr-16498	118	13	grodin	grodin	PROPN
ihlr-16498	118	14	,	,	PUNCT
ihlr-16498	118	15	supranote2l	supranote2l	PROPN
ihlr-16498	118	16	(	(	PUNCT
ihlr-16498	118	17	describ­	describ­	VERB
ihlr-16498	118	18	ing	ing	ADJ
ihlr-16498	118	19	children	child	NOUN
ihlr-16498	118	20	as	as	ADP
ihlr-16498	118	21	research	research	NOUN
ihlr-16498	118	22	subjects	subject	NOUN
ihlr-16498	118	23	in	in	ADP
ihlr-16498	118	24	eighteenth	eighteenth	ADJ
ihlr-16498	118	25	,	,	PUNCT
ihlr-16498	118	26	nineteenth	nineteenth	ADJ
ihlr-16498	118	27	,	,	PUNCT
ihlr-16498	118	28	and	and	CCONJ
ihlr-16498	118	29	twentieth	twentieth	ADJ
ihlr-16498	118	30	centuries	century	NOUN
ihlr-16498	118	31	)	)	PUNCT
ihlr-16498	118	32	;	;	PUNCT
ihlr-16498	118	33	leonard	leonard	PROPN
ihlr-16498	118	34	h.	h.	PROPN
ihlr-16498	118	35	glantz	glantz	PROPN
ihlr-16498	118	36	,	,	PUNCT
ihlr-16498	118	37	the	the	DET
ihlr-16498	118	38	law	law	NOUN
ihlr-16498	118	39	of	of	ADP
ihlr-16498	118	40	human	human	ADJ
ihlr-16498	118	41	experimentation	experimentation	NOUN
ihlr-16498	118	42	with	with	ADP
ihlr-16498	118	43	children	child	NOUN
ihlr-16498	118	44	,	,	PUNCT
ihlr-16498	118	45	in	in	ADP
ihlr-16498	118	46	children	child	NOUN
ihlr-16498	118	47	as	as	ADP
ihlr-16498	118	48	research	research	NOUN
ihlr-16498	118	49	subjects	subject	NOUN
ihlr-16498	118	50	:	:	PUNCT
ihlr-16498	118	51	science	science	NOUN
ihlr-16498	118	52	,	,	PUNCT
ihlr-16498	118	53	elhics	elhic	NOUN
ihlr-16498	118	54	,	,	PUNCT
ihlr-16498	118	55	and	and	CCONJ
ihlr-16498	118	56	law	law	NOUN
ihlr-16498	118	57	103	103	NUM
ihlr-16498	118	58	,	,	PUNCT
ihlr-16498	118	59	103	103	NUM
ihlr-16498	118	60	(	(	PUNCT
ihlr-16498	118	61	michael	michael	PROPN
ihlr-16498	118	62	a.	a.	PROPN
ihlr-16498	118	63	grodin	grodin	PROPN
ihlr-16498	118	64	&	&	CCONJ
ihlr-16498	118	65	leonard	leonard	PROPN
ihlr-16498	118	66	h.	h.	PROPN
ihlr-16498	118	67	glantz	glantz	PROPN
ihlr-16498	118	68	eds	eds	PROPN
ihlr-16498	118	69	.	.	PROPN
ihlr-16498	118	70	,	,	PUNCT
ihlr-16498	118	71	1994	1994	NUM
ihlr-16498	118	72	)	)	PUNCT
ihlr-16498	119	1	[	[	X
ihlr-16498	119	2	hereinafter	hereinafter	NOUN
ihlr-16498	119	3	glantz	glantz	NOUN
ihlr-16498	119	4	,	,	PUNCT
ihlr-16498	119	5	the	the	DET
ihlr-16498	119	6	law	law	NOUN
ihlr-16498	119	7	of	of	ADP
ihlr-16498	119	8	human	human	ADJ
ihlr-16498	119	9	experimentation	experimentation	NOUN
ihlr-16498	119	10	with	with	ADP
ihlr-16498	119	11	children	child	NOUN
ihlr-16498	119	12	]	]	PUNCT
ihlr-16498	119	13	(	(	PUNCT
ihlr-16498	119	14	explaining	explain	VERB
ihlr-16498	119	15	that	that	SCONJ
ihlr-16498	119	16	until	until	SCONJ
ihlr-16498	119	17	the	the	DET
ihlr-16498	119	18	last	last	ADJ
ihlr-16498	119	19	half	half	NOUN
ihlr-16498	119	20	of	of	ADP
ihlr-16498	119	21	the	the	DET
ihlr-16498	119	22	twentieth	twentieth	ADJ
ihlr-16498	119	23	century	century	NOUN
ihlr-16498	119	24	virtually	virtually	ADV
ihlr-16498	119	25	no	no	PRON
ihlr-16498	119	26	regulations	regulation	NOUN
ihlr-16498	119	27	governed	govern	VERB
ihlr-16498	119	28	pediatric	pediatric	ADJ
ihlr-16498	119	29	testing	testing	NOUN
ihlr-16498	119	30	)	)	PUNCT
ihlr-16498	119	31	.	.	PUNCT
ihlr-16498	120	1	23	23	NUM
ihlr-16498	120	2	see	see	VERB
ihlr-16498	120	3	,	,	PUNCT
ihlr-16498	120	4	e.g.	e.g.	ADV
ihlr-16498	120	5	,	,	PUNCT
ihlr-16498	120	6	carrie	carrie	PROPN
ihlr-16498	120	7	fisher	fisher	PROPN
ihlr-16498	120	8	&	&	CCONJ
ihlr-16498	120	9	thomas	thomas	PROPN
ihlr-16498	120	10	g.	g.	PROPN
ihlr-16498	120	11	keens	keens	PROPN
ihlr-16498	120	12	,	,	PUNCT
ihlr-16498	120	13	participation	participation	NOUN
ihlr-16498	120	14	of	of	ADP
ihlr-16498	120	15	children	child	NOUN
ihlr-16498	120	16	in	in	ADP
ihlr-16498	120	17	research	research	NOUN
ihlr-16498	120	18	,	,	PUNCT
ihlr-16498	120	19	26	26	NUM
ihlr-16498	120	20	whitiler	whitiler	NOUN
ihlr-16498	120	21	l.	l.	PROPN
ihlr-16498	120	22	rev	rev	PROPN
ihlr-16498	120	23	.	.	PROPN
ihlr-16498	120	24	823	823	NUM
ihlr-16498	120	25	(	(	PUNCT
ihlr-16498	120	26	2005	2005	NUM
ihlr-16498	120	27	)	)	PUNCT
ihlr-16498	120	28	;	;	PUNCT
ihlr-16498	120	29	glantz	glantz	NOUN
ihlr-16498	120	30	,	,	PUNCT
ihlr-16498	120	31	the	the	DET
ihlr-16498	120	32	law	law	NOUN
ihlr-16498	120	33	of	of	ADP
ihlr-16498	120	34	human	human	ADJ
ihlr-16498	120	35	experimentation	experimentation	NOUN
ihlr-16498	120	36	with	with	ADP
ihlr-16498	120	37	children	child	NOUN
ihlr-16498	120	38	,	,	PUNCT
ihlr-16498	120	39	supra	supra	PROPN
ihlr-16498	120	40	note	note	PROPN
ihlr-16498	120	41	22	22	NUM
ihlr-16498	120	42	;	;	PUNCT
ihlr-16498	120	43	leonard	leonard	PROPN
ihlr-16498	120	44	h.	h.	PROPN
ihlr-16498	120	45	glantz	glantz	PROPN
ihlr-16498	120	46	,	,	PUNCT
ihlr-16498	120	47	research	research	NOUN
ihlr-16498	120	48	with	with	ADP
ihlr-16498	120	49	children	child	NOUN
ihlr-16498	120	50	,	,	PUNCT
ihlr-16498	120	51	24	24	NUM
ihlr-16498	120	52	am	am	NOUN
ihlr-16498	120	53	.	.	PUNCT
ihlr-16498	121	1	j	j	PROPN
ihlr-16498	121	2	.l	.l	PROPN
ihlr-16498	121	3	.	.	PUNCT
ihlr-16498	121	4	&	&	CCONJ
ihlr-16498	121	5	med	med	PROPN
ihlr-16498	121	6	.	.	PUNCT
ihlr-16498	122	1	213	213	NUM
ihlr-16498	122	2	(	(	PUNCT
ihlr-16498	122	3	1998	1998	NUM
ihlr-16498	122	4	)	)	PUNCT
ihlr-16498	122	5	.	.	PUNCT
ihlr-16498	123	1	66	66	NUM
ihlr-16498	123	2	indiana	indiana	PROPN
ihlr-16498	123	3	health	health	PROPN
ihlr-16498	123	4	law	law	NOUN
ihlr-16498	123	5	review	review	NOUN
ihlr-16498	123	6	[	[	X
ihlr-16498	123	7	vol	vol	NOUN
ihlr-16498	123	8	.	.	PUNCT
ihlr-16498	124	1	4:59	4:59	NUM
ihlr-16498	124	2	iii	iii	X
ihlr-16498	124	3	.	.	PUNCT
ihlr-16498	125	1	legislative	legislative	ADJ
ihlr-16498	125	2	history	history	NOUN
ihlr-16498	125	3	of	of	ADP
ihlr-16498	125	4	the	the	DET
ihlr-16498	125	5	acts	act	NOUN
ihlr-16498	125	6	designed	design	VERB
ihlr-16498	125	7	to	to	PART
ihlr-16498	125	8	protect	protect	VERB
ihlr-16498	125	9	children	child	NOUN
ihlr-16498	125	10	in	in	ADP
ihlr-16498	125	11	the	the	DET
ihlr-16498	125	12	testing	testing	NOUN
ihlr-16498	125	13	and	and	CCONJ
ihlr-16498	125	14	use	use	NOUN
ihlr-16498	125	15	of	of	ADP
ihlr-16498	125	16	fda	fda	PROPN
ihlr-16498	125	17	approved	approve	VERB
ihlr-16498	125	18	drugs	drug	NOUN
ihlr-16498	125	19	in	in	ADP
ihlr-16498	125	20	1997	1997	NUM
ihlr-16498	125	21	,	,	PUNCT
ihlr-16498	125	22	congress	congress	PROPN
ihlr-16498	125	23	enacted	enact	VERB
ihlr-16498	125	24	the	the	DET
ihlr-16498	125	25	fdama	fdama	NOUN
ihlr-16498	125	26	,	,	PUNCT
ihlr-16498	125	27	which	which	PRON
ihlr-16498	125	28	,	,	PUNCT
ihlr-16498	125	29	although	although	SCONJ
ihlr-16498	125	30	affecting	affect	VERB
ihlr-16498	125	31	nu­	nu­	SYM
ihlr-16498	125	32	merous	merous	ADJ
ihlr-16498	125	33	fda	fda	PROPN
ihlr-16498	125	34	regulations	regulation	NOUN
ihlr-16498	125	35	,	,	PUNCT
ihlr-16498	125	36	also	also	ADV
ihlr-16498	125	37	has	have	AUX
ihlr-16498	125	38	been	be	AUX
ihlr-16498	125	39	the	the	DET
ihlr-16498	125	40	first	first	ADJ
ihlr-16498	125	41	congressional	congressional	ADJ
ihlr-16498	125	42	action	action	NOUN
ihlr-16498	125	43	to	to	PART
ihlr-16498	125	44	address	address	VERB
ihlr-16498	125	45	specifically	specifically	ADV
ihlr-16498	125	46	the	the	DET
ihlr-16498	125	47	problems	problem	NOUN
ihlr-16498	125	48	of	of	ADP
ihlr-16498	125	49	testing	test	VERB
ihlr-16498	125	50	new	new	ADJ
ihlr-16498	125	51	drugs	drug	NOUN
ihlr-16498	125	52	in	in	ADP
ihlr-16498	125	53	children.24	children.24	NOUN
ihlr-16498	125	54	the	the	DET
ihlr-16498	125	55	fdama	fdama	NOUN
ihlr-16498	125	56	was	be	AUX
ihlr-16498	125	57	followed	follow	VERB
ihlr-16498	125	58	by	by	ADP
ihlr-16498	125	59	key	key	ADJ
ihlr-16498	125	60	regulations	regulation	NOUN
ihlr-16498	125	61	and	and	CCONJ
ihlr-16498	125	62	subsequent	subsequent	ADJ
ihlr-16498	125	63	congressional	congressional	ADJ
ihlr-16498	125	64	acts	act	NOUN
ihlr-16498	125	65	focusing	focus	VERB
ihlr-16498	125	66	on	on	ADP
ihlr-16498	125	67	the	the	DET
ihlr-16498	125	68	emerging	emerge	VERB
ihlr-16498	125	69	recognition	recognition	NOUN
ihlr-16498	125	70	of	of	ADP
ihlr-16498	125	71	the	the	DET
ihlr-16498	125	72	need	need	NOUN
ihlr-16498	125	73	for	for	ADP
ihlr-16498	125	74	pediatric	pediatric	ADJ
ihlr-16498	125	75	drug	drug	NOUN
ihlr-16498	125	76	testing	testing	NOUN
ihlr-16498	125	77	.	.	PUNCT
ihlr-16498	126	1	a.	a.	NOUN
ihlr-16498	126	2	patent	patent	PROPN
ihlr-16498	126	3	exclusivity	exclusivity	NOUN
ihlr-16498	126	4	for	for	ADP
ihlr-16498	126	5	voluntarily	voluntarily	ADV
ihlr-16498	126	6	conducting	conduct	VERB
ihlr-16498	126	7	pediatric	pediatric	ADJ
ihlr-16498	126	8	trials	trial	NOUN
ihlr-16498	126	9	the	the	DET
ihlr-16498	126	10	fdama	fdama	NOUN
ihlr-16498	126	11	significantly	significantly	ADV
ihlr-16498	126	12	changed	change	VERB
ihlr-16498	126	13	the	the	DET
ihlr-16498	126	14	regulatory	regulatory	ADJ
ihlr-16498	126	15	scheme	scheme	NOUN
ihlr-16498	126	16	for	for	ADP
ihlr-16498	126	17	pediatric	pediatric	ADJ
ihlr-16498	126	18	testing	testing	NOUN
ihlr-16498	126	19	.	.	PUNCT
ihlr-16498	127	1	most	most	ADV
ihlr-16498	127	2	notably	notably	ADV
ihlr-16498	127	3	,	,	PUNCT
ihlr-16498	127	4	it	it	PRON
ihlr-16498	127	5	granted	grant	VERB
ihlr-16498	127	6	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	127	7	companies	company	NOUN
ihlr-16498	127	8	a	a	DET
ihlr-16498	127	9	six	six	NUM
ihlr-16498	127	10	-	-	PUNCT
ihlr-16498	127	11	month	month	NOUN
ihlr-16498	127	12	patent	patent	NOUN
ihlr-16498	127	13	extension	extension	NOUN
ihlr-16498	127	14	in.exchange	in.exchange	VERB
ihlr-16498	127	15	for	for	ADP
ihlr-16498	127	16	conducting	conduct	VERB
ihlr-16498	127	17	pediatric	pediatric	ADJ
ihlr-16498	127	18	trials	trial	NOUN
ihlr-16498	127	19	of	of	ADP
ihlr-16498	127	20	their	their	PRON
ihlr-16498	127	21	drug.25	drug.25	NOUN
ihlr-16498	127	22	the	the	DET
ihlr-16498	127	23	patent	patent	NOUN
ihlr-16498	127	24	exclusivity	exclusivity	NOUN
ihlr-16498	127	25	provision	provision	NOUN
ihlr-16498	127	26	applied	apply	VERB
ihlr-16498	127	27	only	only	ADV
ihlr-16498	127	28	to	to	ADP
ihlr-16498	127	29	future	future	NOUN
ihlr-16498	127	30	or	or	CCONJ
ihlr-16498	127	31	existing	exist	VERB
ihlr-16498	127	32	patented	patented	ADJ
ihlr-16498	127	33	drugs.26	drugs.26	NOUN
ihlr-16498	127	34	that	that	PRON
ihlr-16498	127	35	is	be	AUX
ihlr-16498	127	36	,	,	PUNCT
ihlr-16498	127	37	if	if	SCONJ
ihlr-16498	127	38	a	a	DET
ihlr-16498	127	39	drug	drug	NOUN
ihlr-16498	127	40	company	company	NOUN
ihlr-16498	127	41	was	be	AUX
ihlr-16498	127	42	outside	outside	ADP
ihlr-16498	127	43	the	the	DET
ihlr-16498	127	44	exclusive	exclusive	ADJ
ihlr-16498	127	45	period	period	NOUN
ihlr-16498	127	46	provided	provide	VERB
ihlr-16498	127	47	by	by	ADP
ihlr-16498	127	48	the	the	DET
ihlr-16498	127	49	patent	patent	NOUN
ihlr-16498	127	50	,	,	PUNCT
ihlr-16498	127	51	pediatric	pediatric	ADJ
ihlr-16498	127	52	clinical	clinical	ADJ
ihlr-16498	127	53	trials	trial	NOUN
ihlr-16498	127	54	for	for	ADP
ihlr-16498	127	55	that	that	DET
ihlr-16498	127	56	particular	particular	ADJ
ihlr-16498	127	57	drug	drug	NOUN
ihlr-16498	127	58	would	would	AUX
ihlr-16498	127	59	not	not	PART
ihlr-16498	127	60	give	give	VERB
ihlr-16498	127	61	the	the	DET
ihlr-16498	127	62	pharmaceuti­	pharmaceuti­	NOUN
ihlr-16498	127	63	cal	cal	NOUN
ihlr-16498	127	64	company	company	NOUN
ihlr-16498	127	65	an	an	DET
ihlr-16498	127	66	exclusive	exclusive	ADJ
ihlr-16498	127	67	six	six	NUM
ihlr-16498	127	68	-	-	PUNCT
ihlr-16498	127	69	month	month	NOUN
ihlr-16498	127	70	market	market	NOUN
ihlr-16498	127	71	.	.	PUNCT
ihlr-16498	128	1	the	the	DET
ihlr-16498	128	2	market	market	NOUN
ihlr-16498	128	3	exclusivity	exclusivity	NOUN
ihlr-16498	128	4	approach	approach	NOUN
ihlr-16498	128	5	is	be	AUX
ihlr-16498	128	6	similar	similar	ADJ
ihlr-16498	128	7	to	to	ADP
ihlr-16498	128	8	the	the	DET
ihlr-16498	128	9	hatch	hatch	NOUN
ihlr-16498	128	10	-	-	PUNCT
ihlr-16498	128	11	waxman	waxman	PROPN
ihlr-16498	128	12	act	act	PROPN
ihlr-16498	128	13	,	,	PUNCT
ihlr-16498	128	14	which	which	PRON
ihlr-16498	128	15	allows	allow	VERB
ihlr-16498	128	16	patent	patent	NOUN
ihlr-16498	128	17	extensions	extension	NOUN
ihlr-16498	128	18	for	for	ADP
ihlr-16498	128	19	drugs	drug	NOUN
ihlr-16498	128	20	in	in	ADP
ihlr-16498	128	21	order	order	NOUN
ihlr-16498	128	22	to	to	PART
ihlr-16498	128	23	compensate	compensate	VERB
ihlr-16498	128	24	for	for	ADP
ihlr-16498	128	25	the	the	DET
ihlr-16498	128	26	time	time	NOUN
ihlr-16498	128	27	the	the	DET
ihlr-16498	128	28	drug	drug	NOUN
ihlr-16498	128	29	is	be	AUX
ihlr-16498	128	30	moving	move	VERB
ihlr-16498	128	31	through	through	ADP
ihlr-16498	128	32	the	the	DET
ihlr-16498	128	33	regulatory	regulatory	ADJ
ihlr-16498	128	34	process	process	NOUN
ihlr-16498	128	35	.	.	PUNCT
ihlr-16498	129	1	27	27	NUM
ihlr-16498	129	2	prior	prior	ADV
ihlr-16498	129	3	to	to	ADP
ihlr-16498	129	4	the	the	DET
ihlr-16498	129	5	hatch­	hatch­	PROPN
ihlr-16498	129	6	w	w	PROPN
ihlr-16498	129	7	axman	axman	PROPN
ihlr-16498	129	8	act	act	PROPN
ihlr-16498	129	9	,	,	PUNCT
ihlr-16498	129	10	a	a	DET
ihlr-16498	129	11	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	129	12	company	company	NOUN
ihlr-16498	129	13	would	would	AUX
ihlr-16498	129	14	receive	receive	VERB
ihlr-16498	129	15	a	a	DET
ihlr-16498	129	16	patent	patent	NOUN
ihlr-16498	129	17	for	for	ADP
ihlr-16498	129	18	its	its	PRON
ihlr-16498	129	19	drug	drug	NOUN
ihlr-16498	129	20	before	before	ADP
ihlr-16498	129	21	completing	complete	VERB
ihlr-16498	129	22	the	the	DET
ihlr-16498	129	23	fda	fda	PROPN
ihlr-16498	129	24	regulatory	regulatory	ADJ
ihlr-16498	129	25	approval	approval	NOUN
ihlr-16498	129	26	process	process	NOUN
ihlr-16498	129	27	but	but	CCONJ
ihlr-16498	129	28	could	could	AUX
ihlr-16498	129	29	not	not	PART
ihlr-16498	129	30	market	market	VERB
ihlr-16498	129	31	the	the	DET
ihlr-16498	129	32	drug	drug	NOUN
ihlr-16498	129	33	until	until	SCONJ
ihlr-16498	129	34	the	the	DET
ihlr-16498	129	35	fda	fda	PROPN
ihlr-16498	129	36	approved	approve	VERB
ihlr-16498	129	37	it	it	PRON
ihlr-16498	129	38	.	.	PUNCT
ihlr-16498	130	1	therefore	therefore	ADV
ihlr-16498	130	2	,	,	PUNCT
ihlr-16498	130	3	the	the	DET
ihlr-16498	130	4	company	company	NOUN
ihlr-16498	130	5	would	would	AUX
ihlr-16498	130	6	not	not	PART
ihlr-16498	130	7	be	be	AUX
ihlr-16498	130	8	able	able	ADJ
ihlr-16498	130	9	to	to	PART
ihlr-16498	130	10	enjoy	enjoy	VERB
ihlr-16498	130	11	the	the	DET
ihlr-16498	130	12	market	market	NOUN
ihlr-16498	130	13	exclusivity	exclusivity	NOUN
ihlr-16498	130	14	granted	grant	VERB
ihlr-16498	130	15	by	by	ADP
ihlr-16498	130	16	the	the	DET
ihlr-16498	130	17	patent	patent	NOUN
ihlr-16498	130	18	while	while	SCONJ
ihlr-16498	130	19	the	the	DET
ihlr-16498	130	20	drug	drug	NOUN
ihlr-16498	130	21	was	be	AUX
ihlr-16498	130	22	in	in	ADP
ihlr-16498	130	23	the	the	DET
ihlr-16498	130	24	regulatory	regulatory	ADJ
ihlr-16498	130	25	pipeline	pipeline	NOUN
ihlr-16498	130	26	.	.	PUNCT
ihlr-16498	131	1	the	the	DET
ihlr-16498	131	2	hatch	hatch	PROPN
ihlr-16498	131	3	-	-	PUNCT
ihlr-16498	131	4	waxman	waxman	PROPN
ihlr-16498	131	5	act	act	NOUN
ihlr-16498	131	6	allows	allow	VERB
ihlr-16498	131	7	a	a	DET
ihlr-16498	131	8	patent	patent	NOUN
ihlr-16498	131	9	extension	extension	NOUN
ihlr-16498	131	10	tacked	tack	VERB
ihlr-16498	131	11	on	on	ADP
ihlr-16498	131	12	to	to	ADP
ihlr-16498	131	13	the	the	DET
ihlr-16498	131	14	end	end	NOUN
ihlr-16498	131	15	of	of	ADP
ihlr-16498	131	16	a	a	DET
ihlr-16498	131	17	drug	drug	NOUN
ihlr-16498	131	18	's	's	PART
ihlr-16498	131	19	patent	patent	NOUN
ihlr-16498	131	20	term	term	NOUN
ihlr-16498	131	21	to	to	PART
ihlr-16498	131	22	compensate	compensate	VERB
ihlr-16498	131	23	for	for	ADP
ihlr-16498	131	24	the	the	DET
ihlr-16498	131	25	delay	delay	NOUN
ihlr-16498	131	26	experienced	experience	VERB
ihlr-16498	131	27	during	during	ADP
ihlr-16498	131	28	the	the	DET
ihlr-16498	131	29	approval	approval	NOUN
ihlr-16498	131	30	process.28	process.28	NOUN
ihlr-16498	131	31	providing	provide	VERB
ihlr-16498	131	32	patent	patent	NOUN
ihlr-16498	131	33	extensions	extension	NOUN
ihlr-16498	131	34	for	for	ADP
ihlr-16498	131	35	voluntary	voluntary	ADJ
ihlr-16498	131	36	pediatric	pediatric	ADJ
ihlr-16498	131	37	drug	drug	NOUN
ihlr-16498	131	38	testing	testing	NOUN
ihlr-16498	131	39	has	have	AUX
ihlr-16498	131	40	been	be	AUX
ihlr-16498	131	41	described	describe	VERB
ihlr-16498	131	42	as	as	ADP
ihlr-16498	131	43	a	a	DET
ihlr-16498	131	44	"	"	PUNCT
ihlr-16498	131	45	carrot	carrot	NOUN
ihlr-16498	131	46	and	and	CCONJ
ihlr-16498	131	47	stick	stick	NOUN
ihlr-16498	131	48	"	"	PUNCT
ihlr-16498	131	49	approach.29	approach.29	NOUN
ihlr-16498	131	50	the	the	DET
ihlr-16498	131	51	"	"	PUNCT
ihlr-16498	131	52	carrot	carrot	NOUN
ihlr-16498	131	53	"	"	PUNCT
ihlr-16498	131	54	is	be	AUX
ihlr-16498	131	55	the	the	DET
ihlr-16498	131	56	six	six	NUM
ihlr-16498	131	57	-	-	PUNCT
ihlr-16498	131	58	month	month	NOUN
ihlr-16498	131	59	24	24	NUM
ihlr-16498	131	60	see	see	VERB
ihlr-16498	131	61	generally	generally	ADV
ihlr-16498	131	62	food	food	NOUN
ihlr-16498	131	63	and	and	CCONJ
ihlr-16498	131	64	drug	drug	NOUN
ihlr-16498	131	65	modernization	modernization	PROPN
ihlr-16498	131	66	act	act	NOUN
ihlr-16498	131	67	of	of	ADP
ihlr-16498	131	68	1997	1997	NUM
ihlr-16498	131	69	,	,	PUNCT
ihlr-16498	131	70	pub	pub	NOUN
ihlr-16498	131	71	.	.	PUNCT
ihlr-16498	132	1	l.	l.	PROPN
ihlr-16498	132	2	no	no	INTJ
ihlr-16498	132	3	.	.	PROPN
ihlr-16498	133	1	105	105	NUM
ihlr-16498	133	2	-	-	SYM
ihlr-16498	133	3	115	115	NUM
ihlr-16498	133	4	,	,	PUNCT
ihlr-16498	133	5	§	§	PROPN
ihlr-16498	133	6	505a	505a	PROPN
ihlr-16498	133	7	,	,	PUNCT
ihlr-16498	133	8	ill	ill	ADJ
ihlr-16498	133	9	stat	stat	NOUN
ihlr-16498	133	10	.	.	PUNCT
ihlr-16498	134	1	2296,2305	2296,2305	NUM
ihlr-16498	134	2	-	-	SYM
ihlr-16498	134	3	09	09	NUM
ihlr-16498	134	4	(	(	PUNCT
ihlr-16498	134	5	1997	1997	NUM
ihlr-16498	134	6	)	)	PUNCT
ihlr-16498	134	7	(	(	PUNCT
ihlr-16498	134	8	codified	codify	VERB
ihlr-16498	134	9	as	as	SCONJ
ihlr-16498	134	10	amended	amend	VERB
ihlr-16498	134	11	at	at	ADP
ihlr-16498	134	12	21	21	NUM
ihlr-16498	134	13	u.s.c	u.s.c	ADJ
ihlr-16498	134	14	.	.	PUNCT
ihlr-16498	135	1	§	§	PROPN
ihlr-16498	135	2	355a	355a	PROPN
ihlr-16498	135	3	)	)	PUNCT
ihlr-16498	135	4	.	.	PUNCT
ihlr-16498	136	1	while	while	SCONJ
ihlr-16498	136	2	the	the	DET
ihlr-16498	136	3	fda	fda	PROPN
ihlr-16498	136	4	attempted	attempt	VERB
ihlr-16498	136	5	to	to	PART
ihlr-16498	136	6	regulate	regulate	VERB
ihlr-16498	136	7	pediatric	pediatric	ADJ
ihlr-16498	136	8	research	research	NOUN
ihlr-16498	136	9	studies	study	NOUN
ihlr-16498	136	10	through	through	ADP
ihlr-16498	136	11	enactment	enactment	NOUN
ihlr-16498	136	12	of	of	ADP
ihlr-16498	136	13	rules	rule	NOUN
ihlr-16498	136	14	,	,	PUNCT
ihlr-16498	136	15	the	the	DET
ihlr-16498	136	16	fdama	fdama	NOUN
ihlr-16498	136	17	of	of	ADP
ihlr-16498	136	18	1997	1997	NUM
ihlr-16498	136	19	is	be	AUX
ihlr-16498	136	20	the	the	DET
ihlr-16498	136	21	first	first	ADJ
ihlr-16498	136	22	congressional	congressional	ADJ
ihlr-16498	136	23	act	act	NOUN
ihlr-16498	136	24	to	to	PART
ihlr-16498	136	25	specifically	specifically	ADV
ihlr-16498	136	26	address	address	VERB
ihlr-16498	136	27	pediatric	pediatric	ADJ
ihlr-16498	136	28	drug	drug	NOUN
ihlr-16498	136	29	research	research	NOUN
ihlr-16498	136	30	.	.	PUNCT
ihlr-16498	137	1	i	i	PRON
ihlr-16498	137	2	d	d	PROPN
ihlr-16498	137	3	see	see	VERB
ihlr-16498	137	4	chris­	chris­	NUM
ihlr-16498	137	5	topher	topher	NOUN
ihlr-16498	137	6	-	-	PUNCT
ihlr-16498	137	7	paul	paul	PROPN
ihlr-16498	137	8	milne	milne	PROPN
ihlr-16498	137	9	,	,	PUNCT
ihlr-16498	137	10	exploring	explore	VERB
ihlr-16498	137	11	the	the	DET
ihlr-16498	137	12	frontiers	frontier	NOUN
ihlr-16498	137	13	of	of	ADP
ihlr-16498	137	14	law	law	NOUN
ihlr-16498	137	15	and	and	CCONJ
ihlr-16498	137	16	science	science	NOUN
ihlr-16498	137	17	:	:	PUNCT
ihlr-16498	137	18	fdama	fdama	PROPN
ihlr-16498	137	19	's	's	PART
ihlr-16498	137	20	pediatric	pediatric	ADJ
ihlr-16498	137	21	studies	study	NOUN
ihlr-16498	137	22	incentive	incentive	NOUN
ihlr-16498	137	23	,	,	PUNCT
ihlr-16498	137	24	51	51	NUM
ihlr-16498	137	25	fooo&drugl.j	fooo&drugl.j	NOUN
ihlr-16498	137	26	.	.	PUNCT
ihlr-16498	138	1	491,491	491,491	NUM
ihlr-16498	138	2	(	(	PUNCT
ihlr-16498	138	3	2002	2002	NUM
ihlr-16498	138	4	)	)	PUNCT
ihlr-16498	138	5	(	(	PUNCT
ihlr-16498	138	6	describingthepushforthebetterpharmaceu­	describingthepushforthebetterpharmaceu­	SCONJ
ihlr-16498	138	7	ticals	tical	NOUN
ihlr-16498	138	8	for	for	ADP
ihlr-16498	138	9	children	child	NOUN
ihlr-16498	138	10	act	act	VERB
ihlr-16498	138	11	and	and	CCONJ
ihlr-16498	138	12	its	its	PRON
ihlr-16498	138	13	incorporation	incorporation	NOUN
ihlr-16498	138	14	into	into	ADP
ihlr-16498	138	15	the	the	DET
ihlr-16498	138	16	fdama	fdama	NOUN
ihlr-16498	138	17	)	)	PUNCT
ihlr-16498	138	18	;	;	PUNCT
ihlr-16498	138	19	breslow	breslow	ADJ
ihlr-16498	138	20	,	,	PUNCT
ihlr-16498	138	21	supra	supra	PROPN
ihlr-16498	138	22	note	note	NOUN
ihlr-16498	138	23	22	22	NUM
ihlr-16498	138	24	,	,	PUNCT
ihlr-16498	138	25	at	at	ADP
ihlr-16498	138	26	15155	15155	NUM
ihlr-16498	138	27	(	(	PUNCT
ihlr-16498	138	28	describing	describe	VERB
ihlr-16498	138	29	steps	step	NOUN
ihlr-16498	138	30	taken	take	VERB
ihlr-16498	138	31	by	by	ADP
ihlr-16498	138	32	the	the	DET
ihlr-16498	138	33	fda	fda	PROPN
ihlr-16498	138	34	to	to	PART
ihlr-16498	138	35	regulate	regulate	VERB
ihlr-16498	138	36	pediatric	pediatric	ADJ
ihlr-16498	138	37	testing	testing	NOUN
ihlr-16498	138	38	but	but	CCONJ
ihlr-16498	138	39	also	also	ADV
ihlr-16498	138	40	noting	note	VERB
ihlr-16498	138	41	that	that	SCONJ
ihlr-16498	138	42	congress	congress	PROPN
ihlr-16498	138	43	enacted	enact	VERB
ihlr-16498	138	44	the	the	DET
ihlr-16498	138	45	fdama	fdama	NOUN
ihlr-16498	138	46	which	which	PRON
ihlr-16498	138	47	overhauled	overhaul	VERB
ihlr-16498	138	48	the	the	DET
ihlr-16498	138	49	fdca	fdca	NOUN
ihlr-16498	138	50	)	)	PUNCT
ihlr-16498	138	51	.	.	PUNCT
ihlr-16498	139	1	25	25	NUM
ihlr-16498	139	2	21	21	NUM
ihlr-16498	139	3	u.s.c	u.s.c	NOUN
ihlr-16498	139	4	.	.	PUNCT
ihlr-16498	140	1	§	§	PROPN
ihlr-16498	140	2	355a(b	355a(b	PROPN
ihlr-16498	140	3	)	)	PUNCT
ihlr-16498	140	4	(	(	PUNCT
ihlr-16498	140	5	2000	2000	NUM
ihlr-16498	140	6	&	&	CCONJ
ihlr-16498	140	7	supp	supp	PROPN
ihlr-16498	140	8	.	.	PUNCT
ihlr-16498	141	1	iv	iv	NUM
ihlr-16498	141	2	2004	2004	NUM
ihlr-16498	141	3	)	)	PUNCT
ihlr-16498	141	4	;	;	PUNCT
ihlr-16498	141	5	see	see	VERB
ihlr-16498	141	6	breslow	breslow	NOUN
ihlr-16498	141	7	,	,	PUNCT
ihlr-16498	141	8	supra	supra	PROPN
ihlr-16498	141	9	note	note	NOUN
ihlr-16498	141	10	22	22	NUM
ihlr-16498	141	11	,	,	PUNCT
ihlr-16498	141	12	at	at	ADP
ihlr-16498	141	13	155	155	NUM
ihlr-16498	141	14	-	-	SYM
ihlr-16498	141	15	57	57	NUM
ihlr-16498	141	16	(	(	PUNCT
ihlr-16498	141	17	discussing	discuss	VERB
ihlr-16498	141	18	the	the	DET
ihlr-16498	141	19	market	market	NOUN
ihlr-16498	141	20	exclusivity	exclusivity	NOUN
ihlr-16498	141	21	provision	provision	NOUN
ihlr-16498	141	22	)	)	PUNCT
ihlr-16498	141	23	.	.	PUNCT
ihlr-16498	142	1	26	26	NUM
ihlr-16498	142	2	21	21	NUM
ihlr-16498	142	3	u.s.c	u.s.c	NOUN
ihlr-16498	142	4	.	.	PUNCT
ihlr-16498	143	1	§	§	PROPN
ihlr-16498	143	2	355a(b	355a(b	PROPN
ihlr-16498	143	3	)	)	PUNCT
ihlr-16498	144	1	(	(	PUNCT
ihlr-16498	144	2	applying	apply	VERB
ihlr-16498	144	3	to	to	ADP
ihlr-16498	144	4	both	both	DET
ihlr-16498	144	5	new	new	ADJ
ihlr-16498	144	6	drugs	drug	NOUN
ihlr-16498	144	7	and	and	CCONJ
ihlr-16498	144	8	already	already	ADV
ihlr-16498	144	9	-	-	PUNCT
ihlr-16498	144	10	marketed	market	VERB
ihlr-16498	144	11	drugs	drug	NOUN
ihlr-16498	144	12	)	)	PUNCT
ihlr-16498	144	13	.	.	PUNCT
ihlr-16498	145	1	27	27	NUM
ihlr-16498	145	2	21	21	NUM
ihlr-16498	145	3	u.s.c	u.s.c	NOUN
ihlr-16498	145	4	.	.	PUNCT
ihlr-16498	146	1	§	§	PROPN
ihlr-16498	146	2	355	355	NUM
ihlr-16498	146	3	(	(	PUNCT
ihlr-16498	146	4	2000	2000	NUM
ihlr-16498	146	5	&	&	CCONJ
ihlr-16498	146	6	supp	supp	PROPN
ihlr-16498	146	7	.	.	PUNCT
ihlr-16498	147	1	ill	ill	ADJ
ihlr-16498	147	2	2003	2003	NUM
ihlr-16498	147	3	)	)	PUNCT
ihlr-16498	147	4	;	;	PUNCT
ihlr-16498	148	1	35	35	NUM
ihlr-16498	148	2	u.s.c	u.s.c	NOUN
ihlr-16498	148	3	.	.	PUNCT
ihlr-16498	149	1	§	§	PROPN
ihlr-16498	149	2	l56(a)(4	l56(a)(4	PROPN
ihlr-16498	149	3	)	)	PUNCT
ihlr-16498	149	4	(	(	PUNCT
ihlr-16498	149	5	2000	2000	NUM
ihlr-16498	149	6	)	)	PUNCT
ihlr-16498	149	7	.	.	PUNCT
ihlr-16498	150	1	28	28	NUM
ihlr-16498	150	2	21	21	NUM
ihlr-16498	150	3	u.s.c	u.s.c	NOUN
ihlr-16498	150	4	.	.	PUNCT
ihlr-16498	151	1	§	§	PROPN
ihlr-16498	151	2	355	355	NUM
ihlr-16498	151	3	.	.	PUNCT
ihlr-16498	151	4	29	29	NUM
ihlr-16498	151	5	kurt	kurt	PROPN
ihlr-16498	151	6	r.	r.	PROPN
ihlr-16498	151	7	karst	karst	PROPN
ihlr-16498	151	8	,	,	PUNCT
ihlr-16498	151	9	comment	comment	NOUN
ihlr-16498	151	10	,	,	PUNCT
ihlr-16498	151	11	pediatric	pediatric	ADJ
ihlr-16498	151	12	testing	testing	NOUN
ihlr-16498	151	13	of	of	ADP
ihlr-16498	151	14	prescription	prescription	NOUN
ihlr-16498	151	15	drugs	drug	NOUN
ihlr-16498	151	16	:	:	PUNCT
ihlr-16498	151	17	the	the	DET
ihlr-16498	151	18	food	food	NOUN
ihlr-16498	151	19	and	and	CCONJ
ihlr-16498	151	20	drug	drug	PROPN
ihlr-16498	151	21	administration	administration	NOUN
ihlr-16498	151	22	's	's	PART
ihlr-16498	151	23	carrot	carrot	NOUN
ihlr-16498	151	24	and	and	CCONJ
ihlr-16498	151	25	stick	stick	NOUN
ihlr-16498	151	26	for	for	ADP
ihlr-16498	151	27	the	the	DET
ihlr-16498	151	28	phaimaceutical	phaimaceutical	ADJ
ihlr-16498	151	29	industry	industry	NOUN
ihlr-16498	151	30	,	,	PUNCT
ihlr-16498	151	31	49	49	NUM
ihlr-16498	151	32	am	am	NOUN
ihlr-16498	151	33	.	.	PUNCT
ihlr-16498	152	1	u.l	u.l	PROPN
ihlr-16498	152	2	.	.	PROPN
ihlr-16498	152	3	rev	rev	PROPN
ihlr-16498	152	4	.	.	PROPN
ihlr-16498	152	5	2007	2007	NUM
ihlr-16498	152	6	]	]	PUNCT
ihlr-16498	152	7	reforming	reform	VERB
ihlr-16498	152	8	fda	fda	PROPN
ihlr-16498	152	9	policy	policy	NOUN
ihlr-16498	152	10	for	for	ADP
ihlr-16498	152	11	pediatric	pediatric	ADJ
ihlr-16498	152	12	testing	testing	NOUN
ihlr-16498	152	13	67	67	NUM
ihlr-16498	152	14	market	market	NOUN
ihlr-16498	152	15	exclusivity	exclusivity	NOUN
ihlr-16498	152	16	granted	grant	VERB
ihlr-16498	152	17	to	to	ADP
ihlr-16498	152	18	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	152	19	companies	company	NOUN
ihlr-16498	152	20	,	,	PUNCT
ihlr-16498	152	21	beyond	beyond	ADP
ihlr-16498	152	22	the	the	DET
ihlr-16498	152	23	granted	grant	VERB
ihlr-16498	152	24	patent	patent	NOUN
ihlr-16498	152	25	time	time	NOUN
ihlr-16498	152	26	period	period	NOUN
ihlr-16498	152	27	,	,	PUNCT
ihlr-16498	152	28	that	that	PRON
ihlr-16498	152	29	conduct	conduct	VERB
ihlr-16498	152	30	pediatric	pediatric	ADJ
ihlr-16498	152	31	clinical	clinical	ADJ
ihlr-16498	152	32	trials	trial	NOUN
ihlr-16498	152	33	voluntarily.30	voluntarily.30	VERB
ihlr-16498	152	34	this	this	DET
ihlr-16498	152	35	mar­	mar­	NOUN
ihlr-16498	152	36	ket	ket	NOUN
ihlr-16498	152	37	exclusivity	exclusivity	NOUN
ihlr-16498	152	38	provision	provision	NOUN
ihlr-16498	152	39	could	could	AUX
ihlr-16498	152	40	potentially	potentially	ADV
ihlr-16498	152	41	allow	allow	VERB
ihlr-16498	152	42	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	152	43	companies	company	NOUN
ihlr-16498	152	44	to	to	PART
ihlr-16498	152	45	make	make	VERB
ihlr-16498	152	46	millions	million	NOUN
ihlr-16498	152	47	of	of	ADP
ihlr-16498	152	48	dollars	dollar	NOUN
ihlr-16498	152	49	for	for	ADP
ihlr-16498	152	50	heavily	heavily	ADV
ihlr-16498	152	51	prescribed	prescribe	VERB
ihlr-16498	152	52	drugs	drug	NOUN
ihlr-16498	152	53	.	.	PUNCT
ihlr-16498	153	1	the	the	DET
ihlr-16498	153	2	"	"	PUNCT
ihlr-16498	153	3	stick	stick	NOUN
ihlr-16498	153	4	"	"	PUNCT
ihlr-16498	153	5	is	be	AUX
ihlr-16498	153	6	the	the	DET
ihlr-16498	153	7	fda	fda	PROPN
ihlr-16498	153	8	rule	rule	NOUN
ihlr-16498	153	9	that	that	PRON
ihlr-16498	153	10	requires	require	VERB
ihlr-16498	153	11	companies	company	NOUN
ihlr-16498	153	12	to	to	PART
ihlr-16498	153	13	assess	assess	VERB
ihlr-16498	153	14	the	the	DET
ihlr-16498	153	15	safety	safety	NOUN
ihlr-16498	153	16	and	and	CCONJ
ihlr-16498	153	17	effectiveness	effectiveness	NOUN
ihlr-16498	153	18	of	of	ADP
ihlr-16498	153	19	the	the	DET
ihlr-16498	153	20	drug	drug	NOUN
ihlr-16498	153	21	in	in	ADP
ihlr-16498	153	22	pediatric	pediatric	ADJ
ihlr-16498	153	23	populations	population	NOUN
ihlr-16498	153	24	.	.	PUNCT
ihlr-16498	154	1	31	31	NUM
ihlr-16498	154	2	at	at	ADP
ihlr-16498	154	3	that	that	DET
ihlr-16498	154	4	time	time	NOUN
ihlr-16498	154	5	,	,	PUNCT
ihlr-16498	154	6	a	a	DET
ihlr-16498	154	7	second	second	ADJ
ihlr-16498	154	8	provision	provision	NOUN
ihlr-16498	154	9	of	of	ADP
ihlr-16498	154	10	the	the	DET
ihlr-16498	154	11	fdama	fdama	NOUN
ihlr-16498	154	12	stated	state	VERB
ihlr-16498	154	13	that	that	SCONJ
ihlr-16498	154	14	the	the	DET
ihlr-16498	154	15	secretary	secretary	NOUN
ihlr-16498	154	16	is	be	AUX
ihlr-16498	154	17	"	"	PUNCT
ihlr-16498	154	18	to	to	PART
ihlr-16498	154	19	develop	develop	VERB
ihlr-16498	154	20	a	a	DET
ihlr-16498	154	21	list	list	NOUN
ihlr-16498	154	22	of	of	ADP
ihlr-16498	154	23	drugs	drug	NOUN
ihlr-16498	154	24	for	for	ADP
ihlr-16498	154	25	which	which	PRON
ihlr-16498	154	26	additional	additional	ADJ
ihlr-16498	154	27	pediatric	pediatric	ADJ
ihlr-16498	154	28	information	information	NOUN
ihlr-16498	154	29	may	may	AUX
ihlr-16498	154	30	be	be	AUX
ihlr-16498	154	31	beneficial	beneficial	ADJ
ihlr-16498	154	32	.	.	PUNCT
ihlr-16498	155	1	"	"	PUNCT
ihlr-16498	155	2	32	32	NUM
ihlr-16498	155	3	under	under	ADP
ihlr-16498	155	4	this	this	DET
ihlr-16498	155	5	provision	provision	NOUN
ihlr-16498	155	6	,	,	PUNCT
ihlr-16498	155	7	the	the	DET
ihlr-16498	155	8	secretary	secretary	NOUN
ihlr-16498	155	9	is	be	AUX
ihlr-16498	155	10	to	to	PART
ihlr-16498	155	11	publish	publish	VERB
ihlr-16498	155	12	a	a	DET
ihlr-16498	155	13	prioritized	prioritized	ADJ
ihlr-16498	155	14	list	list	NOUN
ihlr-16498	155	15	of	of	ADP
ihlr-16498	155	16	fda	fda	PROPN
ihlr-16498	155	17	approved	approve	VERB
ihlr-16498	155	18	drugs	drug	NOUN
ihlr-16498	155	19	that	that	PRON
ihlr-16498	155	20	are	be	AUX
ihlr-16498	155	21	deemed	deem	VERB
ihlr-16498	155	22	to	to	PART
ihlr-16498	155	23	need	need	VERB
ihlr-16498	155	24	clinical	clinical	ADJ
ihlr-16498	155	25	testing	testing	NOUN
ihlr-16498	155	26	in	in	ADP
ihlr-16498	155	27	pediatric	pediatric	ADJ
ihlr-16498	155	28	patients	patient	NOUN
ihlr-16498	155	29	.	.	PUNCT
ihlr-16498	156	1	33	33	NUM
ihlr-16498	156	2	this	this	DET
ihlr-16498	156	3	list	list	NOUN
ihlr-16498	156	4	is	be	AUX
ihlr-16498	156	5	to	to	PART
ihlr-16498	156	6	be	be	AUX
ihlr-16498	156	7	updated	update	VERB
ihlr-16498	156	8	annually	annually	ADV
ihlr-16498	156	9	.	.	PUNCT
ihlr-16498	157	1	34	34	NUM
ihlr-16498	157	2	another	another	DET
ihlr-16498	157	3	provision	provision	NOUN
ihlr-16498	157	4	applied	apply	VERB
ihlr-16498	157	5	to	to	ADP
ihlr-16498	157	6	conducting	conduct	VERB
ihlr-16498	157	7	pediatric	pediatric	ADJ
ihlr-16498	157	8	studies	study	NOUN
ihlr-16498	157	9	.	.	PUNCT
ihlr-16498	158	1	35	35	NUM
ihlr-16498	158	2	this	this	DET
ihlr-16498	158	3	provision	provision	NOUN
ihlr-16498	158	4	discusses	discuss	VERB
ihlr-16498	158	5	the	the	DET
ihlr-16498	158	6	protocols	protocol	NOUN
ihlr-16498	158	7	and	and	CCONJ
ihlr-16498	158	8	time	time	NOUN
ihlr-16498	158	9	frame	frame	NOUN
ihlr-16498	158	10	for	for	ADP
ihlr-16498	158	11	the	the	DET
ihlr-16498	158	12	requirements	requirement	NOUN
ihlr-16498	158	13	of	of	ADP
ihlr-16498	158	14	pediatric	pediatric	ADJ
ihlr-16498	158	15	clinical	clinical	ADJ
ihlr-16498	158	16	studies.36	studies.36	NOUN
ihlr-16498	158	17	the	the	DET
ihlr-16498	158	18	bpca	bpca	PROPN
ihlr-16498	158	19	,	,	PUNCT
ihlr-16498	158	20	enacted	enact	VERB
ihlr-16498	158	21	in	in	ADP
ihlr-16498	158	22	2002	2002	NUM
ihlr-16498	158	23	,	,	PUNCT
ihlr-16498	158	24	addressed	address	VERB
ihlr-16498	158	25	and	and	CCONJ
ihlr-16498	158	26	changed	change	VERB
ihlr-16498	158	27	section	section	NOUN
ihlr-16498	158	28	111	111	NUM
ihlr-16498	158	29	and	and	CCONJ
ihlr-16498	158	30	is	be	AUX
ihlr-16498	158	31	discussed	discuss	VERB
ihlr-16498	158	32	in	in	ADP
ihlr-16498	158	33	greater	great	ADJ
ihlr-16498	158	34	detail	detail	NOUN
ihlr-16498	158	35	below	below	ADV
ihlr-16498	158	36	.	.	PUNCT
ihlr-16498	159	1	b.	b.	PROPN
ihlr-16498	160	1	the	the	DET
ihlr-16498	160	2	fda	fda	PROPN
ihlr-16498	160	3	required	require	VERB
ihlr-16498	160	4	pediatric	pediatric	ADJ
ihlr-16498	160	5	testing	testing	NOUN
ihlr-16498	160	6	under	under	ADP
ihlr-16498	160	7	the	the	DET
ihlr-16498	160	8	1998	1998	NUM
ihlr-16498	160	9	final	final	ADJ
ihlr-16498	160	10	rule	rule	NOUN
ihlr-16498	160	11	the	the	DET
ihlr-16498	160	12	fda	fda	PROPN
ihlr-16498	160	13	also	also	ADV
ihlr-16498	160	14	proceeded	proceed	VERB
ihlr-16498	160	15	on	on	ADP
ihlr-16498	160	16	its	its	PRON
ihlr-16498	160	17	own	own	ADJ
ihlr-16498	160	18	course	course	NOUN
ihlr-16498	160	19	to	to	PART
ihlr-16498	160	20	regulate	regulate	VERB
ihlr-16498	160	21	drug	drug	NOUN
ihlr-16498	160	22	testing	testing	NOUN
ihlr-16498	160	23	in	in	ADP
ihlr-16498	160	24	pe­	pe­	PROPN
ihlr-16498	160	25	diatric	diatric	PROPN
ihlr-16498	160	26	patients	patient	NOUN
ihlr-16498	160	27	and	and	CCONJ
ihlr-16498	160	28	promulgated	promulgate	VERB
ihlr-16498	160	29	the	the	DET
ihlr-16498	160	30	1998	1998	NUM
ihlr-16498	160	31	final	final	ADJ
ihlr-16498	160	32	rule.37	rule.37	NOUN
ihlr-16498	160	33	the	the	DET
ihlr-16498	160	34	1998	1998	NUM
ihlr-16498	160	35	final	final	ADJ
ihlr-16498	160	36	rule	rule	NOUN
ihlr-16498	160	37	acknowledged	acknowledge	VERB
ihlr-16498	160	38	the	the	DET
ihlr-16498	160	39	market	market	NOUN
ihlr-16498	160	40	exclusivity	exclusivity	NOUN
ihlr-16498	160	41	provision	provision	NOUN
ihlr-16498	160	42	in	in	ADP
ihlr-16498	160	43	the	the	DET
ihlr-16498	160	44	fdama	fdama	NOUN
ihlr-16498	160	45	.	.	PUNCT
ihlr-16498	161	1	the	the	DET
ihlr-16498	161	2	fda	fda	PROPN
ihlr-16498	161	3	rule	rule	NOUN
ihlr-16498	161	4	,	,	PUNCT
ihlr-16498	161	5	however	however	ADV
ihlr-16498	161	6	,	,	PUNCT
ihlr-16498	161	7	went	go	VERB
ihlr-16498	161	8	beyond	beyond	ADP
ihlr-16498	161	9	the	the	DET
ihlr-16498	161	10	voluntary	voluntary	ADJ
ihlr-16498	161	11	pediatric	pediatric	ADJ
ihlr-16498	161	12	testing	testing	NOUN
ihlr-16498	161	13	requirement	requirement	NOUN
ihlr-16498	161	14	in	in	ADP
ihlr-16498	161	15	the	the	DET
ihlr-16498	161	16	fdama	fdama	NOUN
ihlr-16498	161	17	by	by	ADP
ihlr-16498	161	18	allowing	allow	VERB
ihlr-16498	161	19	the	the	DET
ihlr-16498	161	20	fda	fda	PROPN
ihlr-16498	161	21	to	to	PART
ihlr-16498	161	22	require	require	VERB
ihlr-16498	161	23	pediatric	pediatric	ADJ
ihlr-16498	161	24	testing	testing	NOUN
ihlr-16498	161	25	of	of	ADP
ihlr-16498	161	26	already	already	ADV
ihlr-16498	161	27	approved	approve	VERB
ihlr-16498	161	28	and	and	CCONJ
ihlr-16498	161	29	marketed	market	VERB
ihlr-16498	161	30	drugs	drug	NOUN
ihlr-16498	161	31	and	and	CCONJ
ihlr-16498	161	32	to	to	PART
ihlr-16498	161	33	favor	favor	VERB
ihlr-16498	161	34	pediatric	pediatric	ADJ
ihlr-16498	161	35	testing	testing	NOUN
ihlr-16498	161	36	in	in	ADP
ihlr-16498	161	37	new	new	ADJ
ihlr-16498	161	38	drugs.38	drugs.38	NOUN
ihlr-16498	161	39	in	in	ADP
ihlr-16498	161	40	compiling	compile	VERB
ihlr-16498	161	41	the	the	DET
ihlr-16498	161	42	pediatric	pediatric	ADJ
ihlr-16498	161	43	list	list	NOUN
ihlr-16498	161	44	,	,	PUNCT
ihlr-16498	161	45	the	the	DET
ihlr-16498	161	46	fda	fda	PROPN
ihlr-16498	161	47	included	include	VERB
ihlr-16498	161	48	all	all	DET
ihlr-16498	161	49	drugs	drug	NOUN
ihlr-16498	161	50	that	that	PRON
ihlr-16498	161	51	are	be	AUX
ihlr-16498	161	52	approved	approve	VERB
ihlr-16498	161	53	for	for	ADP
ihlr-16498	161	54	use	use	NOUN
ihlr-16498	161	55	in	in	ADP
ihlr-16498	161	56	739	739	NUM
ihlr-16498	161	57	,	,	PUNCT
ihlr-16498	161	58	739	739	NUM
ihlr-16498	161	59	,	,	PUNCT
ihlr-16498	161	60	743	743	NUM
ihlr-16498	161	61	-	-	SYM
ihlr-16498	161	62	44	44	NUM
ihlr-16498	161	63	(	(	PUNCT
ihlr-16498	161	64	2000	2000	NUM
ihlr-16498	161	65	)	)	PUNCT
ihlr-16498	161	66	(	(	PUNCT
ihlr-16498	161	67	describing	describe	VERB
ihlr-16498	161	68	the	the	DET
ihlr-16498	161	69	"	"	PUNCT
ihlr-16498	161	70	carrot	carrot	NOUN
ihlr-16498	161	71	and	and	CCONJ
ihlr-16498	161	72	stick	stick	NOUN
ihlr-16498	161	73	"	"	PUNCT
ihlr-16498	161	74	approach	approach	NOUN
ihlr-16498	161	75	)	)	PUNCT
ihlr-16498	161	76	.	.	PUNCT
ihlr-16498	162	1	30	30	NUM
ihlr-16498	162	2	karst	karst	NOUN
ihlr-16498	162	3	,	,	PUNCT
ihlr-16498	162	4	supra	supra	PROPN
ihlr-16498	162	5	note	note	PROPN
ihlr-16498	162	6	29	29	NUM
ihlr-16498	162	7	,	,	PUNCT
ihlr-16498	162	8	at	at	ADP
ihlr-16498	162	9	743	743	NUM
ihlr-16498	162	10	-	-	SYM
ihlr-16498	162	11	44	44	NUM
ihlr-16498	162	12	;	;	PUNCT
ihlr-16498	162	13	see	see	VERB
ihlr-16498	162	14	breslow	breslow	NOUN
ihlr-16498	162	15	,	,	PUNCT
ihlr-16498	162	16	supra	supra	PROPN
ihlr-16498	162	17	note	note	NOUN
ihlr-16498	162	18	22	22	NUM
ihlr-16498	162	19	,	,	PUNCT
ihlr-16498	162	20	at	at	ADP
ihlr-16498	162	21	155	155	NUM
ihlr-16498	162	22	(	(	PUNCT
ihlr-16498	162	23	describing	describe	VERB
ihlr-16498	162	24	the	the	DET
ihlr-16498	162	25	six	six	NUM
ihlr-16498	162	26	-	-	PUNCT
ihlr-16498	162	27	month	month	NOUN
ihlr-16498	162	28	patent	patent	NOUN
ihlr-16498	162	29	extension	extension	NOUN
ihlr-16498	162	30	as	as	ADP
ihlr-16498	162	31	a	a	DET
ihlr-16498	162	32	"	"	PUNCT
ihlr-16498	162	33	financial	financial	ADJ
ihlr-16498	162	34	boom	boom	NOUN
ihlr-16498	162	35	for	for	ADP
ihlr-16498	162	36	manufacturers	manufacturer	NOUN
ihlr-16498	162	37	"	"	PUNCT
ihlr-16498	162	38	)	)	PUNCT
ihlr-16498	162	39	.	.	PUNCT
ihlr-16498	163	1	31	31	NUM
ihlr-16498	163	2	karst	karst	NOUN
ihlr-16498	163	3	,	,	PUNCT
ihlr-16498	163	4	supra	supra	PROPN
ihlr-16498	163	5	note	note	PROPN
ihlr-16498	163	6	29	29	NUM
ihlr-16498	163	7	,	,	PUNCT
ihlr-16498	163	8	at	at	ADP
ihlr-16498	163	9	744	744	NUM
ihlr-16498	163	10	;	;	PUNCT
ihlr-16498	163	11	cf	cf	NOUN
ihlr-16498	163	12	christopher	christopher	PROPN
ihlr-16498	163	13	-	-	PUNCT
ihlr-16498	163	14	paul	paul	PROPN
ihlr-16498	163	15	milne	milne	PROPN
ihlr-16498	163	16	,	,	PUNCT
ihlr-16498	163	17	supra	supra	PROPN
ihlr-16498	163	18	note	note	PROPN
ihlr-16498	163	19	24	24	NUM
ihlr-16498	163	20	,	,	PUNCT
ihlr-16498	163	21	at	at	ADP
ihlr-16498	163	22	495	495	NUM
ihlr-16498	163	23	(	(	PUNCT
ihlr-16498	163	24	"	"	PUNCT
ihlr-16498	163	25	seemingly	seemingly	ADV
ihlr-16498	163	26	taking	take	VERB
ihlr-16498	163	27	their	their	PRON
ihlr-16498	163	28	cue	cue	NOUN
ihlr-16498	163	29	from	from	ADP
ihlr-16498	163	30	the	the	DET
ihlr-16498	163	31	stance	stance	NOUN
ihlr-16498	163	32	of	of	ADP
ihlr-16498	163	33	the	the	DET
ihlr-16498	163	34	executive	executive	ADJ
ihlr-16498	163	35	office	office	NOUN
ihlr-16498	163	36	,	,	PUNCT
ihlr-16498	163	37	some	some	DET
ihlr-16498	163	38	members	member	NOUN
ihlr-16498	163	39	of	of	ADP
ihlr-16498	163	40	con­	con­	PROPN
ihlr-16498	163	41	gress	gress	PROPN
ihlr-16498	163	42	accused	accuse	VERB
ihlr-16498	163	43	fda	fda	PROPN
ihlr-16498	163	44	of	of	ADP
ihlr-16498	163	45	playing	play	VERB
ihlr-16498	163	46	'	'	PUNCT
ihlr-16498	163	47	hide	hide	VERB
ihlr-16498	163	48	the	the	DET
ihlr-16498	163	49	carrot	carrot	NOUN
ihlr-16498	163	50	'	'	PUNCT
ihlr-16498	163	51	by	by	ADP
ihlr-16498	163	52	requesting	request	VERB
ihlr-16498	163	53	only	only	ADV
ihlr-16498	163	54	a	a	DET
ihlr-16498	163	55	small	small	ADJ
ihlr-16498	163	56	number	number	NOUN
ihlr-16498	163	57	of	of	ADP
ihlr-16498	163	58	pediatric	pediatric	ADJ
ihlr-16498	163	59	trials	trial	NOUN
ihlr-16498	163	60	under	under	ADP
ihlr-16498	163	61	fdama	fdama	NOUN
ihlr-16498	163	62	.	.	PUNCT
ihlr-16498	164	1	at	at	ADP
ihlr-16498	164	2	the	the	DET
ihlr-16498	164	3	same	same	ADJ
ihlr-16498	164	4	time	time	NOUN
ihlr-16498	164	5	,	,	PUNCT
ihlr-16498	164	6	the	the	DET
ihlr-16498	164	7	agency	agency	NOUN
ihlr-16498	164	8	ostentatiously	ostentatiously	ADV
ihlr-16498	164	9	waved	wave	VERB
ihlr-16498	164	10	the	the	DET
ihlr-16498	164	11	stick	stick	NOUN
ihlr-16498	164	12	by	by	ADP
ihlr-16498	164	13	reportedly	reportedly	ADV
ihlr-16498	164	14	stating	state	VERB
ihlr-16498	164	15	that	that	SCONJ
ihlr-16498	164	16	,	,	PUNCT
ihlr-16498	164	17	if	if	SCONJ
ihlr-16498	164	18	the	the	DET
ihlr-16498	164	19	opportunity	opportunity	NOUN
ihlr-16498	164	20	offered	offer	VERB
ihlr-16498	164	21	by	by	ADP
ihlr-16498	164	22	the	the	DET
ihlr-16498	164	23	fdama	fdama	NOUN
ihlr-16498	164	24	incentives	incentive	NOUN
ihlr-16498	164	25	went	go	VERB
ihlr-16498	164	26	unanswered	unanswered	ADJ
ihlr-16498	164	27	,	,	PUNCT
ihlr-16498	164	28	fda	fda	PROPN
ihlr-16498	164	29	would	would	AUX
ihlr-16498	164	30	'	'	AUX
ihlr-16498	164	31	consider	consider	VERB
ihlr-16498	164	32	exercising	exercise	VERB
ihlr-16498	164	33	its	its	PRON
ihlr-16498	164	34	authority	authority	NOUN
ihlr-16498	164	35	to	to	PART
ihlr-16498	164	36	require	require	VERB
ihlr-16498	164	37	studies	study	NOUN
ihlr-16498	164	38	.	.	PUNCT
ihlr-16498	164	39	'	'	PUNCT
ihlr-16498	164	40	"	"	PUNCT
ihlr-16498	164	41	)	)	PUNCT
ihlr-16498	164	42	.	.	PUNCT
ihlr-16498	165	1	32	32	NUM
ihlr-16498	165	2	food	food	NOUN
ihlr-16498	165	3	and	and	CCONJ
ihlr-16498	165	4	drug	drug	PROPN
ihlr-16498	165	5	administration	administration	PROPN
ihlr-16498	165	6	modernization	modernization	PROPN
ihlr-16498	165	7	act	act	PROPN
ihlr-16498	165	8	of1997	of1997	PROPN
ihlr-16498	165	9	,	,	PUNCT
ihlr-16498	165	10	pub	pub	NOUN
ihlr-16498	165	11	.	.	PUNCT
ihlr-16498	166	1	l.	l.	PROPN
ihlr-16498	166	2	no	no	INTJ
ihlr-16498	166	3	.	.	PROPN
ihlr-16498	167	1	105	105	NUM
ihlr-16498	167	2	-	-	SYM
ihlr-16498	167	3	115	115	NUM
ihlr-16498	167	4	,	,	PUNCT
ihlr-16498	167	5	§	§	PROPN
ihlr-16498	167	6	505a(b	505a(b	PROPN
ihlr-16498	167	7	)	)	PUNCT
ihlr-16498	167	8	,	,	PUNCT
ihlr-16498	167	9	ill	ill	ADJ
ihlr-16498	167	10	stat	stat	NOUN
ihlr-16498	167	11	.	.	PUNCT
ihlr-16498	168	1	2296	2296	NUM
ihlr-16498	168	2	,	,	PUNCT
ihlr-16498	168	3	2306	2306	NUM
ihlr-16498	168	4	(	(	PUNCT
ihlr-16498	168	5	1997)(codified	1997)(codifie	VERB
ihlr-16498	168	6	as	as	SCONJ
ihlr-16498	168	7	amended	amend	VERB
ihlr-16498	168	8	at	at	ADP
ihlr-16498	168	9	21	21	NUM
ihlr-16498	168	10	u.s.c	u.s.c	ADJ
ihlr-16498	168	11	.	.	PUNCT
ihlr-16498	169	1	§	§	PROPN
ihlr-16498	169	2	355a	355a	PROPN
ihlr-16498	169	3	)	)	PUNCT
ihlr-16498	169	4	;	;	PUNCT
ihlr-16498	169	5	see	see	VERB
ihlr-16498	169	6	breslow	breslow	NOUN
ihlr-16498	169	7	,	,	PUNCT
ihlr-16498	169	8	supra	supra	PROPN
ihlr-16498	169	9	note	note	NOUN
ihlr-16498	169	10	22	22	NUM
ihlr-16498	169	11	,	,	PUNCT
ihlr-16498	169	12	at	at	ADP
ihlr-16498	169	13	156	156	NUM
ihlr-16498	169	14	.	.	PUNCT
ihlr-16498	170	1	33	33	NUM
ihlr-16498	170	2	food	food	NOUN
ihlr-16498	170	3	and	and	CCONJ
ihlr-16498	170	4	drug	drug	PROPN
ihlr-16498	170	5	administration	administration	PROPN
ihlr-16498	170	6	modernization	modernization	PROPN
ihlr-16498	170	7	act	act	NOUN
ihlr-16498	170	8	of	of	ADP
ihlr-16498	170	9	1997	1997	NUM
ihlr-16498	170	10	§	§	PROPN
ihlr-16498	170	11	505a(b	505a(b	PROPN
ihlr-16498	170	12	)	)	PUNCT
ihlr-16498	170	13	.	.	PUNCT
ihlr-16498	171	1	34	34	NUM
ihlr-16498	171	2	!	!	PUNCT
ihlr-16498	171	3	d.	d.	PROPN
ihlr-16498	171	4	35	35	NUM
ihlr-16498	171	5	!	!	PUNCT
ihlr-16498	172	1	d.	d.	PROPN
ihlr-16498	172	2	§	§	PROPN
ihlr-16498	172	3	505a(d	505a(d	PROPN
ihlr-16498	172	4	)	)	PUNCT
ihlr-16498	172	5	,	,	PUNCT
ihlr-16498	172	6	111	111	NUM
ihlr-16498	172	7	stat	stat	NOUN
ihlr-16498	172	8	.	.	PUNCT
ihlr-16498	173	1	at	at	ADP
ihlr-16498	173	2	2307	2307	NUM
ihlr-16498	173	3	.	.	PUNCT
ihlr-16498	174	1	36	36	NUM
ihlr-16498	174	2	!	!	PUNCT
ihlr-16498	175	1	d.	d.	PROPN
ihlr-16498	175	2	§	§	PROPN
ihlr-16498	175	3	505a(d)(2	505a(d)(2	PROPN
ihlr-16498	175	4	)	)	PUNCT
ihlr-16498	175	5	.	.	PUNCT
ihlr-16498	176	1	37	37	NUM
ihlr-16498	176	2	regulations	regulation	NOUN
ihlr-16498	176	3	requiring	require	VERB
ihlr-16498	176	4	manufacturers	manufacturer	NOUN
ihlr-16498	176	5	to	to	PART
ihlr-16498	176	6	assess	assess	VERB
ihlr-16498	176	7	the	the	DET
ihlr-16498	176	8	safety	safety	NOUN
ihlr-16498	176	9	and	and	CCONJ
ihlr-16498	176	10	effectiveness	effectiveness	NOUN
ihlr-16498	176	11	ofnew	ofnew	ADJ
ihlr-16498	176	12	drugs	drug	NOUN
ihlr-16498	176	13	and	and	CCONJ
ihlr-16498	176	14	biological	biological	ADJ
ihlr-16498	176	15	products	product	NOUN
ihlr-16498	176	16	in	in	ADP
ihlr-16498	176	17	pediatric	pediatric	ADJ
ihlr-16498	176	18	patients	patient	NOUN
ihlr-16498	176	19	,	,	PUNCT
ihlr-16498	176	20	63	63	NUM
ihlr-16498	176	21	fed	feed	VERB
ihlr-16498	176	22	.	.	PUNCT
ihlr-16498	177	1	reg	reg	PROPN
ihlr-16498	177	2	.	.	PROPN
ihlr-16498	177	3	66,632	66,632	NUM
ihlr-16498	177	4	,	,	PUNCT
ihlr-16498	177	5	66,633	66,633	NUM
ihlr-16498	177	6	(	(	PUNCT
ihlr-16498	177	7	dec	dec	PROPN
ihlr-16498	177	8	.	.	PROPN
ihlr-16498	177	9	2	2	NUM
ihlr-16498	177	10	,	,	PUNCT
ihlr-16498	177	11	1998	1998	NUM
ihlr-16498	177	12	)	)	PUNCT
ihlr-16498	178	1	;	;	PUNCT
ihlr-16498	178	2	see	see	VERB
ihlr-16498	178	3	generally	generally	ADV
ihlr-16498	178	4	breslow	breslow	ADJ
ihlr-16498	178	5	,	,	PUNCT
ihlr-16498	178	6	supra	supra	PROPN
ihlr-16498	178	7	note	note	NOUN
ihlr-16498	178	8	22	22	NUM
ihlr-16498	178	9	,	,	PUNCT
ihlr-16498	178	10	at	at	ADP
ihlr-16498	178	11	159	159	NUM
ihlr-16498	178	12	-	-	SYM
ihlr-16498	178	13	63	63	NUM
ihlr-16498	178	14	(	(	PUNCT
ihlr-16498	178	15	discussing	discuss	VERB
ihlr-16498	178	16	the	the	DET
ihlr-16498	178	17	final	final	ADJ
ihlr-16498	178	18	rule	rule	NOUN
ihlr-16498	178	19	)	)	PUNCT
ihlr-16498	178	20	.	.	PUNCT
ihlr-16498	179	1	38	38	NUM
ihlr-16498	179	2	regulations	regulation	NOUN
ihlr-16498	179	3	requiring	require	VERB
ihlr-16498	179	4	manufacturers	manufacturer	NOUN
ihlr-16498	179	5	to	to	PART
ihlr-16498	179	6	assess	assess	VERB
ihlr-16498	179	7	the	the	DET
ihlr-16498	179	8	safety	safety	NOUN
ihlr-16498	179	9	and	and	CCONJ
ihlr-16498	179	10	effectiveness	effectiveness	NOUN
ihlr-16498	179	11	ofnew	ofnew	ADJ
ihlr-16498	179	12	drugs	drug	NOUN
ihlr-16498	179	13	and	and	CCONJ
ihlr-16498	179	14	biological	biological	ADJ
ihlr-16498	179	15	products	product	NOUN
ihlr-16498	179	16	in	in	ADP
ihlr-16498	179	17	pediatric	pediatric	ADJ
ihlr-16498	179	18	patients	patient	NOUN
ihlr-16498	179	19	,	,	PUNCT
ihlr-16498	179	20	63	63	NUM
ihlr-16498	179	21	fed	feed	VERB
ihlr-16498	179	22	.	.	PUNCT
ihlr-16498	180	1	reg	reg	PROPN
ihlr-16498	180	2	.	.	PROPN
ihlr-16498	180	3	66,632	66,632	NUM
ihlr-16498	180	4	,	,	PUNCT
ihlr-16498	180	5	66,634	66,634	NUM
ihlr-16498	180	6	(	(	PUNCT
ihlr-16498	180	7	dec	dec	PROPN
ihlr-16498	180	8	.	.	PROPN
ihlr-16498	180	9	2	2	NUM
ihlr-16498	180	10	,	,	PUNCT
ihlr-16498	180	11	1998	1998	NUM
ihlr-16498	180	12	)	)	PUNCT
ihlr-16498	180	13	.	.	PUNCT
ihlr-16498	181	1	68	68	NUM
ihlr-16498	181	2	indiana	indiana	PROPN
ihlr-16498	181	3	health	health	PROPN
ihlr-16498	181	4	law	law	NOUN
ihlr-16498	181	5	review	review	NOUN
ihlr-16498	181	6	[	[	X
ihlr-16498	181	7	vol	vol	NOUN
ihlr-16498	181	8	.	.	PUNCT
ihlr-16498	182	1	4:59	4:59	NUM
ihlr-16498	182	2	adults	adult	NOUN
ihlr-16498	182	3	for	for	ADP
ihlr-16498	182	4	a	a	DET
ihlr-16498	182	5	disease	disease	NOUN
ihlr-16498	182	6	or	or	CCONJ
ihlr-16498	182	7	condition	condition	NOUN
ihlr-16498	182	8	that	that	PRON
ihlr-16498	182	9	occurs	occur	VERB
ihlr-16498	182	10	in	in	ADP
ihlr-16498	182	11	children	child	NOUN
ihlr-16498	182	12	.	.	PUNCT
ihlr-16498	183	1	39	39	NUM
ihlr-16498	184	1	the	the	DET
ihlr-16498	184	2	fda	fda	PROPN
ihlr-16498	184	3	also	also	ADV
ihlr-16498	184	4	re­	re­	AUX
ihlr-16498	184	5	quires	quire	VERB
ihlr-16498	184	6	new	new	ADJ
ihlr-16498	184	7	drugs	drug	NOUN
ihlr-16498	184	8	that	that	PRON
ihlr-16498	184	9	had	have	VERB
ihlr-16498	184	10	a	a	DET
ihlr-16498	184	11	high	high	ADJ
ihlr-16498	184	12	probability	probability	NOUN
ihlr-16498	184	13	of	of	ADP
ihlr-16498	184	14	use	use	NOUN
ihlr-16498	184	15	in	in	ADP
ihlr-16498	184	16	pediatric	pediatric	ADJ
ihlr-16498	184	17	populations	population	NOUN
ihlr-16498	184	18	to	to	PART
ihlr-16498	184	19	undergo	undergo	VERB
ihlr-16498	184	20	pediatric	pediatric	ADJ
ihlr-16498	184	21	testing.40	testing.40	NOUN
ihlr-16498	184	22	under	under	ADP
ihlr-16498	184	23	the	the	DET
ihlr-16498	184	24	1998	1998	NUM
ihlr-16498	184	25	final	final	ADJ
ihlr-16498	184	26	rule	rule	NOUN
ihlr-16498	184	27	,	,	PUNCT
ihlr-16498	184	28	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	184	29	companies	company	NOUN
ihlr-16498	184	30	could	could	AUX
ihlr-16498	184	31	request	request	VERB
ihlr-16498	184	32	a	a	DET
ihlr-16498	184	33	waiver	waiver	NOUN
ihlr-16498	184	34	for	for	ADP
ihlr-16498	184	35	pediatric	pediatric	ADJ
ihlr-16498	184	36	testing.41	testing.41	NOUN
ihlr-16498	184	37	to	to	PART
ihlr-16498	184	38	receive	receive	VERB
ihlr-16498	184	39	a	a	DET
ihlr-16498	184	40	waiver	waiver	NOUN
ihlr-16498	184	41	,	,	PUNCT
ihlr-16498	184	42	the	the	DET
ihlr-16498	184	43	fda	fda	PROPN
ihlr-16498	184	44	must	must	AUX
ihlr-16498	184	45	be	be	AUX
ihlr-16498	184	46	satisfied	satisfied	ADJ
ihlr-16498	184	47	that	that	SCONJ
ihlr-16498	184	48	(	(	PUNCT
ihlr-16498	184	49	1	1	X
ihlr-16498	184	50	)	)	PUNCT
ihlr-16498	184	51	the	the	DET
ihlr-16498	184	52	drug	drug	NOUN
ihlr-16498	184	53	did	do	AUX
ihlr-16498	184	54	not	not	PART
ihlr-16498	184	55	provide	provide	VERB
ihlr-16498	184	56	a	a	DET
ihlr-16498	184	57	therapeutic	therapeutic	ADJ
ihlr-16498	184	58	benefit	benefit	NOUN
ihlr-16498	184	59	over	over	ADP
ihlr-16498	184	60	the	the	DET
ihlr-16498	184	61	existing	exist	VERB
ihlr-16498	184	62	treat­	treat­	ADV
ihlr-16498	184	63	ment	ment	NOUN
ihlr-16498	184	64	and	and	CCONJ
ihlr-16498	184	65	(	(	PUNCT
ihlr-16498	184	66	2	2	X
ihlr-16498	184	67	)	)	PUNCT
ihlr-16498	184	68	the	the	DET
ihlr-16498	184	69	drug	drug	NOUN
ihlr-16498	184	70	would	would	AUX
ihlr-16498	184	71	not	not	PART
ihlr-16498	184	72	be	be	AUX
ihlr-16498	184	73	used	use	VERB
ihlr-16498	184	74	in	in	ADP
ihlr-16498	184	75	a	a	DET
ihlr-16498	184	76	substantial	substantial	ADJ
ihlr-16498	184	77	number	number	NOUN
ihlr-16498	184	78	of	of	ADP
ihlr-16498	184	79	pediatric	pediatric	ADJ
ihlr-16498	184	80	patients.42	patients.42	NOUN
ihlr-16498	184	81	if	if	SCONJ
ihlr-16498	184	82	a	a	DET
ihlr-16498	184	83	company	company	NOUN
ihlr-16498	184	84	did	do	AUX
ihlr-16498	184	85	not	not	PART
ihlr-16498	184	86	receive	receive	VERB
ihlr-16498	184	87	a	a	DET
ihlr-16498	184	88	waiver	waiver	NOUN
ihlr-16498	184	89	,	,	PUNCT
ihlr-16498	184	90	the	the	DET
ihlr-16498	184	91	fda	fda	PROPN
ihlr-16498	184	92	could	could	AUX
ihlr-16498	184	93	file	file	VERB
ihlr-16498	184	94	an	an	DET
ihlr-16498	184	95	action	action	NOUN
ihlr-16498	184	96	in	in	ADP
ihlr-16498	184	97	federal	federal	ADJ
ihlr-16498	184	98	court	court	NOUN
ihlr-16498	184	99	seeking	seek	VERB
ihlr-16498	184	100	an	an	DET
ihlr-16498	184	101	injunction	injunction	NOUN
ihlr-16498	184	102	based	base	VERB
ihlr-16498	184	103	on	on	ADP
ihlr-16498	184	104	the	the	DET
ihlr-16498	184	105	manufacturer	manufacturer	NOUN
ihlr-16498	184	106	's	's	PART
ihlr-16498	184	107	noncompli­	noncompli­	NOUN
ihlr-16498	184	108	ance.43	ance.43	NOUN
ihlr-16498	184	109	the	the	DET
ihlr-16498	184	110	court	court	NOUN
ihlr-16498	184	111	could	could	AUX
ihlr-16498	184	112	then	then	ADV
ihlr-16498	184	113	require	require	VERB
ihlr-16498	184	114	the	the	DET
ihlr-16498	184	115	manufacturer	manufacturer	NOUN
ihlr-16498	184	116	to	to	PART
ihlr-16498	184	117	assess	assess	VERB
ihlr-16498	184	118	the	the	DET
ihlr-16498	184	119	safety	safety	NOUN
ihlr-16498	184	120	and	and	CCONJ
ihlr-16498	184	121	effectiveness	effectiveness	NOUN
ihlr-16498	184	122	of	of	ADP
ihlr-16498	184	123	the	the	DET
ihlr-16498	184	124	drug	drug	NOUN
ihlr-16498	184	125	in	in	ADP
ihlr-16498	184	126	pediatric	pediatric	ADJ
ihlr-16498	184	127	populations	population	NOUN
ihlr-16498	184	128	.	.	PUNCT
ihlr-16498	185	1	44	44	NUM
ihlr-16498	185	2	in	in	ADP
ihlr-16498	185	3	addition	addition	NOUN
ihlr-16498	185	4	,	,	PUNCT
ihlr-16498	185	5	the	the	DET
ihlr-16498	185	6	fda	fda	PROPN
ihlr-16498	185	7	separated	separate	VERB
ihlr-16498	185	8	the	the	DET
ihlr-16498	185	9	pediatric	pediatric	ADJ
ihlr-16498	185	10	population	population	NOUN
ihlr-16498	185	11	into	into	ADP
ihlr-16498	185	12	the	the	DET
ihlr-16498	185	13	fqllowing	fqllowe	VERB
ihlr-16498	185	14	arbitrary	arbitrary	ADJ
ihlr-16498	185	15	age	age	NOUN
ihlr-16498	185	16	groups	group	NOUN
ihlr-16498	185	17	:	:	PUNCT
ihlr-16498	185	18	neonates	neonate	NOUN
ihlr-16498	185	19	(	(	PUNCT
ihlr-16498	185	20	up	up	ADP
ihlr-16498	185	21	to	to	PART
ihlr-16498	185	22	one	one	NUM
ihlr-16498	185	23	month	month	NOUN
ihlr-16498	185	24	old	old	ADJ
ihlr-16498	185	25	)	)	PUNCT
ihlr-16498	185	26	;	;	PUNCT
ihlr-16498	185	27	infants	infant	NOUN
ihlr-16498	185	28	(	(	PUNCT
ihlr-16498	185	29	one	one	NUM
ihlr-16498	185	30	month	month	NOUN
ihlr-16498	185	31	to	to	ADP
ihlr-16498	185	32	two	two	NUM
ihlr-16498	185	33	years	year	NOUN
ihlr-16498	185	34	old	old	ADJ
ihlr-16498	185	35	)	)	PUNCT
ihlr-16498	185	36	;	;	PUNCT
ihlr-16498	185	37	children	child	NOUN
ihlr-16498	185	38	(	(	PUNCT
ihlr-16498	185	39	two	two	NUM
ihlr-16498	185	40	to	to	PART
ihlr-16498	185	41	twelve	twelve	NUM
ihlr-16498	185	42	years	year	NOUN
ihlr-16498	185	43	old	old	ADJ
ihlr-16498	185	44	)	)	PUNCT
ihlr-16498	185	45	;	;	PUNCT
ihlr-16498	185	46	and	and	CCONJ
ihlr-16498	185	47	adolescents	adolescent	NOUN
ihlr-16498	185	48	(	(	PUNCT
ihlr-16498	185	49	twelve	twelve	NUM
ihlr-16498	185	50	to	to	PART
ihlr-16498	185	51	six­	six­	VERB
ihlr-16498	185	52	teen	teen	NOUN
ihlr-16498	185	53	years	year	NOUN
ihlr-16498	185	54	old).45	old).45	ADP
ihlr-16498	185	55	these	these	DET
ihlr-16498	185	56	age	age	NOUN
ihlr-16498	185	57	ranges	range	VERB
ihlr-16498	185	58	,	,	PUNCT
ihlr-16498	185	59	however	however	ADV
ihlr-16498	185	60	,	,	PUNCT
ihlr-16498	185	61	do	do	AUX
ihlr-16498	185	62	not	not	PART
ihlr-16498	185	63	necessarily	necessarily	ADV
ihlr-16498	185	64	account	account	VERB
ihlr-16498	185	65	for	for	ADP
ihlr-16498	185	66	physiological	physiological	ADJ
ihlr-16498	185	67	differences	difference	NOUN
ihlr-16498	185	68	.	.	PUNCT
ihlr-16498	186	1	moreover	moreover	ADV
ihlr-16498	186	2	,	,	PUNCT
ihlr-16498	186	3	older	old	ADJ
ihlr-16498	186	4	teenagers	teenager	NOUN
ihlr-16498	186	5	and	and	CCONJ
ihlr-16498	186	6	young	young	ADJ
ihlr-16498	186	7	adults	adult	NOUN
ihlr-16498	186	8	may	may	AUX
ihlr-16498	186	9	still	still	ADV
ihlr-16498	186	10	undergo	undergo	VERB
ihlr-16498	186	11	developmental	developmental	ADJ
ihlr-16498	186	12	changes	change	NOUN
ihlr-16498	186	13	.	.	PUNCT
ihlr-16498	187	1	issues	issue	NOUN
ihlr-16498	187	2	regarding	regard	VERB
ihlr-16498	187	3	these	these	DET
ihlr-16498	187	4	age	age	NOUN
ihlr-16498	187	5	groups	group	NOUN
ihlr-16498	187	6	are	be	AUX
ihlr-16498	187	7	further	far	ADV
ihlr-16498	187	8	discussed	discuss	VERB
ihlr-16498	187	9	below	below	ADV
ihlr-16498	187	10	.	.	PUNCT
ihlr-16498	188	1	c.	c.	PROPN
ihlr-16498	188	2	pediatric	pediatric	ADJ
ihlr-16498	188	3	testing	testing	NOUN
ihlr-16498	188	4	of	of	ADP
ihlr-16498	188	5	both	both	DET
ihlr-16498	188	6	patented	patented	ADJ
ihlr-16498	188	7	and	and	CCONJ
ihlr-16498	188	8	off	off	ADP
ihlr-16498	188	9	-	-	PUNCT
ihlr-16498	188	10	patent	patent	NOUN
ihlr-16498	188	11	drugs	drug	NOUN
ihlr-16498	188	12	is	be	AUX
ihlr-16498	188	13	permitted	permit	VERB
ihlr-16498	188	14	under	under	ADP
ihlr-16498	188	15	the	the	DET
ihlr-16498	188	16	best	good	ADJ
ihlr-16498	188	17	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	188	18	for	for	ADP
ihlr-16498	188	19	children	child	NOUN
ihlr-16498	188	20	act	act	VERB
ihlr-16498	188	21	when	when	SCONJ
ihlr-16498	188	22	enacted	enact	VERB
ihlr-16498	188	23	,	,	PUNCT
ihlr-16498	188	24	section	section	NOUN
ihlr-16498	188	25	111	111	NUM
ihlr-16498	188	26	of	of	ADP
ihlr-16498	188	27	the	the	DET
ihlr-16498	188	28	fdama	fdama	NOUN
ihlr-16498	188	29	was	be	AUX
ihlr-16498	188	30	set	set	VERB
ihlr-16498	188	31	to	to	PART
ihlr-16498	188	32	sunset	sunset	VERB
ihlr-16498	188	33	in	in	ADP
ihlr-16498	188	34	2002	2002	NUM
ihlr-16498	188	35	.	.	PUNCT
ihlr-16498	189	1	in	in	ADP
ihlr-16498	189	2	2002	2002	NUM
ihlr-16498	189	3	,	,	PUNCT
ihlr-16498	189	4	however	however	ADV
ihlr-16498	189	5	,	,	PUNCT
ihlr-16498	189	6	congress	congress	PROPN
ihlr-16498	189	7	enacted	enact	VERB
ihlr-16498	189	8	the	the	DET
ihlr-16498	189	9	best	good	ADJ
ihlr-16498	189	10	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	189	11	for	for	ADP
ihlr-16498	189	12	children	child	NOUN
ihlr-16498	189	13	act	act	NOUN
ihlr-16498	189	14	(	(	PUNCT
ihlr-16498	189	15	"	"	PUNCT
ihlr-16498	189	16	bpca	bpca	PROPN
ihlr-16498	189	17	"	"	PUNCT
ihlr-16498	189	18	)	)	PUNCT
ihlr-16498	189	19	,	,	PUNCT
ihlr-16498	189	20	46	46	NUM
ihlr-16498	189	21	which	which	PRON
ihlr-16498	189	22	includes	include	VERB
ihlr-16498	189	23	the	the	DET
ihlr-16498	189	24	market	market	NOUN
ihlr-16498	189	25	-	-	PUNCT
ihlr-16498	189	26	exclusivity	exclusivity	NOUN
ihlr-16498	189	27	provision	provision	NOUN
ihlr-16498	189	28	in	in	ADP
ihlr-16498	189	29	the	the	DET
ihlr-16498	189	30	fdama	fdama	NOUN
ihlr-16498	189	31	39	39	NUM
ihlr-16498	189	32	fda	fda	PROPN
ihlr-16498	189	33	docket	docket	NOUN
ihlr-16498	189	34	no	no	NOUN
ihlr-16498	189	35	.	.	PROPN
ihlr-16498	189	36	98	98	NUM
ihlr-16498	189	37	n-0056	n-0056	PROPN
ihlr-16498	189	38	,	,	PUNCT
ihlr-16498	189	39	list	list	NOUN
ihlr-16498	189	40	of	of	ADP
ihlr-16498	189	41	drugs	drug	NOUN
ihlr-16498	189	42	for	for	ADP
ihlr-16498	189	43	which	which	PRON
ihlr-16498	189	44	additional	additional	ADJ
ihlr-16498	189	45	pediatric	pediatric	ADJ
ihlr-16498	189	46	informa­	informa­	PROPN
ihlr-16498	189	47	tion	tion	NOUN
ihlr-16498	189	48	may	may	AUX
ihlr-16498	189	49	produce	produce	VERB
ihlr-16498	189	50	health	health	NOUN
ihlr-16498	189	51	benefits	benefit	NOUN
ihlr-16498	189	52	in	in	ADP
ihlr-16498	189	53	the	the	DET
ihlr-16498	189	54	pediatric	pediatric	ADJ
ihlr-16498	189	55	population	population	NOUN
ihlr-16498	189	56	1	1	NUM
ihlr-16498	189	57	,	,	PUNCT
ihlr-16498	189	58	1	1	NUM
ihlr-16498	189	59	-	-	SYM
ihlr-16498	189	60	3	3	NUM
ihlr-16498	189	61	(	(	PUNCT
ihlr-16498	189	62	may	may	PROPN
ihlr-16498	189	63	20	20	NUM
ihlr-16498	189	64	,	,	PUNCT
ihlr-16498	189	65	1998	1998	NUM
ihlr-16498	189	66	)	)	PUNCT
ihlr-16498	189	67	;	;	PUNCT
ihlr-16498	189	68	see	see	VERB
ihlr-16498	189	69	mi­	mi­	PROPN
ihlr-16498	189	70	chael	chael	PROPN
ihlr-16498	189	71	s.	s.	PROPN
ihlr-16498	189	72	labson	labson	PROPN
ihlr-16498	189	73	,	,	PUNCT
ihlr-16498	189	74	pediatric	pediatric	ADJ
ihlr-16498	189	75	priorities	priority	NOUN
ihlr-16498	189	76	:	:	PUNCT
ihlr-16498	189	77	legislative	legislative	ADJ
ihlr-16498	189	78	and	and	CCONJ
ihlr-16498	189	79	regulatory	regulatory	ADJ
ihlr-16498	189	80	initiatives	initiative	NOUN
ihlr-16498	189	81	to	to	PART
ihlr-16498	189	82	expand	expand	VERB
ihlr-16498	189	83	research	research	NOUN
ihlr-16498	189	84	on	on	ADP
ihlr-16498	189	85	the	the	DET
ihlr-16498	189	86	use	use	NOUN
ihlr-16498	189	87	of	of	ADP
ihlr-16498	189	88	medicines	medicine	NOUN
ihlr-16498	189	89	in	in	ADP
ihlr-16498	189	90	pediatric	pediatric	ADJ
ihlr-16498	189	91	patients	patient	NOUN
ihlr-16498	189	92	,	,	PUNCT
ihlr-16498	189	93	6	6	NUM
ihlr-16498	189	94	j.	j.	PROPN
ihlr-16498	189	95	health	health	PROPN
ihlr-16498	189	96	carel	carel	PROPN
ihlr-16498	189	97	.	.	PUNCT
ihlr-16498	189	98	&	&	CCONJ
ihlr-16498	189	99	pol'y	pol'y	NOUN
ihlr-16498	189	100	34	34	NUM
ihlr-16498	189	101	,	,	PUNCT
ihlr-16498	189	102	47	47	NUM
ihlr-16498	189	103	(	(	PUNCT
ihlr-16498	189	104	2002	2002	NUM
ihlr-16498	189	105	)	)	PUNCT
ihlr-16498	189	106	(	(	PUNCT
ihlr-16498	189	107	describing	describe	VERB
ihlr-16498	189	108	the	the	DET
ihlr-16498	189	109	pediatric	pediatric	ADJ
ihlr-16498	189	110	list	list	NOUN
ihlr-16498	189	111	)	)	PUNCT
ihlr-16498	189	112	.	.	PUNCT
ihlr-16498	190	1	40	40	NUM
ihlr-16498	190	2	see	see	VERB
ihlr-16498	190	3	labson	labson	NOUN
ihlr-16498	190	4	,	,	PUNCT
ihlr-16498	190	5	supra	supra	PROPN
ihlr-16498	190	6	note	note	NOUN
ihlr-16498	190	7	39	39	NUM
ihlr-16498	190	8	,	,	PUNCT
ihlr-16498	190	9	at	at	ADP
ihlr-16498	190	10	48	48	NUM
ihlr-16498	190	11	(	(	PUNCT
ihlr-16498	190	12	2002	2002	NUM
ihlr-16498	190	13	)	)	PUNCT
ihlr-16498	190	14	.	.	PUNCT
ihlr-16498	191	1	41	41	NUM
ihlr-16498	191	2	regulations	regulation	NOUN
ihlr-16498	191	3	requiring	require	VERB
ihlr-16498	191	4	manufacturers	manufacturer	NOUN
ihlr-16498	191	5	to	to	PART
ihlr-16498	191	6	assess	assess	VERB
ihlr-16498	191	7	the	the	DET
ihlr-16498	191	8	safety	safety	NOUN
ihlr-16498	191	9	and	and	CCONJ
ihlr-16498	191	10	effectiveness	effectiveness	NOUN
ihlr-16498	191	11	ofnew	ofnew	ADJ
ihlr-16498	191	12	drugs	drug	NOUN
ihlr-16498	191	13	and	and	CCONJ
ihlr-16498	191	14	biological	biological	ADJ
ihlr-16498	191	15	products	product	NOUN
ihlr-16498	191	16	in	in	ADP
ihlr-16498	191	17	pediatric	pediatric	ADJ
ihlr-16498	191	18	patients	patient	NOUN
ihlr-16498	191	19	,	,	PUNCT
ihlr-16498	191	20	63	63	NUM
ihlr-16498	191	21	fed	feed	VERB
ihlr-16498	191	22	.	.	PUNCT
ihlr-16498	192	1	reg	reg	PROPN
ihlr-16498	192	2	.	.	PUNCT
ihlr-16498	193	1	66,632	66,632	NUM
ihlr-16498	193	2	(	(	PUNCT
ihlr-16498	193	3	dec	dec	PROPN
ihlr-16498	193	4	.	.	PROPN
ihlr-16498	193	5	2	2	NUM
ihlr-16498	193	6	,	,	PUNCT
ihlr-16498	193	7	1998	1998	NUM
ihlr-16498	193	8	)	)	PUNCT
ihlr-16498	193	9	(	(	PUNCT
ihlr-16498	193	10	codi­	codi­	PROPN
ihlr-16498	193	11	fied	fie	VERB
ihlr-16498	193	12	at	at	ADP
ihlr-16498	193	13	21	21	NUM
ihlr-16498	193	14	c.p.r	c.p.r	NOUN
ihlr-16498	193	15	.	.	PUNCT
ihlr-16498	194	1	pts	pts	PROPN
ihlr-16498	194	2	.	.	PROPN
ihlr-16498	194	3	201	201	NUM
ihlr-16498	194	4	,	,	PUNCT
ihlr-16498	194	5	312,314	312,314	NUM
ihlr-16498	194	6	,	,	PUNCT
ihlr-16498	194	7	and	and	CCONJ
ihlr-16498	194	8	601	601	NUM
ihlr-16498	194	9	(	(	PUNCT
ihlr-16498	194	10	2006	2006	NUM
ihlr-16498	194	11	)	)	PUNCT
ihlr-16498	194	12	)	)	PUNCT
ihlr-16498	194	13	.	.	PUNCT
ihlr-16498	195	1	42	42	NUM
ihlr-16498	195	2	21	21	NUM
ihlr-16498	195	3	c.p.r.§§	c.p.r.§§	NUM
ihlr-16498	195	4	314.55(c)(2)(i	314.55(c)(2)(i	NUM
ihlr-16498	195	5	)	)	PUNCT
ihlr-16498	195	6	,	,	PUNCT
ihlr-16498	195	7	601.27(c)(2)(i	601.27(c)(2)(i	NUM
ihlr-16498	195	8	)	)	PUNCT
ihlr-16498	195	9	(	(	PUNCT
ihlr-16498	195	10	2002	2002	NUM
ihlr-16498	195	11	)	)	PUNCT
ihlr-16498	195	12	.	.	PUNCT
ihlr-16498	196	1	see	see	VERB
ihlr-16498	196	2	labson	labson	ADJ
ihlr-16498	196	3	,	,	PUNCT
ihlr-16498	196	4	supra	supra	PROPN
ihlr-16498	196	5	note	note	NOUN
ihlr-16498	196	6	39	39	NUM
ihlr-16498	196	7	,	,	PUNCT
ihlr-16498	196	8	at	at	ADP
ihlr-16498	196	9	54	54	NUM
ihlr-16498	196	10	(	(	PUNCT
ihlr-16498	196	11	describing	describe	VERB
ihlr-16498	196	12	the	the	DET
ihlr-16498	196	13	waiver	waiver	NOUN
ihlr-16498	196	14	provision	provision	NOUN
ihlr-16498	196	15	)	)	PUNCT
ihlr-16498	196	16	.	.	PUNCT
ihlr-16498	197	1	43	43	NUM
ihlr-16498	197	2	regulations	regulation	NOUN
ihlr-16498	197	3	requiring	require	VERB
ihlr-16498	197	4	manufacturers	manufacturer	NOUN
ihlr-16498	197	5	to	to	PART
ihlr-16498	197	6	assess	assess	VERB
ihlr-16498	197	7	the	the	DET
ihlr-16498	197	8	safety	safety	NOUN
ihlr-16498	197	9	and	and	CCONJ
ihlr-16498	197	10	effectiveness	effectiveness	NOUN
ihlr-16498	197	11	ofnew	ofnew	ADJ
ihlr-16498	197	12	drugs	drug	NOUN
ihlr-16498	197	13	and	and	CCONJ
ihlr-16498	197	14	biological	biological	ADJ
ihlr-16498	197	15	products	product	NOUN
ihlr-16498	197	16	in	in	ADP
ihlr-16498	197	17	pediatric	pediatric	ADJ
ihlr-16498	197	18	patients	patient	NOUN
ihlr-16498	197	19	,	,	PUNCT
ihlr-16498	197	20	63	63	NUM
ihlr-16498	197	21	fed	feed	VERB
ihlr-16498	197	22	.	.	PUNCT
ihlr-16498	198	1	reg	reg	PROPN
ihlr-16498	198	2	.	.	PROPN
ihlr-16498	199	1	66	66	NUM
ihlr-16498	199	2	,	,	PUNCT
ihlr-16498	199	3	632	632	NUM
ihlr-16498	199	4	,	,	PUNCT
ihlr-16498	199	5	66,636	66,636	NUM
ihlr-16498	199	6	(	(	PUNCT
ihlr-16498	199	7	dec	dec	PROPN
ihlr-16498	199	8	.	.	PROPN
ihlr-16498	199	9	2	2	NUM
ihlr-16498	199	10	,	,	PUNCT
ihlr-16498	199	11	1998	1998	NUM
ihlr-16498	199	12	)	)	PUNCT
ihlr-16498	199	13	;	;	PUNCT
ihlr-16498	199	14	see	see	VERB
ihlr-16498	199	15	labson	labson	NOUN
ihlr-16498	199	16	,	,	PUNCT
ihlr-16498	199	17	supra	supra	PROPN
ihlr-16498	199	18	note	note	NOUN
ihlr-16498	199	19	39	39	NUM
ihlr-16498	199	20	,	,	PUNCT
ihlr-16498	199	21	at	at	ADP
ihlr-16498	199	22	56	56	NUM
ihlr-16498	199	23	(	(	PUNCT
ihlr-16498	199	24	describing	describe	VERB
ihlr-16498	199	25	enforcement	enforcement	NOUN
ihlr-16498	199	26	)	)	PUNCT
ihlr-16498	199	27	.	.	PUNCT
ihlr-16498	200	1	44	44	NUM
ihlr-16498	200	2	see	see	VERB
ihlr-16498	200	3	21	21	NUM
ihlr-16498	200	4	c.f	c.f	PROPN
ihlr-16498	200	5	.r	.r	PROPN
ihlr-16498	200	6	.	.	PUNCT
ihlr-16498	201	1	§	§	PROPN
ihlr-16498	201	2	§	§	NOUN
ihlr-16498	201	3	201.23	201.23	NUM
ihlr-16498	201	4	,	,	PUNCT
ihlr-16498	201	5	601.27	601.27	NUM
ihlr-16498	201	6	(	(	PUNCT
ihlr-16498	201	7	2006	2006	NUM
ihlr-16498	201	8	)	)	PUNCT
ihlr-16498	201	9	(	(	PUNCT
ihlr-16498	201	10	requiring	require	VERB
ihlr-16498	201	11	manufacturers	manufacturer	NOUN
ihlr-16498	201	12	to	to	PART
ihlr-16498	201	13	assess	assess	VERB
ihlr-16498	201	14	the	the	DET
ihlr-16498	201	15	safety	safety	NOUN
ihlr-16498	201	16	and	and	CCONJ
ihlr-16498	201	17	effectiveness	effectiveness	NOUN
ihlr-16498	201	18	of	of	ADP
ihlr-16498	201	19	new	new	ADJ
ihlr-16498	201	20	drugs	drug	NOUN
ihlr-16498	201	21	and	and	CCONJ
ihlr-16498	201	22	biological	biological	ADJ
ihlr-16498	201	23	products	product	NOUN
ihlr-16498	201	24	in	in	ADP
ihlr-16498	201	25	pediatric	pediatric	ADJ
ihlr-16498	201	26	patients	patient	NOUN
ihlr-16498	201	27	)	)	PUNCT
ihlr-16498	201	28	.	.	PUNCT
ihlr-16498	202	1	see	see	VERB
ihlr-16498	202	2	also	also	ADV
ihlr-16498	202	3	labson	labson	ADJ
ihlr-16498	202	4	,	,	PUNCT
ihlr-16498	202	5	supra	supra	NOUN
ihlr-16498	202	6	note	note	NOUN
ihlr-16498	202	7	39	39	NUM
ihlr-16498	202	8	,	,	PUNCT
ihlr-16498	202	9	at	at	ADP
ihlr-16498	202	10	56	56	NUM
ihlr-16498	202	11	(	(	PUNCT
ihlr-16498	202	12	describing	describe	VERB
ihlr-16498	202	13	the	the	DET
ihlr-16498	202	14	enforcement	enforcement	NOUN
ihlr-16498	202	15	mechanism	mechanism	NOUN
ihlr-16498	202	16	)	)	PUNCT
ihlr-16498	202	17	.	.	PUNCT
ihlr-16498	203	1	45	45	NUM
ihlr-16498	203	2	william	william	PROPN
ihlr-16498	203	3	j.	j.	PROPN
ihlr-16498	203	4	rodriguez	rodriguez	PROPN
ihlr-16498	203	5	,	,	PUNCT
ihlr-16498	203	6	sci	sci	PROPN
ihlr-16498	203	7	.	.	PROPN
ihlr-16498	203	8	dir	dir	PROPN
ihlr-16498	203	9	.	.	PUNCT
ihlr-16498	204	1	for	for	ADP
ihlr-16498	204	2	pediatrics	pediatric	NOUN
ihlr-16498	204	3	,	,	PUNCT
ihlr-16498	204	4	fda	fda	PROPN
ihlr-16498	204	5	,	,	PUNCT
ihlr-16498	204	6	cder	cder	NOUN
ihlr-16498	204	7	's	's	PART
ihlr-16498	204	8	experience	experience	NOUN
ihlr-16498	204	9	:	:	PUNCT
ihlr-16498	204	10	what	what	PRON
ihlr-16498	204	11	we	we	PRON
ihlr-16498	204	12	have	have	AUX
ihlr-16498	204	13	learned	learn	VERB
ihlr-16498	204	14	from	from	ADP
ihlr-16498	204	15	the	the	DET
ihlr-16498	204	16	pediatric	pediatric	ADJ
ihlr-16498	204	17	initiative	initiative	NOUN
ihlr-16498	204	18	(	(	PUNCT
ihlr-16498	204	19	feb	feb	PROPN
ihlr-16498	204	20	.	.	PROPN
ihlr-16498	204	21	20	20	NUM
ihlr-16498	204	22	,	,	PUNCT
ihlr-16498	204	23	2002	2002	NUM
ihlr-16498	204	24	)	)	PUNCT
ihlr-16498	204	25	,	,	PUNCT
ihlr-16498	204	26	available	available	ADJ
ihlr-16498	204	27	at	at	ADP
ihlr-16498	204	28	http://www.fdagov/cderlpediatriclpresentatioolped	http://www.fdagov/cderlpediatriclpresentatioolpe	VERB
ihlr-16498	204	29	_	_	PRON
ihlr-16498	204	30	init	init	VERB
ihlr-16498	205	1	_	_	PUNCT
ihlr-16498	205	2	rodriguezlsld024.htm	rodriguezlsld024.htm	X
ihlr-16498	205	3	(	(	PUNCT
ihlr-16498	205	4	microsoft	microsoft	PROPN
ihlr-16498	205	5	office	office	PROPN
ihlr-16498	205	6	powerpoint	powerpoint	PROPN
ihlr-16498	205	7	slide	slide	NOUN
ihlr-16498	205	8	no	no	INTJ
ihlr-16498	205	9	.	.	PROPN
ihlr-16498	205	10	24	24	NUM
ihlr-16498	205	11	)	)	PUNCT
ihlr-16498	205	12	.	.	PUNCT
ihlr-16498	206	1	46	46	NUM
ihlr-16498	206	2	best	good	ADJ
ihlr-16498	206	3	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	206	4	for	for	ADP
ihlr-16498	206	5	children	child	NOUN
ihlr-16498	206	6	act	act	NOUN
ihlr-16498	206	7	,	,	PUNCT
ihlr-16498	206	8	pub	pub	NOUN
ihlr-16498	206	9	.	.	PUNCT
ihlr-16498	207	1	l.	l.	PROPN
ihlr-16498	207	2	no	no	INTJ
ihlr-16498	207	3	.	.	PUNCT
ihlr-16498	208	1	107	107	NUM
ihlr-16498	208	2	-	-	SYM
ihlr-16498	208	3	109	109	NUM
ihlr-16498	208	4	,	,	PUNCT
ihlr-16498	208	5	115	115	NUM
ihlr-16498	208	6	stat	stat	NOUN
ihlr-16498	208	7	.	.	PUNCT
ihlr-16498	209	1	1408	1408	NUM
ihlr-16498	209	2	(	(	PUNCT
ihlr-16498	209	3	2002	2002	NUM
ihlr-16498	209	4	)	)	PUNCT
ihlr-16498	209	5	2007	2007	NUM
ihlr-16498	209	6	]	]	PUNCT
ihlr-16498	209	7	reforming	reform	VERB
ihlr-16498	209	8	fda	fda	PROPN
ihlr-16498	209	9	poucy	poucy	PROPN
ihlr-16498	209	10	for	for	ADP
ihlr-16498	209	11	pediatric	pediatric	ADJ
ihlr-16498	209	12	testing	testing	NOUN
ihlr-16498	209	13	69	69	NUM
ihlr-16498	209	14	and	and	CCONJ
ihlr-16498	209	15	also	also	ADV
ihlr-16498	209	16	addresses	address	VERB
ihlr-16498	209	17	some	some	DET
ihlr-16498	209	18	criticisms	criticism	NOUN
ihlr-16498	209	19	of	of	ADP
ihlr-16498	209	20	the	the	DET
ihlr-16498	209	21	fdama.47	fdama.47	NOUN
ihlr-16498	209	22	unlike	unlike	ADP
ihlr-16498	209	23	the	the	DET
ihlr-16498	209	24	fdama	fdama	NOUN
ihlr-16498	209	25	,	,	PUNCT
ihlr-16498	209	26	the	the	DET
ihlr-16498	209	27	bpca	bpca	PROPN
ihlr-16498	209	28	addresses	address	VERB
ihlr-16498	209	29	the	the	DET
ihlr-16498	209	30	testing	testing	NOUN
ihlr-16498	209	31	of	of	ADP
ihlr-16498	209	32	both	both	PRON
ihlr-16498	209	33	on	on	ADP
ihlr-16498	209	34	-	-	PUNCT
ihlr-16498	209	35	patent	patent	NOUN
ihlr-16498	209	36	and	and	CCONJ
ihlr-16498	209	37	off	off	ADP
ihlr-16498	209	38	-	-	PUNCT
ihlr-16498	209	39	patent	patent	NOUN
ihlr-16498	209	40	drugs	drug	NOUN
ihlr-16498	209	41	.	.	PUNCT
ihlr-16498	210	1	under	under	ADP
ihlr-16498	210	2	the	the	DET
ihlr-16498	210	3	bpca	bpca	PROPN
ihlr-16498	210	4	,	,	PUNCT
ihlr-16498	210	5	the	the	DET
ihlr-16498	210	6	nih	nih	PROPN
ihlr-16498	210	7	,	,	PUNCT
ihlr-16498	210	8	in	in	ADP
ihlr-16498	210	9	collaboration	collaboration	NOUN
ihlr-16498	210	10	with	with	ADP
ihlr-16498	210	11	the	the	DET
ihlr-16498	210	12	fda	fda	PROPN
ihlr-16498	210	13	,	,	PUNCT
ihlr-16498	210	14	develops	develop	VERB
ihlr-16498	210	15	lists	list	NOUN
ihlr-16498	210	16	of	of	ADP
ihlr-16498	210	17	drugs	drug	NOUN
ihlr-16498	210	18	that	that	PRON
ihlr-16498	210	19	need	need	VERB
ihlr-16498	210	20	additional	additional	ADJ
ihlr-16498	210	21	studies	study	NOUN
ihlr-16498	210	22	to	to	PART
ihlr-16498	210	23	assess	assess	VERB
ihlr-16498	210	24	the	the	DET
ihlr-16498	210	25	safety	safety	NOUN
ihlr-16498	210	26	and	and	CCONJ
ihlr-16498	210	27	effectiveness	effectiveness	NOUN
ihlr-16498	210	28	in	in	ADP
ihlr-16498	210	29	pediatric	pediatric	ADJ
ihlr-16498	210	30	popu­	popu­	NOUN
ihlr-16498	210	31	lations	lation	NOUN
ihlr-16498	210	32	.	.	PUNCT
ihlr-16498	211	1	48	48	NUM
ihlr-16498	211	2	the	the	DET
ihlr-16498	211	3	nih	nih	PROPN
ihlr-16498	211	4	considers	consider	VERB
ihlr-16498	211	5	the	the	DET
ihlr-16498	211	6	following	follow	VERB
ihlr-16498	211	7	criteria	criterion	NOUN
ihlr-16498	211	8	to	to	PART
ihlr-16498	211	9	determine	determine	VERB
ihlr-16498	211	10	whether	whether	SCONJ
ihlr-16498	211	11	pedi­	pedi­	NOUN
ihlr-16498	211	12	atric	atric	ADJ
ihlr-16498	211	13	testing	testing	NOUN
ihlr-16498	211	14	is	be	AUX
ihlr-16498	211	15	needed	need	VERB
ihlr-16498	211	16	:	:	PUNCT
ihlr-16498	211	17	"	"	PUNCT
ihlr-16498	211	18	(	(	PUNCT
ihlr-16498	211	19	1	1	X
ihlr-16498	211	20	)	)	PUNCT
ihlr-16498	211	21	availability	availability	NOUN
ihlr-16498	211	22	of	of	ADP
ihlr-16498	211	23	infonnation	infonnation	NOUN
ihlr-16498	211	24	conceming	conceme	VERB
ihlr-16498	211	25	the	the	DET
ihlr-16498	211	26	safe	safe	ADJ
ihlr-16498	211	27	and	and	CCONJ
ihlr-16498	211	28	effective	effective	ADJ
ihlr-16498	211	29	use	use	NOUN
ihlr-16498	211	30	of	of	ADP
ihlr-16498	211	31	the	the	DET
ihlr-16498	211	32	drug	drug	NOUN
ihlr-16498	211	33	in	in	ADP
ihlr-16498	211	34	the	the	DET
ihlr-16498	211	35	pediatric	pediatric	ADJ
ihlr-16498	211	36	population	population	NOUN
ihlr-16498	211	37	;	;	PUNCT
ihlr-16498	211	38	(	(	PUNCT
ihlr-16498	211	39	2	2	X
ihlr-16498	211	40	)	)	PUNCT
ihlr-16498	211	41	whether	whether	SCONJ
ihlr-16498	211	42	additional	additional	ADJ
ihlr-16498	211	43	in­	in­	NOUN
ihlr-16498	211	44	fonnation	fonnation	NOUN
ihlr-16498	211	45	is	be	AUX
ihlr-16498	211	46	needed	need	VERB
ihlr-16498	211	47	;	;	PUNCT
ihlr-16498	211	48	(	(	PUNCT
ihlr-16498	211	49	3	3	X
ihlr-16498	211	50	)	)	PUNCT
ihlr-16498	211	51	whether	whether	SCONJ
ihlr-16498	211	52	new	new	ADJ
ihlr-16498	211	53	pediatric	pediatric	ADJ
ihlr-16498	211	54	studies	study	NOUN
ihlr-16498	211	55	concerning	concern	VERB
ihlr-16498	211	56	the	the	DET
ihlr-16498	211	57	drug	drug	NOUN
ihlr-16498	211	58	may	may	AUX
ihlr-16498	211	59	produce	produce	VERB
ihlr-16498	211	60	health	health	NOUN
ihlr-16498	211	61	benefits	benefit	NOUN
ihlr-16498	211	62	in	in	ADP
ihlr-16498	211	63	pediatric	pediatric	ADJ
ihlr-16498	211	64	population	population	NOUN
ihlr-16498	211	65	;	;	PUNCT
ihlr-16498	211	66	and	and	CCONJ
ihlr-16498	211	67	(	(	PUNCT
ihlr-16498	211	68	4	4	X
ihlr-16498	211	69	)	)	PUNCT
ihlr-16498	211	70	whether	whether	SCONJ
ihlr-16498	211	71	refonnation	refonnation	NOUN
ihlr-16498	211	72	of	of	ADP
ihlr-16498	211	73	the	the	DET
ihlr-16498	211	74	drug	drug	NOUN
ihlr-16498	211	75	is	be	AUX
ihlr-16498	211	76	necessary	necessary	ADJ
ihlr-16498	211	77	.	.	PUNCT
ihlr-16498	211	78	'	'	PUNCT
ihlr-16498	211	79	..	..	PUNCT
ihlr-16498	212	1	-9	-9	INTJ
ihlr-16498	212	2	once	once	SCONJ
ihlr-16498	212	3	the	the	DET
ihlr-16498	212	4	list	list	NOUN
ihlr-16498	212	5	is	be	AUX
ihlr-16498	212	6	compiled	compile	VERB
ihlr-16498	212	7	,	,	PUNCT
ihlr-16498	212	8	the	the	DET
ihlr-16498	212	9	fda	fda	PROPN
ihlr-16498	212	10	sends	send	VERB
ihlr-16498	212	11	a	a	DET
ihlr-16498	212	12	written	write	VERB
ihlr-16498	212	13	request	request	NOUN
ihlr-16498	212	14	to	to	ADP
ihlr-16498	212	15	the	the	DET
ihlr-16498	212	16	manufacturer	manufacturer	NOUN
ihlr-16498	212	17	of	of	ADP
ihlr-16498	212	18	each	each	DET
ihlr-16498	212	19	drug	drug	NOUN
ihlr-16498	212	20	to	to	PART
ihlr-16498	212	21	request	request	VERB
ihlr-16498	212	22	the	the	DET
ihlr-16498	212	23	pediatric	pediatric	ADJ
ihlr-16498	212	24	studies	study	NOUN
ihlr-16498	212	25	.	.	PUNCT
ihlr-16498	213	1	50	50	NUM
ihlr-16498	213	2	if	if	SCONJ
ihlr-16498	213	3	the	the	DET
ihlr-16498	213	4	fda	fda	PROPN
ihlr-16498	213	5	does	do	AUX
ihlr-16498	213	6	not	not	PART
ihlr-16498	213	7	receive	receive	VERB
ihlr-16498	213	8	a	a	DET
ihlr-16498	213	9	response	response	NOUN
ihlr-16498	213	10	from	from	ADP
ihlr-16498	213	11	the	the	DET
ihlr-16498	213	12	manufacturer	manufacturer	NOUN
ihlr-16498	213	13	within	within	ADP
ihlr-16498	213	14	thirty	thirty	NUM
ihlr-16498	213	15	days	day	NOUN
ihlr-16498	213	16	,	,	PUNCT
ihlr-16498	213	17	then	then	ADV
ihlr-16498	213	18	the	the	DET
ihlr-16498	213	19	fda	fda	PROPN
ihlr-16498	213	20	will	will	AUX
ihlr-16498	213	21	publish	publish	VERB
ihlr-16498	213	22	a	a	DET
ihlr-16498	213	23	request	request	NOUN
ihlr-16498	213	24	for	for	ADP
ihlr-16498	213	25	third	third	ADJ
ihlr-16498	213	26	parties	party	NOUN
ihlr-16498	213	27	,	,	PUNCT
ihlr-16498	213	28	who	who	PRON
ihlr-16498	213	29	themselves	themselves	PRON
ihlr-16498	213	30	meet	meet	VERB
ihlr-16498	213	31	par­	par­	NOUN
ihlr-16498	213	32	ticularized	ticularize	VERB
ihlr-16498	213	33	criteria	criterion	NOUN
ihlr-16498	213	34	for	for	ADP
ihlr-16498	213	35	conducting	conduct	VERB
ihlr-16498	213	36	pediatric	pediatric	ADJ
ihlr-16498	213	37	trials	trial	NOUN
ihlr-16498	213	38	,	,	PUNCT
ihlr-16498	213	39	to	to	PART
ihlr-16498	213	40	conduct	conduct	VERB
ihlr-16498	213	41	the	the	DET
ihlr-16498	213	42	studies	study	NOUN
ihlr-16498	213	43	.	.	PUNCT
ihlr-16498	214	1	51	51	NUM
ihlr-16498	215	1	once	once	ADV
ihlr-16498	215	2	the	the	DET
ihlr-16498	215	3	pediatric	pediatric	ADJ
ihlr-16498	215	4	studies	study	NOUN
ihlr-16498	215	5	are	be	AUX
ihlr-16498	215	6	conducted	conduct	VERB
ihlr-16498	215	7	,	,	PUNCT
ihlr-16498	215	8	either	either	CCONJ
ihlr-16498	215	9	the	the	DET
ihlr-16498	215	10	manufacturer	manufacturer	NOUN
ihlr-16498	215	11	or	or	CCONJ
ihlr-16498	215	12	the	the	DET
ihlr-16498	215	13	third	third	ADJ
ihlr-16498	215	14	party	party	NOUN
ihlr-16498	215	15	submits	submit	VERB
ihlr-16498	215	16	a	a	DET
ihlr-16498	215	17	report	report	NOUN
ihlr-16498	215	18	that	that	PRON
ihlr-16498	215	19	includes	include	VERB
ihlr-16498	215	20	all	all	DET
ihlr-16498	215	21	data	datum	NOUN
ihlr-16498	215	22	generated	generate	VERB
ihlr-16498	215	23	in	in	ADP
ihlr-16498	215	24	the	the	DET
ihlr-16498	215	25	study	study	NOUN
ihlr-16498	215	26	.	.	PUNCT
ihlr-16498	216	1	52	52	NUM
ihlr-16498	216	2	the	the	DET
ihlr-16498	216	3	fda	fda	PROPN
ihlr-16498	216	4	then	then	ADV
ihlr-16498	216	5	reviews	review	VERB
ihlr-16498	216	6	the	the	DET
ihlr-16498	216	7	report	report	NOUN
ihlr-16498	216	8	and	and	CCONJ
ihlr-16498	216	9	begins	begin	VERB
ihlr-16498	216	10	a	a	DET
ihlr-16498	216	11	negotiation	negotiation	NOUN
ihlr-16498	216	12	process	process	NOUN
ihlr-16498	216	13	with	with	ADP
ihlr-16498	216	14	the	the	DET
ihlr-16498	216	15	manu­	manu­	ADJ
ihlr-16498	216	16	facturer	facturer	NOUN
ihlr-16498	216	17	regarding	regard	VERB
ihlr-16498	216	18	labeling	labeling	NOUN
ihlr-16498	216	19	changes	change	NOUN
ihlr-16498	216	20	.	.	PUNCT
ihlr-16498	217	1	53	53	NUM
ihlr-16498	217	2	if	if	SCONJ
ihlr-16498	217	3	the	the	DET
ihlr-16498	217	4	manufacturer	manufacturer	NOUN
ihlr-16498	217	5	does	do	AUX
ihlr-16498	217	6	not	not	PART
ihlr-16498	217	7	agree	agree	VERB
ihlr-16498	217	8	to	to	ADP
ihlr-16498	217	9	a	a	DET
ihlr-16498	217	10	labeling	labeling	NOUN
ihlr-16498	217	11	change	change	NOUN
ihlr-16498	217	12	,	,	PUNCT
ihlr-16498	217	13	the	the	DET
ihlr-16498	217	14	labeling	labeling	NOUN
ihlr-16498	217	15	request	request	NOUN
ihlr-16498	217	16	is	be	AUX
ihlr-16498	217	17	referred	refer	VERB
ihlr-16498	217	18	to	to	ADP
ihlr-16498	217	19	the	the	DET
ihlr-16498	217	20	pediatric	pediatric	ADJ
ihlr-16498	217	21	advisory	advisory	ADJ
ihlr-16498	217	22	committee	committee	NOUN
ihlr-16498	217	23	to	to	PART
ihlr-16498	217	24	review	review	VERB
ihlr-16498	217	25	the	the	DET
ihlr-16498	217	26	information	information	NOUN
ihlr-16498	217	27	and	and	CCONJ
ihlr-16498	217	28	make	make	VERB
ihlr-16498	217	29	a	a	DET
ihlr-16498	217	30	recommendation	recommendation	NOUN
ihlr-16498	217	31	regarding	regard	VERB
ihlr-16498	217	32	the	the	DET
ihlr-16498	217	33	appropriate	appropriate	ADJ
ihlr-16498	217	34	labeling	labeling	NOUN
ihlr-16498	217	35	changes	change	NOUN
ihlr-16498	217	36	,	,	PUNCT
ihlr-16498	217	37	if	if	SCONJ
ihlr-16498	217	38	any	any	PRON
ihlr-16498	217	39	.	.	PUNCT
ihlr-16498	218	1	54	54	NUM
ihlr-16498	219	1	the	the	DET
ihlr-16498	219	2	fda	fda	PROPN
ihlr-16498	219	3	then	then	ADV
ihlr-16498	219	4	contacts	contact	VERB
ihlr-16498	219	5	the	the	DET
ihlr-16498	219	6	manufac­	manufac­	PROPN
ihlr-16498	219	7	turer	turer	NOUN
ihlr-16498	219	8	with	with	ADP
ihlr-16498	219	9	the	the	DET
ihlr-16498	219	10	committee	committee	NOUN
ihlr-16498	219	11	's	's	PART
ihlr-16498	219	12	request	request	NOUN
ihlr-16498	219	13	.	.	PUNCT
ihlr-16498	220	1	55	55	NUM
ihlr-16498	220	2	if	if	SCONJ
ihlr-16498	220	3	the	the	DET
ihlr-16498	220	4	manufacturer	manufacturer	NOUN
ihlr-16498	220	5	does	do	AUX
ihlr-16498	220	6	not	not	PART
ihlr-16498	220	7	comply	comply	VERB
ihlr-16498	220	8	within	within	ADP
ihlr-16498	220	9	thirty	thirty	NUM
ihlr-16498	220	10	days	day	NOUN
ihlr-16498	220	11	,	,	PUNCT
ihlr-16498	220	12	the	the	DET
ihlr-16498	220	13	fda	fda	PROPN
ihlr-16498	220	14	may	may	AUX
ihlr-16498	220	15	deem	deem	VERB
ihlr-16498	220	16	the	the	DET
ihlr-16498	220	17	drug	drug	NOUN
ihlr-16498	220	18	misbranded	misbrande	VERB
ihlr-16498	220	19	and	and	CCONJ
ihlr-16498	220	20	bring	bring	VERB
ihlr-16498	220	21	an	an	DET
ihlr-16498	220	22	en­	en­	PROPN
ihlr-16498	220	23	forcement	forcement	PROPN
ihlr-16498	220	24	action	action	NOUN
ihlr-16498	220	25	in	in	ADP
ihlr-16498	220	26	federal	federal	ADJ
ihlr-16498	220	27	court	court	NOUN
ihlr-16498	220	28	.	.	PUNCT
ihlr-16498	221	1	56	56	NUM
ihlr-16498	221	2	the	the	DET
ihlr-16498	221	3	bpca	bpca	PROPN
ihlr-16498	221	4	also	also	ADV
ihlr-16498	221	5	addressed	address	VERB
ihlr-16498	221	6	many	many	ADJ
ihlr-16498	221	7	of	of	ADP
ihlr-16498	221	8	the	the	DET
ihlr-16498	221	9	ethical	ethical	ADJ
ihlr-16498	221	10	dilemmas	dilemma	NOUN
ihlr-16498	221	11	involved	involve	VERB
ihlr-16498	221	12	with	with	ADP
ihlr-16498	221	13	conducting	conduct	VERB
ihlr-16498	221	14	pediatric	pediatric	ADJ
ihlr-16498	221	15	research	research	NOUN
ihlr-16498	221	16	.	.	PUNCT
ihlr-16498	222	1	first	first	ADV
ihlr-16498	222	2	,	,	PUNCT
ihlr-16498	222	3	the	the	DET
ihlr-16498	222	4	bpca	bpca	PROPN
ihlr-16498	222	5	establishes	establish	VERB
ihlr-16498	222	6	the	the	DET
ihlr-16498	222	7	office	office	NOUN
ihlr-16498	222	8	ofpediat­	ofpediat­	ADV
ihlr-16498	222	9	ric	ric	VERB
ihlr-16498	222	10	therapeutics	therapeutic	NOUN
ihlr-16498	222	11	within	within	ADP
ihlr-16498	222	12	the	the	DET
ihlr-16498	222	13	fda	fda	PROPN
ihlr-16498	222	14	to	to	PART
ihlr-16498	222	15	coordinate	coordinate	VERB
ihlr-16498	222	16	and	and	CCONJ
ihlr-16498	222	17	facilitate	facilitate	NOUN
ihlr-16498	222	18	activities	activity	NOUN
ihlr-16498	222	19	related	relate	VERB
ihlr-16498	222	20	to	to	ADP
ihlr-16498	222	21	pediatric	pediatric	ADJ
ihlr-16498	222	22	issues	issue	NOUN
ihlr-16498	222	23	.	.	PUNCT
ihlr-16498	223	1	57	57	NUM
ihlr-16498	223	2	second	second	ADJ
ihlr-16498	223	3	,	,	PUNCT
ihlr-16498	223	4	the	the	DET
ihlr-16498	223	5	bpca	bpca	PROPN
ihlr-16498	223	6	establishes	establish	VERB
ihlr-16498	223	7	a	a	DET
ihlr-16498	223	8	procedure	procedure	NOUN
ihlr-16498	223	9	for	for	ADP
ihlr-16498	223	10	contracting	contracting	NOUN
ihlr-16498	223	11	with	with	ADP
ihlr-16498	223	12	the	the	DET
ihlr-16498	223	13	institute	institute	NOUN
ihlr-16498	223	14	ofmedicine	ofmedicine	NOUN
ihlr-16498	223	15	(	(	PUNCT
ihlr-16498	223	16	"	"	PUNCT
ihlr-16498	223	17	10	10	NUM
ihlr-16498	223	18	m	m	NOUN
ihlr-16498	223	19	''	''	PUNCT
ihlr-16498	223	20	)	)	PUNCT
ihlr-16498	223	21	to	to	PART
ihlr-16498	223	22	review	review	VERB
ihlr-16498	223	23	pediatric	pediatric	ADJ
ihlr-16498	223	24	studies	study	NOUN
ihlr-16498	223	25	.	.	PUNCT
ihlr-16498	224	1	58	58	NUM
ihlr-16498	225	1	the	the	DET
ihlr-16498	225	2	10	10	NUM
ihlr-16498	225	3	m	m	VERB
ihlr-16498	225	4	(	(	PUNCT
ihlr-16498	225	5	codified	codify	VERB
ihlr-16498	225	6	as	as	SCONJ
ihlr-16498	225	7	amended	amend	VERB
ihlr-16498	225	8	in	in	ADP
ihlr-16498	225	9	scattered	scatter	VERB
ihlr-16498	225	10	sections	section	NOUN
ihlr-16498	225	11	of21	of21	PROPN
ihlr-16498	225	12	u.s	u.s	PROPN
ihlr-16498	225	13	.	.	PROPN
ihlr-16498	225	14	c.	c.	PROPN
ihlr-16498	225	15	and	and	CCONJ
ihlr-16498	225	16	42	42	NUM
ihlr-16498	225	17	u.s.c	u.s.c	ADJ
ihlr-16498	225	18	.	.	PUNCT
ihlr-16498	225	19	)	)	PUNCT
ihlr-16498	225	20	.	.	PUNCT
ihlr-16498	226	1	47	47	NUM
ihlr-16498	226	2	42	42	NUM
ihlr-16498	226	3	u.s.c	u.s.c	ADJ
ihlr-16498	226	4	.	.	PUNCT
ihlr-16498	227	1	§	§	PROPN
ihlr-16498	227	2	284m(a)(2000&supp	284m(a)(2000&supp	NUM
ihlr-16498	227	3	.	.	PUNCT
ihlr-16498	228	1	iii2003){clarifyingtheapplicationofthepediat­	iii2003){clarifyingtheapplicationofthepediat­	PROPN
ihlr-16498	228	2	ric	ric	PROPN
ihlr-16498	228	3	exclusivity	exclusivity	NOUN
ihlr-16498	228	4	provision	provision	NOUN
ihlr-16498	228	5	under	under	ADP
ihlr-16498	228	6	section	section	NOUN
ihlr-16498	228	7	505a	505a	NOUN
ihlr-16498	228	8	of	of	ADP
ihlr-16498	228	9	the	the	DET
ihlr-16498	228	10	federal	federal	ADJ
ihlr-16498	228	11	food	food	NOUN
ihlr-16498	228	12	,	,	PUNCT
ihlr-16498	228	13	drug	drug	NOUN
ihlr-16498	228	14	,	,	PUNCT
ihlr-16498	228	15	and	and	CCONJ
ihlr-16498	228	16	cosmetic	cosmetic	ADJ
ihlr-16498	228	17	act	act	PROPN
ihlr-16498	228	18	)	)	PUNCT
ihlr-16498	228	19	;	;	PUNCT
ihlr-16498	228	20	see	see	VERB
ihlr-16498	228	21	also	also	ADV
ihlr-16498	228	22	breslow	breslow	ADJ
ihlr-16498	228	23	,	,	PUNCT
ihlr-16498	228	24	supra	supra	PROPN
ihlr-16498	228	25	note	note	NOUN
ihlr-16498	228	26	22	22	NUM
ihlr-16498	228	27	,	,	PUNCT
ihlr-16498	228	28	at	at	ADP
ihlr-16498	228	29	173	173	NUM
ihlr-16498	228	30	-	-	SYM
ihlr-16498	228	31	74	74	NUM
ihlr-16498	228	32	(	(	PUNCT
ihlr-16498	228	33	describing	describe	VERB
ihlr-16498	228	34	the	the	DET
ihlr-16498	228	35	bpca	bpca	PROPN
ihlr-16498	228	36	as	as	ADP
ihlr-16498	228	37	"	"	PUNCT
ihlr-16498	228	38	a	a	DET
ihlr-16498	228	39	greatly	greatly	ADV
ihlr-16498	228	40	matured	mature	VERB
ihlr-16498	228	41	successor	successor	NOUN
ihlr-16498	228	42	to	to	ADP
ihlr-16498	228	43	the	the	DET
ihlr-16498	228	44	ori~	ori~	ADJ
ihlr-16498	228	45	pediatric	pediatric	ADJ
ihlr-16498	228	46	exclusivity	exclusivity	NOUN
ihlr-16498	228	47	provision	provision	NOUN
ihlr-16498	228	48	of	of	ADP
ihlr-16498	228	49	the	the	DET
ihlr-16498	228	50	fdama	fdama	NOUN
ihlr-16498	228	51	.	.	PUNCT
ihlr-16498	228	52	''	''	PUNCT
ihlr-16498	228	53	)	)	PUNCT
ihlr-16498	228	54	.	.	PUNCT
ihlr-16498	229	1	8	8	NUM
ihlr-16498	229	2	program	program	NOUN
ihlr-16498	229	3	for	for	ADP
ihlr-16498	229	4	pediatric	pediatric	ADJ
ihlr-16498	229	5	studies	study	NOUN
ihlr-16498	229	6	of	of	ADP
ihlr-16498	229	7	drugs	drug	NOUN
ihlr-16498	229	8	,	,	PUNCT
ihlr-16498	229	9	42	42	NUM
ihlr-16498	229	10	u.s.c	u.s.c	ADJ
ihlr-16498	229	11	.	.	PUNCT
ihlr-16498	230	1	§	§	PROPN
ihlr-16498	230	2	284	284	NUM
ihlr-16498	230	3	m	m	PROPN
ihlr-16498	230	4	(	(	PUNCT
ihlr-16498	230	5	a	a	NOUN
ihlr-16498	230	6	)	)	PUNCT
ihlr-16498	230	7	(	(	PUNCT
ihlr-16498	230	8	supp	supp	PROPN
ihlr-16498	230	9	.	.	PUNCT
ihlr-16498	231	1	iii	iii	NUM
ihlr-16498	231	2	2003	2003	NUM
ihlr-16498	231	3	)	)	PUNCT
ihlr-16498	231	4	;	;	PUNCT
ihlr-16498	231	5	see	see	VERB
ihlr-16498	231	6	breslow	breslow	NOUN
ihlr-16498	231	7	,	,	PUNCT
ihlr-16498	231	8	supra	supra	PROPN
ihlr-16498	231	9	note	note	NOUN
ihlr-16498	231	10	22	22	NUM
ihlr-16498	231	11	,	,	PUNCT
ihlr-16498	231	12	at	at	ADP
ihlr-16498	231	13	174	174	NUM
ihlr-16498	231	14	-	-	SYM
ihlr-16498	231	15	77	77	NUM
ihlr-16498	231	16	(	(	PUNCT
ihlr-16498	231	17	describing	describe	VERB
ihlr-16498	231	18	the	the	DET
ihlr-16498	231	19	program	program	NOUN
ihlr-16498	231	20	for	for	ADP
ihlr-16498	231	21	pediatric	pediatric	ADJ
ihlr-16498	231	22	studies	study	NOUN
ihlr-16498	231	23	of	of	ADP
ihlr-16498	231	24	drugs	drug	NOUN
ihlr-16498	231	25	)	)	PUNCT
ihlr-16498	231	26	.	.	PUNCT
ihlr-16498	232	1	49	49	NUM
ihlr-16498	232	2	42	42	NUM
ihlr-16498	232	3	u.s.c	u.s.c	ADJ
ihlr-16498	232	4	.	.	PUNCT
ihlr-16498	233	1	§	§	PROPN
ihlr-16498	233	2	284m(ax2	284m(ax2	NUM
ihlr-16498	233	3	)	)	PUNCT
ihlr-16498	233	4	.	.	PUNCT
ihlr-16498	234	1	50	50	NUM
ihlr-16498	234	2	/d	/d	PUNCT
ihlr-16498	234	3	.	.	PUNCT
ihlr-16498	235	1	§	§	PROPN
ihlr-16498	235	2	284m(bxc	284m(bxc	NUM
ihlr-16498	235	3	)	)	PUNCT
ihlr-16498	235	4	.	.	PUNCT
ihlr-16498	236	1	51	51	NUM
ihlr-16498	236	2	see	see	VERB
ihlr-16498	236	3	i	i	PROPN
ihlr-16498	236	4	d.	d.	PROPN
ihlr-16498	236	5	§	§	PROPN
ihlr-16498	236	6	284m(cx2	284m(cx2	NUM
ihlr-16498	236	7	)	)	PUNCT
ihlr-16498	236	8	.	.	PUNCT
ihlr-16498	237	1	52	52	NUM
ihlr-16498	237	2	see	see	VERB
ihlr-16498	237	3	i	i	PROPN
ihlr-16498	237	4	d	d	PROPN
ihlr-16498	237	5	§	§	PROPN
ihlr-16498	237	6	284m(cx6xa	284m(cx6xa	PROPN
ihlr-16498	237	7	)	)	PUNCT
ihlr-16498	237	8	.	.	PUNCT
ihlr-16498	238	1	53	53	NUM
ihlr-16498	238	2	see	see	VERB
ihlr-16498	238	3	i	i	PROPN
ihlr-16498	238	4	d	d	PROPN
ihlr-16498	238	5	§	§	PROPN
ihlr-16498	238	6	284	284	NUM
ihlr-16498	238	7	m	m	PROPN
ihlr-16498	238	8	(	(	PUNCT
ihlr-16498	238	9	c	c	NOUN
ihlr-16498	238	10	x7	x7	NOUN
ihlr-16498	238	11	)	)	PUNCT
ihlr-16498	238	12	.	.	PUNCT
ihlr-16498	239	1	54	54	NUM
ihlr-16498	239	2	see	see	VERB
ihlr-16498	239	3	i	i	PROPN
ihlr-16498	239	4	d	d	PROPN
ihlr-16498	239	5	§	§	PROPN
ihlr-16498	239	6	284m(cx8	284m(cx8	NUM
ihlr-16498	239	7	)	)	PUNCT
ihlr-16498	239	8	.	.	PUNCT
ihlr-16498	240	1	55	55	NUM
ihlr-16498	240	2	/d	/d	PUNCT
ihlr-16498	240	3	.	.	PUNCT
ihlr-16498	241	1	§	§	PROPN
ihlr-16498	241	2	284m(cx9	284m(cx9	NUM
ihlr-16498	241	3	)	)	PUNCT
ihlr-16498	241	4	.	.	PUNCT
ihlr-16498	242	1	56	56	NUM
ihlr-16498	242	2	see	see	VERB
ihlr-16498	242	3	i	i	PROPN
ihlr-16498	242	4	d.	d.	PROPN
ihlr-16498	242	5	§	§	PROPN
ihlr-16498	242	6	§	§	PROPN
ihlr-16498	242	7	284m(cx10)-(ll	284m(cx10)-(ll	NUM
ihlr-16498	242	8	)	)	PUNCT
ihlr-16498	242	9	.	.	PUNCT
ihlr-16498	243	1	51	51	NUM
ihlr-16498	243	2	21	21	NUM
ihlr-16498	243	3	u.s.c	u.s.c	NOUN
ihlr-16498	243	4	.	.	PUNCT
ihlr-16498	244	1	§	§	PROPN
ihlr-16498	244	2	393a(a)-(b)(supp	393a(a)-(b)(supp	NUM
ihlr-16498	244	3	.	.	PUNCT
ihlr-16498	244	4	iv2004	iv2004	PROPN
ihlr-16498	244	5	)	)	PUNCT
ihlr-16498	244	6	;	;	PUNCT
ihlr-16498	244	7	seebreslow	seebreslow	NOUN
ihlr-16498	244	8	,	,	PUNCT
ihlr-16498	244	9	supranote22	supranote22	NOUN
ihlr-16498	244	10	,	,	PUNCT
ihlr-16498	244	11	at	at	ADP
ihlr-16498	244	12	178	178	NUM
ihlr-16498	244	13	-	-	PUNCT
ihlr-16498	244	14	79(describin~	79(describin~	NOUN
ihlr-16498	244	15	"	"	PUNCT
ihlr-16498	244	16	structural	structural	ADJ
ihlr-16498	244	17	administrative	administrative	ADJ
ihlr-16498	244	18	changes	change	NOUN
ihlr-16498	244	19	"	"	PUNCT
ihlr-16498	244	20	)	)	PUNCT
ihlr-16498	244	21	.	.	PUNCT
ihlr-16498	245	1	·	·	PUNCT
ihlr-16498	245	2	8	8	NUM
ihlr-16498	245	3	best	good	ADJ
ihlr-16498	245	4	pharmaceuticals	pharmaceutical	NOUN
ihlr-16498	245	5	for	for	ADP
ihlr-16498	245	6	children	child	NOUN
ihlr-16498	245	7	act	act	NOUN
ihlr-16498	245	8	,	,	PUNCT
ihlr-16498	245	9	pub	pub	NOUN
ihlr-16498	245	10	.	.	PUNCT
ihlr-16498	246	1	l.	l.	PROPN
ihlr-16498	246	2	no	no	INTJ
ihlr-16498	246	3	.	.	PUNCT
ihlr-16498	247	1	107	107	NUM
ihlr-16498	247	2	-	-	SYM
ihlr-16498	247	3	109	109	NUM
ihlr-16498	247	4	,	,	PUNCT
ihlr-16498	247	5	115	115	NUM
ihlr-16498	247	6	stat	stat	NOUN
ihlr-16498	247	7	.	.	PUNCT
ihlr-16498	248	1	1416	1416	NUM
ihlr-16498	248	2	(	(	PUNCT
ihlr-16498	248	3	2002	2002	NUM
ihlr-16498	248	4	)	)	PUNCT
ihlr-16498	248	5	70	70	NUM
ihlr-16498	248	6	indiana	indiana	PROPN
ihlr-16498	248	7	health	health	PROPN
ihlr-16498	248	8	law	law	PROPN
ihlr-16498	248	9	review	review	NOUN
ihlr-16498	249	1	[	[	X
ihlr-16498	249	2	vol	vol	NOUN
ihlr-16498	249	3	.	.	PUNCT
ihlr-16498	249	4	4:59	4:59	NUM
ihlr-16498	249	5	is	be	AUX
ihlr-16498	249	6	to	to	PART
ihlr-16498	249	7	review	review	VERB
ihlr-16498	249	8	numerous	numerous	ADJ
ihlr-16498	249	9	areas	area	NOUN
ihlr-16498	249	10	including	include	VERB
ihlr-16498	249	11	assent	assent	NOUN
ihlr-16498	249	12	,	,	PUNCT
ihlr-16498	249	13	informed	informed	ADJ
ihlr-16498	249	14	consent	consent	NOUN
ihlr-16498	249	15	,	,	PUNCT
ihlr-16498	249	16	benefits	benefit	NOUN
ihlr-16498	249	17	and	and	CCONJ
ihlr-16498	249	18	risk	risk	NOUN
ihlr-16498	249	19	,	,	PUNCT
ihlr-16498	249	20	"	"	PUNCT
ihlr-16498	249	21	minimal	minimal	ADJ
ihlr-16498	249	22	risk	risk	NOUN
ihlr-16498	249	23	,	,	PUNCT
ihlr-16498	249	24	"	"	PUNCT
ihlr-16498	249	25	and	and	CCONJ
ihlr-16498	249	26	the	the	DET
ihlr-16498	249	27	role	role	NOUN
ihlr-16498	249	28	of	of	ADP
ihlr-16498	249	29	the	the	DET
ihlr-16498	249	30	institutional	institutional	ADJ
ihlr-16498	249	31	review	review	NOUN
ihlr-16498	249	32	board	board	NOUN
ihlr-16498	249	33	in	in	ADP
ihlr-16498	249	34	conducting	conduct	VERB
ihlr-16498	249	35	the	the	DET
ihlr-16498	249	36	trial	trial	NOUN
ihlr-16498	249	37	.	.	PUNCT
ihlr-16498	250	1	59	59	NUM
ihlr-16498	250	2	the	the	DET
ihlr-16498	250	3	bpca	bpca	PROPN
ihlr-16498	250	4	also	also	ADV
ihlr-16498	250	5	contains	contain	VERB
ihlr-16498	250	6	an	an	DET
ihlr-16498	250	7	october	october	PROPN
ihlr-16498	250	8	1	1	NUM
ihlr-16498	250	9	,	,	PUNCT
ihlr-16498	250	10	2007	2007	NUM
ihlr-16498	250	11	,	,	PUNCT
ihlr-16498	250	12	sunset	sunset	NOUN
ihlr-16498	250	13	clause.60	clause.60	PROPN
ihlr-16498	250	14	with	with	ADP
ihlr-16498	250	15	the	the	DET
ihlr-16498	250	16	enactment	enactment	NOUN
ihlr-16498	250	17	of	of	ADP
ihlr-16498	250	18	the	the	DET
ihlr-16498	250	19	bpca	bpca	PROPN
ihlr-16498	250	20	,	,	PUNCT
ihlr-16498	250	21	the	the	DET
ihlr-16498	250	22	bush	bush	PROPN
ihlr-16498	250	23	administration	administration	NOUN
ihlr-16498	250	24	suspended	suspend	VERB
ihlr-16498	250	25	the	the	DET
ihlr-16498	250	26	1998	1998	NUM
ihlr-16498	250	27	final	final	ADJ
ihlr-16498	250	28	rule	rule	NOUN
ihlr-16498	250	29	in	in	ADP
ihlr-16498	250	30	may	may	PROPN
ihlr-16498	250	31	2002.61	2002.61	NUM
ihlr-16498	250	32	in	in	ADP
ihlr-16498	250	33	response	response	NOUN
ihlr-16498	250	34	,	,	PUNCT
ihlr-16498	250	35	the	the	DET
ihlr-16498	250	36	department	department	NOUN
ihlr-16498	250	37	of	of	ADP
ihlr-16498	250	38	health	health	PROPN
ihlr-16498	250	39	and	and	CCONJ
ihlr-16498	250	40	human	human	PROPN
ihlr-16498	250	41	services	service	NOUN
ihlr-16498	250	42	(	(	PUNCT
ihlr-16498	250	43	"	"	PUNCT
ihlr-16498	250	44	hhs	hhs	NOUN
ihlr-16498	250	45	"	"	PUNCT
ihlr-16498	250	46	)	)	PUNCT
ihlr-16498	250	47	announced	announce	VERB
ihlr-16498	250	48	the	the	DET
ihlr-16498	250	49	bpca	bpca	PROPN
ihlr-16498	250	50	and	and	CCONJ
ihlr-16498	250	51	the	the	DET
ihlr-16498	250	52	1998	1998	NUM
ihlr-16498	250	53	final	final	ADJ
ihlr-16498	250	54	rule	rule	NOUN
ihlr-16498	250	55	could	could	AUX
ihlr-16498	250	56	coexist	coexist	VERB
ihlr-16498	250	57	but	but	CCONJ
ihlr-16498	250	58	asked	ask	VERB
ihlr-16498	250	59	for	for	ADP
ihlr-16498	250	60	public	public	ADJ
ihlr-16498	250	61	comment	comment	NOUN
ihlr-16498	250	62	regarding	regard	VERB
ihlr-16498	250	63	what	what	PRON
ihlr-16498	250	64	steps	step	NOUN
ihlr-16498	250	65	to	to	PART
ihlr-16498	250	66	take	take	VERB
ihlr-16498	250	67	for	for	SCONJ
ihlr-16498	250	68	the	the	DET
ihlr-16498	250	69	fda	fda	PROPN
ihlr-16498	250	70	to	to	PART
ihlr-16498	250	71	accommodate	accommodate	VERB
ihlr-16498	250	72	the	the	DET
ihlr-16498	250	73	bpca.62	bpca.62	NOUN
ihlr-16498	250	74	the	the	DET
ihlr-16498	250	75	common	common	ADJ
ihlr-16498	250	76	ground	ground	NOUN
ihlr-16498	250	77	hhs	hhs	PROPN
ihlr-16498	250	78	asked	ask	VERB
ihlr-16498	250	79	for	for	ADP
ihlr-16498	250	80	never	never	ADV
ihlr-16498	250	81	came	come	VERB
ihlr-16498	250	82	to	to	ADP
ihlr-16498	250	83	fruition	fruition	NOUN
ihlr-16498	250	84	because	because	SCONJ
ihlr-16498	250	85	,	,	PUNCT
ihlr-16498	250	86	in	in	ADP
ihlr-16498	250	87	2002	2002	NUM
ihlr-16498	250	88	,	,	PUNCT
ihlr-16498	250	89	the	the	DET
ihlr-16498	250	90	district	district	NOUN
ihlr-16498	250	91	court	court	NOUN
ihlr-16498	250	92	for	for	ADP
ihlr-16498	250	93	the	the	DET
ihlr-16498	250	94	district	district	PROPN
ihlr-16498	250	95	of	of	ADP
ihlr-16498	250	96	columbia	columbia	PROPN
ihlr-16498	250	97	held	hold	VERB
ihlr-16498	250	98	the	the	DET
ihlr-16498	250	99	1998	1998	NUM
ihlr-16498	250	100	final	final	ADJ
ihlr-16498	250	101	rule	rule	NOUN
ihlr-16498	250	102	"	"	PUNCT
ihlr-16498	250	103	[	[	PUNCT
ihlr-16498	250	104	exceeded	exceed	VERB
ihlr-16498	250	105	]	]	PUNCT
ihlr-16498	250	106	the	the	DET
ihlr-16498	250	107	fda	fda	PROPN
ihlr-16498	250	108	's	's	PART
ihlr-16498	250	109	statutory	statutory	PROPN
ihlr-16498	250	110	authority	authority	NOUN
ihlr-16498	250	111	and	and	CCONJ
ihlr-16498	250	112	[	[	X
ihlr-16498	250	113	was	be	AUX
ihlr-16498	250	114	]	]	X
ihlr-16498	250	115	there­	there­	NUM
ihlr-16498	250	116	fore	fore	NOUN
ihlr-16498	250	117	invalid	invalid	ADJ
ihlr-16498	250	118	.	.	PUNCT
ihlr-16498	251	1	'o63	'o63	PROPN
ihlr-16498	251	2	d.	d.	PROPN
ihlr-16498	251	3	the	the	DET
ihlr-16498	251	4	pediatric	pediatric	PROPN
ihlr-16498	251	5	research	research	PROPN
ihlr-16498	251	6	equity	equity	PROPN
ihlr-16498	251	7	act	act	PROPN
ihlr-16498	251	8	essentially	essentially	ADV
ihlr-16498	251	9	codified	codify	VERB
ihlr-16498	251	10	the	the	DET
ihlr-16498	251	11	1998	1998	NUM
ihlr-16498	251	12	final	final	ADJ
ihlr-16498	251	13	rule	rule	NOUN
ihlr-16498	251	14	in	in	ADP
ihlr-16498	251	15	response	response	NOUN
ihlr-16498	251	16	to	to	ADP
ihlr-16498	251	17	the	the	DET
ihlr-16498	251	18	district	district	NOUN
ihlr-16498	251	19	court	court	NOUN
ihlr-16498	251	20	's	's	PART
ihlr-16498	251	21	decision	decision	NOUN
ihlr-16498	251	22	,	,	PUNCT
ihlr-16498	251	23	in	in	ADP
ihlr-16498	251	24	2003	2003	NUM
ihlr-16498	251	25	congress	congress	PROPN
ihlr-16498	251	26	amended	amend	VERB
ihlr-16498	251	27	the	the	DET
ihlr-16498	251	28	fdca	fdca	NOUN
ihlr-16498	251	29	by	by	ADP
ihlr-16498	251	30	enacting	enact	VERB
ihlr-16498	251	31	the	the	DET
ihlr-16498	251	32	pediatric	pediatric	ADJ
ihlr-16498	251	33	research	research	NOUN
ihlr-16498	251	34	equity	equity	PROPN
ihlr-16498	251	35	act	act	NOUN
ihlr-16498	251	36	(	(	PUNCT
ihlr-16498	251	37	"	"	PUNCT
ihlr-16498	251	38	prea	prea	X
ihlr-16498	251	39	"	"	PUNCT
ihlr-16498	251	40	)	)	PUNCT
ihlr-16498	251	41	.	.	PUNCT
ihlr-16498	252	1	64	64	NUM
ihlr-16498	252	2	the	the	DET
ihlr-16498	252	3	prea	prea	PROPN
ihlr-16498	252	4	essentially	essentially	ADV
ihlr-16498	252	5	codifies	codify	VERB
ihlr-16498	252	6	the	the	DET
ihlr-16498	252	7	1998	1998	NUM
ihlr-16498	252	8	final	final	ADJ
ihlr-16498	252	9	rule	rule	NOUN
ihlr-16498	252	10	and	and	CCONJ
ihlr-16498	252	11	specifically	specifically	ADV
ihlr-16498	252	12	grants	grant	VERB
ihlr-16498	252	13	the	the	DET
ihlr-16498	252	14	fda	fda	PROPN
ihlr-16498	252	15	the	the	DET
ihlr-16498	252	16	authority	authority	NOUN
ihlr-16498	252	17	to	to	PART
ihlr-16498	252	18	require	require	VERB
ihlr-16498	252	19	pediatric	pediatric	ADJ
ihlr-16498	252	20	testing	testing	NOUN
ihlr-16498	252	21	of	of	ADP
ihlr-16498	252	22	new	new	ADJ
ihlr-16498	252	23	and	and	CCONJ
ihlr-16498	252	24	already	already	ADV
ihlr-16498	252	25	approved	approve	VERB
ihlr-16498	252	26	drugs	drug	NOUN
ihlr-16498	252	27	.	.	PUNCT
ihlr-16498	253	1	65	65	NUM
ihlr-16498	253	2	for	for	ADP
ihlr-16498	253	3	new	new	ADJ
ihlr-16498	253	4	drug	drug	NOUN
ihlr-16498	253	5	applications	application	NOUN
ihlr-16498	253	6	,	,	PUNCT
ihlr-16498	253	7	the	the	DET
ihlr-16498	253	8	fda	fda	PROPN
ihlr-16498	253	9	has	have	VERB
ihlr-16498	253	10	the	the	DET
ihlr-16498	253	11	authority	authority	NOUN
ihlr-16498	253	12	to	to	PART
ihlr-16498	253	13	grant	grant	VERB
ihlr-16498	253	14	manufac­	manufac­	PROPN
ihlr-16498	253	15	turers	turer	NOUN
ihlr-16498	253	16	either	either	CCONJ
ihlr-16498	253	17	a	a	DET
ihlr-16498	253	18	full	full	ADJ
ihlr-16498	253	19	or	or	CCONJ
ihlr-16498	253	20	partial	partial	ADJ
ihlr-16498	253	21	waiver	waiver	NOUN
ihlr-16498	253	22	for	for	ADP
ihlr-16498	253	23	pediatric	pediatric	ADJ
ihlr-16498	253	24	testing	testing	NOUN
ihlr-16498	253	25	.	.	PUNCT
ihlr-16498	254	1	a	a	DET
ihlr-16498	254	2	full	full	ADJ
ihlr-16498	254	3	waiver	waiver	NOUN
ihlr-16498	254	4	for	for	ADP
ihlr-16498	254	5	new	new	ADJ
ihlr-16498	254	6	drugs	drug	NOUN
ihlr-16498	254	7	is	be	AUX
ihlr-16498	254	8	allowed	allow	VERB
ihlr-16498	254	9	in	in	ADP
ihlr-16498	254	10	the	the	DET
ihlr-16498	254	11	following	follow	VERB
ihlr-16498	254	12	circumstances	circumstance	NOUN
ihlr-16498	254	13	:	:	PUNCT
ihlr-16498	254	14	(	(	PUNCT
ihlr-16498	254	15	1	1	X
ihlr-16498	254	16	)	)	PUNCT
ihlr-16498	254	17	when	when	SCONJ
ihlr-16498	254	18	a	a	DET
ihlr-16498	254	19	small	small	ADJ
ihlr-16498	254	20	patient	patient	NOUN
ihlr-16498	254	21	popu­	popu­	NOUN
ihlr-16498	254	22	lation	lation	NOUN
ihlr-16498	254	23	makes	make	VERB
ihlr-16498	254	24	studies	study	NOUN
ihlr-16498	254	25	practically	practically	ADV
ihlr-16498	254	26	impossible	impossible	ADJ
ihlr-16498	254	27	;	;	PUNCT
ihlr-16498	254	28	(	(	PUNCT
ihlr-16498	254	29	2	2	X
ihlr-16498	254	30	)	)	PUNCT
ihlr-16498	254	31	when	when	SCONJ
ihlr-16498	254	32	evidence	evidence	NOUN
ihlr-16498	254	33	suggests	suggest	VERB
ihlr-16498	254	34	the	the	DET
ihlr-16498	254	35	drug	drug	NOUN
ihlr-16498	254	36	will	will	AUX
ihlr-16498	254	37	be	be	AUX
ihlr-16498	254	38	ineffective	ineffective	ADJ
ihlr-16498	254	39	or	or	CCONJ
ihlr-16498	254	40	unsafe	unsafe	ADJ
ihlr-16498	254	41	for	for	ADP
ihlr-16498	254	42	all	all	DET
ihlr-16498	254	43	pediatric	pediatric	ADJ
ihlr-16498	254	44	ages	age	NOUN
ihlr-16498	254	45	;	;	PUNCT
ihlr-16498	254	46	(	(	PUNCT
ihlr-16498	254	47	3	3	X
ihlr-16498	254	48	)	)	PUNCT
ihlr-16498	254	49	when	when	SCONJ
ihlr-16498	254	50	the	the	DET
ihlr-16498	254	51	drug	drug	NOUN
ihlr-16498	254	52	does	do	AUX
ihlr-16498	254	53	not	not	PART
ihlr-16498	254	54	represent	represent	VERB
ihlr-16498	254	55	a	a	DET
ihlr-16498	254	56	meaningful	meaningful	ADJ
ihlr-16498	254	57	benefit	benefit	NOUN
ihlr-16498	254	58	over	over	ADP
ihlr-16498	254	59	existing	exist	VERB
ihlr-16498	254	60	therapies	therapy	NOUN
ihlr-16498	254	61	;	;	PUNCT
ihlr-16498	254	62	or	or	CCONJ
ihlr-16498	254	63	(	(	PUNCT
ihlr-16498	254	64	4	4	X
ihlr-16498	254	65	)	)	PUNCT
ihlr-16498	254	66	when	when	SCONJ
ihlr-16498	254	67	the	the	DET
ihlr-16498	254	68	drug	drug	NOUN
ihlr-16498	254	69	will	will	AUX
ihlr-16498	254	70	not	not	PART
ihlr-16498	254	71	be	be	AUX
ihlr-16498	254	72	used	use	VERB
ihlr-16498	254	73	in	in	ADP
ihlr-16498	254	74	a	a	DET
ihlr-16498	254	75	substantial	substantial	ADJ
ihlr-16498	254	76	number	number	NOUN
ihlr-16498	254	77	of	of	ADP
ihlr-16498	254	78	pediatric	pediatric	ADJ
ihlr-16498	254	79	patients	patient	NOUN
ihlr-16498	254	80	.	.	PUNCT
ihlr-16498	255	1	66	66	NUM
ihlr-16498	255	2	a	a	DET
ihlr-16498	255	3	partial	partial	ADJ
ihlr-16498	255	4	waiver	waiver	NOUN
ihlr-16498	255	5	for	for	ADP
ihlr-16498	255	6	new	new	ADJ
ihlr-16498	255	7	drugs	drug	NOUN
ihlr-16498	255	8	may	may	AUX
ihlr-16498	255	9	be	be	AUX
ihlr-16498	255	10	granted	grant	VERB
ihlr-16498	255	11	for	for	ADP
ihlr-16498	255	12	particular	particular	ADJ
ihlr-16498	255	13	age	age	NOUN
ihlr-16498	255	14	groups	group	NOUN
ihlr-16498	255	15	for	for	ADP
ihlr-16498	255	16	the	the	DET
ihlr-16498	255	17	same	same	ADJ
ihlr-16498	255	18	reasons	reason	NOUN
ihlr-16498	255	19	as	as	SCONJ
ihlr-16498	255	20	described	describe	VERB
ihlr-16498	255	21	for	for	ADP
ihlr-16498	255	22	granting	grant	VERB
ihlr-16498	255	23	a	a	DET
ihlr-16498	255	24	full	full	ADJ
ihlr-16498	255	25	waiver	waiver	NOUN
ihlr-16498	255	26	,	,	PUNCT
ihlr-16498	255	27	but	but	CCONJ
ihlr-16498	255	28	granting	grant	VERB
ihlr-16498	255	29	a	a	DET
ihlr-16498	255	30	partial	partial	ADJ
ihlr-16498	255	31	waiver	waiver	NOUN
ihlr-16498	255	32	also	also	ADV
ihlr-16498	255	33	requires	require	VERB
ihlr-16498	255	34	the	the	DET
ihlr-16498	255	35	manufacturer	manufacturer	NOUN
ihlr-16498	255	36	to	to	PART
ihlr-16498	255	37	show	show	VERB
ihlr-16498	255	38	that	that	SCONJ
ihlr-16498	255	39	reasonable	reasonable	ADJ
ihlr-16498	255	40	attempts	attempt	NOUN
ihlr-16498	255	41	to	to	PART
ihlr-16498	255	42	produce	produce	VERB
ihlr-16498	255	43	a	a	DET
ihlr-16498	255	44	pediatric	pediatric	ADJ
ihlr-16498	255	45	formu(codified	formu(codifie	VERB
ihlr-16498	255	46	at42	at42	PROPN
ihlr-16498	255	47	usc§§	usc§§	NOUN
ihlr-16498	255	48	289	289	NUM
ihlr-16498	255	49	note(a	note(a	NOUN
ihlr-16498	255	50	)	)	PUNCT
ihlr-16498	255	51	,	,	PUNCT
ihlr-16498	255	52	note(b	note(b	ADJ
ihlr-16498	255	53	)	)	PUNCT
ihlr-16498	255	54	)	)	PUNCT
ihlr-16498	255	55	;	;	PUNCT
ihlr-16498	255	56	42	42	NUM
ihlr-16498	255	57	u.s.c	u.s.c	ADJ
ihlr-16498	255	58	.	.	PUNCT
ihlr-16498	256	1	§	§	PROPN
ihlr-16498	256	2	289	289	NUM
ihlr-16498	256	3	note(a)(supp	note(a)(supp	NOUN
ihlr-16498	256	4	.	.	PUNCT
ihlr-16498	257	1	iii	iii	NUM
ihlr-16498	257	2	2003	2003	NUM
ihlr-16498	257	3	)	)	PUNCT
ihlr-16498	257	4	.	.	PUNCT
ihlr-16498	258	1	59	59	NUM
ihlr-16498	258	2	42	42	NUM
ihlr-16498	258	3	u.s.c	u.s.c	ADJ
ihlr-16498	258	4	.	.	PUNCT
ihlr-16498	259	1	§	§	PROPN
ihlr-16498	259	2	289	289	NUM
ihlr-16498	259	3	note(b	note(b	NOUN
ihlr-16498	259	4	)	)	PUNCT
ihlr-16498	259	5	.	.	PUNCT
ihlr-16498	260	1	60	60	NUM
ihlr-16498	260	2	21	21	NUM
ihlr-16498	260	3	u.s.c	u.s.c	NOUN
ihlr-16498	260	4	.	.	PUNCT
ihlr-16498	261	1	§	§	PROPN
ihlr-16498	261	2	355a(n	355a(n	PROPN
ihlr-16498	261	3	)	)	PUNCT
ihlr-16498	261	4	(	(	PUNCT
ihlr-16498	261	5	supp	supp	PROPN
ihlr-16498	261	6	.	.	PUNCT
ihlr-16498	262	1	iv	iv	NUM
ihlr-16498	262	2	2004	2004	NUM
ihlr-16498	262	3	)	)	PUNCT
ihlr-16498	262	4	.	.	PUNCT
ihlr-16498	263	1	61	61	NUM
ihlr-16498	263	2	breslow	breslow	NOUN
ihlr-16498	263	3	,	,	PUNCT
ihlr-16498	263	4	supra	supra	PROPN
ihlr-16498	263	5	note	note	NOUN
ihlr-16498	263	6	22	22	NUM
ihlr-16498	263	7	,	,	PUNCT
ihlr-16498	263	8	at	at	ADP
ihlr-16498	263	9	185	185	NUM
ihlr-16498	263	10	(	(	PUNCT
ihlr-16498	263	11	"	"	PUNCT
ihlr-16498	263	12	(	(	PUNCT
ihlr-16498	263	13	i]n	i]n	NOUN
ihlr-16498	263	14	may	may	AUX
ihlr-16498	263	15	2002	2002	NUM
ihlr-16498	263	16	,	,	PUNCT
ihlr-16498	263	17	the	the	DET
ihlr-16498	263	18	bush	bush	PROPN
ihlr-16498	263	19	administration	administration	NOUN
ihlr-16498	263	20	decided	decide	VERB
ihlr-16498	263	21	to	to	PART
ihlr-16498	263	22	suspend	suspend	VERB
ihlr-16498	263	23	the	the	DET
ihlr-16498	263	24	rule	rule	NOUN
ihlr-16498	263	25	in	in	ADP
ihlr-16498	263	26	light	light	NOUN
ihlr-16498	263	27	of	of	ADP
ihlr-16498	263	28	the	the	DET
ihlr-16498	263	29	bpca	bpca	PROPN
ihlr-16498	263	30	's	's	PART
ihlr-16498	263	31	comprehensive	comprehensive	ADJ
ihlr-16498	263	32	structure	structure	NOUN
ihlr-16498	263	33	.	.	PUNCT
ihlr-16498	263	34	"	"	PUNCT
ihlr-16498	263	35	)	)	PUNCT
ihlr-16498	263	36	.	.	PUNCT
ihlr-16498	264	1	62	62	NUM
ihlr-16498	264	2	i	i	NOUN
ihlr-16498	264	3	d	d	PROPN
ihlr-16498	264	4	(	(	PUNCT
ihlr-16498	264	5	"	"	PUNCT
ihlr-16498	264	6	hhs	hhs	PROPN
ihlr-16498	264	7	announced	announce	VERB
ihlr-16498	264	8	that	that	SCONJ
ihlr-16498	264	9	the	the	DET
ihlr-16498	264	10	bpca	bpca	PROPN
ihlr-16498	264	11	and	and	CCONJ
ihlr-16498	264	12	the	the	DET
ihlr-16498	264	13	1998	1998	NUM
ihlr-16498	264	14	final	final	ADJ
ihlr-16498	264	15	rule	rule	NOUN
ihlr-16498	264	16	could	could	AUX
ihlr-16498	264	17	coexist	coexist	VERB
ihlr-16498	264	18	,	,	PUNCT
ihlr-16498	264	19	but	but	CCONJ
ihlr-16498	264	20	also	also	ADV
ihlr-16498	264	21	asked	ask	VERB
ihlr-16498	264	22	for	for	ADP
ihlr-16498	264	23	public	public	ADJ
ihlr-16498	264	24	comment	comment	NOUN
ihlr-16498	264	25	on	on	ADP
ihlr-16498	264	26	'	'	PUNCT
ihlr-16498	264	27	what	what	DET
ihlr-16498	264	28	additional	additional	ADJ
ihlr-16498	264	29	steps	step	NOUN
ihlr-16498	264	30	[	[	X
ihlr-16498	264	31	the	the	DET
ihlr-16498	264	32	fda	fda	PROPN
ihlr-16498	264	33	could	could	AUX
ihlr-16498	264	34	]	]	AUX
ihlr-16498	264	35	take	take	VERB
ihlr-16498	264	36	to	to	PART
ihlr-16498	264	37	assure	assure	VERB
ihlr-16498	264	38	adequate	adequate	ADJ
ihlr-16498	264	39	study	study	NOUN
ihlr-16498	264	40	of	of	ADP
ihlr-16498	264	41	drugs	drug	NOUN
ihlr-16498	264	42	in	in	ADP
ihlr-16498	264	43	children	child	NOUN
ihlr-16498	264	44	in	in	ADP
ihlr-16498	264	45	light	light	NOUN
ihlr-16498	264	46	of	of	ADP
ihlr-16498	264	47	'	'	PUNCT
ihlr-16498	264	48	the	the	DET
ihlr-16498	264	49	bpca	bpca	PROPN
ihlr-16498	264	50	"	"	PUNCT
ihlr-16498	264	51	)	)	PUNCT
ihlr-16498	264	52	.	.	PUNCT
ihlr-16498	265	1	63	63	NUM
ihlr-16498	265	2	ass'n	ass'n	PROPN
ihlr-16498	265	3	of	of	ADP
ihlr-16498	265	4	am	am	NOUN
ihlr-16498	265	5	.	.	PUNCT
ihlr-16498	265	6	,	,	PUNCT
ihlr-16498	265	7	physicians	physician	NOUN
ihlr-16498	265	8	&	&	CCONJ
ihlr-16498	265	9	surgeons	surgeons	PROPN
ihlr-16498	265	10	,	,	PUNCT
ihlr-16498	265	11	inc	inc	PROPN
ihlr-16498	265	12	.	.	PROPN
ihlr-16498	266	1	v.	v.	PROPN
ihlr-16498	266	2	fda	fda	PROPN
ihlr-16498	266	3	,	,	PUNCT
ihlr-16498	266	4	226	226	NUM
ihlr-16498	266	5	f.	f.	PROPN
ihlr-16498	266	6	supp	supp	PROPN
ihlr-16498	266	7	.	.	PUNCT
ihlr-16498	267	1	2d204	2d204	NUM
ihlr-16498	267	2	,	,	PUNCT
ihlr-16498	267	3	222	222	NUM
ihlr-16498	267	4	(	(	PUNCT
ihlr-16498	267	5	d.d.c	d.d.c	PROPN
ihlr-16498	267	6	.	.	PROPN
ihlr-16498	267	7	2002	2002	NUM
ihlr-16498	267	8	)	)	PUNCT
ihlr-16498	267	9	.	.	PUNCT
ihlr-16498	268	1	64	64	NUM
ihlr-16498	268	2	pediatric	pediatric	ADJ
ihlr-16498	268	3	research	research	NOUN
ihlr-16498	268	4	equity	equity	PROPN
ihlr-16498	268	5	act	act	PROPN
ihlr-16498	268	6	of2003	of2003	PROPN
ihlr-16498	268	7	,	,	PUNCT
ihlr-16498	268	8	pub	pub	NOUN
ihlr-16498	268	9	.	.	PUNCT
ihlr-16498	269	1	l.	l.	PROPN
ihlr-16498	269	2	no	no	INTJ
ihlr-16498	269	3	.	.	PROPN
ihlr-16498	270	1	108	108	NUM
ihlr-16498	270	2	-	-	SYM
ihlr-16498	270	3	155	155	NUM
ihlr-16498	270	4	,	,	PUNCT
ihlr-16498	270	5	117	117	NUM
ihlr-16498	270	6	stat	stat	NOUN
ihlr-16498	270	7	1936	1936	NUM
ihlr-16498	270	8	(	(	PUNCT
ihlr-16498	270	9	codified	codify	VERB
ihlr-16498	270	10	as	as	SCONJ
ihlr-16498	270	11	amended	amend	VERB
ihlr-16498	270	12	at	at	ADP
ihlr-16498	270	13	21	21	NUM
ihlr-16498	270	14	u.s.c	u.s.c	ADJ
ihlr-16498	270	15	.	.	PUNCT
ihlr-16498	271	1	§	§	PROPN
ihlr-16498	271	2	355c	355c	PROPN
ihlr-16498	271	3	(	(	PUNCT
ihlr-16498	271	4	supp	supp	PROPN
ihlr-16498	271	5	.	.	PUNCT
ihlr-16498	272	1	iv	iv	NUM
ihlr-16498	272	2	2004	2004	NUM
ihlr-16498	272	3	)	)	PUNCT
ihlr-16498	272	4	)	)	PUNCT
ihlr-16498	272	5	.	.	PUNCT
ihlr-16498	273	1	65	65	NUM
ihlr-16498	273	2	21	21	NUM
ihlr-16498	273	3	u.s.c	u.s.c	NOUN
ihlr-16498	273	4	.	.	PUNCT
ihlr-16498	274	1	§	§	PROPN
ihlr-16498	274	2	355c(a)-(b	355c(a)-(b	NUM
ihlr-16498	274	3	)	)	PUNCT
ihlr-16498	274	4	(	(	PUNCT
ihlr-16498	274	5	supp	supp	PROPN
ihlr-16498	274	6	.	.	PUNCT
ihlr-16498	275	1	iv	iv	NUM
ihlr-16498	275	2	2004	2004	NUM
ihlr-16498	275	3	)	)	PUNCT
ihlr-16498	275	4	;	;	PUNCT
ihlr-16498	275	5	groopman	groopman	NOUN
ihlr-16498	275	6	,	,	PUNCT
ihlr-16498	275	7	supranote	supranote	NOUN
ihlr-16498	275	8	1	1	NUM
ihlr-16498	275	9	,	,	PUNCT
ihlr-16498	275	10	at35	at35	PROPN
ihlr-16498	275	11	(	(	PUNCT
ihlr-16498	275	12	"	"	PUNCT
ihlr-16498	275	13	in	in	ADP
ihlr-16498	275	14	2003	2003	NUM
ihlr-16498	275	15	,	,	PUNCT
ihlr-16498	275	16	congress	congress	PROPN
ihlr-16498	275	17	passed	pass	VERB
ihlr-16498	275	18	legislation	legislation	NOUN
ihlr-16498	275	19	that	that	PRON
ihlr-16498	275	20	codified	codify	VERB
ihlr-16498	275	21	what	what	PRON
ihlr-16498	275	22	is	be	AUX
ihlr-16498	275	23	known	know	VERB
ihlr-16498	275	24	as	as	ADP
ihlr-16498	275	25	the	the	DET
ihlr-16498	275	26	pediatric	pediatric	ADJ
ihlr-16498	275	27	rule	rule	NOUN
ihlr-16498	275	28	.	.	PUNCT
ihlr-16498	276	1	a	a	DET
ihlr-16498	276	2	drug	drug	NOUN
ihlr-16498	276	3	company	company	NOUN
ihlr-16498	276	4	working	work	VERB
ihlr-16498	276	5	on	on	ADP
ihlr-16498	276	6	a	a	DET
ihlr-16498	276	7	new	new	ADJ
ihlr-16498	276	8	treatment	treatment	NOUN
ihlr-16498	276	9	for	for	ADP
ihlr-16498	276	10	a	a	DET
ihlr-16498	276	11	disease	disease	NOUN
ihlr-16498	276	12	that	that	PRON
ihlr-16498	276	13	affects	affect	VERB
ihlr-16498	276	14	both	both	DET
ihlr-16498	276	15	adults	adult	NOUN
ihlr-16498	276	16	and	and	CCONJ
ihlr-16498	276	17	children	child	NOUN
ihlr-16498	276	18	is	be	AUX
ihlr-16498	276	19	now	now	ADV
ihlr-16498	276	20	required	require	VERB
ihlr-16498	276	21	to	to	PART
ihlr-16498	276	22	conduct	conduct	VERB
ihlr-16498	276	23	pediatric	pediatric	ADJ
ihlr-16498	276	24	studies	study	NOUN
ihlr-16498	276	25	.	.	PUNCT
ihlr-16498	277	1	"	"	PUNCT
ihlr-16498	277	2	)	)	PUNCT
ihlr-16498	277	3	.	.	PUNCT
ihlr-16498	278	1	66	66	NUM
ihlr-16498	278	2	21	21	NUM
ihlr-16498	278	3	u.s.c	u.s.c	NOUN
ihlr-16498	278	4	.	.	PUNCT
ihlr-16498	279	1	§	§	PROPN
ihlr-16498	279	2	355c(a)(4xa	355c(a)(4xa	NOUN
ihlr-16498	279	3	)	)	PUNCT
ihlr-16498	279	4	.	.	PUNCT
ihlr-16498	280	1	2007	2007	NUM
ihlr-16498	280	2	]	]	PUNCT
ihlr-16498	280	3	reforming	reform	VERB
ihlr-16498	280	4	fda	fda	PROPN
ihlr-16498	280	5	poucy	poucy	PROPN
ihlr-16498	280	6	for	for	ADP
ihlr-16498	280	7	pediatric	pediatric	ADJ
ihlr-16498	280	8	testing	testing	NOUN
ihlr-16498	280	9	71	71	NUM
ihlr-16498	280	10	lation	lation	NOUN
ihlr-16498	280	11	for	for	ADP
ihlr-16498	280	12	a	a	DET
ihlr-16498	280	13	particular	particular	ADJ
ihlr-16498	280	14	age	age	NOUN
ihlr-16498	280	15	group	group	NOUN
ihlr-16498	280	16	have	have	AUX
ihlr-16498	280	17	failed	fail	VERB
ihlr-16498	280	18	.	.	PUNCT
ihlr-16498	281	1	67	67	NUM
ihlr-16498	281	2	for	for	ADP
ihlr-16498	281	3	already	already	ADV
ihlr-16498	281	4	approved	approve	VERB
ihlr-16498	281	5	drugs	drug	NOUN
ihlr-16498	281	6	,	,	PUNCT
ihlr-16498	281	7	the	the	DET
ihlr-16498	281	8	prea	prea	PROPN
ihlr-16498	281	9	grants	grant	VERB
ihlr-16498	281	10	the	the	DET
ihlr-16498	281	11	fda	fda	PROPN
ihlr-16498	281	12	authority	authority	PROPN
ihlr-16498	281	13	to	to	PART
ihlr-16498	281	14	re­	re­	AUX
ihlr-16498	281	15	quire	quire	VERB
ihlr-16498	281	16	pediatric	pediatric	ADJ
ihlr-16498	281	17	studies	study	NOUN
ihlr-16498	281	18	if	if	SCONJ
ihlr-16498	281	19	the	the	DET
ihlr-16498	281	20	drug	drug	NOUN
ihlr-16498	281	21	is	be	AUX
ihlr-16498	281	22	used	use	VERB
ihlr-16498	281	23	in	in	ADP
ihlr-16498	281	24	a	a	DET
ihlr-16498	281	25	substantial	substantial	ADJ
ihlr-16498	281	26	number	number	NOUN
ihlr-16498	281	27	of	of	ADP
ihlr-16498	281	28	pediatric	pediatric	ADJ
ihlr-16498	281	29	patients	patient	NOUN
ihlr-16498	281	30	for	for	ADP
ihlr-16498	281	31	uses	use	NOUN
ihlr-16498	281	32	indicated	indicate	VERB
ihlr-16498	281	33	on	on	ADP
ihlr-16498	281	34	the	the	DET
ihlr-16498	281	35	label	label	NOUN
ihlr-16498	281	36	,	,	PUNCT
ihlr-16498	281	37	the	the	DET
ihlr-16498	281	38	absence	absence	NOUN
ihlr-16498	281	39	of	of	ADP
ihlr-16498	281	40	pediatric	pediatric	ADJ
ihlr-16498	281	41	labeling	labeling	NOUN
ihlr-16498	281	42	poses	pose	VERB
ihlr-16498	281	43	significant	significant	ADJ
ihlr-16498	281	44	risks	risk	NOUN
ihlr-16498	281	45	,	,	PUNCT
ihlr-16498	281	46	and	and	CCONJ
ihlr-16498	281	47	data	datum	NOUN
ihlr-16498	281	48	suggest	suggest	VERB
ihlr-16498	281	49	the	the	DET
ihlr-16498	281	50	drug	drug	NOUN
ihlr-16498	281	51	will	will	AUX
ihlr-16498	281	52	represent	represent	VERB
ihlr-16498	281	53	a	a	DET
ihlr-16498	281	54	meaningful	meaningful	ADJ
ihlr-16498	281	55	thera­	thera­	DET
ihlr-16498	281	56	peutic	peutic	ADJ
ihlr-16498	281	57	benefit	benefit	NOUN
ihlr-16498	281	58	over	over	ADP
ihlr-16498	281	59	existing	exist	VERB
ihlr-16498	281	60	therapies.68	therapies.68	NOUN
ihlr-16498	281	61	the	the	DET
ihlr-16498	281	62	fda	fda	PROPN
ihlr-16498	281	63	can	can	AUX
ihlr-16498	281	64	grant	grant	VERB
ihlr-16498	281	65	a	a	DET
ihlr-16498	281	66	full	full	ADJ
ihlr-16498	281	67	waiver	waiver	NOUN
ihlr-16498	281	68	for	for	ADP
ihlr-16498	281	69	pediatric	pediatric	ADJ
ihlr-16498	281	70	studies	study	NOUN
ihlr-16498	281	71	if	if	SCONJ
ihlr-16498	281	72	the	the	DET
ihlr-16498	281	73	studies	study	NOUN
ihlr-16498	281	74	are	be	AUX
ihlr-16498	281	75	practically	practically	ADV
ihlr-16498	281	76	impossible	impossible	ADJ
ihlr-16498	281	77	to	to	PART
ihlr-16498	281	78	complete	complete	VERB
ihlr-16498	281	79	or	or	CCONJ
ihlr-16498	281	80	there	there	PRON
ihlr-16498	281	81	is	be	VERB
ihlr-16498	281	82	strong	strong	ADJ
ihlr-16498	281	83	evidence	evidence	NOUN
ihlr-16498	281	84	the	the	DET
ihlr-16498	281	85	drug	drug	NOUN
ihlr-16498	281	86	would	would	AUX
ihlr-16498	281	87	be	be	AUX
ihlr-16498	281	88	unsafe	unsafe	ADJ
ihlr-16498	281	89	or	or	CCONJ
ihlr-16498	281	90	ineffective	ineffective	ADJ
ihlr-16498	281	91	in	in	ADP
ihlr-16498	281	92	all	all	DET
ihlr-16498	281	93	pediatric	pediatric	ADJ
ihlr-16498	281	94	popula­	popula­	ADJ
ihlr-16498	281	95	tions.69	tions.69	NOUN
ihlr-16498	281	96	a	a	DET
ihlr-16498	281	97	partial	partial	ADJ
ihlr-16498	281	98	waiver	waiver	NOUN
ihlr-16498	281	99	for	for	ADP
ihlr-16498	281	100	particular	particular	ADJ
ihlr-16498	281	101	age	age	NOUN
ihlr-16498	281	102	groups	group	NOUN
ihlr-16498	281	103	for	for	ADP
ihlr-16498	281	104	already	already	ADV
ihlr-16498	281	105	approved	approve	VERB
ihlr-16498	281	106	drugs	drug	NOUN
ihlr-16498	281	107	may	may	AUX
ihlr-16498	281	108	be	be	AUX
ihlr-16498	281	109	granted	grant	VERB
ihlr-16498	281	110	for	for	ADP
ihlr-16498	281	111	the	the	DET
ihlr-16498	281	112	same	same	ADJ
ihlr-16498	281	113	reasons	reason	NOUN
ihlr-16498	281	114	as	as	ADP
ihlr-16498	281	115	a	a	DET
ihlr-16498	281	116	full	full	ADJ
ihlr-16498	281	117	waiver	waiver	NOUN
ihlr-16498	281	118	.	.	PUNCT
ihlr-16498	282	1	70	70	NUM
ihlr-16498	282	2	in	in	ADP
ihlr-16498	282	3	addition	addition	NOUN
ihlr-16498	282	4	,	,	PUNCT
ihlr-16498	282	5	a	a	DET
ihlr-16498	282	6	partial	partial	ADJ
ihlr-16498	282	7	waiver	waiver	NOUN
ihlr-16498	282	8	for	for	ADP
ihlr-16498	282	9	a	a	DET
ihlr-16498	282	10	particular	particular	ADJ
ihlr-16498	282	11	age	age	NOUN
ihlr-16498	282	12	group	group	NOUN
ihlr-16498	282	13	will	will	AUX
ihlr-16498	282	14	be	be	AUX
ihlr-16498	282	15	granted	grant	VERB
ihlr-16498	282	16	if	if	SCONJ
ihlr-16498	282	17	the	the	DET
ihlr-16498	282	18	fda	fda	PROPN
ihlr-16498	282	19	determines	determine	VERB
ihlr-16498	282	20	four	four	NUM
ihlr-16498	282	21	criteria	criterion	NOUN
ihlr-16498	282	22	:	:	PUNCT
ihlr-16498	282	23	(	(	PUNCT
ihlr-16498	282	24	1	1	X
ihlr-16498	282	25	)	)	PUNCT
ihlr-16498	282	26	the	the	DET
ihlr-16498	282	27	drug	drug	NOUN
ihlr-16498	282	28	will	will	AUX
ihlr-16498	282	29	not	not	PART
ihlr-16498	282	30	represent	represent	VERB
ihlr-16498	282	31	a	a	DET
ihlr-16498	282	32	meaningful	meaningful	ADJ
ihlr-16498	282	33	therapeutic	therapeutic	ADJ
ihlr-16498	282	34	benefit	benefit	NOUN
ihlr-16498	282	35	over	over	ADP
ihlr-16498	282	36	existing	exist	VERB
ihlr-16498	282	37	treatment	treatment	NOUN
ihlr-16498	282	38	;	;	PUNCT
ihlr-16498	282	39	(	(	PUNCT
ihlr-16498	282	40	2	2	X
ihlr-16498	282	41	)	)	PUNCT
ihlr-16498	282	42	the	the	DET
ihlr-16498	282	43	drug	drug	NOUN
ihlr-16498	282	44	is	be	AUX
ihlr-16498	282	45	not	not	PART
ihlr-16498	282	46	likely	likely	ADJ
ihlr-16498	282	47	to	to	PART
ihlr-16498	282	48	be	be	AUX
ihlr-16498	282	49	used	use	VERB
ihlr-16498	282	50	in	in	ADP
ihlr-16498	282	51	a	a	DET
ihlr-16498	282	52	substantial	substantial	ADJ
ihlr-16498	282	53	number	number	NOUN
ihlr-16498	282	54	of	of	ADP
ihlr-16498	282	55	pediatric	pediatric	ADJ
ihlr-16498	282	56	patients	patient	NOUN
ihlr-16498	282	57	in	in	ADP
ihlr-16498	282	58	a	a	DET
ihlr-16498	282	59	particular	particular	ADJ
ihlr-16498	282	60	age	age	NOUN
ihlr-16498	282	61	group	group	NOUN
ihlr-16498	282	62	;	;	PUNCT
ihlr-16498	282	63	(	(	PUNCT
ihlr-16498	282	64	3	3	X
ihlr-16498	282	65	)	)	PUNCT
ihlr-16498	282	66	the	the	DET
ihlr-16498	282	67	absence	absence	NOUN
ihlr-16498	282	68	oflabeling	oflabeling	NOUN
ihlr-16498	282	69	does	do	AUX
ihlr-16498	282	70	not	not	PART
ihlr-16498	282	71	pose	pose	VERB
ihlr-16498	282	72	a	a	DET
ihlr-16498	282	73	significant	significant	ADJ
ihlr-16498	282	74	threat	threat	NOUN
ihlr-16498	282	75	;	;	PUNCT
ihlr-16498	282	76	and	and	CCONJ
ihlr-16498	282	77	(	(	PUNCT
ihlr-16498	282	78	4	4	X
ihlr-16498	282	79	)	)	PUNCT
ihlr-16498	282	80	the	the	DET
ihlr-16498	282	81	manufacturer	manufacturer	NOUN
ihlr-16498	282	82	can	can	AUX
ihlr-16498	282	83	demonstrate	demonstrate	VERB
ihlr-16498	282	84	that	that	SCONJ
ihlr-16498	282	85	rea­	rea­	VERB
ihlr-16498	282	86	sonable	sonable	ADJ
ihlr-16498	282	87	attempts	attempt	NOUN
ihlr-16498	282	88	to	to	PART
ihlr-16498	282	89	produce	produce	VERB
ihlr-16498	282	90	a	a	DET
ihlr-16498	282	91	formula	formula	NOUN
ihlr-16498	282	92	for	for	ADP
ihlr-16498	282	93	that	that	DET
ihlr-16498	282	94	age	age	NOUN
ihlr-16498	282	95	group	group	NOUN
ihlr-16498	282	96	have	have	VERB
ihlr-16498	282	97	failed.71	failed.71	PROPN
ihlr-16498	282	98	the	the	DET
ihlr-16498	282	99	drug	drug	NOUN
ihlr-16498	282	100	label	label	NOUN
ihlr-16498	282	101	must	must	AUX
ihlr-16498	282	102	indicate	indicate	VERB
ihlr-16498	282	103	whether	whether	SCONJ
ihlr-16498	282	104	a	a	DET
ihlr-16498	282	105	waiver	waiver	NOUN
ihlr-16498	282	106	has	have	AUX
ihlr-16498	282	107	been	be	AUX
ihlr-16498	282	108	granted	grant	VERB
ihlr-16498	282	109	.	.	PUNCT
ihlr-16498	283	1	72	72	NUM
ihlr-16498	284	1	upon	upon	SCONJ
ihlr-16498	284	2	passage	passage	NOUN
ihlr-16498	284	3	,	,	PUNCT
ihlr-16498	284	4	senator	senator	PROPN
ihlr-16498	284	5	dodd	dodd	PROPN
ihlr-16498	284	6	addressed	address	VERB
ihlr-16498	284	7	the	the	DET
ihlr-16498	284	8	senate	senate	PROPN
ihlr-16498	284	9	to	to	PART
ihlr-16498	284	10	explain	explain	VERB
ihlr-16498	284	11	that	that	SCONJ
ihlr-16498	284	12	the	the	DET
ihlr-16498	284	13	main	main	ADJ
ihlr-16498	284	14	point	point	NOUN
ihlr-16498	284	15	of	of	ADP
ihlr-16498	284	16	the	the	DET
ihlr-16498	284	17	prea	prea	PROPN
ihlr-16498	284	18	is	be	AUX
ihlr-16498	284	19	to	to	PART
ihlr-16498	284	20	give	give	VERB
ihlr-16498	284	21	the	the	DET
ihlr-16498	284	22	"	"	PUNCT
ihlr-16498	284	23	fda	fda	PROPN
ihlr-16498	284	24	the	the	DET
ihlr-16498	284	25	clear	clear	ADJ
ihlr-16498	284	26	authority	authority	NOUN
ihlr-16498	284	27	to	to	PART
ihlr-16498	284	28	require	require	VERB
ihlr-16498	284	29	that	that	SCONJ
ihlr-16498	284	30	drugs	drug	NOUN
ihlr-16498	284	31	be	be	AUX
ihlr-16498	284	32	tested	test	VERB
ihlr-16498	284	33	and	and	CCONJ
ihlr-16498	284	34	formulated	formulate	VERB
ihlr-16498	284	35	for	for	ADP
ihlr-16498	284	36	children	child	NOUN
ihlr-16498	284	37	.	.	PUNCT
ihlr-16498	285	1	"73	"73	NOUN
ihlr-16498	285	2	like	like	ADP
ihlr-16498	285	3	the	the	DET
ihlr-16498	285	4	bpca	bpca	PROPN
ihlr-16498	285	5	,	,	PUNCT
ihlr-16498	285	6	the	the	DET
ihlr-16498	285	7	prea	prea	PROPN
ihlr-16498	285	8	will	will	AUX
ihlr-16498	285	9	sunset	sunset	VERB
ihlr-16498	285	10	in	in	ADP
ihlr-16498	285	11	2007.74	2007.74	NUM
ihlr-16498	285	12	iv	iv	NUM
ihlr-16498	285	13	.	.	PUNCT
ihlr-16498	286	1	the	the	DET
ihlr-16498	286	2	antidepressant	antidepressant	ADJ
ihlr-16498	286	3	story	story	NOUN
ihlr-16498	286	4	is	be	AUX
ihlr-16498	286	5	a	a	DET
ihlr-16498	286	6	model	model	NOUN
ihlr-16498	286	7	for	for	ADP
ihlr-16498	286	8	the	the	DET
ihlr-16498	286	9	deficiencies	deficiency	NOUN
ihlr-16498	286	10	in	in	ADP
ihlr-16498	286	11	the	the	DET
ihlr-16498	286	12	current	current	ADJ
ihlr-16498	286	13	legislation	legislation	NOUN
ihlr-16498	286	14	although	although	SCONJ
ihlr-16498	286	15	the	the	DET
ihlr-16498	286	16	bpca	bpca	PROPN
ihlr-16498	286	17	and	and	CCONJ
ihlr-16498	286	18	the	the	DET
ihlr-16498	286	19	prea	prea	PROPN
ihlr-16498	286	20	provide	provide	VERB
ihlr-16498	286	21	for	for	ADP
ihlr-16498	286	22	the	the	DET
ihlr-16498	286	23	identification	identification	NOUN
ihlr-16498	286	24	of	of	ADP
ihlr-16498	286	25	drugs	drug	NOUN
ihlr-16498	286	26	that	that	PRON
ihlr-16498	286	27	need	need	VERB
ihlr-16498	286	28	to	to	PART
ihlr-16498	286	29	be	be	AUX
ihlr-16498	286	30	tested	test	VERB
ihlr-16498	286	31	in	in	ADP
ihlr-16498	286	32	pediatric	pediatric	ADJ
ihlr-16498	286	33	patients	patient	NOUN
ihlr-16498	286	34	and	and	CCONJ
ihlr-16498	286	35	offer	offer	VERB
ihlr-16498	286	36	protection	protection	NOUN
ihlr-16498	286	37	for	for	ADP
ihlr-16498	286	38	children	child	NOUN
ihlr-16498	286	39	en­	en­	X
ihlr-16498	286	40	tering	tere	VERB
ihlr-16498	286	41	clinical	clinical	ADJ
ihlr-16498	286	42	studies	study	NOUN
ihlr-16498	286	43	,	,	PUNCT
ihlr-16498	286	44	they	they	PRON
ihlr-16498	286	45	do	do	AUX
ihlr-16498	286	46	not	not	PART
ihlr-16498	286	47	go	go	VERB
ihlr-16498	286	48	far	far	ADV
ihlr-16498	286	49	enough	enough	ADV
ihlr-16498	286	50	to	to	PART
ihlr-16498	286	51	address	address	VERB
ihlr-16498	286	52	many	many	ADJ
ihlr-16498	286	53	other	other	ADJ
ihlr-16498	286	54	health	health	NOUN
ihlr-16498	286	55	and	and	CCONJ
ihlr-16498	286	56	safety	safety	NOUN
ihlr-16498	286	57	concerns	concern	NOUN
ihlr-16498	286	58	.	.	PUNCT
ihlr-16498	287	1	the	the	DET
ihlr-16498	287	2	controversy	controversy	NOUN
ihlr-16498	287	3	surrounding	surround	VERB
ihlr-16498	287	4	the	the	DET
ihlr-16498	287	5	use	use	NOUN
ihlr-16498	287	6	of	of	ADP
ihlr-16498	287	7	antidepressant	antidepressant	ADJ
ihlr-16498	287	8	medication	medication	NOUN
ihlr-16498	287	9	in	in	ADP
ihlr-16498	287	10	pediatric	pediatric	ADJ
ihlr-16498	287	11	patients	patient	NOUN
ihlr-16498	287	12	offers	offer	VERB
ihlr-16498	287	13	a	a	DET
ihlr-16498	287	14	good	good	ADJ
ihlr-16498	287	15	case	case	NOUN
ihlr-16498	287	16	study	study	NOUN
ihlr-16498	287	17	to	to	PART
ihlr-16498	287	18	analyze	analyze	VERB
ihlr-16498	287	19	the	the	DET
ihlr-16498	287	20	defi­	defi­	PROPN
ihlr-16498	287	21	ciencies	ciencie	NOUN
ihlr-16498	287	22	in	in	ADP
ihlr-16498	287	23	the	the	DET
ihlr-16498	287	24	current	current	ADJ
ihlr-16498	287	25	legislative	legislative	ADJ
ihlr-16498	287	26	scheme	scheme	NOUN
ihlr-16498	287	27	.	.	PUNCT
ihlr-16498	288	1	as	as	SCONJ
ihlr-16498	288	2	is	be	AUX
ihlr-16498	288	3	often	often	ADV
ihlr-16498	288	4	the	the	DET
ihlr-16498	288	5	case	case	NOUN
ihlr-16498	288	6	,	,	PUNCT
ihlr-16498	288	7	it	it	PRON
ihlr-16498	288	8	may	may	AUX
ihlr-16498	288	9	be	be	AUX
ihlr-16498	288	10	diffi­	diffi­	PROPN
ihlr-16498	288	11	cult	cult	NOUN
ihlr-16498	288	12	to	to	PART
ihlr-16498	288	13	cover	cover	VERB
ihlr-16498	288	14	all	all	DET
ihlr-16498	288	15	areas	area	NOUN
ihlr-16498	288	16	ex	ex	PRON
ihlr-16498	288	17	ante	ante	NOUN
ihlr-16498	288	18	when	when	SCONJ
ihlr-16498	288	19	promulgating	promulgate	VERB
ihlr-16498	288	20	legislative	legislative	ADJ
ihlr-16498	288	21	and	and	CCONJ
ihlr-16498	288	22	regulatory	regulatory	ADJ
ihlr-16498	288	23	schemes	scheme	NOUN
ihlr-16498	288	24	.	.	PUNCT
ihlr-16498	289	1	over	over	ADP
ihlr-16498	289	2	the	the	DET
ihlr-16498	289	3	past	past	ADJ
ihlr-16498	289	4	few	few	ADJ
ihlr-16498	289	5	years	year	NOUN
ihlr-16498	289	6	,	,	PUNCT
ihlr-16498	289	7	tests	test	NOUN
ihlr-16498	289	8	of	of	ADP
ihlr-16498	289	9	multiple	multiple	ADJ
ihlr-16498	289	10	antidepressant	antidepressant	ADJ
ihlr-16498	289	11	medications	medication	NOUN
ihlr-16498	289	12	in	in	ADP
ihlr-16498	289	13	pediatric	pediatric	ADJ
ihlr-16498	289	14	patients	patient	NOUN
ihlr-16498	289	15	revealed	reveal	VERB
ihlr-16498	289	16	antidepressants	antidepressant	NOUN
ihlr-16498	289	17	either	either	CCONJ
ihlr-16498	289	18	did	do	AUX
ihlr-16498	289	19	not	not	PART
ihlr-16498	289	20	work	work	VERB
ihlr-16498	289	21	,	,	PUNCT
ihlr-16498	289	22	induced	induce	VERB
ihlr-16498	289	23	sui­	sui­	ADJ
ihlr-16498	289	24	cidal	cidal	ADJ
ihlr-16498	289	25	behavior	behavior	NOUN
ihlr-16498	289	26	,	,	PUNCT
ihlr-16498	289	27	or	or	CCONJ
ihlr-16498	289	28	caused	cause	VERB
ihlr-16498	289	29	withdrawal	withdrawal	NOUN
ihlr-16498	289	30	symptoms	symptom	NOUN
ihlr-16498	289	31	when	when	SCONJ
ihlr-16498	289	32	the	the	DET
ihlr-16498	289	33	patient	patient	NOUN
ihlr-16498	289	34	was	be	AUX
ihlr-16498	289	35	taken	take	VERB
ihlr-16498	289	36	off	off	ADP
ihlr-16498	289	37	67	67	NUM
ihlr-16498	289	38	i	i	PROPN
ihlr-16498	289	39	d.	d.	PROPN
ihlr-16498	289	40	§	§	PROPN
ihlr-16498	289	41	355c(a)(4)(b	355c(a)(4)(b	PROPN
ihlr-16498	289	42	)	)	PUNCT
ihlr-16498	289	43	.	.	PUNCT
ihlr-16498	290	1	68	68	NUM
ihlr-16498	291	1	i	i	PRON
ihlr-16498	291	2	d.	d.	PROPN
ihlr-16498	291	3	§	§	PROPN
ihlr-16498	291	4	355c(bxi	355c(bxi	NUM
ihlr-16498	291	5	)	)	PUNCT
ihlr-16498	291	6	.	.	PUNCT
ihlr-16498	292	1	69	69	NUM
ihlr-16498	293	1	i	i	PRON
ihlr-16498	293	2	d.	d.	PROPN
ihlr-16498	293	3	§	§	PROPN
ihlr-16498	293	4	355c(bx2xa	355c(bx2xa	PROPN
ihlr-16498	293	5	)	)	PUNCT
ihlr-16498	293	6	.	.	PUNCT
ihlr-16498	294	1	70	70	NUM
ihlr-16498	295	1	i	i	PRON
ihlr-16498	295	2	d.	d.	PROPN
ihlr-16498	295	3	§	§	PROPN
ihlr-16498	295	4	355c(b	355c(b	PROPN
ihlr-16498	295	5	x2)(b	x2)(b	PROPN
ihlr-16498	295	6	)	)	PUNCT
ihlr-16498	295	7	.	.	PUNCT
ihlr-16498	296	1	71	71	NUM
ihlr-16498	296	2	jd	jd	PROPN
ihlr-16498	296	3	.	.	PUNCT
ihlr-16498	297	1	§	§	PROPN
ihlr-16498	297	2	§	§	PROPN
ihlr-16498	297	3	355c(bx2)(bxiii)(aa	355c(bx2)(bxiii)(aa	NUM
ihlr-16498	297	4	)	)	PUNCT
ihlr-16498	297	5	,	,	PUNCT
ihlr-16498	297	6	(	(	PUNCT
ihlr-16498	297	7	bb	bb	NOUN
ihlr-16498	297	8	)	)	PUNCT
ihlr-16498	297	9	,	,	PUNCT
ihlr-16498	297	10	(	(	PUNCT
ihlr-16498	297	11	iv	iv	X
ihlr-16498	297	12	)	)	PUNCT
ihlr-16498	297	13	.	.	PUNCT
ihlr-16498	298	1	72	72	NUM
ihlr-16498	299	1	i	i	PRON
ihlr-16498	299	2	d.	d.	PROPN
ihlr-16498	299	3	§	§	PROPN
ihlr-16498	299	4	355c(bx2xd	355c(bx2xd	PROPN
ihlr-16498	299	5	)	)	PUNCT
ihlr-16498	299	6	.	.	PUNCT
ihlr-16498	300	1	73	73	NUM
ihlr-16498	300	2	149	149	NUM
ihlr-16498	300	3	con	con	NOUN
ihlr-16498	300	4	.	.	PUNCT
ihlr-16498	301	1	rec	rec	PROPN
ihlr-16498	301	2	.	.	PROPN
ihlr-16498	302	1	s9811	s9811	PROPN
ihlr-16498	302	2	,	,	PUNCT
ihlr-16498	302	3	s9818	s9818	X
ihlr-16498	302	4	(	(	PUNCT
ihlr-16498	302	5	2003	2003	NUM
ihlr-16498	302	6	)	)	PUNCT
ihlr-16498	302	7	.	.	PUNCT
ihlr-16498	303	1	74	74	NUM
ihlr-16498	303	2	21	21	NUM
ihlr-16498	303	3	u.s	u.s	PROPN
ihlr-16498	303	4	.	.	PROPN
ihlr-16498	303	5	c.	c.	PROPN
ihlr-16498	303	6	§	§	PROPN
ihlr-16498	303	7	355a(n	355a(n	PROPN
ihlr-16498	303	8	)	)	PUNCT
ihlr-16498	304	1	(	(	PUNCT
ihlr-16498	304	2	referring	refer	VERB
ihlr-16498	304	3	to	to	ADP
ihlr-16498	304	4	amendment	amendment	NOUN
ihlr-16498	304	5	of21	of21	PROPN
ihlr-16498	304	6	u.s.c	u.s.c	NOUN
ihlr-16498	304	7	.	.	PUNCT
ihlr-16498	305	1	351	351	NUM
ihlr-16498	305	2	et	et	PROPN
ihlr-16498	305	3	seq	seq	PROPN
ihlr-16498	305	4	.	.	PUNCT
ihlr-16498	305	5	)	)	PUNCT
ihlr-16498	305	6	.	.	PUNCT
ihlr-16498	306	1	72	72	NUM
ihlr-16498	306	2	indiana	indiana	PROPN
ihlr-16498	306	3	health	health	PROPN
ihlr-16498	306	4	law	law	PROPN
ihlr-16498	306	5	review	review	NOUN
ihlr-16498	306	6	[	[	X
ihlr-16498	306	7	vol	vol	NOUN
ihlr-16498	306	8	.	.	PUNCT
ihlr-16498	307	1	4:59	4:59	NUM
ihlr-16498	308	1	the	the	DET
ihlr-16498	308	2	drug	drug	NOUN
ihlr-16498	308	3	.	.	PUNCT
ihlr-16498	309	1	75	75	NUM
ihlr-16498	309	2	indeed	indeed	ADV
ihlr-16498	309	3	,	,	PUNCT
ihlr-16498	309	4	reports	report	NOUN
ihlr-16498	309	5	surfaced	surface	VERB
ihlr-16498	309	6	that	that	SCONJ
ihlr-16498	309	7	some	some	DET
ihlr-16498	309	8	drug	drug	NOUN
ihlr-16498	309	9	manufacturers	manufacturer	NOUN
ihlr-16498	309	10	may	may	AUX
ihlr-16498	309	11	have	have	AUX
ihlr-16498	309	12	known	know	VERB
ihlr-16498	309	13	about	about	ADP
ihlr-16498	309	14	the	the	DET
ihlr-16498	309	15	ineffectiveness	ineffectiveness	NOUN
ihlr-16498	309	16	or	or	CCONJ
ihlr-16498	309	17	even	even	ADV
ihlr-16498	309	18	negative	negative	ADJ
ihlr-16498	309	19	effects	effect	NOUN
ihlr-16498	309	20	of	of	ADP
ihlr-16498	309	21	antidepressants	antidepressant	NOUN
ihlr-16498	309	22	for	for	ADP
ihlr-16498	309	23	years.76	years.76	PROPN
ihlr-16498	309	24	the	the	DET
ihlr-16498	309	25	fda	fda	PROPN
ihlr-16498	309	26	's	's	PART
ihlr-16498	309	27	authority	authority	NOUN
ihlr-16498	309	28	to	to	PART
ihlr-16498	309	29	require	require	VERB
ihlr-16498	309	30	pediatric	pediatric	ADJ
ihlr-16498	309	31	testing	testing	NOUN
ihlr-16498	309	32	may	may	AUX
ihlr-16498	309	33	have	have	AUX
ihlr-16498	309	34	brought	bring	VERB
ihlr-16498	309	35	some	some	PRON
ihlr-16498	309	36	of	of	ADP
ihlr-16498	309	37	the	the	DET
ihlr-16498	309	38	negative	negative	ADJ
ihlr-16498	309	39	effects	effect	NOUN
ihlr-16498	309	40	of	of	ADP
ihlr-16498	309	41	antidepressant	antidepressant	ADJ
ihlr-16498	309	42	drug	drug	NOUN
ihlr-16498	309	43	use	use	NOUN
ihlr-16498	309	44	in	in	ADP
ihlr-16498	309	45	children	child	NOUN
ihlr-16498	309	46	to	to	ADP
ihlr-16498	309	47	light	light	NOUN
ihlr-16498	309	48	,	,	PUNCT
ihlr-16498	309	49	but	but	CCONJ
ihlr-16498	309	50	the	the	DET
ihlr-16498	309	51	regulatory	regulatory	ADJ
ihlr-16498	309	52	scheme	scheme	NOUN
ihlr-16498	309	53	was	be	AUX
ihlr-16498	309	54	neither	neither	CCONJ
ihlr-16498	309	55	able	able	ADJ
ihlr-16498	309	56	to	to	PART
ihlr-16498	309	57	address	address	VERB
ihlr-16498	309	58	anecdotal	anecdotal	ADJ
ihlr-16498	309	59	information	information	NOUN
ihlr-16498	309	60	effec­	effec­	PRON
ihlr-16498	309	61	tively	tively	ADV
ihlr-16498	309	62	,	,	PUNCT
ihlr-16498	309	63	follow	follow	VERB
ihlr-16498	309	64	-	-	PUNCT
ihlr-16498	309	65	up	up	NOUN
ihlr-16498	309	66	on	on	ADP
ihlr-16498	309	67	manufacturer	manufacturer	NOUN
ihlr-16498	309	68	's	's	PART
ihlr-16498	309	69	information	information	NOUN
ihlr-16498	309	70	in	in	ADP
ihlr-16498	309	71	clinical	clinical	ADJ
ihlr-16498	309	72	studies	study	NOUN
ihlr-16498	309	73	,	,	PUNCT
ihlr-16498	309	74	nor	nor	CCONJ
ihlr-16498	309	75	respond	respond	VERB
ihlr-16498	309	76	quickly	quickly	ADV
ihlr-16498	309	77	to	to	ADP
ihlr-16498	309	78	developments	development	NOUN
ihlr-16498	309	79	in	in	ADP
ihlr-16498	309	80	sister	sister	NOUN
ihlr-16498	309	81	organizations	organization	NOUN
ihlr-16498	309	82	in	in	ADP
ihlr-16498	309	83	other	other	ADJ
ihlr-16498	309	84	countries	country	NOUN
ihlr-16498	309	85	.	.	PUNCT
ihlr-16498	310	1	therefore	therefore	ADV
ihlr-16498	310	2	,	,	PUNCT
ihlr-16498	310	3	the	the	DET
ihlr-16498	310	4	antidepressant	antidepressant	ADJ
ihlr-16498	310	5	story	story	NOUN
ihlr-16498	310	6	can	can	AUX
ihlr-16498	310	7	be	be	AUX
ihlr-16498	310	8	used	use	VERB
ihlr-16498	310	9	to	to	PART
ihlr-16498	310	10	highlight	highlight	VERB
ihlr-16498	310	11	where	where	SCONJ
ihlr-16498	310	12	the	the	DET
ihlr-16498	310	13	deficiencies	deficiency	NOUN
ihlr-16498	310	14	in	in	ADP
ihlr-16498	310	15	pedi­	pedi­	NOUN
ihlr-16498	310	16	atric	atric	ADJ
ihlr-16498	310	17	testing	testing	NOUN
ihlr-16498	310	18	exist	exist	VERB
ihlr-16498	310	19	and	and	CCONJ
ihlr-16498	310	20	mark	mark	VERB
ihlr-16498	310	21	a	a	DET
ihlr-16498	310	22	good	good	ADJ
ihlr-16498	310	23	starting	starting	NOUN
ihlr-16498	310	24	point	point	NOUN
ihlr-16498	310	25	to	to	PART
ihlr-16498	310	26	broaden	broaden	VERB
ihlr-16498	310	27	the	the	DET
ihlr-16498	310	28	fda	fda	PROPN
ihlr-16498	310	29	's	's	PART
ihlr-16498	310	30	regula­	regula­	PROPN
ihlr-16498	310	31	tory	tory	PROPN
ihlr-16498	310	32	authority	authority	NOUN
ihlr-16498	310	33	to	to	PART
ihlr-16498	310	34	protect	protect	VERB
ihlr-16498	310	35	children	child	NOUN
ihlr-16498	310	36	.	.	PUNCT
ihlr-16498	311	1	a.	a.	NOUN
ihlr-16498	312	1	the	the	DET
ihlr-16498	312	2	forest	forest	NOUN
ihlr-16498	312	3	laboratories	laboratory	NOUN
ihlr-16498	312	4	clinical	clinical	ADJ
ihlr-16498	312	5	studies	study	NOUN
ihlr-16498	312	6	demonstrate	demonstrate	VERB
ihlr-16498	312	7	conflicting	conflicting	ADJ
ihlr-16498	312	8	clinical	clinical	ADJ
ihlr-16498	312	9	results	result	NOUN
ihlr-16498	312	10	in	in	ADP
ihlr-16498	312	11	the	the	DET
ihlr-16498	312	12	spring	spring	NOUN
ihlr-16498	312	13	of2004	of2004	NOUN
ihlr-16498	312	14	,	,	PUNCT
ihlr-16498	312	15	forest	forest	NOUN
ihlr-16498	312	16	laboratories	laboratory	NOUN
ihlr-16498	312	17	announced	announce	VERB
ihlr-16498	312	18	that	that	SCONJ
ihlr-16498	312	19	its	its	PRON
ihlr-16498	312	20	antidepres­	antidepres­	PROPN
ihlr-16498	312	21	sant	sant	ADJ
ihlr-16498	312	22	drug	drug	NOUN
ihlr-16498	312	23	,	,	PUNCT
ihlr-16498	312	24	lexapro	lexapro	NOUN
ihlr-16498	312	25	,	,	PUNCT
ihlr-16498	312	26	did	do	AUX
ihlr-16498	312	27	not	not	PART
ihlr-16498	312	28	help	help	VERB
ihlr-16498	312	29	depressed	depressed	ADJ
ihlr-16498	312	30	pediatric	pediatric	ADJ
ihlr-16498	312	31	patients.77	patients.77	ADJ
ihlr-16498	312	32	lexapro	lexapro	NOUN
ihlr-16498	312	33	con­	con­	PROPN
ihlr-16498	312	34	tains	tain	NOUN
ihlr-16498	312	35	the	the	DET
ihlr-16498	312	36	same	same	ADJ
ihlr-16498	312	37	active	active	ADJ
ihlr-16498	312	38	ingredient	ingredient	NOUN
ihlr-16498	312	39	as	as	ADP
ihlr-16498	312	40	celexa	celexa	NOUN
ihlr-16498	312	41	.	.	PUNCT
ihlr-16498	313	1	78	78	NUM
ihlr-16498	314	1	the	the	DET
ihlr-16498	314	2	patent	patent	NOUN
ihlr-16498	314	3	on	on	ADP
ihlr-16498	314	4	celexa	celexa	PROPN
ihlr-16498	314	5	is	be	AUX
ihlr-16498	314	6	about	about	ADJ
ihlr-16498	314	7	to	to	PART
ihlr-16498	314	8	expire	expire	VERB
ihlr-16498	314	9	and	and	CCONJ
ihlr-16498	314	10	it	it	PRON
ihlr-16498	314	11	has	have	AUX
ihlr-16498	314	12	been	be	AUX
ihlr-16498	314	13	reported	report	VERB
ihlr-16498	314	14	that	that	SCONJ
ihlr-16498	314	15	perhaps	perhaps	ADV
ihlr-16498	314	16	forest	forest	NOUN
ihlr-16498	314	17	laboratories	laboratory	NOUN
ihlr-16498	314	18	is	be	AUX
ihlr-16498	314	19	promoting	promote	VERB
ihlr-16498	314	20	lexapro	lexapro	NOUN
ihlr-16498	314	21	so	so	SCONJ
ihlr-16498	314	22	as	as	SCONJ
ihlr-16498	314	23	to	to	PART
ihlr-16498	314	24	make	make	VERB
ihlr-16498	314	25	money	money	NOUN
ihlr-16498	314	26	during	during	ADP
ihlr-16498	314	27	the	the	DET
ihlr-16498	314	28	patent	patent	NOUN
ihlr-16498	314	29	exclusivity	exclusivity	NOUN
ihlr-16498	314	30	time	time	NOUN
ihlr-16498	314	31	period	period	NOUN
ihlr-16498	314	32	.	.	PUNCT
ihlr-16498	315	1	79	79	NUM
ihlr-16498	315	2	in	in	ADP
ihlr-16498	315	3	the	the	DET
ihlr-16498	315	4	wake	wake	NOUN
ihlr-16498	315	5	of	of	ADP
ihlr-16498	315	6	the	the	DET
ihlr-16498	315	7	lexapro	lexapro	ADJ
ihlr-16498	315	8	announcement	announcement	NOUN
ihlr-16498	315	9	,	,	PUNCT
ihlr-16498	315	10	forest	forest	NOUN
ihlr-16498	315	11	laboratories	laboratory	NOUN
ihlr-16498	315	12	also	also	ADV
ihlr-16498	315	13	addressed	address	VERB
ihlr-16498	315	14	its	its	PRON
ihlr-16498	315	15	inadequate	inadequate	ADJ
ihlr-16498	315	16	disclosure	disclosure	NOUN
ihlr-16498	315	17	of	of	ADP
ihlr-16498	315	18	a	a	DET
ihlr-16498	315	19	failed	fail	VERB
ihlr-16498	315	20	unpublished	unpublished	ADJ
ihlr-16498	315	21	study	study	NOUN
ihlr-16498	315	22	in	in	ADP
ihlr-16498	315	23	2002	2002	NUM
ihlr-16498	315	24	regarding	regard	VERB
ihlr-16498	315	25	use	use	NOUN
ihlr-16498	315	26	of	of	ADP
ihlr-16498	315	27	celexa	celexa	NOUN
ihlr-16498	315	28	in	in	ADP
ihlr-16498	315	29	children	child	NOUN
ihlr-16498	315	30	.	.	PUNCT
ihlr-16498	316	1	only	only	ADV
ihlr-16498	316	2	now	now	ADV
ihlr-16498	316	3	,	,	PUNCT
ihlr-16498	316	4	forest	forest	NOUN
ihlr-16498	316	5	laboratories	laboratory	NOUN
ihlr-16498	316	6	stated	state	VERB
ihlr-16498	316	7	that	that	SCONJ
ihlr-16498	316	8	a	a	DET
ihlr-16498	316	9	more	more	ADV
ihlr-16498	316	10	recent	recent	ADJ
ihlr-16498	316	11	2004	2004	NUM
ihlr-16498	316	12	test	test	NOUN
ihlr-16498	316	13	indicates	indicate	VERB
ihlr-16498	316	14	celexa	celexa	NOUN
ihlr-16498	316	15	may	may	AUX
ihlr-16498	316	16	indeed	indeed	ADV
ihlr-16498	316	17	help	help	VERB
ihlr-16498	316	18	children	child	NOUN
ihlr-16498	316	19	.	.	PUNCT
ihlr-16498	317	1	the	the	DET
ihlr-16498	317	2	results	result	NOUN
ihlr-16498	317	3	of	of	ADP
ihlr-16498	317	4	the	the	DET
ihlr-16498	317	5	study	study	NOUN
ihlr-16498	317	6	,	,	PUNCT
ihlr-16498	317	7	which	which	PRON
ihlr-16498	317	8	was	be	AUX
ihlr-16498	317	9	conducted	conduct	VERB
ihlr-16498	317	10	in	in	ADP
ihlr-16498	317	11	eur':e	eur':e	PROPN
ihlr-16498	317	12	from	from	ADP
ihlr-16498	317	13	1996	1996	NUM
ihlr-16498	317	14	to	to	ADP
ihlr-16498	317	15	2002	2002	NUM
ihlr-16498	317	16	,	,	PUNCT
ihlr-16498	317	17	showed	show	VERB
ihlr-16498	317	18	celexa	celexa	NOUN
ihlr-16498	317	19	had	have	VERB
ihlr-16498	317	20	no	no	DET
ihlr-16498	317	21	greater	great	ADJ
ihlr-16498	317	22	effects	effect	NOUN
ihlr-16498	317	23	than	than	ADP
ihlr-16498	317	24	a	a	DET
ihlr-16498	317	25	placebo	placebo	NOUN
ihlr-16498	317	26	.	.	PUNCT
ihlr-16498	318	1	that	that	DET
ihlr-16498	318	2	study	study	NOUN
ihlr-16498	318	3	,	,	PUNCT
ihlr-16498	318	4	however	however	ADV
ihlr-16498	318	5	,	,	PUNCT
ihlr-16498	318	6	was	be	AUX
ihlr-16498	318	7	published	publish	VERB
ihlr-16498	318	8	in	in	ADP
ihlr-16498	318	9	a	a	DET
ihlr-16498	318	10	dan­	dan­	NOUN
ihlr-16498	318	11	ish	ish	NOUN
ihlr-16498	318	12	textbook	textbook	NOUN
ihlr-16498	318	13	and	and	CCONJ
ihlr-16498	318	14	therefore	therefore	ADV
ihlr-16498	318	15	received	receive	VERB
ihlr-16498	318	16	little	little	ADJ
ihlr-16498	318	17	attention	attention	NOUN
ihlr-16498	318	18	.	.	PUNCT
ihlr-16498	319	1	81	81	NUM
ihlr-16498	319	2	two	two	NUM
ihlr-16498	319	3	of	of	ADP
ihlr-16498	319	4	the	the	DET
ihlr-16498	319	5	outside	outside	ADJ
ihlr-16498	319	6	re­	re­	PROPN
ihlr-16498	319	7	searchers	searcher	NOUN
ihlr-16498	319	8	involved	involve	VERB
ihlr-16498	319	9	in	in	ADP
ihlr-16498	319	10	the	the	DET
ihlr-16498	319	11	positive	positive	ADJ
ihlr-16498	319	12	study	study	NOUN
ihlr-16498	319	13	on	on	ADP
ihlr-16498	319	14	celexa	celexa	PROPN
ihlr-16498	319	15	stated	state	VERB
ihlr-16498	319	16	they	they	PRON
ihlr-16498	319	17	did	do	AUX
ihlr-16498	319	18	not	not	PART
ihlr-16498	319	19	know	know	VERB
ihlr-16498	319	20	75	75	NUM
ihlr-16498	319	21	barry	barry	PROPN
ihlr-16498	319	22	meier	meier	PROPN
ihlr-16498	319	23	,	,	PUNCT
ihlr-16498	319	24	drug	drug	NOUN
ihlr-16498	319	25	maker	maker	NOUN
ihlr-16498	319	26	acknowledges	acknowledge	VERB
ihlr-16498	319	27	some	some	DET
ihlr-16498	319	28	negative	negative	ADJ
ihlr-16498	319	29	test	test	NOUN
ihlr-16498	319	30	results	result	NOUN
ihlr-16498	319	31	,	,	PUNCT
ihlr-16498	319	32	n.y	n.y	PROPN
ihlr-16498	319	33	.	.	PROPN
ihlr-16498	319	34	times	times	PROPN
ihlr-16498	319	35	,	,	PUNCT
ihlr-16498	319	36	june	june	PROPN
ihlr-16498	319	37	26	26	NUM
ihlr-16498	319	38	,	,	PUNCT
ihlr-16498	319	39	2004	2004	NUM
ihlr-16498	319	40	,	,	PUNCT
ihlr-16498	319	41	at	at	ADP
ihlr-16498	319	42	c3	c3	PROPN
ihlr-16498	320	1	[	[	X
ihlr-16498	320	2	hereinafter	hereinafter	NOUN
ihlr-16498	320	3	meier	meier	NOUN
ihlr-16498	320	4	,	,	PUNCT
ihlr-16498	320	5	negative	negative	ADJ
ihlr-16498	320	6	test	test	NOUN
ihlr-16498	320	7	results	result	NOUN
ihlr-16498	320	8	)	)	PUNCT
ihlr-16498	320	9	;	;	PUNCT
ihlr-16498	320	10	groopman	groopman	NOUN
ihlr-16498	320	11	,	,	PUNCT
ihlr-16498	320	12	supra	supra	PROPN
ihlr-16498	320	13	note	note	NOUN
ihlr-16498	320	14	1	1	NUM
ihlr-16498	320	15	,	,	PUNCT
ihlr-16498	320	16	at	at	ADP
ihlr-16498	320	17	356	356	NUM
ihlr-16498	320	18	.	.	PUNCT
ihlr-16498	321	1	76	76	NUM
ihlr-16498	321	2	meier	meier	PROPN
ihlr-16498	321	3	,	,	PUNCT
ihlr-16498	321	4	negative	negative	ADJ
ihlr-16498	321	5	test	test	NOUN
ihlr-16498	321	6	results	result	NOUN
ihlr-16498	321	7	,	,	PUNCT
ihlr-16498	321	8	supra	supra	PROPN
ihlr-16498	321	9	note	note	NOUN
ihlr-16498	321	10	75	75	NUM
ihlr-16498	321	11	(	(	PUNCT
ihlr-16498	321	12	stating	state	VERB
ihlr-16498	321	13	that	that	SCONJ
ihlr-16498	321	14	forest	forest	NOUN
ihlr-16498	321	15	officials	official	NOUN
ihlr-16498	321	16	had	have	AUX
ihlr-16498	321	17	not	not	PART
ihlr-16498	321	18	told	tell	VERB
ihlr-16498	321	19	a	a	DET
ihlr-16498	321	20	medical	medical	ADJ
ihlr-16498	321	21	journal	journal	NOUN
ihlr-16498	321	22	about	about	ADP
ihlr-16498	321	23	a	a	DET
ihlr-16498	321	24	failed	fail	VERB
ihlr-16498	321	25	unpublished	unpublished	ADJ
ihlr-16498	321	26	study	study	NOUN
ihlr-16498	321	27	in	in	ADP
ihlr-16498	321	28	2002	2002	NUM
ihlr-16498	321	29	regarding	regard	VERB
ihlr-16498	321	30	the	the	DET
ihlr-16498	321	31	use	use	NOUN
ihlr-16498	321	32	ofcelexa	ofcelexa	PRON
ihlr-16498	321	33	in	in	ADP
ihlr-16498	321	34	children	child	NOUN
ihlr-16498	321	35	and	and	CCONJ
ihlr-16498	321	36	adolescents	adolescent	NOUN
ihlr-16498	321	37	prior	prior	ADV
ihlr-16498	321	38	to	to	ADP
ihlr-16498	321	39	the	the	DET
ihlr-16498	321	40	medical	medical	ADJ
ihlr-16498	321	41	journal	journal	NOUN
ihlr-16498	321	42	's	's	PART
ihlr-16498	321	43	publication	publication	NOUN
ihlr-16498	321	44	of	of	ADP
ihlr-16498	321	45	an	an	DET
ihlr-16498	321	46	article	article	NOUN
ihlr-16498	321	47	about	about	ADP
ihlr-16498	321	48	a	a	DET
ihlr-16498	321	49	separate	separate	ADJ
ihlr-16498	321	50	test	test	NOUN
ihlr-16498	321	51	indi­	indi­	NOUN
ihlr-16498	321	52	cating	cat	VERB
ihlr-16498	321	53	the	the	DET
ihlr-16498	321	54	drug	drug	NOUN
ihlr-16498	321	55	could	could	AUX
ihlr-16498	321	56	help	help	VERB
ihlr-16498	321	57	young	young	ADJ
ihlr-16498	321	58	people	people	NOUN
ihlr-16498	321	59	.	.	PUNCT
ihlr-16498	322	1	further	far	ADV
ihlr-16498	322	2	,	,	PUNCT
ihlr-16498	322	3	some	some	PRON
ihlr-16498	322	4	of	of	ADP
ihlr-16498	322	5	the	the	DET
ihlr-16498	322	6	authors	author	NOUN
ihlr-16498	322	7	of	of	ADP
ihlr-16498	322	8	this	this	DET
ihlr-16498	322	9	article	article	NOUN
ihlr-16498	322	10	were	be	AUX
ihlr-16498	322	11	forest	forest	NOUN
ihlr-16498	322	12	employees	employee	NOUN
ihlr-16498	322	13	.	.	PUNCT
ihlr-16498	322	14	)	)	PUNCT
ihlr-16498	322	15	.	.	PUNCT
ihlr-16498	323	1	77	77	NUM
ihlr-16498	323	2	!	!	PUNCT
ihlr-16498	324	1	d.	d.	PROPN
ihlr-16498	324	2	(	(	PUNCT
ihlr-16498	324	3	"	"	PUNCT
ihlr-16498	324	4	forest	forest	NOUN
ihlr-16498	324	5	laboratories	laboratory	NOUN
ihlr-16498	324	6	has	have	AUX
ihlr-16498	324	7	said	say	VERB
ihlr-16498	324	8	a	a	DET
ihlr-16498	324	9	recently	recently	ADV
ihlr-16498	324	10	concluded	conclude	VERB
ihlr-16498	324	11	test	test	NOUN
ihlr-16498	324	12	found	find	VERB
ihlr-16498	324	13	that	that	SCONJ
ihlr-16498	324	14	its	its	PRON
ihlr-16498	324	15	antidepres­	antidepres­	PROPN
ihlr-16498	324	16	sant	sant	NOUN
ihlr-16498	324	17	lexapro	lexapro	NOUN
ihlr-16498	324	18	did	do	AUX
ihlr-16498	324	19	not	not	PART
ihlr-16498	324	20	help	help	VERB
ihlr-16498	324	21	depressed	depressed	ADJ
ihlr-16498	324	22	children	child	NOUN
ihlr-16498	324	23	and	and	CCONJ
ihlr-16498	324	24	adolescents	adolescent	NOUN
ihlr-16498	324	25	,	,	PUNCT
ihlr-16498	324	26	an	an	DET
ihlr-16498	324	27	announcement	announcement	NOUN
ihlr-16498	324	28	that	that	PRON
ihlr-16498	324	29	comes	come	VERB
ihlr-16498	324	30	amid	amid	ADP
ihlr-16498	324	31	the	the	DET
ihlr-16498	324	32	growing	grow	VERB
ihlr-16498	324	33	controversy	controversy	NOUN
ihlr-16498	324	34	over	over	ADP
ihlr-16498	324	35	clinical	clinical	ADJ
ihlr-16498	324	36	drng	drng	NOUN
ihlr-16498	324	37	tests	test	NOUN
ihlr-16498	324	38	.	.	PUNCT
ihlr-16498	325	1	j.	j.	PROPN
ihlr-16498	325	2	78	78	NUM
ihlr-16498	326	1	i	i	PRON
ihlr-16498	326	2	d.	d.	PROPN
ihlr-16498	326	3	79	79	NUM
ihlr-16498	326	4	/d	/d	PUNCT
ihlr-16498	326	5	.	.	PROPN
ihlr-16498	326	6	80	80	NUM
ihlr-16498	327	1	i	i	PRON
ihlr-16498	327	2	d.	d.	PROPN
ihlr-16498	327	3	81	81	NUM
ihlr-16498	327	4	/d	/d	PUNCT
ihlr-16498	327	5	.	.	PUNCT
ihlr-16498	328	1	(	(	PUNCT
ihlr-16498	328	2	"	"	PUNCT
ihlr-16498	328	3	the	the	DET
ihlr-16498	328	4	european	european	ADJ
ihlr-16498	328	5	study	study	NOUN
ihlr-16498	328	6	was	be	AUX
ihlr-16498	328	7	sponsored	sponsor	VERB
ihlr-16498	328	8	by	by	ADP
ihlr-16498	328	9	h.	h.	PROPN
ihlr-16498	328	10	lundbeck	lundbeck	PROPN
ihlr-16498	328	11	,	,	PUNCT
ihlr-16498	328	12	the	the	DET
ihlr-16498	328	13	danish	danish	ADJ
ihlr-16498	328	14	company	company	NOUN
ihlr-16498	328	15	that	that	PRON
ihlr-16498	328	16	developed	develop	VERB
ihlr-16498	328	17	citalopram	citalopram	NOUN
ihlr-16498	328	18	,	,	PUNCT
ihlr-16498	328	19	which	which	DET
ihlr-16498	328	20	forest	forest	NOUN
ihlr-16498	328	21	markets	market	NOUN
ihlr-16498	328	22	in	in	ADP
ihlr-16498	328	23	this	this	DET
ihlr-16498	328	24	country	country	NOUN
ihlr-16498	328	25	as	as	ADP
ihlr-16498	328	26	celexa	celexa	NOUN
ihlr-16498	328	27	.	.	PUNCT
ihlr-16498	329	1	j.	j.	PROPN
ihlr-16498	329	2	the	the	DET
ihlr-16498	329	3	basic	basic	ADJ
ihlr-16498	329	4	finding	finding	NOUN
ihlr-16498	329	5	of	of	ADP
ihlr-16498	329	6	that	that	DET
ihlr-16498	329	7	study	study	NOUN
ihlr-16498	329	8	,	,	PUNCT
ihlr-16498	329	9	which	which	PRON
ihlr-16498	329	10	reported	report	VERB
ihlr-16498	329	11	that	that	SCONJ
ihlr-16498	329	12	celexa	celexa	PROPN
ihlr-16498	329	13	"	"	PUNCT
ihlr-16498	329	14	showed	show	VERB
ihlr-16498	329	15	no	no	DET
ihlr-16498	329	16	effects	effect	NOUN
ihlr-16498	329	17	greater	great	ADJ
ihlr-16498	329	18	than	than	ADP
ihlr-16498	329	19	a	a	DET
ihlr-16498	329	20	placebo	placebo	NOUN
ihlr-16498	329	21	-	-	PUNCT
ihlr-16498	329	22	was	be	AUX
ihlr-16498	329	23	noted	note	VERB
ihlr-16498	329	24	in	in	ADP
ihlr-16498	329	25	a	a	DET
ihlr-16498	329	26	chart	chart	NOUN
ihlr-16498	329	27	published	publish	VERB
ihlr-16498	329	28	"	"	PUNCT
ihlr-16498	329	29	in	in	ADP
ihlr-16498	329	30	october	october	PROPN
ihlr-16498	329	31	2003	2003	NUM
ihlr-16498	329	32	in	in	ADP
ihlr-16498	329	33	a	a	DET
ihlr-16498	329	34	medical	medical	ADJ
ihlr-16498	329	35	textbook	textbook	NOUN
ihlr-16498	329	36	written	write	VERB
ihlr-16498	329	37	in	in	ADP
ihlr-16498	329	38	danish	danish	PROPN
ihlr-16498	329	39	.	.	PUNCT
ihlr-16498	330	1	jd	jd	PROPN
ihlr-16498	330	2	2007	2007	NUM
ihlr-16498	330	3	]	]	PUNCT
ihlr-16498	330	4	reforming	reform	VERB
ihlr-16498	330	5	fda	fda	PROPN
ihlr-16498	330	6	poucy	poucy	PROPN
ihlr-16498	330	7	for	for	ADP
ihlr-16498	330	8	pediatric	pediatric	ADJ
ihlr-16498	330	9	testing	testing	NOUN
ihlr-16498	330	10	73	73	NUM
ihlr-16498	330	11	about	about	ADP
ihlr-16498	330	12	the	the	DET
ihlr-16498	330	13	results	result	NOUN
ihlr-16498	330	14	of	of	ADP
ihlr-16498	330	15	the	the	DET
ihlr-16498	330	16	earlier	early	ADJ
ihlr-16498	330	17	study	study	NOUN
ihlr-16498	330	18	.	.	PUNCT
ihlr-16498	331	1	82	82	NUM
ihlr-16498	332	1	the	the	DET
ihlr-16498	332	2	lexapro	lexapro	NOUN
ihlr-16498	332	3	and	and	CCONJ
ihlr-16498	332	4	celexa	celexa	NOUN
ihlr-16498	332	5	clinical	clinical	ADJ
ihlr-16498	332	6	studies	study	NOUN
ihlr-16498	332	7	raise	raise	VERB
ihlr-16498	332	8	a	a	DET
ihlr-16498	332	9	number	number	NOUN
ihlr-16498	332	10	of	of	ADP
ihlr-16498	332	11	concerns	concern	NOUN
ihlr-16498	332	12	.	.	PUNCT
ihlr-16498	333	1	first	first	ADV
ihlr-16498	333	2	,	,	PUNCT
ihlr-16498	333	3	forest	forest	NOUN
ihlr-16498	333	4	laboratories	laboratory	NOUN
ihlr-16498	333	5	has	have	AUX
ihlr-16498	333	6	not	not	PART
ihlr-16498	333	7	explained	explain	VERB
ihlr-16498	333	8	the	the	DET
ihlr-16498	333	9	discrepancies	discrepancy	NOUN
ihlr-16498	333	10	between	between	ADP
ihlr-16498	333	11	the	the	DET
ihlr-16498	333	12	ear­	ear­	ADJ
ihlr-16498	333	13	lier	lier	ADJ
ihlr-16498	333	14	study	study	NOUN
ihlr-16498	333	15	of	of	ADP
ihlr-16498	333	16	celexa	celexa	NOUN
ihlr-16498	333	17	that	that	PRON
ihlr-16498	333	18	found	find	VERB
ihlr-16498	333	19	no	no	DET
ihlr-16498	333	20	greater	great	ADJ
ihlr-16498	333	21	effect	effect	NOUN
ihlr-16498	333	22	than	than	ADP
ihlr-16498	333	23	a	a	DET
ihlr-16498	333	24	placebo	placebo	NOUN
ihlr-16498	333	25	and	and	CCONJ
ihlr-16498	333	26	the	the	DET
ihlr-16498	333	27	more	more	ADV
ihlr-16498	333	28	recent	recent	ADJ
ihlr-16498	333	29	study	study	NOUN
ihlr-16498	333	30	that	that	PRON
ihlr-16498	333	31	concluded	conclude	VERB
ihlr-16498	333	32	the	the	DET
ihlr-16498	333	33	drug	drug	NOUN
ihlr-16498	333	34	could	could	AUX
ihlr-16498	333	35	help	help	VERB
ihlr-16498	333	36	pediatric	pediatric	ADJ
ihlr-16498	333	37	patients	patient	NOUN
ihlr-16498	333	38	.	.	PUNCT
ihlr-16498	334	1	second	second	ADJ
ihlr-16498	334	2	,	,	PUNCT
ihlr-16498	334	3	it	it	PRON
ihlr-16498	334	4	is	be	AUX
ihlr-16498	334	5	disconcerting	disconcert	VERB
ihlr-16498	334	6	that	that	SCONJ
ihlr-16498	334	7	previous	previous	ADJ
ihlr-16498	334	8	tests	test	NOUN
ihlr-16498	334	9	regarding	regard	VERB
ihlr-16498	334	10	the	the	DET
ihlr-16498	334	11	efficacy	efficacy	NOUN
ihlr-16498	334	12	of	of	ADP
ihlr-16498	334	13	celexa	celexa	NOUN
ihlr-16498	334	14	in	in	ADP
ihlr-16498	334	15	pediatric	pediatric	ADJ
ihlr-16498	334	16	patients	patient	NOUN
ihlr-16498	334	17	were	be	AUX
ihlr-16498	334	18	not	not	PART
ihlr-16498	334	19	disclosed	disclose	VERB
ihlr-16498	334	20	in	in	ADP
ihlr-16498	334	21	a	a	DET
ihlr-16498	334	22	major	major	ADJ
ihlr-16498	334	23	medical	medical	ADJ
ihlr-16498	334	24	or	or	CCONJ
ihlr-16498	334	25	pharmaceutical	pharmaceutical	NOUN
ihlr-16498	334	26	journal	journal	NOUN
ihlr-16498	334	27	or	or	CCONJ
ihlr-16498	334	28	to	to	ADP
ihlr-16498	334	29	the	the	DET
ihlr-16498	334	30	fda	fda	PROPN
ihlr-16498	334	31	.	.	PUNCT
ihlr-16498	335	1	third	third	PROPN
ihlr-16498	335	2	,	,	PUNCT
ihlr-16498	335	3	the	the	DET
ihlr-16498	335	4	results	result	NOUN
ihlr-16498	335	5	of	of	ADP
ihlr-16498	335	6	the	the	DET
ihlr-16498	335	7	lexapro	lexapro	ADJ
ihlr-16498	335	8	study	study	NOUN
ihlr-16498	335	9	showing	show	VERB
ihlr-16498	335	10	that	that	SCONJ
ihlr-16498	335	11	lexapro	lexapro	NOUN
ihlr-16498	335	12	did	do	AUX
ihlr-16498	335	13	not	not	PART
ihlr-16498	335	14	help	help	VERB
ihlr-16498	335	15	depressed	depressed	ADJ
ihlr-16498	335	16	pediatric	pediatric	ADJ
ihlr-16498	335	17	patients	patient	NOUN
ihlr-16498	335	18	is	be	AUX
ihlr-16498	335	19	inconsistent	inconsistent	ADJ
ihlr-16498	335	20	with	with	ADP
ihlr-16498	335	21	the	the	DET
ihlr-16498	335	22	recent	recent	ADJ
ihlr-16498	335	23	positive	positive	ADJ
ihlr-16498	335	24	results	result	NOUN
ihlr-16498	335	25	in	in	ADP
ihlr-16498	335	26	the	the	DET
ihlr-16498	335	27	celexa	celexa	NOUN
ihlr-16498	335	28	study	study	NOUN
ihlr-16498	335	29	because	because	SCONJ
ihlr-16498	335	30	they	they	PRON
ihlr-16498	335	31	contain	contain	VERB
ihlr-16498	335	32	essentially	essentially	ADV
ihlr-16498	335	33	the	the	DET
ihlr-16498	335	34	same	same	ADJ
ihlr-16498	335	35	active	active	ADJ
ihlr-16498	335	36	ingredient	ingredient	NOUN
ihlr-16498	335	37	.	.	PUNCT
ihlr-16498	336	1	perhaps	perhaps	ADV
ihlr-16498	336	2	other	other	ADJ
ihlr-16498	336	3	factors	factor	NOUN
ihlr-16498	336	4	in	in	ADP
ihlr-16498	336	5	the	the	DET
ihlr-16498	336	6	design	design	NOUN
ihlr-16498	336	7	of	of	ADP
ihlr-16498	336	8	the	the	DET
ihlr-16498	336	9	clinical	clinical	ADJ
ihlr-16498	336	10	study	study	NOUN
ihlr-16498	336	11	contributed	contribute	VERB
ihlr-16498	336	12	to	to	ADP
ihlr-16498	336	13	the	the	DET
ihlr-16498	336	14	dif­	dif­	NOUN
ihlr-16498	336	15	ferences	ference	NOUN
ihlr-16498	336	16	in	in	ADP
ihlr-16498	336	17	the	the	DET
ihlr-16498	336	18	results	result	NOUN
ihlr-16498	336	19	.	.	PUNCT
ihlr-16498	337	1	this	this	PRON
ihlr-16498	337	2	suggests	suggest	VERB
ihlr-16498	337	3	a	a	DET
ihlr-16498	337	4	more	more	ADV
ihlr-16498	337	5	comprehensive	comprehensive	ADJ
ihlr-16498	337	6	scheme	scheme	NOUN
ihlr-16498	337	7	is	be	AUX
ihlr-16498	337	8	needed	need	VERB
ihlr-16498	337	9	to	to	PART
ihlr-16498	337	10	regulate	regulate	VERB
ihlr-16498	337	11	the	the	DET
ihlr-16498	337	12	design	design	NOUN
ihlr-16498	337	13	of	of	ADP
ihlr-16498	337	14	pediatric	pediatric	ADJ
ihlr-16498	337	15	trials	trial	NOUN
ihlr-16498	337	16	.	.	PUNCT
ihlr-16498	338	1	the	the	DET
ihlr-16498	338	2	fda	fda	PROPN
ihlr-16498	338	3	appears	appear	VERB
ihlr-16498	338	4	inept	inept	ADJ
ihlr-16498	338	5	at	at	ADP
ihlr-16498	338	6	addressing	address	VERB
ihlr-16498	338	7	the	the	DET
ihlr-16498	338	8	information	information	NOUN
ihlr-16498	338	9	obtained	obtain	VERB
ihlr-16498	338	10	from	from	ADP
ihlr-16498	338	11	these	these	DET
ihlr-16498	338	12	clinical	clinical	ADJ
ihlr-16498	338	13	trials	trial	NOUN
ihlr-16498	338	14	.	.	PUNCT
ihlr-16498	339	1	b.	b.	PROPN
ihlr-16498	339	2	anecdotal	anecdotal	ADJ
ihlr-16498	339	3	reports	report	NOUN
ihlr-16498	339	4	regarding	regard	VERB
ihlr-16498	339	5	selective	selective	ADJ
ihlr-16498	339	6	serotonin	serotonin	NOUN
ihlr-16498	339	7	re	re	NOUN
ihlr-16498	339	8	-	-	ADJ
ihlr-16498	339	9	uptake	uptake	ADJ
ihlr-16498	339	10	inhibitors	inhibitor	NOUN
ihlr-16498	339	11	caused	cause	VERB
ihlr-16498	339	12	the	the	DET
ihlr-16498	339	13	british	british	PROPN
ihlr-16498	339	14	medical	medical	PROPN
ihlr-16498	339	15	health	health	PROPN
ihlr-16498	339	16	regulatory	regulatory	ADJ
ihlr-16498	339	17	agency	agency	NOUN
ihlr-16498	339	18	to	to	PART
ihlr-16498	339	19	ban	ban	VERB
ihlr-16498	339	20	the	the	DET
ihlr-16498	339	21	use	use	NOUN
ihlr-16498	339	22	of	of	ADP
ihlr-16498	339	23	this	this	DET
ihlr-16498	339	24	class	class	NOUN
ihlr-16498	339	25	of	of	ADP
ihlr-16498	339	26	antidepressant	antidepressant	ADJ
ihlr-16498	339	27	drugs	drug	NOUN
ihlr-16498	339	28	in	in	ADP
ihlr-16498	339	29	children	child	NOUN
ihlr-16498	339	30	another	another	DET
ihlr-16498	339	31	class	class	NOUN
ihlr-16498	339	32	of	of	ADP
ihlr-16498	339	33	antidepressant	antidepressant	ADJ
ihlr-16498	339	34	drugs	drug	NOUN
ihlr-16498	339	35	,	,	PUNCT
ihlr-16498	339	36	selective	selective	ADJ
ihlr-16498	339	37	serotonin	serotonin	NOUN
ihlr-16498	339	38	re	re	NOUN
ihlr-16498	339	39	-	-	ADJ
ihlr-16498	339	40	uptake	uptake	ADJ
ihlr-16498	339	41	in­	in­	NOUN
ihlr-16498	339	42	hibitors	hibitor	NOUN
ihlr-16498	339	43	(	(	PUNCT
ihlr-16498	339	44	"	"	PUNCT
ihlr-16498	339	45	ssris	ssris	NOUN
ihlr-16498	339	46	"	"	PUNCT
ihlr-16498	339	47	)	)	PUNCT
ihlr-16498	339	48	,	,	PUNCT
ihlr-16498	339	49	has	have	AUX
ihlr-16498	339	50	caused	cause	VERB
ihlr-16498	339	51	negative	negative	ADJ
ihlr-16498	339	52	effects	effect	NOUN
ihlr-16498	339	53	in	in	ADP
ihlr-16498	339	54	pediatric	pediatric	ADJ
ihlr-16498	339	55	patients	patient	NOUN
ihlr-16498	339	56	.	.	PUNCT
ihlr-16498	340	1	in	in	ADP
ihlr-16498	340	2	the	the	DET
ihlr-16498	340	3	late	late	ADJ
ihlr-16498	340	4	1980s	1980	NOUN
ihlr-16498	340	5	,	,	PUNCT
ihlr-16498	340	6	the	the	DET
ihlr-16498	340	7	british	british	PROPN
ihlr-16498	340	8	medical	medical	PROPN
ihlr-16498	340	9	health	health	PROPN
ihlr-16498	340	10	regulatory	regulatory	ADJ
ihlr-16498	340	11	agency	agency	NOUN
ihlr-16498	340	12	(	(	PUNCT
ihlr-16498	340	13	"	"	PUNCT
ihlr-16498	340	14	bmhra	bmhra	NOUN
ihlr-16498	340	15	"	"	PUNCT
ihlr-16498	340	16	)	)	PUNCT
ihlr-16498	340	17	,	,	PUNCT
ihlr-16498	340	18	which	which	PRON
ihlr-16498	340	19	is	be	AUX
ihlr-16498	340	20	the	the	DET
ihlr-16498	340	21	british	british	ADJ
ihlr-16498	340	22	counterpart	counterpart	NOUN
ihlr-16498	340	23	to	to	ADP
ihlr-16498	340	24	the	the	DET
ihlr-16498	340	25	fda	fda	PROPN
ihlr-16498	340	26	,	,	PUNCT
ihlr-16498	340	27	began	begin	VERB
ihlr-16498	340	28	monitoring	monitor	VERB
ihlr-16498	340	29	reports	report	NOUN
ihlr-16498	340	30	of	of	ADP
ihlr-16498	340	31	suicidal	suicidal	ADJ
ihlr-16498	340	32	behav­	behav­	PROPN
ihlr-16498	340	33	ior	ior	NOUN
ihlr-16498	340	34	and	and	CCONJ
ihlr-16498	340	35	withdrawal	withdrawal	NOUN
ihlr-16498	340	36	symptoms	symptom	NOUN
ihlr-16498	340	37	among	among	ADP
ihlr-16498	340	38	minors	minor	NOUN
ihlr-16498	340	39	.	.	PUNCT
ihlr-16498	341	1	83	83	NUM
ihlr-16498	342	1	the	the	DET
ihlr-16498	342	2	british	british	ADJ
ihlr-16498	342	3	government	government	NOUN
ihlr-16498	342	4	issued	issue	VERB
ihlr-16498	342	5	warnings	warning	NOUN
ihlr-16498	342	6	in	in	ADP
ihlr-16498	342	7	1993	1993	NUM
ihlr-16498	342	8	and	and	CCONJ
ihlr-16498	342	9	2000.84	2000.84	NUM
ihlr-16498	342	10	in	in	ADP
ihlr-16498	342	11	june	june	PROPN
ihlr-16498	342	12	2003	2003	NUM
ihlr-16498	342	13	,	,	PUNCT
ihlr-16498	342	14	the	the	DET
ihlr-16498	342	15	bmhra	bmhra	NOUN
ihlr-16498	342	16	convened	convene	VERB
ihlr-16498	342	17	an	an	DET
ihlr-16498	342	18	emer­	emer­	NOUN
ihlr-16498	342	19	gency	gency	NOUN
ihlr-16498	342	20	meeting	meeting	NOUN
ihlr-16498	342	21	and	and	CCONJ
ihlr-16498	342	22	concluded	conclude	VERB
ihlr-16498	342	23	the	the	DET
ihlr-16498	342	24	drug	drug	NOUN
ihlr-16498	342	25	should	should	AUX
ihlr-16498	342	26	not	not	PART
ihlr-16498	342	27	be	be	AUX
ihlr-16498	342	28	used	use	VERB
ihlr-16498	342	29	for	for	ADP
ihlr-16498	342	30	pediatric	pediatric	ADJ
ihlr-16498	342	31	pa­	pa­	ADJ
ihlr-16498	342	32	tients	tient	NOUN
ihlr-16498	342	33	.	.	PUNCT
ihlr-16498	343	1	85	85	NUM
ihlr-16498	343	2	the	the	DET
ihlr-16498	343	3	united	united	PROPN
ihlr-16498	343	4	states	states	PROPN
ihlr-16498	343	5	followed	follow	VERB
ihlr-16498	343	6	suit	suit	NOUN
ihlr-16498	343	7	ten	ten	NUM
ihlr-16498	343	8	months	month	NOUN
ihlr-16498	343	9	later	later	ADV
ihlr-16498	343	10	and	and	CCONJ
ihlr-16498	343	11	banned	ban	VERB
ihlr-16498	343	12	doctors	doctor	NOUN
ihlr-16498	343	13	from	from	ADP
ihlr-16498	343	14	prescribing	prescribe	VERB
ihlr-16498	343	15	paxil	paxil	NOUN
ihlr-16498	343	16	to	to	ADP
ihlr-16498	343	17	children	child	NOUN
ihlr-16498	343	18	.	.	PUNCT
ihlr-16498	344	1	86	86	NUM
ihlr-16498	344	2	this	this	DET
ihlr-16498	344	3	ten	ten	NUM
ihlr-16498	344	4	-	-	PUNCT
ihlr-16498	344	5	month	month	NOUN
ihlr-16498	344	6	delay	delay	NOUN
ihlr-16498	344	7	prompted	prompt	VERB
ihlr-16498	344	8	,	,	PUNCT
ihlr-16498	344	9	in	in	ADP
ihlr-16498	344	10	part	part	NOUN
ihlr-16498	344	11	,	,	PUNCT
ihlr-16498	344	12	a	a	DET
ihlr-16498	344	13	congressional	congressional	ADJ
ihlr-16498	344	14	investigation	investigation	NOUN
ihlr-16498	344	15	into	into	ADP
ihlr-16498	344	16	the	the	DET
ihlr-16498	344	17	fda	fda	PROPN
ihlr-16498	344	18	with	with	ADP
ihlr-16498	344	19	respect	respect	NOUN
ihlr-16498	344	20	to	to	ADP
ihlr-16498	344	21	pediatric	pediatric	ADJ
ihlr-16498	344	22	testing	testing	NOUN
ihlr-16498	344	23	.	.	PUNCT
ihlr-16498	345	1	87	87	NUM
ihlr-16498	345	2	the	the	DET
ihlr-16498	345	3	situation	situation	NOUN
ihlr-16498	345	4	with	with	ADP
ihlr-16498	345	5	paxil	paxil	NOUN
ihlr-16498	345	6	raises	raise	VERB
ihlr-16498	345	7	additional	additional	ADJ
ihlr-16498	345	8	concerns	concern	NOUN
ihlr-16498	345	9	.	.	PUNCT
ihlr-16498	346	1	first	first	ADV
ihlr-16498	346	2	,	,	PUNCT
ihlr-16498	346	3	why	why	SCONJ
ihlr-16498	346	4	did	do	AUX
ihlr-16498	346	5	it	it	PRON
ihlr-16498	346	6	take	take	VERB
ihlr-16498	346	7	82	82	NUM
ihlr-16498	346	8	/d	/d	PUNCT
ihlr-16498	346	9	.	.	PUNCT
ihlr-16498	347	1	two	two	NUM
ihlr-16498	347	2	outside	outside	ADJ
ihlr-16498	347	3	researchers	researcher	NOUN
ihlr-16498	347	4	involved	involve	VERB
ihlr-16498	347	5	in	in	ADP
ihlr-16498	347	6	the	the	DET
ihlr-16498	347	7	positive	positive	ADJ
ihlr-16498	347	8	celexa	celexa	NOUN
ihlr-16498	347	9	study	study	NOUN
ihlr-16498	347	10	also	also	ADV
ihlr-16498	347	11	said	say	VERB
ihlr-16498	347	12	in	in	ADP
ihlr-16498	347	13	recent	recent	ADJ
ihlr-16498	347	14	interviews	interview	NOUN
ihlr-16498	347	15	that	that	PRON
ihlr-16498	347	16	forest	forest	NOUN
ihlr-16498	347	17	did	do	AUX
ihlr-16498	347	18	not	not	PART
ihlr-16498	347	19	tell	tell	VERB
ihlr-16498	347	20	them	they	PRON
ihlr-16498	347	21	about	about	ADP
ihlr-16498	347	22	the	the	DET
ihlr-16498	347	23	efficacy	efficacy	NOUN
ihlr-16498	347	24	findings	finding	NOUN
ihlr-16498	347	25	of	of	ADP
ihlr-16498	347	26	the	the	DET
ihlr-16498	347	27	european	european	ADJ
ihlr-16498	347	28	study	study	NOUN
ihlr-16498	347	29	and	and	CCONJ
ihlr-16498	347	30	that	that	SCONJ
ihlr-16498	347	31	they	they	PRON
ihlr-16498	347	32	were	be	AUX
ihlr-16498	347	33	not	not	PART
ihlr-16498	347	34	independently	independently	ADV
ihlr-16498	347	35	aware	aware	ADJ
ihlr-16498	347	36	of	of	ADP
ihlr-16498	347	37	them	they	PRON
ihlr-16498	347	38	.	.	PUNCT
ihlr-16498	348	1	/d	/d	INTJ
ihlr-16498	348	2	.	.	PUNCT
ihlr-16498	348	3	83	83	NUM
ihlr-16498	348	4	groopman	groopman	NOUN
ihlr-16498	348	5	,	,	PUNCT
ihlr-16498	348	6	supra	supra	PROPN
ihlr-16498	348	7	note	note	NOUN
ihlr-16498	348	8	1	1	NUM
ihlr-16498	348	9	,	,	PUNCT
ihlr-16498	348	10	at	at	ADP
ihlr-16498	348	11	35	35	NUM
ihlr-16498	348	12	(	(	PUNCT
ihlr-16498	348	13	"	"	PUNCT
ihlr-16498	348	14	in	in	ADP
ihlr-16498	348	15	the	the	DET
ihlr-16498	348	16	late	late	ADJ
ihlr-16498	348	17	nineteen	nineteen	NUM
ihlr-16498	348	18	-	-	PUNCT
ihlr-16498	348	19	eighties	eighty	NOUN
ihlr-16498	348	20	,	,	PUNCT
ihlr-16498	348	21	britain	britain	PROPN
ihlr-16498	348	22	's	's	PART
ihlr-16498	348	23	medical	medical	ADJ
ihlr-16498	348	24	regu­	regu­	PROPN
ihlr-16498	348	25	latory	latory	PROPN
ihlr-16498	348	26	agency	agency	NOUN
ihlr-16498	348	27	began	begin	VERB
ihlr-16498	348	28	closely	closely	ADV
ihlr-16498	348	29	monitoring	monitor	VERB
ihlr-16498	348	30	anecdotal	anecdotal	ADJ
ihlr-16498	348	31	reports	report	NOUN
ihlr-16498	348	32	of	of	ADP
ihlr-16498	348	33	suicidal	suicidal	ADJ
ihlr-16498	348	34	behavior	behavior	NOUN
ihlr-16498	348	35	and	and	CCONJ
ihlr-16498	348	36	withdrawal	withdrawal	NOUN
ihlr-16498	348	37	symptoms	symptom	NOUN
ihlr-16498	348	38	related	relate	VERB
ihlr-16498	348	39	to	to	ADP
ihlr-16498	348	40	one	one	NUM
ihlr-16498	348	41	class	class	NOUN
ihlr-16498	348	42	of	of	ADP
ihlr-16498	348	43	antidepressants	antidepressant	NOUN
ihlr-16498	348	44	....	....	PUNCT
ihlr-16498	349	1	"	"	PUNCT
ihlr-16498	349	2	)	)	PUNCT
ihlr-16498	349	3	.	.	PUNCT
ihlr-16498	350	1	84	84	NUM
ihlr-16498	351	1	i	i	PRON
ihlr-16498	351	2	d.	d.	PROPN
ihlr-16498	351	3	85	85	NUM
ihlr-16498	351	4	i	i	PRON
ihlr-16498	351	5	d.	d.	PROPN
ihlr-16498	351	6	(	(	PUNCT
ihlr-16498	351	7	"	"	PUNCT
ihlr-16498	351	8	in	in	ADP
ihlr-16498	351	9	june	june	PROPN
ihlr-16498	351	10	,	,	PUNCT
ihlr-16498	351	11	2003	2003	NUM
ihlr-16498	351	12	,	,	PUNCT
ihlr-16498	351	13	the	the	DET
ihlr-16498	351	14	agency	agency	NOUN
ihlr-16498	351	15	convened	convene	VERB
ihlr-16498	351	16	an	an	DET
ihlr-16498	351	17	emergency	emergency	NOUN
ihlr-16498	351	18	meeting	meeting	NOUN
ihlr-16498	351	19	to	to	PART
ihlr-16498	351	20	review	review	VERB
ihlr-16498	351	21	pediatric	pediatric	ADJ
ihlr-16498	351	22	trial	trial	NOUN
ihlr-16498	351	23	data	datum	NOUN
ihlr-16498	351	24	on	on	ADP
ihlr-16498	351	25	seroxat	seroxat	NOUN
ihlr-16498	351	26	,	,	PUNCT
ihlr-16498	351	27	and	and	CCONJ
ihlr-16498	351	28	s.s.r.i	s.s.r.i	PROPN
ihlr-16498	351	29	.	.	PROPN
ihlr-16498	351	30	known	know	VERB
ihlr-16498	351	31	in	in	ADP
ihlr-16498	351	32	the	the	DET
ihlr-16498	351	33	united	united	PROPN
ihlr-16498	351	34	states	states	PROPN
ihlr-16498	351	35	as	as	ADP
ihlr-16498	351	36	paxil	paxil	NOUN
ihlr-16498	351	37	,	,	PUNCT
ihlr-16498	351	38	and	and	CCONJ
ihlr-16498	351	39	concluded	conclude	VERB
ihlr-16498	351	40	that	that	SCONJ
ihlr-16498	351	41	the	the	DET
ihlr-16498	351	42	drug	drug	NOUN
ihlr-16498	351	43	should	should	AUX
ihlr-16498	351	44	not	not	PART
ihlr-16498	351	45	be	be	AUX
ihlr-16498	351	46	prescribed	prescribe	VERB
ihlr-16498	351	47	for	for	ADP
ihlr-16498	351	48	minors.j	minors.j	PROPN
ihlr-16498	351	49	.	.	PUNCT
ihlr-16498	351	50	86	86	NUM
ihlr-16498	351	51	jd	jd	PROPN
ihlr-16498	351	52	.	.	PUNCT
ihlr-16498	352	1	(	(	PUNCT
ihlr-16498	352	2	''	''	PUNCT
ihlr-16498	352	3	ten	ten	NUM
ihlr-16498	352	4	more	more	ADJ
ihlr-16498	352	5	months	month	NOUN
ihlr-16498	352	6	passed	pass	VERB
ihlr-16498	352	7	before	before	ADP
ihlr-16498	352	8	the	the	DET
ihlr-16498	352	9	f.d.a	f.d.a	NOUN
ihlr-16498	352	10	.	.	PUNCT
ihlr-16498	353	1	took	take	VERB
ihlr-16498	353	2	similar	similar	ADJ
ihlr-16498	353	3	action	action	NOUN
ihlr-16498	353	4	on	on	ADP
ihlr-16498	353	5	children	child	NOUN
ihlr-16498	353	6	and	and	CCONJ
ihlr-16498	353	7	antidepressants	antidepressant	NOUN
ihlr-16498	353	8	.	.	PUNCT
ihlr-16498	354	1	"	"	PUNCT
ihlr-16498	354	2	)	)	PUNCT
ihlr-16498	354	3	.	.	PUNCT
ihlr-16498	355	1	87	87	NUM
ihlr-16498	355	2	publication	publication	NOUN
ihlr-16498	355	3	and	and	CCONJ
ihlr-16498	355	4	disclosure	disclosure	NOUN
ihlr-16498	355	5	issues	issue	NOUN
ihlr-16498	355	6	in	in	ADP
ihlr-16498	355	7	antidepressant	antidepressant	ADJ
ihlr-16498	355	8	pediatric	pediatric	ADJ
ihlr-16498	355	9	clinical	clinical	ADJ
ihlr-16498	355	10	trials	trial	NOUN
ihlr-16498	355	11	:	:	PUNCT
ihlr-16498	355	12	hear­	hear­	AUX
ihlr-16498	355	13	ing	e	VERB
ihlr-16498	355	14	before	before	ADP
ihlr-16498	355	15	the	the	DET
ihlr-16498	355	16	subcomm	subcomm	NOUN
ihlr-16498	355	17	.	.	PUNCT
ihlr-16498	356	1	on	on	ADP
ihlr-16498	356	2	oversight	oversight	NOUN
ihlr-16498	356	3	and	and	CCONJ
ihlr-16498	356	4	investigations	investigation	NOUN
ihlr-16498	356	5	of	of	ADP
ihlr-16498	356	6	the	the	DET
ihlr-16498	356	7	h.	h.	PROPN
ihlr-16498	356	8	comm	comm	NOUN
ihlr-16498	356	9	.	.	PUNCT
ihlr-16498	357	1	on	on	ADP
ihlr-16498	357	2	energy	energy	NOUN
ihlr-16498	357	3	and	and	CCONJ
ihlr-16498	357	4	com­	com­	PROPN
ihlr-16498	357	5	merce	merce	PROPN
ihlr-16498	357	6	,	,	PUNCT
ihlr-16498	357	7	1	1	NUM
ihlr-16498	357	8	08th	08th	NOUN
ihlr-16498	357	9	cong	cong	NOUN
ihlr-16498	357	10	.	.	PUNCT
ihlr-16498	358	1	(	(	PUNCT
ihlr-16498	358	2	2004	2004	NUM
ihlr-16498	358	3	)	)	PUNCT
ihlr-16498	359	1	[	[	X
ihlr-16498	359	2	hereinafter	hereinafter	NOUN
ihlr-16498	359	3	hearing	hearing	NOUN
ihlr-16498	359	4	on	on	ADP
ihlr-16498	359	5	antidepressant	antidepressant	ADJ
ihlr-16498	359	6	pediatric	pediatric	ADJ
ihlr-16498	359	7	trials	trial	NOUN
ihlr-16498	359	8	]	]	PUNCT
ihlr-16498	359	9	(	(	PUNCT
ihlr-16498	359	10	statement	statement	NOUN
ihlr-16498	359	11	of	of	ADP
ihlr-16498	359	12	u.s	u.s	PROPN
ihlr-16498	359	13	.	.	PROPN
ihlr-16498	359	14	rep	rep	PROPN
ihlr-16498	359	15	.	.	PROPN
ihlr-16498	359	16	greg	greg	PROPN
ihlr-16498	359	17	walden	walden	PROPN
ihlr-16498	359	18	of	of	ADP
ihlr-16498	359	19	oregon	oregon	PROPN
ihlr-16498	359	20	)	)	PUNCT
ihlr-16498	359	21	.	.	PUNCT
ihlr-16498	360	1	74	74	NUM
ihlr-16498	360	2	indiana	indiana	PROPN
ihlr-16498	360	3	health	health	PROPN
ihlr-16498	360	4	law	law	NOUN
ihlr-16498	360	5	review	review	NOUN
ihlr-16498	360	6	[	[	X
ihlr-16498	360	7	vol	vol	NOUN
ihlr-16498	360	8	.	.	PUNCT
ihlr-16498	361	1	4:59	4:59	NUM
ihlr-16498	361	2	over	over	ADP
ihlr-16498	361	3	ten	ten	NUM
ihlr-16498	361	4	years	year	NOUN
ihlr-16498	361	5	of	of	ADP
ihlr-16498	361	6	anecdotal	anecdotal	ADJ
ihlr-16498	361	7	reports	report	NOUN
ihlr-16498	361	8	suggesting	suggest	VERB
ihlr-16498	361	9	serious	serious	ADJ
ihlr-16498	361	10	negative	negative	ADJ
ihlr-16498	361	11	consequences	consequence	NOUN
ihlr-16498	361	12	before	before	SCONJ
ihlr-16498	361	13	the	the	DET
ihlr-16498	361	14	united	united	PROPN
ihlr-16498	361	15	states	states	PROPN
ihlr-16498	361	16	decided	decide	VERB
ihlr-16498	361	17	to	to	PART
ihlr-16498	361	18	ban	ban	VERB
ihlr-16498	361	19	the	the	DET
ihlr-16498	361	20	use	use	NOUN
ihlr-16498	361	21	of	of	ADP
ihlr-16498	361	22	paxil	paxil	NOUN
ihlr-16498	361	23	in	in	ADP
ihlr-16498	361	24	pediatric	pediatric	ADJ
ihlr-16498	361	25	popula­	popula­	ADJ
ihlr-16498	361	26	tions	tion	NOUN
ihlr-16498	361	27	?	?	PUNCT
ihlr-16498	362	1	this	this	PRON
ihlr-16498	362	2	suggests	suggest	VERB
ihlr-16498	362	3	the	the	DET
ihlr-16498	362	4	fda	fda	PROPN
ihlr-16498	362	5	does	do	AUX
ihlr-16498	362	6	not	not	PART
ihlr-16498	362	7	collect	collect	VERB
ihlr-16498	362	8	and	and	CCONJ
ihlr-16498	362	9	react	react	VERB
ihlr-16498	362	10	to	to	ADP
ihlr-16498	362	11	anecdotal	anecdotal	ADJ
ihlr-16498	362	12	reporting	reporting	NOUN
ihlr-16498	362	13	effectively	effectively	ADV
ihlr-16498	362	14	.	.	PUNCT
ihlr-16498	363	1	the	the	DET
ihlr-16498	363	2	prea	prea	PROPN
ihlr-16498	363	3	is	be	AUX
ihlr-16498	363	4	a	a	DET
ihlr-16498	363	5	good	good	ADJ
ihlr-16498	363	6	start	start	NOUN
ihlr-16498	363	7	to	to	PART
ihlr-16498	363	8	grant	grant	VERB
ihlr-16498	363	9	the	the	DET
ihlr-16498	363	10	fda	fda	PROPN
ihlr-16498	363	11	authority	authority	NOUN
ihlr-16498	363	12	to	to	PART
ihlr-16498	363	13	require	require	VERB
ihlr-16498	363	14	clinical	clinical	ADJ
ihlr-16498	363	15	trials	trial	NOUN
ihlr-16498	363	16	for	for	ADP
ihlr-16498	363	17	drugs	drug	NOUN
ihlr-16498	363	18	used	use	VERB
ihlr-16498	363	19	in	in	ADP
ihlr-16498	363	20	pediatric	pediatric	ADJ
ihlr-16498	363	21	populations	population	NOUN
ihlr-16498	363	22	.	.	PUNCT
ihlr-16498	364	1	the	the	DET
ihlr-16498	364	2	fda	fda	PROPN
ihlr-16498	364	3	,	,	PUNCT
ihlr-16498	364	4	however	however	ADV
ihlr-16498	364	5	,	,	PUNCT
ihlr-16498	364	6	must	must	AUX
ihlr-16498	364	7	be	be	AUX
ihlr-16498	364	8	capable	capable	ADJ
ihlr-16498	364	9	of	of	ADP
ihlr-16498	364	10	responding	respond	VERB
ihlr-16498	364	11	on	on	ADP
ihlr-16498	364	12	various	various	ADJ
ihlr-16498	364	13	fronts	front	NOUN
ihlr-16498	364	14	in	in	ADP
ihlr-16498	364	15	addition	addition	NOUN
ihlr-16498	364	16	to	to	ADP
ihlr-16498	364	17	requiring	require	VERB
ihlr-16498	364	18	pediatric	pediatric	ADJ
ihlr-16498	364	19	studies	study	NOUN
ihlr-16498	364	20	.	.	PUNCT
ihlr-16498	365	1	second	second	ADJ
ihlr-16498	365	2	,	,	PUNCT
ihlr-16498	365	3	why	why	SCONJ
ihlr-16498	365	4	did	do	AUX
ihlr-16498	365	5	the	the	DET
ihlr-16498	365	6	united	united	PROPN
ihlr-16498	365	7	states	states	PROPN
ihlr-16498	365	8	take	take	VERB
ihlr-16498	365	9	ten	ten	NUM
ihlr-16498	365	10	months	month	NOUN
ihlr-16498	365	11	to	to	PART
ihlr-16498	365	12	ban	ban	VERB
ihlr-16498	365	13	pediatric	pediatric	ADJ
ihlr-16498	365	14	prescriptions	prescription	NOUN
ihlr-16498	365	15	after	after	SCONJ
ihlr-16498	365	16	the	the	DET
ihlr-16498	365	17	bmhra	bmhra	NOUN
ihlr-16498	365	18	concluded	conclude	VERB
ihlr-16498	365	19	its	its	PRON
ihlr-16498	365	20	emergency	emergency	NOUN
ihlr-16498	365	21	study	study	NOUN
ihlr-16498	365	22	?	?	PUNCT
ihlr-16498	366	1	the	the	DET
ihlr-16498	366	2	fda	fda	PROPN
ihlr-16498	366	3	should	should	AUX
ihlr-16498	366	4	have	have	VERB
ihlr-16498	366	5	the	the	DET
ihlr-16498	366	6	capability	capability	NOUN
ihlr-16498	366	7	to	to	PART
ihlr-16498	366	8	combine	combine	VERB
ihlr-16498	366	9	resources	resource	NOUN
ihlr-16498	366	10	with	with	ADP
ihlr-16498	366	11	its	its	PRON
ihlr-16498	366	12	sister	sister	NOUN
ihlr-16498	366	13	organizations	organization	NOUN
ihlr-16498	366	14	in	in	ADP
ihlr-16498	366	15	·	·	PUNCT
ihlr-16498	366	16	other	other	ADJ
ihlr-16498	366	17	countries	country	NOUN
ihlr-16498	366	18	.	.	PUNCT
ihlr-16498	367	1	third	third	ADJ
ihlr-16498	367	2	,	,	PUNCT
ihlr-16498	367	3	why	why	SCONJ
ihlr-16498	367	4	does	do	AUX
ihlr-16498	367	5	the	the	DET
ihlr-16498	367	6	fda	fda	PROPN
ihlr-16498	367	7	appear	appear	VERB
ihlr-16498	367	8	to	to	PART
ihlr-16498	367	9	have	have	VERB
ihlr-16498	367	10	such	such	DET
ihlr-16498	367	11	a	a	DET
ihlr-16498	367	12	difficult	difficult	ADJ
ihlr-16498	367	13	time	time	NOUN
ihlr-16498	367	14	determining	determine	VERB
ihlr-16498	367	15	drug	drug	NOUN
ihlr-16498	367	16	safety	safety	NOUN
ihlr-16498	367	17	in	in	ADP
ihlr-16498	367	18	pediatric	pediatric	ADJ
ihlr-16498	367	19	patients	patient	NOUN
ihlr-16498	367	20	?	?	PUNCT
ihlr-16498	368	1	c.	c.	NOUN
ihlr-16498	368	2	the	the	DET
ihlr-16498	368	3	eli	eli	PROPN
ihlr-16498	368	4	lilly	lilly	PROPN
ihlr-16498	368	5	clinical	clinical	ADJ
ihlr-16498	368	6	studies	study	NOUN
ihlr-16498	368	7	showed	show	VERB
ihlr-16498	368	8	that	that	SCONJ
ihlr-16498	368	9	the	the	DET
ihlr-16498	368	10	fda	fda	PROPN
ihlr-16498	368	11	and	and	CCONJ
ihlr-16498	368	12	researchers	researcher	NOUN
ihlr-16498	368	13	must	must	AUX
ihlr-16498	368	14	be	be	AUX
ihlr-16498	368	15	attentive	attentive	ADJ
ihlr-16498	368	16	when	when	SCONJ
ihlr-16498	368	17	taking	take	VERB
ihlr-16498	368	18	adolescents	adolescent	NOUN
ihlr-16498	368	19	off	off	ADP
ihlr-16498	368	20	antidepressants	antidepressant	NOUN
ihlr-16498	368	21	eli	eli	PROPN
ihlr-16498	368	22	lilly	lilly	PROPN
ihlr-16498	368	23	recently	recently	ADV
ihlr-16498	368	24	made	make	VERB
ihlr-16498	368	25	headlines	headline	NOUN
ihlr-16498	368	26	when	when	SCONJ
ihlr-16498	368	27	traci	traci	PROPN
ihlr-16498	368	28	johnson	johnson	PROPN
ihlr-16498	368	29	,	,	PUNCT
ihlr-16498	368	30	a	a	DET
ihlr-16498	368	31	college	college	NOUN
ihlr-16498	368	32	student	student	NOUN
ihlr-16498	368	33	,	,	PUNCT
ihlr-16498	368	34	committed	commit	VERB
ihlr-16498	368	35	suicide	suicide	NOUN
ihlr-16498	368	36	after	after	ADP
ihlr-16498	368	37	being	be	AUX
ihlr-16498	368	38	switched	switch	VERB
ihlr-16498	368	39	to	to	ADP
ihlr-16498	368	40	a	a	DET
ihlr-16498	368	41	placebo	placebo	NOUN
ihlr-16498	368	42	in	in	ADP
ihlr-16498	368	43	a	a	DET
ihlr-16498	368	44	clinical	clinical	ADJ
ihlr-16498	368	45	trial	trial	NOUN
ihlr-16498	368	46	of	of	ADP
ihlr-16498	368	47	cym­	cym­	PROPN
ihlr-16498	368	48	balta	balta	PROPN
ihlr-16498	368	49	.	.	PUNCT
ihlr-16498	368	50	88	88	NUM
ihlr-16498	368	51	the	the	DET
ihlr-16498	368	52	severe	severe	ADJ
ihlr-16498	368	53	depression	depression	NOUN
ihlr-16498	368	54	,	,	PUNCT
ihlr-16498	368	55	leading	lead	VERB
ihlr-16498	368	56	ultimately	ultimately	ADV
ihlr-16498	368	57	to	to	PART
ihlr-16498	368	58	suicide	suicide	VERB
ihlr-16498	368	59	,	,	PUNCT
ihlr-16498	368	60	was	be	AUX
ihlr-16498	368	61	believed	believe	VERB
ihlr-16498	368	62	to	to	PART
ihlr-16498	368	63	be	be	AUX
ihlr-16498	368	64	caused	cause	VERB
ihlr-16498	368	65	by	by	ADP
ihlr-16498	368	66	"	"	PUNCT
ihlr-16498	368	67	hallucinations	hallucination	NOUN
ihlr-16498	368	68	and	and	CCONJ
ihlr-16498	368	69	paranoid	paranoid	ADJ
ihlr-16498	368	70	delusions	delusion	NOUN
ihlr-16498	368	71	[	[	PUNCT
ihlr-16498	368	72	that	that	PRON
ihlr-16498	368	73	]	]	PUNCT
ihlr-16498	368	74	can	can	AUX
ihlr-16498	368	75	occur	occur	VERB
ihlr-16498	368	76	when	when	SCONJ
ihlr-16498	368	77	a	a	DET
ihlr-16498	368	78	pa­	pa­	ADJ
ihlr-16498	368	79	tient	tient	NOUN
ihlr-16498	368	80	is	be	AUX
ihlr-16498	368	81	withdrawn	withdraw	VERB
ihlr-16498	368	82	from	from	ADP
ihlr-16498	368	83	an	an	DET
ihlr-16498	368	84	antidepressant	antidepressant	NOUN
ihlr-16498	368	85	.	.	PUNCT
ihlr-16498	368	86	'	'	PUNCT
ihlr-16498	368	87	.s9	.s9	PUNCT
ihlr-16498	369	1	although	although	SCONJ
ihlr-16498	369	2	eli	eli	PROPN
ihlr-16498	369	3	lilly	lilly	PROPN
ihlr-16498	369	4	officially	officially	ADV
ihlr-16498	369	5	was	be	AUX
ihlr-16498	369	6	cleared	clear	VERB
ihlr-16498	369	7	of	of	ADP
ihlr-16498	369	8	all	all	DET
ihlr-16498	369	9	wrongdoing	wrongdoing	NOUN
ihlr-16498	369	10	,	,	PUNCT
ihlr-16498	369	11	this	this	DET
ihlr-16498	369	12	experience	experience	NOUN
ihlr-16498	369	13	begs	beg	VERB
ihlr-16498	369	14	at	at	ADP
ihlr-16498	369	15	least	least	ADV
ihlr-16498	369	16	two	two	NUM
ihlr-16498	369	17	questions	question	NOUN
ihlr-16498	369	18	:	:	PUNCT
ihlr-16498	369	19	(	(	PUNCT
ihlr-16498	369	20	1	1	X
ihlr-16498	369	21	)	)	PUNCT
ihlr-16498	369	22	what	what	PRON
ihlr-16498	369	23	were	be	AUX
ihlr-16498	369	24	the	the	DET
ihlr-16498	369	25	deficiencies	deficiency	NOUN
ihlr-16498	369	26	in	in	ADP
ihlr-16498	369	27	the	the	DET
ihlr-16498	369	28	clinical	clinical	ADJ
ihlr-16498	369	29	design	design	NOUN
ihlr-16498	369	30	of	of	ADP
ihlr-16498	369	31	the	the	DET
ihlr-16498	369	32	cymbalta	cymbalta	PROPN
ihlr-16498	369	33	trial	trial	NOUN
ihlr-16498	369	34	,	,	PUNCT
ihlr-16498	369	35	if	if	SCONJ
ihlr-16498	369	36	any	any	PRON
ihlr-16498	369	37	,	,	PUNCT
ihlr-16498	369	38	and	and	CCONJ
ihlr-16498	369	39	(	(	PUNCT
ihlr-16498	369	40	2	2	X
ihlr-16498	369	41	)	)	PUNCT
ihlr-16498	369	42	how	how	SCONJ
ihlr-16498	369	43	can	can	AUX
ihlr-16498	369	44	the	the	DET
ihlr-16498	369	45	fda	fda	PROPN
ihlr-16498	369	46	ensure	ensure	VERB
ihlr-16498	369	47	this	this	DET
ihlr-16498	369	48	tragedy	tragedy	NOUN
ihlr-16498	369	49	will	will	AUX
ihlr-16498	369	50	not	not	PART
ihlr-16498	369	51	be	be	AUX
ihlr-16498	369	52	repeated	repeat	VERB
ihlr-16498	369	53	?	?	PUNCT
ihlr-16498	370	1	the	the	DET
ihlr-16498	370	2	cymbalta	cymbalta	PROPN
ihlr-16498	370	3	study	study	NOUN
ihlr-16498	370	4	indicates	indicate	VERB
ihlr-16498	370	5	that	that	SCONJ
ihlr-16498	370	6	children	child	NOUN
ihlr-16498	370	7	may	may	AUX
ihlr-16498	370	8	still	still	ADV
ihlr-16498	370	9	be	be	AUX
ihlr-16498	370	10	undergoing	undergo	VERB
ihlr-16498	370	11	developmental	developmental	ADJ
ihlr-16498	370	12	changes	change	NOUN
ihlr-16498	370	13	until	until	ADP
ihlr-16498	370	14	their	their	PRON
ihlr-16498	370	15	late	late	ADJ
ihlr-16498	370	16	teens	teen	NOUN
ihlr-16498	370	17	or	or	CCONJ
ihlr-16498	370	18	early	early	ADJ
ihlr-16498	370	19	twenties	twenty	NOUN
ihlr-16498	370	20	.	.	PUNCT
ihlr-16498	371	1	the	the	DET
ihlr-16498	371	2	fda	fda	PROPN
ihlr-16498	371	3	should	should	AUX
ihlr-16498	371	4	consider	consider	VERB
ihlr-16498	371	5	redefining	redefine	VERB
ihlr-16498	371	6	their	their	PRON
ihlr-16498	371	7	pediatric	pediatric	ADJ
ihlr-16498	371	8	age	age	NOUN
ihlr-16498	371	9	groups	group	NOUN
ihlr-16498	371	10	to	to	PART
ihlr-16498	371	11	include	include	VERB
ihlr-16498	371	12	college	college	NOUN
ihlr-16498	371	13	-	-	PUNCT
ihlr-16498	371	14	age	age	NOUN
ihlr-16498	371	15	students.90	students.90	NOUN
ihlr-16498	371	16	the	the	DET
ihlr-16498	371	17	bpca	bpca	PROPN
ihlr-16498	371	18	allows	allow	VERB
ihlr-16498	371	19	for	for	SCONJ
ihlr-16498	371	20	the	the	DET
ihlr-16498	371	21	10	10	NUM
ihlr-16498	371	22	m	m	NOUN
ihlr-16498	371	23	to	to	PART
ihlr-16498	371	24	oversee	oversee	VERB
ihlr-16498	371	25	many	many	ADJ
ihlr-16498	371	26	of	of	ADP
ihlr-16498	371	27	the	the	DET
ihlr-16498	371	28	ethical	ethical	ADJ
ihlr-16498	371	29	concerns	concern	NOUN
ihlr-16498	371	30	regarding	regard	VERB
ihlr-16498	371	31	pediatric	pediatric	ADJ
ihlr-16498	371	32	research	research	NOUN
ihlr-16498	371	33	and	and	CCONJ
ihlr-16498	371	34	to	to	PART
ihlr-16498	371	35	coordinate	coordinate	VERB
ihlr-16498	371	36	with	with	ADP
ihlr-16498	371	37	institutional	institutional	ADJ
ihlr-16498	371	38	review	review	NOUN
ihlr-16498	371	39	boards	board	NOUN
ihlr-16498	371	40	(	(	PUNCT
ihlr-16498	371	41	"	"	PUNCT
ihlr-16498	371	42	irbs	irbs	PROPN
ihlr-16498	371	43	"	"	PUNCT
ihlr-16498	371	44	)	)	PUNCT
ihlr-16498	371	45	.	.	PUNCT
ihlr-16498	372	1	although	although	SCONJ
ihlr-16498	372	2	this	this	PRON
ihlr-16498	372	3	is	be	AUX
ihlr-16498	372	4	a	a	DET
ihlr-16498	372	5	good	good	ADJ
ihlr-16498	372	6	move	move	NOUN
ihlr-16498	372	7	toward	toward	ADP
ihlr-16498	372	8	addressing	address	VERB
ihlr-16498	372	9	the	the	DET
ihlr-16498	372	10	ethical	ethical	ADJ
ihlr-16498	372	11	prob­	prob­	NUM
ihlr-16498	372	12	lems	lem	NOUN
ihlr-16498	372	13	associated	associate	VERB
ihlr-16498	372	14	with	with	ADP
ihlr-16498	372	15	pediatric	pediatric	ADJ
ihlr-16498	372	16	research	research	NOUN
ihlr-16498	372	17	,	,	PUNCT
ihlr-16498	372	18	it	it	PRON
ihlr-16498	372	19	appears	appear	VERB
ihlr-16498	372	20	that	that	SCONJ
ihlr-16498	372	21	anecdotal	anecdotal	ADJ
ihlr-16498	372	22	reporting	reporting	NOUN
ihlr-16498	372	23	of	of	ADP
ihlr-16498	372	24	withdrawal	withdrawal	NOUN
ihlr-16498	372	25	symptoms	symptom	NOUN
ihlr-16498	372	26	may	may	AUX
ihlr-16498	372	27	not	not	PART
ihlr-16498	372	28	have	have	AUX
ihlr-16498	372	29	been	be	AUX
ihlr-16498	372	30	inco	inco	NOUN
ihlr-16498	372	31	:	:	PUNCT
ihlr-16498	372	32	rporated	rporate	VERB
ihlr-16498	372	33	into	into	ADP
ihlr-16498	372	34	pediatric	pediatric	ADJ
ihlr-16498	372	35	trials	trial	NOUN
ihlr-16498	372	36	.	.	PUNCT
ihlr-16498	373	1	the	the	DET
ihlr-16498	373	2	policy	policy	NOUN
ihlr-16498	373	3	recommendations	recommendation	NOUN
ihlr-16498	373	4	described	describe	VERB
ihlr-16498	373	5	in	in	ADP
ihlr-16498	373	6	part	part	NOUN
ihlr-16498	373	7	v	v	NOUN
ihlr-16498	373	8	may	may	AUX
ihlr-16498	373	9	allow	allow	VERB
ihlr-16498	373	10	a	a	DET
ihlr-16498	373	11	larger	large	ADJ
ihlr-16498	373	12	breadth	breadth	NOUN
ihlr-16498	373	13	of	of	ADP
ihlr-16498	373	14	in­	in­	NOUN
ihlr-16498	373	15	formation	formation	NOUN
ihlr-16498	373	16	for	for	ADP
ihlr-16498	373	17	the	the	DET
ihlr-16498	373	18	fda	fda	PROPN
ihlr-16498	373	19	,	,	PUNCT
ihlr-16498	373	20	the	the	DET
ihlr-16498	373	21	10	10	NUM
ihlr-16498	373	22	m	m	NOUN
ihlr-16498	373	23	,	,	PUNCT
ihlr-16498	373	24	and	and	CCONJ
ihlr-16498	373	25	the	the	DET
ihlr-16498	373	26	irbs	irb	NOUN
ihlr-16498	373	27	to	to	PART
ihlr-16498	373	28	use	use	VERB
ihlr-16498	373	29	when	when	SCONJ
ihlr-16498	373	30	establishing	establish	VERB
ihlr-16498	373	31	and	and	CCONJ
ihlr-16498	373	32	conducting	conduct	VERB
ihlr-16498	373	33	pediatric	pediatric	ADJ
ihlr-16498	373	34	trials	trial	NOUN
ihlr-16498	373	35	.	.	PUNCT
ihlr-16498	374	1	d.	d.	PROPN
ihlr-16498	374	2	committee	committee	PROPN
ihlr-16498	374	3	hearings	hearing	NOUN
ihlr-16498	374	4	addressed	address	VERB
ihlr-16498	374	5	antidepressant	antidepressant	ADJ
ihlr-16498	374	6	clinical	clinical	ADJ
ihlr-16498	374	7	studies	study	NOUN
ihlr-16498	374	8	in	in	ADP
ihlr-16498	374	9	pediatric	pediatric	ADJ
ihlr-16498	374	10	populations	population	NOUN
ihlr-16498	374	11	in	in	ADP
ihlr-16498	374	12	2004	2004	NUM
ihlr-16498	374	13	,	,	PUNCT
ihlr-16498	374	14	committee	committee	NOUN
ihlr-16498	374	15	hearings	hearing	NOUN
ihlr-16498	374	16	commenced	commence	VERB
ihlr-16498	374	17	to	to	PART
ihlr-16498	374	18	address	address	VERB
ihlr-16498	374	19	pediatric	pediatric	ADJ
ihlr-16498	374	20	trials	trial	NOUN
ihlr-16498	374	21	,	,	PUNCT
ihlr-16498	374	22	and	and	CCONJ
ihlr-16498	374	23	88	88	NUM
ihlr-16498	374	24	groopman	groopman	NOUN
ihlr-16498	374	25	,	,	PUNCT
ihlr-16498	374	26	supra	supra	PROPN
ihlr-16498	374	27	note	note	NOUN
ihlr-16498	374	28	1	1	NUM
ihlr-16498	374	29	,	,	PUNCT
ihlr-16498	374	30	at	at	ADP
ihlr-16498	374	31	35	35	NUM
ihlr-16498	374	32	.	.	NUM
ihlr-16498	374	33	89	89	NUM
ihlr-16498	375	1	i	i	PRON
ihlr-16498	375	2	d.	d.	PROPN
ihlr-16498	375	3	at	at	ADP
ihlr-16498	375	4	34	34	NUM
ihlr-16498	375	5	(	(	PUNCT
ihlr-16498	375	6	describing	describe	VERB
ihlr-16498	375	7	the	the	DET
ihlr-16498	375	8	cymbalta	cymbalta	PROPN
ihlr-16498	375	9	study	study	NOUN
ihlr-16498	375	10	and	and	CCONJ
ihlr-16498	375	11	stating	state	VERB
ihlr-16498	375	12	the	the	DET
ihlr-16498	375	13	fda	fda	PROPN
ihlr-16498	375	14	cleared	clear	VERB
ihlr-16498	375	15	eli	eli	PROPN
ihlr-16498	375	16	lilly	lilly	PROPN
ihlr-16498	375	17	of	of	ADP
ihlr-16498	375	18	wrongdoing	wrongdoing	NOUN
ihlr-16498	375	19	)	)	PUNCT
ihlr-16498	375	20	.	.	PUNCT
ihlr-16498	376	1	90	90	NUM
ihlr-16498	376	2	cf	cf	NOUN
ihlr-16498	376	3	.	.	PUNCT
ihlr-16498	377	1	rodriguez	rodriguez	NOUN
ihlr-16498	377	2	,	,	PUNCT
ihlr-16498	377	3	supra	supra	PROPN
ihlr-16498	377	4	note	note	PROPN
ihlr-16498	377	5	45	45	NUM
ihlr-16498	377	6	(	(	PUNCT
ihlr-16498	377	7	identifying	identify	VERB
ihlr-16498	377	8	pediatric	pediatric	ADJ
ihlr-16498	377	9	age	age	NOUN
ihlr-16498	377	10	groups	group	NOUN
ihlr-16498	377	11	up	up	ADP
ihlr-16498	377	12	through	through	ADP
ihlr-16498	377	13	age	age	NOUN
ihlr-16498	377	14	six­	six­	NOUN
ihlr-16498	377	15	teen	teen	PROPN
ihlr-16498	377	16	)	)	PUNCT
ihlr-16498	377	17	.	.	PUNCT
ihlr-16498	378	1	2007	2007	NUM
ihlr-16498	378	2	]	]	PUNCT
ihlr-16498	378	3	reforming	reform	VERB
ihlr-16498	378	4	fda	fda	PROPN
ihlr-16498	378	5	poucy	poucy	PROPN
ihlr-16498	378	6	for	for	ADP
ihlr-16498	378	7	pediatric	pediatric	ADJ
ihlr-16498	378	8	testing	testing	NOUN
ihlr-16498	378	9	75	75	NUM
ihlr-16498	378	10	the	the	DET
ihlr-16498	378	11	house	house	NOUN
ihlr-16498	378	12	representatives	representative	NOUN
ihlr-16498	378	13	learned	learn	VERB
ihlr-16498	378	14	the	the	DET
ihlr-16498	378	15	fda	fda	PROPN
ihlr-16498	378	16	knew	know	VERB
ihlr-16498	378	17	that	that	SCONJ
ihlr-16498	378	18	twelve	twelve	NUM
ihlr-16498	378	19	of	of	ADP
ihlr-16498	378	20	:	:	PUNCT
ihlr-16498	378	21	fifteen	fifteen	NUM
ihlr-16498	378	22	pediatric	pediatric	ADJ
ihlr-16498	378	23	trials	trial	NOUN
ihlr-16498	378	24	of	of	ADP
ihlr-16498	378	25	antidepressant	antidepressant	ADJ
ihlr-16498	378	26	drugs	drug	NOUN
ihlr-16498	378	27	proved	prove	VERB
ihlr-16498	378	28	that	that	SCONJ
ihlr-16498	378	29	the	the	DET
ihlr-16498	378	30	drugs	drug	NOUN
ihlr-16498	378	31	were	be	AUX
ihlr-16498	378	32	ineffective	ineffective	ADJ
ihlr-16498	378	33	.	.	PUNCT
ihlr-16498	379	1	91	91	NUM
ihlr-16498	379	2	more­	more­	NOUN
ihlr-16498	379	3	over	over	ADV
ihlr-16498	379	4	,	,	PUNCT
ihlr-16498	379	5	only	only	ADV
ihlr-16498	379	6	three	three	NUM
ihlr-16498	379	7	of	of	ADP
ihlr-16498	379	8	the	the	DET
ihlr-16498	379	9	fifteen	fifteen	ADJ
ihlr-16498	379	10	studies	study	NOUN
ihlr-16498	379	11	were	be	AUX
ihlr-16498	379	12	published.92	published.92	PROPN
ihlr-16498	379	13	representative	representative	NOUN
ihlr-16498	379	14	joe	joe	PROPN
ihlr-16498	379	15	bar­	bar­	PROPN
ihlr-16498	379	16	ton	ton	PROPN
ihlr-16498	379	17	of	of	ADP
ihlr-16498	379	18	texas	texas	PROPN
ihlr-16498	379	19	stated	state	VERB
ihlr-16498	379	20	,	,	PUNCT
ihlr-16498	379	21	[	[	X
ihlr-16498	379	22	m]any	m]any	NOUN
ihlr-16498	379	23	people	people	NOUN
ihlr-16498	379	24	want	want	VERB
ihlr-16498	379	25	to	to	PART
ihlr-16498	379	26	know	know	VERB
ihlr-16498	379	27	what	what	PRON
ihlr-16498	379	28	was	be	AUX
ihlr-16498	379	29	in	in	ADP
ihlr-16498	379	30	the	the	DET
ihlr-16498	379	31	other	other	ADJ
ihlr-16498	379	32	12	12	NUM
ihlr-16498	379	33	studies	study	NOUN
ihlr-16498	379	34	?	?	PUNCT
ihlr-16498	380	1	what	what	PRON
ihlr-16498	380	2	do	do	AUX
ihlr-16498	380	3	these	these	DET
ihlr-16498	380	4	studies	study	NOUN
ihlr-16498	380	5	show	show	VERB
ihlr-16498	380	6	?	?	PUNCT
ihlr-16498	381	1	why	why	SCONJ
ihlr-16498	381	2	have	have	AUX
ihlr-16498	381	3	n't	not	PART
ihlr-16498	381	4	those	those	DET
ihlr-16498	381	5	other	other	ADJ
ihlr-16498	381	6	12	12	NUM
ihlr-16498	381	7	studies	study	NOUN
ihlr-16498	381	8	been	be	AUX
ihlr-16498	381	9	published	publish	VERB
ihlr-16498	381	10	in	in	ADP
ihlr-16498	381	11	peer	peer	NOUN
ihlr-16498	381	12	reviewed	review	VERB
ihlr-16498	381	13	journals	journal	NOUN
ihlr-16498	381	14	?	?	PUNCT
ihlr-16498	382	1	was	be	AUX
ihlr-16498	382	2	there	there	PRON
ihlr-16498	382	3	sufficient	sufficient	ADJ
ihlr-16498	382	4	information	information	NOUN
ihlr-16498	382	5	available	available	ADJ
ihlr-16498	382	6	to	to	ADP
ihlr-16498	382	7	the	the	DET
ihlr-16498	382	8	public	public	NOUN
ihlr-16498	382	9	about	about	ADP
ihlr-16498	382	10	these	these	DET
ihlr-16498	382	11	un­	un­	PUNCT
ihlr-16498	382	12	published	publish	VERB
ihlr-16498	382	13	studies	study	NOUN
ihlr-16498	382	14	to	to	PART
ihlr-16498	382	15	make	make	VERB
ihlr-16498	382	16	informed	inform	VERB
ihlr-16498	382	17	decisions?93	decisions?93	PROPN
ihlr-16498	382	18	the	the	DET
ihlr-16498	382	19	committee	committee	NOUN
ihlr-16498	382	20	hearing	hearing	NOUN
ihlr-16498	382	21	focused	focus	VERB
ihlr-16498	382	22	on	on	ADP
ihlr-16498	382	23	the	the	DET
ihlr-16498	382	24	problems	problem	NOUN
ihlr-16498	382	25	of	of	ADP
ihlr-16498	382	26	disclosure	disclosure	NOUN
ihlr-16498	382	27	in	in	ADP
ihlr-16498	382	28	clinical	clinical	ADJ
ihlr-16498	382	29	trials	trial	NOUN
ihlr-16498	382	30	.	.	PUNCT
ihlr-16498	383	1	one	one	NUM
ihlr-16498	383	2	proposed	propose	VERB
ihlr-16498	383	3	bill	bill	NOUN
ihlr-16498	383	4	would	would	AUX
ihlr-16498	383	5	require	require	VERB
ihlr-16498	383	6	manufacturers	manufacturer	NOUN
ihlr-16498	383	7	and	and	CCONJ
ihlr-16498	383	8	researchers	researcher	NOUN
ihlr-16498	383	9	to	to	ADP
ihlr-16498	383	10	regis­	regis­	NUM
ihlr-16498	383	11	ter	ter	NOUN
ihlr-16498	383	12	with	with	ADP
ihlr-16498	383	13	an	an	DET
ihlr-16498	383	14	online	online	ADJ
ihlr-16498	383	15	database	database	NOUN
ihlr-16498	383	16	as	as	ADP
ihlr-16498	383	17	a	a	DET
ihlr-16498	383	18	prerequisite	prerequisite	NOUN
ihlr-16498	383	19	for	for	ADP
ihlr-16498	383	20	irb	irb	NOUN
ihlr-16498	383	21	approval	approval	NOUN
ihlr-16498	383	22	.	.	PUNCT
ihlr-16498	384	1	94	94	NUM
ihlr-16498	385	1	this	this	DET
ihlr-16498	385	2	database	database	NOUN
ihlr-16498	385	3	would	would	AUX
ihlr-16498	385	4	then	then	ADV
ihlr-16498	385	5	include	include	VERB
ihlr-16498	385	6	the	the	DET
ihlr-16498	385	7	results	result	NOUN
ihlr-16498	385	8	of	of	ADP
ihlr-16498	385	9	all	all	DET
ihlr-16498	385	10	clinical	clinical	ADJ
ihlr-16498	385	11	trials	trial	NOUN
ihlr-16498	385	12	whether	whether	SCONJ
ihlr-16498	385	13	positive	positive	ADJ
ihlr-16498	385	14	,	,	PUNCT
ihlr-16498	385	15	inconclu­	inconclu­	NOUN
ihlr-16498	385	16	sive	sive	ADJ
ihlr-16498	385	17	,	,	PUNCT
ihlr-16498	385	18	or	or	CCONJ
ihlr-16498	385	19	negative	negative	ADJ
ihlr-16498	385	20	.	.	PUNCT
ihlr-16498	386	1	the	the	DET
ihlr-16498	386	2	proposed	propose	VERB
ihlr-16498	386	3	bill	bill	NOUN
ihlr-16498	386	4	would	would	AUX
ihlr-16498	386	5	give	give	VERB
ihlr-16498	386	6	the	the	DET
ihlr-16498	386	7	fda	fda	PROPN
ihlr-16498	386	8	authority	authority	NOUN
ihlr-16498	386	9	to	to	PART
ihlr-16498	386	10	require	require	VERB
ihlr-16498	386	11	this	this	DET
ihlr-16498	386	12	registration	registration	NOUN
ihlr-16498	386	13	and	and	CCONJ
ihlr-16498	386	14	noncompliance	noncompliance	NOUN
ihlr-16498	386	15	would	would	AUX
ihlr-16498	386	16	be	be	AUX
ihlr-16498	386	17	enforced	enforce	VERB
ihlr-16498	386	18	through	through	ADP
ihlr-16498	386	19	civil	civil	ADJ
ihlr-16498	386	20	penal­	penal­	NOUN
ihlr-16498	386	21	ties	tie	NOUN
ihlr-16498	386	22	.	.	PUNCT
ihlr-16498	387	1	95	95	NUM
ihlr-16498	387	2	the	the	DET
ihlr-16498	387	3	reporting	reporting	NOUN
ihlr-16498	387	4	system	system	NOUN
ihlr-16498	387	5	would	would	AUX
ihlr-16498	387	6	give	give	VERB
ihlr-16498	387	7	clinicians	clinician	NOUN
ihlr-16498	387	8	all	all	DET
ihlr-16498	387	9	the	the	DET
ihlr-16498	387	10	relevant	relevant	ADJ
ihlr-16498	387	11	information	information	NOUN
ihlr-16498	387	12	needed	need	VERB
ihlr-16498	387	13	to	to	PART
ihlr-16498	387	14	make	make	VERB
ihlr-16498	387	15	informed	informed	ADJ
ihlr-16498	387	16	decisions	decision	NOUN
ihlr-16498	387	17	.	.	PUNCT
ihlr-16498	388	1	96	96	NUM
ihlr-16498	388	2	in	in	ADP
ihlr-16498	388	3	addition	addition	NOUN
ihlr-16498	388	4	,	,	PUNCT
ihlr-16498	388	5	the	the	DET
ihlr-16498	388	6	committee	committee	NOUN
ihlr-16498	388	7	noted	note	VERB
ihlr-16498	388	8	that	that	SCONJ
ihlr-16498	388	9	only	only	ADV
ihlr-16498	388	10	one	one	NUM
ihlr-16498	388	11	antid	antid	NOUN
ihlr-16498	388	12	:	:	PUNCT
ihlr-16498	388	13	pressant	pressant	ADJ
ihlr-16498	388	14	medication	medication	NOUN
ihlr-16498	388	15	,	,	PUNCT
ihlr-16498	388	16	prozac	prozac	NOUN
ihlr-16498	388	17	,	,	PUNCT
ihlr-16498	388	18	is	be	AUX
ihlr-16498	388	19	approved	approve	VERB
ihlr-16498	388	20	for	for	ADP
ihlr-16498	388	21	treating	treat	VERB
ihlr-16498	388	22	depression	depression	NOUN
ihlr-16498	388	23	in	in	ADP
ihlr-16498	388	24	children.9	children.9	PROPN
ihlr-16498	388	25	four	four	NUM
ihlr-16498	388	26	other	other	ADJ
ihlr-16498	388	27	drugs	drug	NOUN
ihlr-16498	388	28	,	,	PUNCT
ihlr-16498	388	29	however	however	ADV
ihlr-16498	388	30	,	,	PUNCT
ihlr-16498	388	31	are	be	AUX
ihlr-16498	388	32	prescribed	prescribe	VERB
ihlr-16498	388	33	to	to	ADP
ihlr-16498	388	34	children	child	NOUN
ihlr-16498	388	35	with	with	ADP
ihlr-16498	388	36	depression	depression	NOUN
ihlr-16498	388	37	in	in	ADP
ihlr-16498	388	38	greater	great	ADJ
ihlr-16498	388	39	frequency	frequency	NOUN
ihlr-16498	388	40	than	than	SCONJ
ihlr-16498	388	41	prozac.98	prozac.98	VERB
ihlr-16498	388	42	this	this	PRON
ihlr-16498	388	43	is	be	AUX
ihlr-16498	388	44	particularly	particularly	ADV
ihlr-16498	388	45	troubling	troubling	ADJ
ihlr-16498	388	46	because	because	SCONJ
ihlr-16498	388	47	studies	study	NOUN
ihlr-16498	388	48	suggest	suggest	VERB
ihlr-16498	388	49	that	that	SCONJ
ihlr-16498	388	50	children	child	NOUN
ihlr-16498	388	51	taking	take	VERB
ihlr-16498	388	52	some	some	DET
ihlr-16498	388	53	antidepressants	antidepressant	NOUN
ihlr-16498	388	54	are	be	AUX
ihlr-16498	388	55	1.89	1.89	NUM
ihlr-16498	388	56	times	time	NOUN
ihlr-16498	388	57	more	more	ADV
ihlr-16498	388	58	likely	likely	ADJ
ihlr-16498	388	59	to	to	PART
ihlr-16498	388	60	have	have	VERB
ihlr-16498	388	61	suicidal	suicidal	ADJ
ihlr-16498	388	62	thoughts	thought	NOUN
ihlr-16498	388	63	than	than	ADP
ihlr-16498	388	64	those	those	PRON
ihlr-16498	388	65	given	give	VERB
ihlr-16498	388	66	a	a	DET
ihlr-16498	388	67	placebo.99	placebo.99	NOUN
ihlr-16498	388	68	this	this	PRON
ihlr-16498	388	69	highlights	highlight	VERB
ihlr-16498	388	70	the	the	DET
ihlr-16498	388	71	importance	importance	NOUN
ihlr-16498	388	72	of	of	ADP
ihlr-16498	388	73	con­	con­	NOUN
ihlr-16498	388	74	ducting	ducte	VERB
ihlr-16498	388	75	clinical	clinical	ADJ
ihlr-16498	388	76	trials	trial	NOUN
ihlr-16498	388	77	for	for	ADP
ihlr-16498	388	78	all	all	DET
ihlr-16498	388	79	antidepressant	antidepressant	ADJ
ihlr-16498	388	80	medications	medication	NOUN
ihlr-16498	388	81	used	use	VERB
ihlr-16498	388	82	to	to	PART
ihlr-16498	388	83	treat	treat	VERB
ihlr-16498	388	84	childhood	childhood	NOUN
ihlr-16498	388	85	depression	depression	NOUN
ihlr-16498	388	86	and	and	CCONJ
ihlr-16498	388	87	establishing	establish	VERB
ihlr-16498	388	88	post	post	ADJ
ihlr-16498	388	89	-	-	ADJ
ihlr-16498	388	90	market	market	ADJ
ihlr-16498	388	91	-	-	PUNCT
ihlr-16498	388	92	approval	approval	NOUN
ihlr-16498	388	93	surveillance	surveillance	NOUN
ihlr-16498	388	94	to	to	PART
ihlr-16498	388	95	determine	determine	VERB
ihlr-16498	388	96	whether	whether	SCONJ
ihlr-16498	388	97	additional	additional	ADJ
ihlr-16498	388	98	side	side	NOUN
ihlr-16498	388	99	effects	effect	NOUN
ihlr-16498	388	100	are	be	AUX
ihlr-16498	388	101	present	present	ADJ
ihlr-16498	388	102	.	.	PUNCT
ihlr-16498	389	1	91	91	NUM
ihlr-16498	389	2	hearing	hearing	NOUN
ihlr-16498	389	3	on	on	ADP
ihlr-16498	389	4	antidepressanj	antidepressanj	ADJ
ihlr-16498	389	5	pediatric	pediatric	ADJ
ihlr-16498	389	6	trials	trial	NOUN
ihlr-16498	389	7	.	.	PUNCT
ihlr-16498	390	1	supra	supra	PROPN
ihlr-16498	390	2	note	note	PROPN
ihlr-16498	390	3	87	87	NUM
ihlr-16498	390	4	,	,	PUNCT
ihlr-16498	390	5	at	at	ADP
ihlr-16498	390	6	30	30	NUM
ihlr-16498	390	7	(	(	PUNCT
ihlr-16498	390	8	statement	statement	NOUN
ihlr-16498	390	9	ofu.s	ofu.s	PROPN
ihlr-16498	390	10	.	.	PUNCT
ihlr-16498	390	11	rep	rep	PROPN
ihlr-16498	390	12	.	.	PROPN
ihlr-16498	390	13	greg	greg	PROPN
ihlr-16498	390	14	walden	walden	PROPN
ihlr-16498	390	15	of	of	ADP
ihlr-16498	390	16	oregon	oregon	PROPN
ihlr-16498	390	17	)	)	PUNCT
ihlr-16498	390	18	.	.	PUNCT
ihlr-16498	391	1	92	92	NUM
ihlr-16498	392	1	i	i	PRON
ihlr-16498	392	2	d.	d.	NOUN
ihlr-16498	392	3	at	at	ADP
ihlr-16498	392	4	1	1	NUM
ihlr-16498	392	5	(	(	PUNCT
ihlr-16498	392	6	statement	statement	NOUN
ihlr-16498	392	7	ofu.s	ofu.s	PROPN
ihlr-16498	392	8	.	.	PUNCT
ihlr-16498	392	9	rep	rep	PROPN
ihlr-16498	392	10	.	.	PROPN
ihlr-16498	392	11	joe	joe	PROPN
ihlr-16498	392	12	barton	barton	PROPN
ihlr-16498	392	13	oftexas	oftexas	PROPN
ihlr-16498	392	14	,	,	PUNCT
ihlr-16498	392	15	chairman	chairman	NOUN
ihlr-16498	392	16	,	,	PUNCT
ihlr-16498	392	17	subcomm	subcomm	NOUN
ihlr-16498	392	18	.	.	PUNCT
ihlr-16498	393	1	on	on	ADP
ihlr-16498	393	2	over­	over­	PROPN
ihlr-16498	393	3	sight	sight	NOUN
ihlr-16498	393	4	and	and	CCONJ
ihlr-16498	393	5	investigations	investigation	NOUN
ihlr-16498	393	6	)	)	PUNCT
ihlr-16498	393	7	.	.	PUNCT
ihlr-16498	394	1	93	93	NUM
ihlr-16498	395	1	i	i	PROPN
ihlr-16498	395	2	d.	d.	PROPN
ihlr-16498	395	3	(	(	PUNCT
ihlr-16498	395	4	statement	statement	NOUN
ihlr-16498	395	5	ofu.s	ofu.s	PROPN
ihlr-16498	395	6	.	.	PUNCT
ihlr-16498	395	7	rep	rep	PROPN
ihlr-16498	395	8	.	.	PROPN
ihlr-16498	395	9	joe	joe	PROPN
ihlr-16498	395	10	barton	barton	PROPN
ihlr-16498	395	11	oftexas	oftexas	PROPN
ihlr-16498	395	12	,	,	PUNCT
ihlr-16498	395	13	chairman	chairman	NOUN
ihlr-16498	395	14	,	,	PUNCT
ihlr-16498	395	15	subcomm	subcomm	NOUN
ihlr-16498	395	16	.	.	PUNCT
ihlr-16498	396	1	on	on	ADP
ihlr-16498	396	2	oversight	oversight	NOUN
ihlr-16498	396	3	and	and	CCONJ
ihlr-16498	396	4	investigations	investigation	NOUN
ihlr-16498	396	5	)	)	PUNCT
ihlr-16498	396	6	.	.	PUNCT
ihlr-16498	397	1	94	94	NUM
ihlr-16498	398	1	i	i	PRON
ihlr-16498	398	2	d.	d.	PROPN
ihlr-16498	398	3	at	at	ADP
ihlr-16498	398	4	13	13	NUM
ihlr-16498	398	5	(	(	PUNCT
ihlr-16498	398	6	statement	statement	NOUN
ihlr-16498	398	7	ofu.s	ofu.s	PROPN
ihlr-16498	398	8	.	.	PUNCT
ihlr-16498	398	9	rep	rep	PROPN
ihlr-16498	398	10	.	.	PROPN
ihlr-16498	398	11	edward	edward	PROPN
ihlr-16498	398	12	markey	markey	PROPN
ihlr-16498	398	13	ofmassachusetts	ofmassachusetts	PROPN
ihlr-16498	398	14	)	)	PUNCT
ihlr-16498	398	15	.	.	PUNCT
ihlr-16498	399	1	95	95	NUM
ihlr-16498	399	2	1d	1d	NUM
ihlr-16498	399	3	.	.	PUNCT
ihlr-16498	400	1	(	(	PUNCT
ihlr-16498	400	2	statement	statement	NOUN
ihlr-16498	400	3	ofu.s	ofu.s	PROPN
ihlr-16498	400	4	.	.	PUNCT
ihlr-16498	400	5	rep	rep	PROPN
ihlr-16498	400	6	.	.	PROPN
ihlr-16498	400	7	edward	edward	PROPN
ihlr-16498	400	8	markey	markey	PROPN
ihlr-16498	400	9	ofmassachusetts	ofmassachusetts	PROPN
ihlr-16498	400	10	)	)	PUNCT
ihlr-16498	400	11	.	.	PUNCT
ihlr-16498	401	1	96	96	NUM
ihlr-16498	402	1	i	i	PRON
ihlr-16498	402	2	d.	d.	PROPN
ihlr-16498	402	3	(	(	PUNCT
ihlr-16498	402	4	statement	statement	NOUN
ihlr-16498	402	5	ofu.s	ofu.s	PROPN
ihlr-16498	402	6	.	.	PUNCT
ihlr-16498	402	7	rep	rep	PROPN
ihlr-16498	402	8	.	.	PROPN
ihlr-16498	402	9	edward	edward	PROPN
ihlr-16498	402	10	markey	markey	PROPN
ihlr-16498	402	11	ofmassachusetts	ofmassachusetts	PROPN
ihlr-16498	402	12	)	)	PUNCT
ihlr-16498	402	13	.	.	PUNCT
ihlr-16498	403	1	97	97	NUM
ihlr-16498	404	1	i	i	NOUN
ihlr-16498	404	2	d	d	PROPN
ihlr-16498	404	3	at	at	ADP
ihlr-16498	404	4	39	39	NUM
ihlr-16498	404	5	(	(	PUNCT
ihlr-16498	404	6	statement	statement	NOUN
ihlr-16498	404	7	ofjanet	ofjanet	NOUN
ihlr-16498	404	8	woodcock	woodcock	NOUN
ihlr-16498	404	9	,	,	PUNCT
ihlr-16498	404	10	fda	fda	PROPN
ihlr-16498	404	11	deputy	deputy	NOUN
ihlr-16498	404	12	commissioner	commissioner	NOUN
ihlr-16498	404	13	of	of	ADP
ihlr-16498	404	14	operations	operation	NOUN
ihlr-16498	404	15	)	)	PUNCT
ihlr-16498	404	16	.	.	PUNCT
ihlr-16498	405	1	98	98	NUM
ihlr-16498	406	1	i	i	PRON
ihlr-16498	406	2	d.	d.	NOUN
ihlr-16498	406	3	at	at	ADP
ihlr-16498	406	4	218	218	NUM
ihlr-16498	406	5	(	(	PUNCT
ihlr-16498	406	6	statement	statement	NOUN
ihlr-16498	406	7	ofu.s	ofu.s	PROPN
ihlr-16498	406	8	.	.	PUNCT
ihlr-16498	406	9	rep	rep	PROPN
ihlr-16498	406	10	.	.	PROPN
ihlr-16498	406	11	greg	greg	PROPN
ihlr-16498	406	12	walden	walden	PROPN
ihlr-16498	406	13	of	of	ADP
ihlr-16498	406	14	oregon	oregon	PROPN
ihlr-16498	406	15	,	,	PUNCT
ihlr-16498	406	16	vice	vice	NOUN
ihlr-16498	406	17	chairman	chairman	NOUN
ihlr-16498	406	18	,	,	PUNCT
ihlr-16498	406	19	subcomm	subcomm	NOUN
ihlr-16498	406	20	.	.	PUNCT
ihlr-16498	407	1	on	on	ADP
ihlr-16498	407	2	oversight	oversight	NOUN
ihlr-16498	407	3	and	and	CCONJ
ihlr-16498	407	4	investigations	investigation	NOUN
ihlr-16498	407	5	)	)	PUNCT
ihlr-16498	407	6	.	.	PUNCT
ihlr-16498	408	1	99	99	NUM
ihlr-16498	409	1	i	i	PRON
ihlr-16498	409	2	d.	d.	PROPN
ihlr-16498	409	3	at	at	ADP
ihlr-16498	409	4	7	7	NUM
ihlr-16498	409	5	(	(	PUNCT
ihlr-16498	409	6	statement	statement	NOUN
ihlr-16498	409	7	ofu.s	ofu.s	PROPN
ihlr-16498	409	8	.	.	PUNCT
ihlr-16498	409	9	rep	rep	PROPN
ihlr-16498	409	10	.	.	PROPN
ihlr-16498	409	11	greg	greg	PROPN
ihlr-16498	409	12	walden	walden	PROPN
ihlr-16498	409	13	of	of	ADP
ihlr-16498	409	14	oregon	oregon	PROPN
ihlr-16498	409	15	,	,	PUNCT
ihlr-16498	409	16	vice	vice	NOUN
ihlr-16498	409	17	chairman	chairman	NOUN
ihlr-16498	409	18	,	,	PUNCT
ihlr-16498	409	19	subcomm	subcomm	NOUN
ihlr-16498	409	20	.	.	PUNCT
ihlr-16498	410	1	on	on	ADP
ihlr-16498	410	2	oversight	oversight	NOUN
ihlr-16498	410	3	and	and	CCONJ
ihlr-16498	410	4	investigations	investigation	NOUN
ihlr-16498	410	5	)	)	PUNCT
ihlr-16498	410	6	.	.	PUNCT
ihlr-16498	411	1	76	76	NUM
ihlr-16498	411	2	indiana	indiana	PROPN
ihlr-16498	411	3	healtii	healtii	PROPN
ihlr-16498	411	4	law	law	PROPN
ihlr-16498	411	5	review	review	NOUN
ihlr-16498	411	6	[	[	X
ihlr-16498	411	7	vol	vol	NOUN
ihlr-16498	411	8	.	.	PUNCT
ihlr-16498	412	1	4:59	4:59	NUM
ihlr-16498	413	1	v.	v.	ADP
ihlr-16498	413	2	policy	policy	NOUN
ihlr-16498	413	3	recommendations	recommendation	NOUN
ihlr-16498	413	4	to	to	PART
ihlr-16498	413	5	address	address	VERB
ihlr-16498	413	6	the	the	DET
ihlr-16498	413	7	difficulties	difficulty	NOUN
ihlr-16498	413	8	associated	associate	VERB
ihlr-16498	413	9	with	with	ADP
ihlr-16498	413	10	pediatric	pediatric	ADJ
ihlr-16498	413	11	studies	study	NOUN
ihlr-16498	413	12	pediatric	pediatric	ADJ
ihlr-16498	413	13	clinical	clinical	ADJ
ihlr-16498	413	14	studies	study	NOUN
ihlr-16498	413	15	are	be	AUX
ihlr-16498	413	16	needed	need	VERB
ihlr-16498	413	17	to	to	PART
ihlr-16498	413	18	determine	determine	VERB
ihlr-16498	413	19	safe	safe	ADJ
ihlr-16498	413	20	and	and	CCONJ
ihlr-16498	413	21	effective	effective	ADJ
ihlr-16498	413	22	doses	dose	NOUN
ihlr-16498	413	23	in	in	ADP
ihlr-16498	413	24	children	child	NOUN
ihlr-16498	413	25	.	.	PUNCT
ihlr-16498	414	1	the	the	DET
ihlr-16498	414	2	protocol	protocol	NOUN
ihlr-16498	414	3	of"dosing	of"dose	VERB
ihlr-16498	414	4	down	down	ADP
ihlr-16498	414	5	"	"	PUNCT
ihlr-16498	414	6	adult	adult	NOUN
ihlr-16498	414	7	prescriptions	prescription	NOUN
ihlr-16498	414	8	to	to	PART
ihlr-16498	414	9	account	account	VERB
ihlr-16498	414	10	for	for	ADP
ihlr-16498	414	11	the	the	DET
ihlr-16498	414	12	smaller	small	ADJ
ihlr-16498	414	13	size	size	NOUN
ihlr-16498	414	14	of	of	ADP
ihlr-16498	414	15	children	child	NOUN
ihlr-16498	414	16	does	do	AUX
ihlr-16498	414	17	not	not	PART
ihlr-16498	414	18	address	address	VERB
ihlr-16498	414	19	physiological	physiological	ADJ
ihlr-16498	414	20	differences	difference	NOUN
ihlr-16498	414	21	between	between	ADP
ihlr-16498	414	22	adults	adult	NOUN
ihlr-16498	414	23	and	and	CCONJ
ihlr-16498	414	24	children	child	NOUN
ihlr-16498	414	25	.	.	PUNCT
ihlr-16498	415	1	medications	medication	NOUN
ihlr-16498	415	2	that	that	PRON
ihlr-16498	415	3	may	may	AUX
ihlr-16498	415	4	be	be	AUX
ihlr-16498	415	5	safe	safe	ADJ
ihlr-16498	415	6	for	for	ADP
ihlr-16498	415	7	use	use	NOUN
ihlr-16498	415	8	in	in	ADP
ihlr-16498	415	9	adults	adult	NOUN
ihlr-16498	415	10	could	could	AUX
ihlr-16498	415	11	be	be	AUX
ihlr-16498	415	12	quite	quite	ADV
ihlr-16498	415	13	unsafe	unsafe	ADJ
ihlr-16498	415	14	in	in	ADP
ihlr-16498	415	15	children	child	NOUN
ihlr-16498	415	16	.	.	PUNCT
ihlr-16498	416	1	children	child	NOUN
ihlr-16498	416	2	should	should	AUX
ihlr-16498	416	3	not	not	PART
ihlr-16498	416	4	be	be	AUX
ihlr-16498	416	5	put	put	VERB
ihlr-16498	416	6	at	at	ADP
ihlr-16498	416	7	risk	risk	NOUN
ihlr-16498	416	8	when	when	SCONJ
ihlr-16498	416	9	a	a	DET
ihlr-16498	416	10	comprehen­	comprehen­	PROPN
ihlr-16498	416	11	sive	sive	ADJ
ihlr-16498	416	12	program	program	NOUN
ihlr-16498	416	13	can	can	AUX
ihlr-16498	416	14	be	be	AUX
ihlr-16498	416	15	instituted	institute	VERB
ihlr-16498	416	16	to	to	PART
ihlr-16498	416	17	address	address	VERB
ihlr-16498	416	18	their	their	PRON
ihlr-16498	416	19	particularities	particularity	NOUN
ihlr-16498	416	20	.	.	PUNCT
ihlr-16498	417	1	although	although	SCONJ
ihlr-16498	417	2	the	the	DET
ihlr-16498	417	3	fdama	fdama	NOUN
ihlr-16498	417	4	,	,	PUNCT
ihlr-16498	417	5	bpca	bpca	PROPN
ihlr-16498	417	6	,	,	PUNCT
ihlr-16498	417	7	and	and	CCONJ
ihlr-16498	417	8	prea	prea	PROPN
ihlr-16498	417	9	are	be	AUX
ihlr-16498	417	10	good	good	ADJ
ihlr-16498	417	11	starting	starting	NOUN
ihlr-16498	417	12	points	point	NOUN
ihlr-16498	417	13	with	with	ADP
ihlr-16498	417	14	their	their	PRON
ihlr-16498	417	15	particular	particular	ADJ
ihlr-16498	417	16	em­	em­	NOUN
ihlr-16498	417	17	phasis	phasis	NOUN
ihlr-16498	417	18	on	on	ADP
ihlr-16498	417	19	the	the	DET
ihlr-16498	417	20	treatment	treatment	NOUN
ihlr-16498	417	21	of	of	ADP
ihlr-16498	417	22	children	child	NOUN
ihlr-16498	417	23	engaged	engage	VERB
ihlr-16498	417	24	in	in	ADP
ihlr-16498	417	25	a	a	DET
ihlr-16498	417	26	clinical	clinical	ADJ
ihlr-16498	417	27	trial	trial	NOUN
ihlr-16498	417	28	,	,	PUNCT
ihlr-16498	417	29	specific	specific	ADJ
ihlr-16498	417	30	changes	change	NOUN
ihlr-16498	417	31	and	and	CCONJ
ihlr-16498	417	32	further	further	ADJ
ihlr-16498	417	33	regulation	regulation	NOUN
ihlr-16498	417	34	are	be	AUX
ihlr-16498	417	35	needed	need	VERB
ihlr-16498	417	36	to	to	PART
ihlr-16498	417	37	protect	protect	VERB
ihlr-16498	417	38	pediatric	pediatric	ADJ
ihlr-16498	417	39	patients	patient	NOUN
ihlr-16498	417	40	.	.	PUNCT
ihlr-16498	418	1	as	as	SCONJ
ihlr-16498	418	2	the	the	DET
ihlr-16498	418	3	fda	fda	PROPN
ihlr-16498	418	4	comes	come	VERB
ihlr-16498	418	5	under	under	ADP
ihlr-16498	418	6	increased	increased	ADJ
ihlr-16498	418	7	scrutiny	scrutiny	NOUN
ihlr-16498	418	8	following	follow	VERB
ihlr-16498	418	9	the	the	DET
ihlr-16498	418	10	wake	wake	NOUN
ihlr-16498	418	11	of	of	ADP
ihlr-16498	418	12	the	the	DET
ihlr-16498	418	13	an­	an­	NOUN
ihlr-16498	418	14	tidepressants	tidepressant	NOUN
ihlr-16498	418	15	and	and	CCONJ
ihlr-16498	418	16	vioxx	vioxx	NOUN
ihlr-16498	418	17	100	100	NUM
ihlr-16498	418	18	scandals	scandal	NOUN
ihlr-16498	418	19	,	,	PUNCT
ihlr-16498	418	20	the	the	DET
ihlr-16498	418	21	time	time	NOUN
ihlr-16498	418	22	is	be	AUX
ihlr-16498	418	23	ripe	ripe	ADJ
ihlr-16498	418	24	to	to	PART
ihlr-16498	418	25	address	address	VERB
ihlr-16498	418	26	obvious	obvious	ADJ
ihlr-16498	418	27	and	and	CCONJ
ihlr-16498	418	28	no­	no­	ADV
ihlr-16498	418	29	table	table	NOUN
ihlr-16498	418	30	deficiencies	deficiency	NOUN
ihlr-16498	418	31	in	in	ADP
ihlr-16498	418	32	the	the	DET
ihlr-16498	418	33	current	current	ADJ
ihlr-16498	418	34	regulatory	regulatory	ADJ
ihlr-16498	418	35	scheme	scheme	NOUN
ihlr-16498	418	36	.	.	PUNCT
ihlr-16498	419	1	moreover	moreover	ADV
ihlr-16498	419	2	,	,	PUNCT
ihlr-16498	419	3	because	because	SCONJ
ihlr-16498	419	4	the	the	DET
ihlr-16498	419	5	act	act	NOUN
ihlr-16498	419	6	will	will	AUX
ihlr-16498	419	7	sunset	sunset	VERB
ihlr-16498	419	8	in	in	ADP
ihlr-16498	419	9	2007	2007	NUM
ihlr-16498	419	10	,	,	PUNCT
ihlr-16498	419	11	new	new	ADJ
ihlr-16498	419	12	policy	policy	NOUN
ihlr-16498	419	13	changes	change	NOUN
ihlr-16498	419	14	need	need	VERB
ihlr-16498	419	15	to	to	PART
ihlr-16498	419	16	be	be	AUX
ihlr-16498	419	17	implemented	implement	VERB
ihlr-16498	419	18	.	.	PUNCT
ihlr-16498	420	1	a	a	DET
ihlr-16498	420	2	variety	variety	NOUN
ihlr-16498	420	3	of	of	ADP
ihlr-16498	420	4	policy	policy	NOUN
ihlr-16498	420	5	recommendations	recommendation	NOUN
ihlr-16498	420	6	should	should	AUX
ihlr-16498	420	7	be	be	AUX
ihlr-16498	420	8	considered	consider	VERB
ihlr-16498	420	9	as	as	SCONJ
ihlr-16498	420	10	both	both	DET
ihlr-16498	420	11	congress	congress	PROPN
ihlr-16498	420	12	and	and	CCONJ
ihlr-16498	420	13	the	the	DET
ihlr-16498	420	14	fda	fda	PROPN
ihlr-16498	420	15	move	move	VERB
ihlr-16498	420	16	forward	forward	ADV
ihlr-16498	420	17	to	to	PART
ihlr-16498	420	18	meet	meet	VERB
ihlr-16498	420	19	these	these	DET
ihlr-16498	420	20	challenges	challenge	NOUN
ihlr-16498	420	21	.	.	PUNCT
ihlr-16498	421	1	policy	policy	NOUN
ihlr-16498	421	2	suggestions	suggestion	NOUN
ihlr-16498	421	3	include	include	VERB
ihlr-16498	421	4	the	the	DET
ihlr-16498	421	5	follow­	follow­	NOUN
ihlr-16498	421	6	ing	ing	ADJ
ihlr-16498	421	7	:	:	PUNCT
ihlr-16498	421	8	(	(	PUNCT
ihlr-16498	421	9	1	1	X
ihlr-16498	421	10	)	)	PUNCT
ihlr-16498	421	11	listing	list	VERB
ihlr-16498	421	12	the	the	DET
ihlr-16498	421	13	trials	trial	NOUN
ihlr-16498	421	14	of	of	ADP
ihlr-16498	421	15	drugs	drug	NOUN
ihlr-16498	421	16	in	in	ADP
ihlr-16498	421	17	public	public	ADJ
ihlr-16498	421	18	databases	database	NOUN
ihlr-16498	421	19	and	and	CCONJ
ihlr-16498	421	20	including	include	VERB
ihlr-16498	421	21	reports	report	NOUN
ihlr-16498	421	22	of	of	ADP
ihlr-16498	421	23	inconclusive	inconclusive	ADJ
ihlr-16498	421	24	or	or	CCONJ
ihlr-16498	421	25	negative	negative	ADJ
ihlr-16498	421	26	clinical	clinical	ADJ
ihlr-16498	421	27	trials	trial	NOUN
ihlr-16498	421	28	,	,	PUNCT
ihlr-16498	421	29	(	(	PUNCT
ihlr-16498	421	30	2	2	X
ihlr-16498	421	31	)	)	PUNCT
ihlr-16498	421	32	changing	change	VERB
ihlr-16498	421	33	the	the	DET
ihlr-16498	421	34	exclusivity	exclusivity	NOUN
ihlr-16498	421	35	provision	provision	NOUN
ihlr-16498	421	36	,	,	PUNCT
ihlr-16498	421	37	(	(	PUNCT
ihlr-16498	421	38	3	3	X
ihlr-16498	421	39	)	)	PUNCT
ihlr-16498	421	40	labeling	labeling	NOUN
ihlr-16498	421	41	changes	change	NOUN
ihlr-16498	421	42	,	,	PUNCT
ihlr-16498	421	43	and	and	CCONJ
ihlr-16498	421	44	(	(	PUNCT
ihlr-16498	421	45	4	4	X
ihlr-16498	421	46	)	)	PUNCT
ihlr-16498	421	47	implementing	implement	VERB
ihlr-16498	421	48	effective	effective	ADJ
ihlr-16498	421	49	post	post	ADJ
ihlr-16498	421	50	-	-	ADJ
ihlr-16498	421	51	approval	approval	ADJ
ihlr-16498	421	52	surveillance	surveillance	NOUN
ihlr-16498	421	53	mechanisms	mechanism	NOUN
ihlr-16498	421	54	.	.	PUNCT
ihlr-16498	422	1	a.	a.	NOUN
ihlr-16498	422	2	public	public	ADJ
ihlr-16498	422	3	databases	database	NOUN
ihlr-16498	422	4	that	that	PRON
ihlr-16498	422	5	disclose	disclose	VERB
ihlr-16498	422	6	medical	medical	ADJ
ihlr-16498	422	7	device	device	NOUN
ihlr-16498	422	8	and	and	CCONJ
ihlr-16498	422	9	drog	drog	NOUN
ihlr-16498	422	10	tests	test	NOUN
ihlr-16498	422	11	by	by	ADP
ihlr-16498	422	12	reporting	report	VERB
ihlr-16498	422	13	inconclusive	inconclusive	ADJ
ihlr-16498	422	14	or	or	CCONJ
ihlr-16498	422	15	negative	negative	ADJ
ihlr-16498	422	16	clinical	clinical	ADJ
ihlr-16498	422	17	trials	trial	NOUN
ihlr-16498	422	18	the	the	DET
ihlr-16498	422	19	fda	fda	PROPN
ihlr-16498	422	20	should	should	AUX
ihlr-16498	422	21	establish	establish	VERB
ihlr-16498	422	22	a	a	DET
ihlr-16498	422	23	public	public	ADJ
ihlr-16498	422	24	database	database	NOUN
ihlr-16498	422	25	that	that	PRON
ihlr-16498	422	26	lists	list	VERB
ihlr-16498	422	27	all	all	DET
ihlr-16498	422	28	drugs	drug	NOUN
ihlr-16498	422	29	,	,	PUNCT
ihlr-16498	422	30	clinical	clinical	ADJ
ihlr-16498	422	31	trials	trial	NOUN
ihlr-16498	422	32	,	,	PUNCT
ihlr-16498	422	33	and	and	CCONJ
ihlr-16498	422	34	results	result	NOUN
ihlr-16498	422	35	of	of	ADP
ihlr-16498	422	36	the	the	DET
ihlr-16498	422	37	clinical	clinical	ADJ
ihlr-16498	422	38	trials	trial	NOUN
ihlr-16498	422	39	.	.	PUNCT
ihlr-16498	423	1	the	the	DET
ihlr-16498	423	2	american	american	PROPN
ihlr-16498	423	3	medical	medical	PROPN
ihlr-16498	423	4	association	association	PROPN
ihlr-16498	423	5	(	(	PUNCT
ihlr-16498	423	6	"	"	PUNCT
ihlr-16498	423	7	ama	ama	NOUN
ihlr-16498	423	8	"	"	PUNCT
ihlr-16498	423	9	)	)	PUNCT
ihlr-16498	423	10	and	and	CCONJ
ihlr-16498	423	11	other	other	ADJ
ihlr-16498	423	12	medical	medical	ADJ
ihlr-16498	423	13	groups	group	NOUN
ihlr-16498	423	14	are	be	AUX
ihlr-16498	423	15	placing	place	VERB
ihlr-16498	423	16	pressure	pressure	NOUN
ihlr-16498	423	17	on	on	ADP
ihlr-16498	423	18	the	the	DET
ihlr-16498	423	19	fda	fda	PROPN
ihlr-16498	423	20	to	to	ADP
ihlr-16498	423	21	estab­	estab­	NOUN
ihlr-16498	423	22	lish	lish	VERB
ihlr-16498	423	23	a	a	DET
ihlr-16498	423	24	database	database	NOUN
ihlr-16498	423	25	where	where	SCONJ
ihlr-16498	423	26	clinical	clinical	ADJ
ihlr-16498	423	27	trials	trial	NOUN
ihlr-16498	423	28	can	can	AUX
ihlr-16498	423	29	be	be	AUX
ihlr-16498	423	30	tracked	track	VERB
ihlr-16498	423	31	from	from	ADP
ihlr-16498	423	32	beginning	begin	VERB
ihlr-16498	423	33	to	to	ADP
ihlr-16498	423	34	end.101	end.101	NOUN
ihlr-16498	423	35	in	in	ADP
ihlr-16498	423	36	addition	addition	NOUN
ihlr-16498	423	37	,	,	PUNCT
ihlr-16498	423	38	some	some	DET
ihlr-16498	423	39	medical	medical	ADJ
ihlr-16498	423	40	journals	journal	NOUN
ihlr-16498	423	41	are	be	AUX
ihlr-16498	423	42	contemplating	contemplate	VERB
ihlr-16498	423	43	requiring	require	VERB
ihlr-16498	423	44	manufacturers	manufacturer	NOUN
ihlr-16498	423	45	to	to	ADP
ihlr-16498	423	46	100	100	NUM
ihlr-16498	423	47	see	see	VERB
ihlr-16498	423	48	gina	gina	PROPN
ihlr-16498	423	49	kolata	kolata	PROPN
ihlr-16498	423	50	,	,	PUNCT
ihlr-16498	423	51	merck	merck	PROPN
ihlr-16498	423	52	and	and	CCONJ
ihlr-16498	423	53	vioxx	vioxx	PROPN
ihlr-16498	423	54	:	:	PUNCT
ihlr-16498	423	55	the	the	DET
ihlr-16498	423	56	overview	overview	NOUN
ihlr-16498	423	57	,	,	PUNCT
ihlr-16498	423	58	n.y	n.y	PROPN
ihlr-16498	423	59	.	.	PROPN
ihlr-16498	423	60	times	times	PROPN
ihlr-16498	423	61	,	,	PUNCT
ihlr-16498	423	62	oct	oct	PROPN
ihlr-16498	423	63	.	.	PROPN
ihlr-16498	423	64	1	1	NUM
ihlr-16498	423	65	,	,	PUNCT
ihlr-16498	423	66	2004	2004	NUM
ihlr-16498	423	67	,	,	PUNCT
ihlr-16498	423	68	at	at	ADP
ihlr-16498	423	69	ai	ai	NOUN
ihlr-16498	423	70	;	;	PUNCT
ihlr-16498	423	71	gardiner	gardiner	PROPN
ihlr-16498	423	72	harris	harris	PROPN
ihlr-16498	423	73	,	,	PUNCT
ihlr-16498	423	74	drug	drug	NOUN
ihlr-16498	423	75	-	-	PUNCT
ihlr-16498	423	76	safety	safety	NOUN
ihlr-16498	423	77	reviewer	reviewer	NOUN
ihlr-16498	423	78	says	say	VERB
ihlr-16498	423	79	f.d.a	f.d.a	NOUN
ihlr-16498	423	80	.	.	PROPN
ihlr-16498	423	81	delayed	delay	VERB
ihlr-16498	423	82	vioxx	vioxx	NOUN
ihlr-16498	423	83	study	study	NOUN
ihlr-16498	423	84	,	,	PUNCT
ihlr-16498	423	85	n.y	n.y	PROPN
ihlr-16498	423	86	.	.	PROPN
ihlr-16498	423	87	times	times	PROPN
ihlr-16498	423	88	,	,	PUNCT
ihlr-16498	423	89	nov	nov	PROPN
ihlr-16498	423	90	.	.	PROPN
ihlr-16498	423	91	4	4	NUM
ihlr-16498	423	92	,	,	PUNCT
ihlr-16498	423	93	2004	2004	NUM
ihlr-16498	423	94	,	,	PUNCT
ihlr-16498	423	95	at	at	ADP
ihlr-16498	423	96	a21	a21	NOUN
ihlr-16498	423	97	;	;	PUNCT
ihlr-16498	423	98	anna	anna	PROPN
ihlr-16498	423	99	wilde	wilde	PROPN
ihlr-16498	423	100	mathews	mathews	PROPN
ihlr-16498	423	101	&	&	CCONJ
ihlr-16498	423	102	barbara	barbara	PROPN
ihlr-16498	423	103	martinez	martinez	PROPN
ihlr-16498	423	104	,	,	PUNCT
ihlr-16498	423	105	warning	warning	NOUN
ihlr-16498	423	106	signs	sign	NOUN
ihlr-16498	423	107	:	:	PUNCT
ihlr-16498	423	108	e	e	X
ihlr-16498	423	109	-	-	NOUN
ihlr-16498	423	110	mails	mail	NOUN
ihlr-16498	423	111	suggest	suggest	VERB
ihlr-16498	423	112	merck	merck	PROPN
ihlr-16498	423	113	knew	know	VERB
ihlr-16498	423	114	vioxx	vioxx	NOUN
ihlr-16498	423	115	's	's	PART
ihlr-16498	423	116	dangers	danger	NOUN
ihlr-16498	423	117	at	at	ADP
ihlr-16498	423	118	early	early	ADJ
ihlr-16498	423	119	stage	stage	NOUN
ihlr-16498	423	120	;	;	PUNCT
ihlr-16498	423	121	as	as	SCONJ
ihlr-16498	423	122	heart	heart	NOUN
ihlr-16498	423	123	-	-	PUNCT
ihlr-16498	423	124	risk	risk	NOUN
ihlr-16498	423	125	evidence	evidence	NOUN
ihlr-16498	423	126	rose	rise	VERB
ihlr-16498	423	127	,	,	PUNCT
ihlr-16498	423	128	qlficials	qlficial	NOUN
ihlr-16498	423	129	played	play	VERB
ihlr-16498	423	130	hardball	hardball	PROPN
ihlr-16498	423	131	;	;	PUNCT
ihlr-16498	423	132	internal	internal	ADJ
ihlr-16498	423	133	message	message	NOUN
ihlr-16498	423	134	:	:	PUNCT
ihlr-16498	423	135	'	'	PUNCT
ihlr-16498	423	136	dodge	dodge	VERB
ihlr-16498	423	137	!	!	PUNCT
ihlr-16498	423	138	'	'	PUNCT
ihlr-16498	423	139	;	;	PUNCT
ihlr-16498	423	140	company	company	NOUN
ihlr-16498	423	141	says	say	VERB
ihlr-16498	423	142	'	'	PUNCT
ihlr-16498	423	143	out	out	ADP
ihlr-16498	423	144	of	of	ADP
ihlr-16498	423	145	context	context	NOUN
ihlr-16498	423	146	,	,	PUNCT
ihlr-16498	423	147	'	'	PUNCT
ihlr-16498	423	148	wall	wall	PROPN
ihlr-16498	423	149	st	st	PROPN
ihlr-16498	423	150	.	.	PROPN
ihlr-16498	423	151	j.	j.	PROPN
ihlr-16498	423	152	,	,	PUNCT
ihlr-16498	423	153	nov	nov	PROPN
ihlr-16498	423	154	.	.	PROPN
ihlr-16498	423	155	1	1	NUM
ihlr-16498	423	156	,	,	PUNCT
ihlr-16498	423	157	2004	2004	NUM
ihlr-16498	423	158	,	,	PUNCT
ihlr-16498	423	159	atal	atal	PROPN
ihlr-16498	423	160	;	;	PUNCT
ihlr-16498	423	161	eric	eric	PROPN
ihlr-16498	423	162	j.	j.	PROPN
ihlr-16498	423	163	topol	topol	PROPN
ihlr-16498	423	164	,	,	PUNCT
ihlr-16498	423	165	failing	fail	VERB
ihlr-16498	423	166	the	the	DET
ihlr-16498	423	167	pubic	pubic	NOUN
ihlr-16498	423	168	healthrofecoxib	healthrofecoxib	NOUN
ihlr-16498	423	169	,	,	PUNCT
ihlr-16498	423	170	merck	merck	PROPN
ihlr-16498	423	171	,	,	PUNCT
ihlr-16498	423	172	and	and	CCONJ
ihlr-16498	423	173	the	the	DET
ihlr-16498	423	174	fda	fda	PROPN
ihlr-16498	423	175	,	,	PUNCT
ihlr-16498	423	176	351	351	NUM
ihlr-16498	423	177	n.	n.	PROPN
ihlr-16498	423	178	eng	eng	PROPN
ihlr-16498	423	179	.	.	PUNCT
ihlr-16498	424	1	j.	j.	PROPN
ihlr-16498	424	2	meo	meo	PROPN
ihlr-16498	424	3	.	.	PROPN
ihlr-16498	424	4	1707	1707	NUM
ihlr-16498	424	5	,	,	PUNCT
ihlr-16498	424	6	l	l	PROPN
ihlr-16498	424	7	707	707	NUM
ihlr-16498	424	8	-	-	SYM
ihlr-16498	424	9	09	09	NUM
ihlr-16498	424	10	(	(	PUNCT
ihlr-16498	424	11	2004	2004	NUM
ihlr-16498	424	12	)	)	PUNCT
ihlr-16498	424	13	.	.	PUNCT
ihlr-16498	425	1	101	101	NUM
ihlr-16498	425	2	see	see	VERB
ihlr-16498	425	3	meier	meier	PROPN
ihlr-16498	425	4	,	,	PUNCT
ihlr-16498	425	5	negative	negative	ADJ
ihlr-16498	425	6	test	test	NOUN
ihlr-16498	425	7	results	result	NOUN
ihlr-16498	425	8	,	,	PUNCT
ihlr-16498	425	9	supra	supra	PROPN
ihlr-16498	425	10	note	note	NOUN
ihlr-16498	425	11	75	75	NUM
ihlr-16498	425	12	(	(	PUNCT
ihlr-16498	425	13	"	"	PUNCT
ihlr-16498	425	14	the	the	DET
ihlr-16498	425	15	american	american	PROPN
ihlr-16498	425	16	medical	medical	PROPN
ihlr-16498	425	17	association	association	PROPN
ihlr-16498	425	18	has	have	AUX
ihlr-16498	425	19	called	call	VERB
ihlr-16498	425	20	on	on	ADP
ihlr-16498	425	21	the	the	DET
ihlr-16498	425	22	federal	federal	ADJ
ihlr-16498	425	23	government	government	NOUN
ihlr-16498	425	24	to	to	PART
ihlr-16498	425	25	create	create	VERB
ihlr-16498	425	26	a	a	DET
ihlr-16498	425	27	database	database	NOUN
ihlr-16498	425	28	in	in	ADP
ihlr-16498	425	29	which	which	PRON
ihlr-16498	425	30	trials	trial	NOUN
ihlr-16498	425	31	can	can	AUX
ihlr-16498	425	32	be	be	AUX
ihlr-16498	425	33	tracked	track	VERB
ihlr-16498	425	34	from	from	ADP
ihlr-16498	425	35	start	start	NOUN
ihlr-16498	425	36	to	to	ADP
ihlr-16498	425	37	finish	finish	NOUN
ihlr-16498	425	38	.	.	PUNCT
ihlr-16498	425	39	"	"	PUNCT
ihlr-16498	425	40	)	)	PUNCT
ihlr-16498	425	41	;	;	PUNCT
ihlr-16498	425	42	see	see	VERB
ihlr-16498	425	43	also	also	ADV
ihlr-16498	425	44	barry	barry	PROPN
ihlr-16498	425	45	meier	meier	PROPN
ihlr-16498	425	46	,	,	PUNCT
ihlr-16498	425	47	medicine	medicine	NOUN
ihlr-16498	425	48	's	's	PART
ihlr-16498	425	49	data	data	NOUN
ihlr-16498	425	50	gap	gap	NOUN
ihlr-16498	425	51	:	:	PUNCT
ihlr-16498	425	52	when	when	SCONJ
ihlr-16498	425	53	labels	label	NOUN
ihlr-16498	425	54	mislead	mislead	VERB
ihlr-16498	425	55	;	;	PUNCT
ihlr-16498	425	56	results	result	NOUN
ihlr-16498	425	57	of	of	ADP
ihlr-16498	425	58	drug	drug	NOUN
ihlr-16498	425	59	trials	trial	NOUN
ihlr-16498	425	60	can	can	AUX
ihlr-16498	425	61	mystify	mystify	VERB
ihlr-16498	425	62	doctors	doctor	NOUN
ihlr-16498	425	63	through	through	ADP
ihlr-16498	425	64	omission	omission	NOUN
ihlr-16498	425	65	,	,	PUNCT
ihlr-16498	425	66	n.y	n.y	PROPN
ihlr-16498	425	67	.	.	PROPN
ihlr-16498	425	68	'	'	PUNCT
ihlr-16498	425	69	dmes	dme	NOUN
ihlr-16498	425	70	,	,	PUNCT
ihlr-16498	425	71	july	july	PROPN
ihlr-16498	425	72	21	21	NUM
ihlr-16498	425	73	,	,	PUNCT
ihlr-16498	425	74	2004	2004	NUM
ihlr-16498	425	75	,	,	PUNCT
ihlr-16498	425	76	at	at	ADP
ihlr-16498	425	77	cl	cl	NOUN
ihlr-16498	425	78	(	(	PUNCT
ihlr-16498	425	79	"	"	PUNCT
ihlr-16498	425	80	in	in	ADP
ihlr-16498	425	81	recent	recent	ADJ
ihlr-16498	425	82	weeks	week	NOUN
ihlr-16498	425	83	,	,	PUNCT
ihlr-16498	425	84	the	the	DET
ihlr-16498	425	85	academy	academy	NOUN
ihlr-16498	425	86	and	and	CCONJ
ihlr-16498	425	87	other	other	ADJ
ihlr-16498	425	88	medical	medical	ADJ
ihlr-16498	425	89	groups	group	NOUN
ihlr-16498	425	90	have	have	AUX
ihlr-16498	425	91	met	meet	VERB
ihlr-16498	425	92	with	with	ADP
ihlr-16498	425	93	lawmakers	lawmaker	NOUN
ihlr-16498	425	94	to	to	PART
ihlr-16498	425	95	discuss	discuss	VERB
ihlr-16498	425	96	possi­	possi­	PROPN
ihlr-16498	425	97	ble	ble	ADJ
ihlr-16498	425	98	legislation	legislation	NOUN
ihlr-16498	425	99	requiring	require	VERB
ihlr-16498	425	100	companies	company	NOUN
ihlr-16498	425	101	to	to	PART
ihlr-16498	425	102	list	list	VERB
ihlr-16498	425	103	tests	test	NOUN
ihlr-16498	425	104	of	of	ADP
ihlr-16498	425	105	drugs	drug	NOUN
ihlr-16498	425	106	and	and	CCONJ
ihlr-16498	425	107	medical	medical	ADJ
ihlr-16498	425	108	devices	device	NOUN
ihlr-16498	425	109	in	in	ADP
ihlr-16498	425	110	a	a	DET
ihlr-16498	425	111	public	public	ADJ
ihlr-16498	425	112	data­	data­	NOUN
ihlr-16498	425	113	base	base	NOUN
ihlr-16498	425	114	.	.	PUNCT
ihlr-16498	425	115	"	"	PUNCT
ihlr-16498	425	116	)	)	PUNCT
ihlr-16498	425	117	.	.	PUNCT
ihlr-16498	426	1	2007	2007	NUM
ihlr-16498	426	2	]	]	PUNCT
ihlr-16498	426	3	reforming	reform	VERB
ihlr-16498	426	4	fda	fda	PROPN
ihlr-16498	426	5	poucy	poucy	PROPN
ihlr-16498	426	6	for	for	ADP
ihlr-16498	426	7	pediatric	pediatric	ADJ
ihlr-16498	426	8	testing	testing	NOUN
ihlr-16498	426	9	77	77	NUM
ihlr-16498	426	10	register	register	VERB
ihlr-16498	426	11	their	their	PRON
ihlr-16498	426	12	clinical	clinical	ADJ
ihlr-16498	426	13	trials	trial	NOUN
ihlr-16498	426	14	with	with	ADP
ihlr-16498	426	15	the	the	DET
ihlr-16498	426	16	journal	journal	NOUN
ihlr-16498	426	17	as	as	ADP
ihlr-16498	426	18	a	a	DET
ihlr-16498	426	19	prerequisite	prerequisite	NOUN
ihlr-16498	426	20	to	to	ADP
ihlr-16498	426	21	publication.102	publication.102	PRON
ihlr-16498	426	22	although	although	SCONJ
ihlr-16498	426	23	this	this	DET
ihlr-16498	426	24	type	type	NOUN
ihlr-16498	426	25	of	of	ADP
ihlr-16498	426	26	policy	policy	NOUN
ihlr-16498	426	27	reform	reform	NOUN
ihlr-16498	426	28	could	could	AUX
ihlr-16498	426	29	be	be	AUX
ihlr-16498	426	30	applied	apply	VERB
ihlr-16498	426	31	to	to	ADP
ihlr-16498	426	32	the	the	DET
ihlr-16498	426	33	fda	fda	PROPN
ihlr-16498	426	34	as	as	ADP
ihlr-16498	426	35	a	a	DET
ihlr-16498	426	36	whole	whole	NOUN
ihlr-16498	426	37	,	,	PUNCT
ihlr-16498	426	38	perhaps	perhaps	ADV
ihlr-16498	426	39	a	a	DET
ihlr-16498	426	40	smaller	small	ADJ
ihlr-16498	426	41	sample	sample	NOUN
ihlr-16498	426	42	size	size	NOUN
ihlr-16498	426	43	that	that	PRON
ihlr-16498	426	44	is	be	AUX
ihlr-16498	426	45	focused	focus	VERB
ihlr-16498	426	46	on	on	ADP
ihlr-16498	426	47	pediatric	pediatric	ADJ
ihlr-16498	426	48	trials	trial	NOUN
ihlr-16498	426	49	will	will	AUX
ihlr-16498	426	50	allow	allow	VERB
ihlr-16498	426	51	the	the	DET
ihlr-16498	426	52	fda	fda	PROPN
ihlr-16498	426	53	to	to	PART
ihlr-16498	426	54	learn	learn	VERB
ihlr-16498	426	55	how	how	SCONJ
ihlr-16498	426	56	to	to	PART
ihlr-16498	426	57	manage	manage	VERB
ihlr-16498	426	58	this	this	DET
ihlr-16498	426	59	type	type	NOUN
ihlr-16498	426	60	of	of	ADP
ihlr-16498	426	61	public	public	ADJ
ihlr-16498	426	62	database	database	NOUN
ihlr-16498	426	63	before	before	ADP
ihlr-16498	426	64	expanding	expand	VERB
ihlr-16498	426	65	it	it	PRON
ihlr-16498	426	66	to	to	ADP
ihlr-16498	426	67	every	every	DET
ihlr-16498	426	68	clinical	clinical	ADJ
ihlr-16498	426	69	trial	trial	NOUN
ihlr-16498	426	70	.	.	PUNCT
ihlr-16498	427	1	to	to	ADP
ihlr-16498	427	2	date	date	NOUN
ihlr-16498	427	3	,	,	PUNCT
ihlr-16498	427	4	if	if	SCONJ
ihlr-16498	427	5	a	a	DET
ihlr-16498	427	6	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	427	7	company	company	NOUN
ihlr-16498	427	8	performs	perform	VERB
ihlr-16498	427	9	a	a	DET
ihlr-16498	427	10	clinical	clinical	ADJ
ihlr-16498	427	11	study	study	NOUN
ihlr-16498	427	12	in	in	ADP
ihlr-16498	427	13	which	which	PRON
ihlr-16498	427	14	the	the	DET
ihlr-16498	427	15	results	result	NOUN
ihlr-16498	427	16	show	show	VERB
ihlr-16498	427	17	the	the	DET
ihlr-16498	427	18	drug	drug	NOUN
ihlr-16498	427	19	is	be	AUX
ihlr-16498	427	20	not	not	PART
ihlr-16498	427	21	helpful	helpful	ADJ
ihlr-16498	427	22	for	for	ADP
ihlr-16498	427	23	a	a	DET
ihlr-16498	427	24	particular	particular	ADJ
ihlr-16498	427	25	condition	condition	NOUN
ihlr-16498	427	26	,	,	PUNCT
ihlr-16498	427	27	then	then	ADV
ihlr-16498	427	28	the	the	DET
ihlr-16498	427	29	clini­	clini­	PROPN
ihlr-16498	427	30	cal	cal	ADJ
ihlr-16498	427	31	study	study	NOUN
ihlr-16498	427	32	is	be	AUX
ihlr-16498	427	33	often	often	ADV
ihlr-16498	427	34	not	not	PART
ihlr-16498	427	35	published	publish	VERB
ihlr-16498	427	36	.	.	PUNCT
ihlr-16498	428	1	for	for	ADP
ihlr-16498	428	2	example	example	NOUN
ihlr-16498	428	3	,	,	PUNCT
ihlr-16498	428	4	if	if	SCONJ
ihlr-16498	428	5	a	a	DET
ihlr-16498	428	6	manufacturer	manufacturer	NOUN
ihlr-16498	428	7	conducts	conduct	VERB
ihlr-16498	428	8	a	a	DET
ihlr-16498	428	9	clinical	clinical	ADJ
ihlr-16498	428	10	trial	trial	NOUN
ihlr-16498	428	11	to	to	PART
ihlr-16498	428	12	determine	determine	VERB
ihlr-16498	428	13	whether	whether	SCONJ
ihlr-16498	428	14	its	its	PRON
ihlr-16498	428	15	fda	fda	PROPN
ihlr-16498	428	16	-	-	PUNCT
ihlr-16498	428	17	approved	approve	VERB
ihlr-16498	428	18	drug	drug	NOUN
ihlr-16498	428	19	for	for	ADP
ihlr-16498	428	20	headaches	headache	NOUN
ihlr-16498	428	21	may	may	AUX
ihlr-16498	428	22	also	also	ADV
ihlr-16498	428	23	be	be	AUX
ihlr-16498	428	24	beneficial	beneficial	ADJ
ihlr-16498	428	25	for	for	ADP
ihlr-16498	428	26	muscle	muscle	NOUN
ihlr-16498	428	27	aches	ache	NOUN
ihlr-16498	428	28	,	,	PUNCT
ihlr-16498	428	29	but	but	CCONJ
ihlr-16498	428	30	the	the	DET
ihlr-16498	428	31	results	result	NOUN
ihlr-16498	428	32	of	of	ADP
ihlr-16498	428	33	the	the	DET
ihlr-16498	428	34	study	study	NOUN
ihlr-16498	428	35	show	show	VERB
ihlr-16498	428	36	that	that	SCONJ
ihlr-16498	428	37	the	the	DET
ihlr-16498	428	38	drug	drug	NOUN
ihlr-16498	428	39	is	be	AUX
ihlr-16498	428	40	not	not	PART
ihlr-16498	428	41	clinically	clinically	ADV
ihlr-16498	428	42	helpful	helpful	ADJ
ihlr-16498	428	43	for	for	ADP
ihlr-16498	428	44	muscle	muscle	NOUN
ihlr-16498	428	45	aches	ache	NOUN
ihlr-16498	428	46	,	,	PUNCT
ihlr-16498	428	47	then	then	ADV
ihlr-16498	428	48	the	the	DET
ihlr-16498	428	49	study	study	NOUN
ihlr-16498	428	50	may	may	AUX
ihlr-16498	428	51	not	not	PART
ihlr-16498	428	52	be	be	AUX
ihlr-16498	428	53	re­	re­	PROPN
ihlr-16498	428	54	ported	port	VERB
ihlr-16498	428	55	.	.	PUNCT
ihlr-16498	429	1	in	in	ADP
ihlr-16498	429	2	this	this	DET
ihlr-16498	429	3	example	example	NOUN
ihlr-16498	429	4	,	,	PUNCT
ihlr-16498	429	5	no	no	DET
ihlr-16498	429	6	negative	negative	ADJ
ihlr-16498	429	7	side	side	NOUN
ihlr-16498	429	8	effects	effect	NOUN
ihlr-16498	429	9	are	be	AUX
ihlr-16498	429	10	reported	report	VERB
ihlr-16498	429	11	,	,	PUNCT
ihlr-16498	429	12	so	so	SCONJ
ihlr-16498	429	13	it	it	PRON
ihlr-16498	429	14	may	may	AUX
ihlr-16498	429	15	not	not	PART
ihlr-16498	429	16	cause	cause	VERB
ihlr-16498	429	17	a	a	DET
ihlr-16498	429	18	public	public	ADJ
ihlr-16498	429	19	health	health	NOUN
ihlr-16498	429	20	hazard	hazard	NOUN
ihlr-16498	429	21	.	.	PUNCT
ihlr-16498	430	1	although	although	SCONJ
ihlr-16498	430	2	it	it	PRON
ihlr-16498	430	3	may	may	AUX
ihlr-16498	430	4	not	not	PART
ihlr-16498	430	5	harm	harm	VERB
ihlr-16498	430	6	a	a	DET
ihlr-16498	430	7	person	person	NOUN
ihlr-16498	430	8	to	to	PART
ihlr-16498	430	9	take	take	VERB
ihlr-16498	430	10	the	the	DET
ihlr-16498	430	11	headache	headache	NOUN
ihlr-16498	430	12	medicine	medicine	NOUN
ihlr-16498	430	13	for	for	ADP
ihlr-16498	430	14	a	a	DET
ihlr-16498	430	15	muscle	muscle	NOUN
ihlr-16498	430	16	ache	ache	ADV
ihlr-16498	430	17	,	,	PUNCT
ihlr-16498	430	18	would	would	AUX
ihlr-16498	430	19	it	it	PRON
ihlr-16498	430	20	not	not	PART
ihlr-16498	430	21	be	be	AUX
ihlr-16498	430	22	helpful	helpful	ADJ
ihlr-16498	430	23	for	for	ADP
ihlr-16498	430	24	that	that	DET
ihlr-16498	430	25	person	person	NOUN
ihlr-16498	430	26	to	to	PART
ihlr-16498	430	27	at	at	ADV
ihlr-16498	430	28	least	least	ADJ
ihlr-16498	430	29	know	know	VERB
ihlr-16498	430	30	that	that	SCONJ
ihlr-16498	430	31	the	the	DET
ihlr-16498	430	32	test	test	NOUN
ihlr-16498	430	33	has	have	AUX
ihlr-16498	430	34	been	be	AUX
ihlr-16498	430	35	conducted	conduct	VERB
ihlr-16498	430	36	?	?	PUNCT
ihlr-16498	431	1	what	what	PRON
ihlr-16498	431	2	if	if	SCONJ
ihlr-16498	431	3	the	the	DET
ihlr-16498	431	4	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	431	5	company	company	NOUN
ihlr-16498	431	6	learned	learn	VERB
ihlr-16498	431	7	in	in	ADP
ihlr-16498	431	8	its	its	PRON
ihlr-16498	431	9	study	study	NOUN
ihlr-16498	431	10	that	that	SCONJ
ihlr-16498	431	11	its	its	PRON
ihlr-16498	431	12	fda­	fda­	NOUN
ihlr-16498	431	13	approved	approve	VERB
ihlr-16498	431	14	drug	drug	NOUN
ihlr-16498	431	15	indeed	indeed	ADV
ihlr-16498	431	16	causes	cause	VERB
ihlr-16498	431	17	muscle	muscle	NOUN
ihlr-16498	431	18	aches	ache	VERB
ihlr-16498	431	19	?	?	PUNCT
ihlr-16498	432	1	is	be	AUX
ihlr-16498	432	2	the	the	DET
ihlr-16498	432	3	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	432	4	company	company	NOUN
ihlr-16498	432	5	now	now	ADV
ihlr-16498	432	6	required	require	VERB
ihlr-16498	432	7	to	to	PART
ihlr-16498	432	8	publish	publish	VERB
ihlr-16498	432	9	the	the	DET
ihlr-16498	432	10	results	result	NOUN
ihlr-16498	432	11	of	of	ADP
ihlr-16498	432	12	the	the	DET
ihlr-16498	432	13	negative	negative	ADJ
ihlr-16498	432	14	study	study	NOUN
ihlr-16498	432	15	?	?	PUNCT
ihlr-16498	433	1	to	to	ADP
ihlr-16498	433	2	date	date	NOUN
ihlr-16498	433	3	,	,	PUNCT
ihlr-16498	433	4	the	the	DET
ihlr-16498	433	5	pharma­	pharma­	X
ihlr-16498	433	6	ceutical	ceutical	ADJ
ihlr-16498	433	7	company	company	NOUN
ihlr-16498	433	8	must	must	AUX
ihlr-16498	433	9	make	make	VERB
ihlr-16498	433	10	the	the	DET
ihlr-16498	433	11	results	result	NOUN
ihlr-16498	433	12	of	of	ADP
ihlr-16498	433	13	its	its	PRON
ihlr-16498	433	14	study	study	NOUN
ihlr-16498	433	15	known	know	VERB
ihlr-16498	433	16	to	to	ADP
ihlr-16498	433	17	the	the	DET
ihlr-16498	433	18	fda	fda	PROPN
ihlr-16498	433	19	,	,	PUNCT
ihlr-16498	433	20	but	but	CCONJ
ihlr-16498	433	21	nei­	nei­	ADV
ihlr-16498	433	22	ther	ther	VERB
ihlr-16498	433	23	the	the	DET
ihlr-16498	433	24	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	433	25	company	company	NOUN
ihlr-16498	433	26	nor	nor	CCONJ
ihlr-16498	433	27	the	the	DET
ihlr-16498	433	28	fda	fda	PROPN
ihlr-16498	433	29	seems	seem	VERB
ihlr-16498	433	30	to	to	PART
ihlr-16498	433	31	disseminate	disseminate	VERB
ihlr-16498	433	32	the	the	DET
ihlr-16498	433	33	results.103	results.103	NOUN
ihlr-16498	433	34	in	in	ADP
ihlr-16498	433	35	addition	addition	NOUN
ihlr-16498	433	36	to	to	ADP
ihlr-16498	433	37	labeling	labeling	NOUN
ihlr-16498	433	38	requirements	requirement	NOUN
ihlr-16498	433	39	,	,	PUNCT
ihlr-16498	433	40	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	433	41	companies	company	NOUN
ihlr-16498	433	42	should	should	AUX
ihlr-16498	433	43	be	be	AUX
ihlr-16498	433	44	required	require	VERB
ihlr-16498	433	45	to	to	PART
ihlr-16498	433	46	publish	publish	VERB
ihlr-16498	433	47	the	the	DET
ihlr-16498	433	48	results	result	NOUN
ihlr-16498	433	49	of	of	ADP
ihlr-16498	433	50	clinical	clinical	ADJ
ihlr-16498	433	51	studies	study	NOUN
ihlr-16498	433	52	that	that	PRON
ihlr-16498	433	53	have	have	VERB
ihlr-16498	433	54	negative	negative	ADJ
ihlr-16498	433	55	clinical	clinical	ADJ
ihlr-16498	433	56	results	result	NOUN
ihlr-16498	433	57	on	on	ADP
ihlr-16498	433	58	a	a	DET
ihlr-16498	433	59	particular	particular	ADJ
ihlr-16498	433	60	patient	patient	ADJ
ihlr-16498	433	61	population	population	NOUN
ihlr-16498	433	62	in	in	ADP
ihlr-16498	433	63	a	a	DET
ihlr-16498	433	64	public	public	ADJ
ihlr-16498	433	65	database	database	NOUN
ihlr-16498	433	66	.	.	PUNCT
ihlr-16498	434	1	in	in	ADP
ihlr-16498	434	2	addition	addition	NOUN
ihlr-16498	434	3	to	to	ADP
ihlr-16498	434	4	the	the	DET
ihlr-16498	434	5	failure	failure	NOUN
ihlr-16498	434	6	to	to	PART
ihlr-16498	434	7	report	report	VERB
ihlr-16498	434	8	negative	negative	ADJ
ihlr-16498	434	9	or	or	CCONJ
ihlr-16498	434	10	inconclusive	inconclusive	ADJ
ihlr-16498	434	11	clinical	clinical	ADJ
ihlr-16498	434	12	trials	trial	NOUN
ihlr-16498	434	13	,	,	PUNCT
ihlr-16498	434	14	a	a	DET
ihlr-16498	434	15	recent	recent	ADJ
ihlr-16498	434	16	study	study	NOUN
ihlr-16498	434	17	suggests	suggest	VERB
ihlr-16498	434	18	that	that	SCONJ
ihlr-16498	434	19	a	a	DET
ihlr-16498	434	20	publication	publication	NOUN
ihlr-16498	434	21	bias	bias	NOUN
ihlr-16498	434	22	exists	exist	VERB
ihlr-16498	434	23	for	for	ADP
ihlr-16498	434	24	studies	study	NOUN
ihlr-16498	434	25	funded	fund	VERB
ihlr-16498	434	26	by	by	ADP
ihlr-16498	434	27	phar­	phar­	PROPN
ihlr-16498	434	28	maceutical	maceutical	ADJ
ihlr-16498	434	29	companies.104	companies.104	PROPN
ihlr-16498	435	1	it	it	PRON
ihlr-16498	435	2	appears	appear	VERB
ihlr-16498	435	3	that	that	SCONJ
ihlr-16498	435	4	journals	journal	NOUN
ihlr-16498	435	5	are	be	AUX
ihlr-16498	435	6	more	more	ADV
ihlr-16498	435	7	likely	likely	ADJ
ihlr-16498	435	8	to	to	ADP
ihlr-16498	435	9	a	a	DET
ihlr-16498	435	10	publish	publish	ADJ
ihlr-16498	435	11	research	research	NOUN
ihlr-16498	435	12	supported	support	VERB
ihlr-16498	435	13	by	by	ADP
ihlr-16498	435	14	drug	drug	NOUN
ihlr-16498	435	15	companies	company	NOUN
ihlr-16498	435	16	compared	compare	VERB
ihlr-16498	435	17	with	with	ADP
ihlr-16498	435	18	clinical	clinical	ADJ
ihlr-16498	435	19	trials	trial	NOUN
ihlr-16498	435	20	unsup­	unsup­	ADV
ihlr-16498	435	21	ported	port	VERB
ihlr-16498	435	22	by	by	ADP
ihlr-16498	435	23	drug	drug	NOUN
ihlr-16498	435	24	companies.105	companies.105	NOUN
ihlr-16498	435	25	if	if	SCONJ
ihlr-16498	435	26	this	this	PRON
ihlr-16498	435	27	is	be	AUX
ihlr-16498	435	28	true	true	ADJ
ihlr-16498	435	29	,	,	PUNCT
ihlr-16498	435	30	then	then	ADV
ihlr-16498	435	31	a	a	DET
ihlr-16498	435	32	public	public	ADJ
ihlr-16498	435	33	database	database	NOUN
ihlr-16498	435	34	of	of	ADP
ihlr-16498	435	35	all	all	DET
ihlr-16498	435	36	clini­	clini­	NOUN
ihlr-16498	435	37	cal	cal	ADJ
ihlr-16498	435	38	trials	trial	NOUN
ihlr-16498	435	39	and	and	CCONJ
ihlr-16498	435	40	their	their	PRON
ihlr-16498	435	41	results	result	NOUN
ihlr-16498	435	42	should	should	AUX
ihlr-16498	435	43	be	be	AUX
ihlr-16498	435	44	available	available	ADJ
ihlr-16498	435	45	to	to	ADP
ihlr-16498	435	46	the	the	DET
ihlr-16498	435	47	public	public	NOUN
ihlr-16498	435	48	.	.	PUNCT
ihlr-16498	436	1	this	this	PRON
ihlr-16498	436	2	will	will	AUX
ihlr-16498	436	3	allow	allow	VERB
ihlr-16498	436	4	physicians	physician	NOUN
ihlr-16498	436	5	to	to	PART
ihlr-16498	436	6	receive	receive	VERB
ihlr-16498	436	7	unfiltered	unfiltered	ADJ
ihlr-16498	436	8	information	information	NOUN
ihlr-16498	436	9	and	and	CCONJ
ihlr-16498	436	10	then	then	ADV
ihlr-16498	436	11	narrow	narrow	VERB
ihlr-16498	436	12	their	their	PRON
ihlr-16498	436	13	drug	drug	NOUN
ihlr-16498	436	14	choice	choice	NOUN
ihlr-16498	436	15	when	when	SCONJ
ihlr-16498	436	16	prescribing	prescribing	NOUN
ihlr-16498	436	17	medications	medication	NOUN
ihlr-16498	436	18	to	to	ADP
ihlr-16498	436	19	patients	patient	NOUN
ihlr-16498	436	20	.	.	PUNCT
ihlr-16498	437	1	the	the	DET
ihlr-16498	437	2	lexapro	lexapro	NOUN
ihlr-16498	437	3	and	and	CCONJ
ihlr-16498	437	4	celexa	celexa	PROPN
ihlr-16498	437	5	clinical	clinical	ADJ
ihlr-16498	437	6	studies	study	NOUN
ihlr-16498	437	7	illustrate	illustrate	VERB
ihlr-16498	437	8	the	the	DET
ihlr-16498	437	9	importance	importance	NOUN
ihlr-16498	437	10	of	of	ADP
ihlr-16498	437	11	this	this	DET
ihlr-16498	437	12	type	type	NOUN
ihlr-16498	437	13	of	of	ADP
ihlr-16498	437	14	information	information	NOUN
ihlr-16498	437	15	dissemination	dissemination	NOUN
ihlr-16498	437	16	.	.	PUNCT
ihlr-16498	438	1	a	a	DET
ihlr-16498	438	2	mandatory	mandatory	ADJ
ihlr-16498	438	3	database	database	NOUN
ihlr-16498	438	4	that	that	PRON
ihlr-16498	438	5	publishes	publish	VERB
ihlr-16498	438	6	all	all	DET
ihlr-16498	438	7	clinical	clinical	ADJ
ihlr-16498	438	8	trials	trial	NOUN
ihlr-16498	438	9	and	and	CCONJ
ihlr-16498	438	10	their	their	PRON
ihlr-16498	438	11	results	result	NOUN
ihlr-16498	438	12	would	would	AUX
ihlr-16498	438	13	provide	provide	VERB
ihlr-16498	438	14	a	a	DET
ihlr-16498	438	15	full	full	ADJ
ihlr-16498	438	16	picture	picture	NOUN
ihlr-16498	438	17	to	to	ADP
ihlr-16498	438	18	the	the	DET
ihlr-16498	438	19	medical	medical	ADJ
ihlr-16498	438	20	com102	com102	PROPN
ihlr-16498	438	21	meier	meier	PROPN
ihlr-16498	438	22	,	,	PUNCT
ihlr-16498	438	23	negative	negative	ADJ
ihlr-16498	438	24	test	test	NOUN
ihlr-16498	438	25	results	result	NOUN
ihlr-16498	438	26	,	,	PUNCT
ihlr-16498	438	27	supra	supra	PROPN
ihlr-16498	438	28	note	note	NOUN
ihlr-16498	438	29	75	75	NUM
ihlr-16498	438	30	(	(	PUNCT
ihlr-16498	438	31	"	"	PUNCT
ihlr-16498	438	32	and	and	CCONJ
ihlr-16498	438	33	several	several	ADJ
ihlr-16498	438	34	medical	medical	ADJ
ihlr-16498	438	35	journals	journal	NOUN
ihlr-16498	438	36	are	be	AUX
ihlr-16498	438	37	con­	con­	NOUN
ihlr-16498	438	38	sidering	sidere	VERB
ihlr-16498	438	39	a	a	DET
ihlr-16498	438	40	proposal	proposal	NOUN
ihlr-16498	438	41	that	that	PRON
ihlr-16498	438	42	would	would	AUX
ihlr-16498	438	43	require	require	VERB
ihlr-16498	438	44	trials	trial	NOUN
ihlr-16498	438	45	to	to	PART
ihlr-16498	438	46	be	be	AUX
ihlr-16498	438	47	registered	register	VERB
ihlr-16498	438	48	at	at	ADP
ihlr-16498	438	49	the	the	DET
ihlr-16498	438	50	outset	outset	NOUN
ihlr-16498	438	51	as	as	ADP
ihlr-16498	438	52	a	a	DET
ihlr-16498	438	53	prerequisite	prerequisite	NOUN
ihlr-16498	438	54	to	to	ADP
ihlr-16498	438	55	the	the	DET
ihlr-16498	438	56	results	result	NOUN
ihlr-16498	438	57	'	'	PART
ihlr-16498	438	58	eventual	eventual	ADJ
ihlr-16498	438	59	publication	publication	NOUN
ihlr-16498	438	60	.	.	PUNCT
ihlr-16498	438	61	"	"	PUNCT
ihlr-16498	438	62	)	)	PUNCT
ihlr-16498	438	63	.	.	PUNCT
ihlr-16498	439	1	103	103	NUM
ihlr-16498	439	2	hearing	hearing	NOUN
ihlr-16498	439	3	on	on	ADP
ihlr-16498	439	4	antidepressant	antidepressant	ADJ
ihlr-16498	439	5	pediatric	pediatric	ADJ
ihlr-16498	439	6	trials	trial	NOUN
ihlr-16498	439	7	,	,	PUNCT
ihlr-16498	439	8	supra	supra	PROPN
ihlr-16498	439	9	note	note	VERB
ihlr-16498	439	10	87	87	NUM
ihlr-16498	439	11	,	,	PUNCT
ihlr-16498	439	12	at	at	ADP
ihlr-16498	439	13	8	8	NUM
ihlr-16498	439	14	(	(	PUNCT
ihlr-16498	439	15	statement	statement	NOUN
ihlr-16498	439	16	of	of	ADP
ihlr-16498	439	17	u.s	u.s	PROPN
ihlr-16498	439	18	.	.	PROPN
ihlr-16498	439	19	rep	rep	PROPN
ihlr-16498	439	20	.	.	PROPN
ihlr-16498	439	21	henry	henry	PROPN
ihlr-16498	439	22	waxman	waxman	PROPN
ihlr-16498	439	23	of	of	ADP
ihlr-16498	439	24	california	california	PROPN
ihlr-16498	439	25	)	)	PUNCT
ihlr-16498	439	26	(	(	PUNCT
ihlr-16498	439	27	"	"	PUNCT
ihlr-16498	439	28	they	they	PRON
ihlr-16498	439	29	are	be	AUX
ihlr-16498	439	30	making	make	VERB
ihlr-16498	439	31	it	it	PRON
ihlr-16498	439	32	known	know	VERB
ihlr-16498	439	33	to	to	ADP
ihlr-16498	439	34	the	the	DET
ihlr-16498	439	35	fda	fda	PROPN
ihlr-16498	439	36	because	because	SCONJ
ihlr-16498	439	37	they	they	PRON
ihlr-16498	439	38	have	have	VERB
ihlr-16498	439	39	to	to	PART
ihlr-16498	439	40	,	,	PUNCT
ihlr-16498	439	41	and	and	CCONJ
ihlr-16498	439	42	we	we	PRON
ihlr-16498	439	43	want	want	VERB
ihlr-16498	439	44	to	to	PART
ihlr-16498	439	45	ask	ask	VERB
ihlr-16498	439	46	why	why	SCONJ
ihlr-16498	439	47	[	[	X
ihlr-16498	439	48	the	the	X
ihlr-16498	439	49	]	]	X
ihlr-16498	439	50	fda	fda	PROPN
ihlr-16498	439	51	has	have	AUX
ihlr-16498	439	52	not	not	PART
ihlr-16498	439	53	done	do	VERB
ihlr-16498	439	54	more	more	ADJ
ihlr-16498	439	55	to	to	PART
ihlr-16498	439	56	get	get	VERB
ihlr-16498	439	57	this	this	DET
ihlr-16498	439	58	information	information	NOUN
ihlr-16498	439	59	out	out	ADP
ihlr-16498	439	60	,	,	PUNCT
ihlr-16498	439	61	but	but	CCONJ
ihlr-16498	439	62	there	there	PRON
ihlr-16498	439	63	is	be	VERB
ihlr-16498	439	64	a	a	DET
ihlr-16498	439	65	clear	clear	ADJ
ihlr-16498	439	66	responsibility	responsibility	NOUN
ihlr-16498	439	67	for	for	ADP
ihlr-16498	439	68	the	the	DET
ihlr-16498	439	69	companies	company	NOUN
ihlr-16498	439	70	•	•	VERB
ihlr-16498	439	71	...	...	PUNCT
ihlr-16498	439	72	"	"	PUNCT
ihlr-16498	439	73	)	)	PUNCT
ihlr-16498	439	74	.	.	PUNCT
ihlr-16498	440	1	104	104	NUM
ihlr-16498	440	2	john	john	PROPN
ihlr-16498	440	3	y	y	PROPN
ihlr-16498	440	4	apbe	apbe	PROPN
ihlr-16498	440	5	,	,	PUNCT
ihlr-16498	440	6	richard	richard	PROPN
ihlr-16498	440	7	edman	edman	PROPN
ihlr-16498	440	8	,	,	PUNCT
ihlr-16498	440	9	barry	barry	PROPN
ihlr-16498	440	10	knisbkowy	knisbkowy	PROPN
ihlr-16498	440	11	&	&	CCONJ
ihlr-16498	440	12	joseph	joseph	PROPN
ihlr-16498	440	13	herman	herman	PROPN
ihlr-16498	440	14	,	,	PUNCT
ihlr-16498	440	15	the	the	DET
ihlr-16498	440	16	association	association	NOUN
ihlr-16498	440	17	between	between	ADP
ihlr-16498	440	18	funding	funding	NOUN
ihlr-16498	440	19	by	by	ADP
ihlr-16498	440	20	commercial	commercial	ADJ
ihlr-16498	440	21	interests	interest	NOUN
ihlr-16498	440	22	and	and	CCONJ
ihlr-16498	440	23	study	study	NOUN
ihlr-16498	440	24	outcome	outcome	NOUN
ihlr-16498	440	25	in	in	ADP
ihlr-16498	440	26	randomized	randomized	ADJ
ihlr-16498	440	27	controlled	control	VERB
ihlr-16498	440	28	drug	drug	NOUN
ihlr-16498	440	29	trials	trial	NOUN
ihlr-16498	440	30	,	,	PUNCT
ihlr-16498	440	31	18	18	NUM
ihlr-16498	440	32	fam	fam	NOUN
ihlr-16498	440	33	.	.	PUNCT
ihlr-16498	441	1	prac	prac	NOUN
ihlr-16498	441	2	.	.	PROPN
ihlr-16498	442	1	565	565	NUM
ihlr-16498	442	2	,	,	PUNCT
ihlr-16498	442	3	567	567	NUM
ihlr-16498	442	4	(	(	PUNCT
ihlr-16498	442	5	2001	2001	NUM
ihlr-16498	442	6	)	)	PUNCT
ihlr-16498	442	7	(	(	PUNCT
ihlr-16498	442	8	discussing	discuss	VERB
ihlr-16498	442	9	the	the	DET
ihlr-16498	442	10	results	result	NOUN
ihlr-16498	442	11	of	of	ADP
ihlr-16498	442	12	their	their	PRON
ihlr-16498	442	13	publication	publication	NOUN
ihlr-16498	442	14	bias	bias	NOUN
ihlr-16498	442	15	study	study	NOUN
ihlr-16498	442	16	)	)	PUNCT
ihlr-16498	442	17	.	.	PUNCT
ihlr-16498	443	1	los	los	PROPN
ihlr-16498	443	2	/d	/d	PROPN
ihlr-16498	443	3	.	.	PROPN
ihlr-16498	444	1	78	78	NUM
ihlr-16498	444	2	indiana	indiana	PROPN
ihlr-16498	444	3	health	health	PROPN
ihlr-16498	444	4	law	law	PROPN
ihlr-16498	444	5	review	review	NOUN
ihlr-16498	444	6	[	[	X
ihlr-16498	444	7	vol	vol	NOUN
ihlr-16498	444	8	.	.	PUNCT
ihlr-16498	445	1	4:59	4:59	NUM
ihlr-16498	445	2	munity	munity	NOUN
ihlr-16498	445	3	.	.	PUNCT
ihlr-16498	446	1	106	106	NUM
ihlr-16498	447	1	it	it	PRON
ihlr-16498	447	2	would	would	AUX
ihlr-16498	447	3	most	most	ADV
ihlr-16498	447	4	likely	likely	ADV
ihlr-16498	447	5	be	be	AUX
ihlr-16498	447	6	cumbersome	cumbersome	ADJ
ihlr-16498	447	7	and	and	CCONJ
ihlr-16498	447	8	difficult	difficult	ADJ
ihlr-16498	447	9	to	to	PART
ihlr-16498	447	10	parse	parse	VERB
ihlr-16498	447	11	through	through	ADP
ihlr-16498	447	12	the	the	DET
ihlr-16498	447	13	information	information	NOUN
ihlr-16498	447	14	if	if	SCONJ
ihlr-16498	447	15	each	each	DET
ihlr-16498	447	16	phase	phase	NOUN
ihlr-16498	447	17	of	of	ADP
ihlr-16498	447	18	the	the	DET
ihlr-16498	447	19	pediatric	pediatric	ADJ
ihlr-16498	447	20	trials	trial	NOUN
ihlr-16498	447	21	were	be	AUX
ihlr-16498	447	22	recorded	record	VERB
ihlr-16498	447	23	in	in	ADP
ihlr-16498	447	24	the	the	DET
ihlr-16498	447	25	data­	data­	NOUN
ihlr-16498	447	26	base	base	NOUN
ihlr-16498	447	27	.	.	PUNCT
ihlr-16498	448	1	therefore	therefore	ADV
ihlr-16498	448	2	,	,	PUNCT
ihlr-16498	448	3	each	each	DET
ihlr-16498	448	4	phase	phase	NOUN
ihlr-16498	448	5	iii	iii	NOUN
ihlr-16498	448	6	trial	trial	NOUN
ihlr-16498	448	7	should	should	AUX
ihlr-16498	448	8	be	be	AUX
ihlr-16498	448	9	registered	register	VERB
ihlr-16498	448	10	in	in	ADP
ihlr-16498	448	11	the	the	DET
ihlr-16498	448	12	database	database	NOUN
ihlr-16498	448	13	and	and	CCONJ
ihlr-16498	448	14	include	include	VERB
ihlr-16498	448	15	background	background	NOUN
ihlr-16498	448	16	information	information	NOUN
ihlr-16498	448	17	regarding	regard	VERB
ihlr-16498	448	18	the	the	DET
ihlr-16498	448	19	earlier	early	ADJ
ihlr-16498	448	20	phases	phase	NOUN
ihlr-16498	448	21	.	.	PUNCT
ihlr-16498	449	1	if	if	SCONJ
ihlr-16498	449	2	,	,	PUNCT
ihlr-16498	449	3	however	however	ADV
ihlr-16498	449	4	,	,	PUNCT
ihlr-16498	449	5	the	the	DET
ihlr-16498	449	6	drug	drug	NOUN
ihlr-16498	449	7	never	never	ADV
ihlr-16498	449	8	makes	make	VERB
ihlr-16498	449	9	it	it	PRON
ihlr-16498	449	10	past	past	ADP
ihlr-16498	449	11	a	a	DET
ihlr-16498	449	12	phase	phase	NOUN
ihlr-16498	449	13	i	i	PRON
ihlr-16498	449	14	trial	trial	NOUN
ihlr-16498	449	15	for	for	ADP
ihlr-16498	449	16	either	either	DET
ihlr-16498	449	17	safety	safety	NOUN
ihlr-16498	449	18	or	or	CCONJ
ihlr-16498	449	19	efficacy	efficacy	NOUN
ihlr-16498	449	20	reasons	reason	NOUN
ihlr-16498	449	21	,	,	PUNCT
ihlr-16498	449	22	then	then	ADV
ihlr-16498	449	23	this	this	DET
ihlr-16498	449	24	information	information	NOUN
ihlr-16498	449	25	should	should	AUX
ihlr-16498	449	26	be	be	AUX
ihlr-16498	449	27	uploaded	upload	VERB
ihlr-16498	449	28	to	to	ADP
ihlr-16498	449	29	the	the	DET
ihlr-16498	449	30	database	database	NOUN
ihlr-16498	449	31	and	and	CCONJ
ihlr-16498	449	32	also	also	ADV
ihlr-16498	449	33	indicated	indicate	VERB
ihlr-16498	449	34	on	on	ADP
ihlr-16498	449	35	the	the	DET
ihlr-16498	449	36	label	label	NOUN
ihlr-16498	449	37	.	.	PUNCT
ihlr-16498	450	1	in	in	ADP
ihlr-16498	450	2	this	this	DET
ihlr-16498	450	3	way	way	NOUN
ihlr-16498	450	4	,	,	PUNCT
ihlr-16498	450	5	public	public	ADJ
ihlr-16498	450	6	disclosure	disclosure	NOUN
ihlr-16498	450	7	of	of	ADP
ihlr-16498	450	8	all	all	DET
ihlr-16498	450	9	registered	register	VERB
ihlr-16498	450	10	clinical	clinical	ADJ
ihlr-16498	450	11	trials	trial	NOUN
ihlr-16498	450	12	will	will	AUX
ihlr-16498	450	13	include	include	VERB
ihlr-16498	450	14	positive	positive	ADJ
ihlr-16498	450	15	,	,	PUNCT
ihlr-16498	450	16	inconclusive	inconclusive	ADJ
ihlr-16498	450	17	,	,	PUNCT
ihlr-16498	450	18	and	and	CCONJ
ihlr-16498	450	19	negative	negative	ADJ
ihlr-16498	450	20	results	result	NOUN
ihlr-16498	450	21	.	.	PUNCT
ihlr-16498	451	1	for	for	ADP
ihlr-16498	451	2	example	example	NOUN
ihlr-16498	451	3	,	,	PUNCT
ihlr-16498	451	4	this	this	DET
ihlr-16498	451	5	type	type	NOUN
ihlr-16498	451	6	of	of	ADP
ihlr-16498	451	7	informa­	informa­	PROPN
ihlr-16498	451	8	tion	tion	NOUN
ihlr-16498	451	9	dissemination	dissemination	NOUN
ihlr-16498	451	10	of	of	ADP
ihlr-16498	451	11	antidepressant	antidepressant	ADJ
ihlr-16498	451	12	medication	medication	NOUN
ihlr-16498	451	13	trials	trial	NOUN
ihlr-16498	451	14	could	could	AUX
ihlr-16498	451	15	have	have	AUX
ihlr-16498	451	16	impacted	impact	VERB
ihlr-16498	451	17	the	the	DET
ihlr-16498	451	18	medications	medication	NOUN
ihlr-16498	451	19	physicians	physician	NOUN
ihlr-16498	451	20	prescribed	prescribe	VERB
ihlr-16498	451	21	to	to	ADP
ihlr-16498	451	22	their	their	PRON
ihlr-16498	451	23	patients	patient	NOUN
ihlr-16498	451	24	.	.	PUNCT
ihlr-16498	452	1	indeed	indeed	ADV
ihlr-16498	452	2	,	,	PUNCT
ihlr-16498	452	3	pediatric	pediatric	ADJ
ihlr-16498	452	4	trials	trial	NOUN
ihlr-16498	452	5	of	of	ADP
ihlr-16498	452	6	many	many	ADJ
ihlr-16498	452	7	of	of	ADP
ihlr-16498	452	8	the	the	DET
ihlr-16498	452	9	drugs	drug	NOUN
ihlr-16498	452	10	believed	believe	VERB
ihlr-16498	452	11	to	to	PART
ihlr-16498	452	12	cause	cause	VERB
ihlr-16498	452	13	suicidal	suicidal	ADJ
ihlr-16498	452	14	thoughts	thought	NOUN
ihlr-16498	452	15	were	be	AUX
ihlr-16498	452	16	conducted	conduct	VERB
ihlr-16498	452	17	,	,	PUNCT
ihlr-16498	452	18	but	but	CCONJ
ihlr-16498	452	19	the	the	DET
ihlr-16498	452	20	results	result	NOUN
ihlr-16498	452	21	of	of	ADP
ihlr-16498	452	22	these	these	DET
ihlr-16498	452	23	studies	study	NOUN
ihlr-16498	452	24	were	be	AUX
ihlr-16498	452	25	not	not	PART
ihlr-16498	452	26	widely	widely	ADV
ihlr-16498	452	27	available	available	ADJ
ihlr-16498	452	28	.	.	PUNCT
ihlr-16498	453	1	if	if	SCONJ
ihlr-16498	453	2	the	the	DET
ihlr-16498	453	3	antidepressants	antidepressant	NOUN
ihlr-16498	453	4	either	either	CCONJ
ihlr-16498	453	5	did	do	AUX
ihlr-16498	453	6	not	not	PART
ihlr-16498	453	7	help	help	VERB
ihlr-16498	453	8	pediatric	pediatric	ADJ
ihlr-16498	453	9	patients	patient	NOUN
ihlr-16498	453	10	or	or	CCONJ
ihlr-16498	453	11	worse	bad	ADJ
ihlr-16498	453	12	yet	yet	ADV
ihlr-16498	453	13	caused	cause	VERB
ihlr-16498	453	14	negative	negative	ADJ
ihlr-16498	453	15	side	side	NOUN
ihlr-16498	453	16	effects	effect	NOUN
ihlr-16498	453	17	,	,	PUNCT
ihlr-16498	453	18	this	this	DET
ihlr-16498	453	19	information	information	NOUN
ihlr-16498	453	20	should	should	AUX
ihlr-16498	453	21	be	be	AUX
ihlr-16498	453	22	made	make	VERB
ihlr-16498	453	23	public	public	ADJ
ihlr-16498	453	24	.	.	PUNCT
ihlr-16498	454	1	under	under	ADP
ihlr-16498	454	2	the	the	DET
ihlr-16498	454	3	current	current	ADJ
ihlr-16498	454	4	regulatory	regulatory	ADJ
ihlr-16498	454	5	scheme	scheme	NOUN
ihlr-16498	454	6	,	,	PUNCT
ihlr-16498	454	7	these	these	DET
ihlr-16498	454	8	studies	study	NOUN
ihlr-16498	454	9	are	be	AUX
ihlr-16498	454	10	not	not	PART
ihlr-16498	454	11	required	require	VERB
ihlr-16498	454	12	to	to	PART
ihlr-16498	454	13	be	be	AUX
ihlr-16498	454	14	published	publish	VERB
ihlr-16498	454	15	.	.	PUNCT
ihlr-16498	455	1	a	a	DET
ihlr-16498	455	2	federal	federal	ADJ
ihlr-16498	455	3	registry	registry	NOUN
ihlr-16498	455	4	of	of	ADP
ihlr-16498	455	5	these	these	DET
ihlr-16498	455	6	test	test	NOUN
ihlr-16498	455	7	results	result	NOUN
ihlr-16498	455	8	,	,	PUNCT
ihlr-16498	455	9	compiled	compile	VERB
ihlr-16498	455	10	by	by	ADP
ihlr-16498	455	11	the	the	DET
ihlr-16498	455	12	fda	fda	PROPN
ihlr-16498	455	13	,	,	PUNCT
ihlr-16498	455	14	could	could	AUX
ihlr-16498	455	15	alleviate	alleviate	VERB
ihlr-16498	455	16	this	this	DET
ihlr-16498	455	17	problem	problem	NOUN
ihlr-16498	455	18	.	.	PUNCT
ihlr-16498	456	1	opponents	opponent	NOUN
ihlr-16498	456	2	to	to	ADP
ihlr-16498	456	3	the	the	DET
ihlr-16498	456	4	required	require	VERB
ihlr-16498	456	5	public	public	ADJ
ihlr-16498	456	6	disclosure	disclosure	NOUN
ihlr-16498	456	7	ofthe	ofthe	NOUN
ihlr-16498	456	8	results	result	NOUN
ihlr-16498	456	9	of	of	ADP
ihlr-16498	456	10	all	all	DET
ihlr-16498	456	11	clinical	clinical	ADJ
ihlr-16498	456	12	trials	trial	NOUN
ihlr-16498	456	13	might	might	AUX
ihlr-16498	456	14	argue	argue	VERB
ihlr-16498	456	15	against	against	ADP
ihlr-16498	456	16	heightened	heightened	ADJ
ihlr-16498	456	17	regulatory	regulatory	ADJ
ihlr-16498	456	18	schemes	scheme	NOUN
ihlr-16498	456	19	.	.	PUNCT
ihlr-16498	457	1	they	they	PRON
ihlr-16498	457	2	might	might	AUX
ihlr-16498	457	3	argue	argue	VERB
ihlr-16498	457	4	that	that	SCONJ
ihlr-16498	457	5	increased	increase	VERB
ihlr-16498	457	6	regulatory	regulatory	ADJ
ihlr-16498	457	7	measures	measure	NOUN
ihlr-16498	457	8	in	in	ADP
ihlr-16498	457	9	one	one	NUM
ihlr-16498	457	10	area	area	NOUN
ihlr-16498	457	11	might	might	AUX
ihlr-16498	457	12	lead	lead	VERB
ihlr-16498	457	13	to	to	ADP
ihlr-16498	457	14	increased	increase	VERB
ihlr-16498	457	15	regula­	regula­	PROPN
ihlr-16498	457	16	tory	tory	NOUN
ihlr-16498	457	17	measures	measure	NOUN
ihlr-16498	457	18	in	in	ADP
ihlr-16498	457	19	other	other	ADJ
ihlr-16498	457	20	areas	area	NOUN
ihlr-16498	457	21	.	.	PUNCT
ihlr-16498	458	1	for	for	ADP
ihlr-16498	458	2	example	example	NOUN
ihlr-16498	458	3	,	,	PUNCT
ihlr-16498	458	4	the	the	DET
ihlr-16498	458	5	fda	fda	PROPN
ihlr-16498	458	6	might	might	AUX
ihlr-16498	458	7	begin	begin	VERB
ihlr-16498	458	8	to	to	PART
ihlr-16498	458	9	regulate	regulate	VERB
ihlr-16498	458	10	a	a	DET
ihlr-16498	458	11	physician	physician	NOUN
ihlr-16498	458	12	•	•	NOUN
ihlr-16498	458	13	s	s	NOUN
ihlr-16498	458	14	ability	ability	NOUN
ihlr-16498	458	15	to	to	PART
ihlr-16498	458	16	prescribe	prescribe	VERB
ihlr-16498	458	17	drugs	drug	NOUN
ihlr-16498	458	18	"	"	PUNCT
ihlr-16498	458	19	off	off	ADP
ihlr-16498	458	20	-	-	PUNCT
ihlr-16498	458	21	label	label	NOUN
ihlr-16498	458	22	.	.	PUNCT
ihlr-16498	459	1	••	••	NOUN
ihlr-16498	459	2	this	this	PRON
ihlr-16498	459	3	is	be	AUX
ihlr-16498	459	4	unlikely	unlikely	ADJ
ihlr-16498	459	5	,	,	PUNCT
ihlr-16498	459	6	however	however	ADV
ihlr-16498	459	7	,	,	PUNCT
ihlr-16498	459	8	because	because	SCONJ
ihlr-16498	459	9	off	off	ADP
ihlr-16498	459	10	-	-	PUNCT
ihlr-16498	459	11	label	label	NOUN
ihlr-16498	459	12	use	use	NOUN
ihlr-16498	459	13	of	of	ADP
ihlr-16498	459	14	drugs	drug	NOUN
ihlr-16498	459	15	is	be	AUX
ihlr-16498	459	16	an	an	DET
ihlr-16498	459	17	accepted	accepted	ADJ
ihlr-16498	459	18	practice	practice	NOUN
ihlr-16498	459	19	and	and	CCONJ
ihlr-16498	459	20	even	even	ADV
ihlr-16498	459	21	defined	define	VERB
ihlr-16498	459	22	in	in	ADP
ihlr-16498	459	23	the	the	DET
ihlr-16498	459	24	regulations	regulation	NOUN
ihlr-16498	459	25	.	.	PUNCT
ihlr-16498	460	1	107	107	NUM
ihlr-16498	460	2	opponents	opponent	NOUN
ihlr-16498	460	3	may	may	AUX
ihlr-16498	460	4	also	also	ADV
ihlr-16498	460	5	argue	argue	VERB
ihlr-16498	460	6	that	that	SCONJ
ihlr-16498	460	7	the	the	DET
ihlr-16498	460	8	drug	drug	NOUN
ihlr-16498	460	9	industry	industry	NOUN
ihlr-16498	460	10	will	will	AUX
ihlr-16498	460	11	set	set	VERB
ihlr-16498	460	12	up	up	ADP
ihlr-16498	460	13	a	a	DET
ihlr-16498	460	14	public	public	ADJ
ihlr-16498	460	15	regis­	regis­	NOUN
ihlr-16498	460	16	try	try	VERB
ihlr-16498	460	17	voluntarily	voluntarily	ADV
ihlr-16498	460	18	,	,	PUNCT
ihlr-16498	460	19	thus	thus	ADV
ihlr-16498	460	20	obviating	obviate	VERB
ihlr-16498	460	21	the	the	DET
ihlr-16498	460	22	need	need	NOUN
ihlr-16498	460	23	for	for	ADP
ihlr-16498	460	24	legislation.108	legislation.108	NUM
ihlr-16498	460	25	in	in	ADP
ihlr-16498	460	26	light	light	NOUN
ihlr-16498	460	27	of	of	ADP
ihlr-16498	460	28	the	the	DET
ihlr-16498	460	29	unre­	unre­	PROPN
ihlr-16498	460	30	ported	port	VERB
ihlr-16498	460	31	forest	forest	NOUN
ihlr-16498	460	32	laboratories	laboratory	NOUN
ihlr-16498	460	33	studies	study	NOUN
ihlr-16498	460	34	described	describe	VERB
ihlr-16498	460	35	earlier	early	ADV
ihlr-16498	460	36	,	,	PUNCT
ihlr-16498	460	37	a	a	DET
ihlr-16498	460	38	clear	clear	ADJ
ihlr-16498	460	39	requirement	requirement	NOUN
ihlr-16498	460	40	to	to	PART
ihlr-16498	460	41	report	report	VERB
ihlr-16498	460	42	pediatric	pediatric	ADJ
ihlr-16498	460	43	trials	trial	NOUN
ihlr-16498	460	44	appears	appear	VERB
ihlr-16498	460	45	necessary	necessary	ADJ
ihlr-16498	460	46	to	to	PART
ihlr-16498	460	47	address	address	VERB
ihlr-16498	460	48	inconclusive	inconclusive	ADJ
ihlr-16498	460	49	and	and	CCONJ
ihlr-16498	460	50	negative	negative	ADJ
ihlr-16498	460	51	results	result	NOUN
ihlr-16498	460	52	.	.	PUNCT
ihlr-16498	461	1	regulations	regulation	NOUN
ihlr-16498	461	2	aimed	aim	VERB
ihlr-16498	461	3	at	at	ADP
ihlr-16498	461	4	full	full	ADJ
ihlr-16498	461	5	disclosure	disclosure	NOUN
ihlr-16498	461	6	of	of	ADP
ihlr-16498	461	7	clinical	clinical	ADJ
ihlr-16498	461	8	trials	trial	NOUN
ihlr-16498	461	9	are	be	AUX
ihlr-16498	461	10	needed	need	VERB
ihlr-16498	461	11	to	to	PART
ihlr-16498	461	12	fully	fully	ADV
ihlr-16498	461	13	inform	inform	VERB
ihlr-16498	461	14	the	the	DET
ihlr-16498	461	15	medical	medical	ADJ
ihlr-16498	461	16	community	community	NOUN
ihlr-16498	461	17	.	.	PUNCT
ihlr-16498	462	1	b.	b.	PROPN
ihlr-16498	462	2	changes	change	NOUN
ihlr-16498	462	3	should	should	AUX
ihlr-16498	462	4	be	be	AUX
ihlr-16498	462	5	made	make	VERB
ihlr-16498	462	6	to	to	ADP
ihlr-16498	462	7	the	the	DET
ihlr-16498	462	8	exclusivity	exclusivity	NOUN
ihlr-16498	462	9	provision	provision	NOUN
ihlr-16498	462	10	when	when	SCONJ
ihlr-16498	462	11	the	the	DET
ihlr-16498	462	12	bpca	bpca	PROPN
ihlr-16498	462	13	was	be	AUX
ihlr-16498	462	14	first	first	ADV
ihlr-16498	462	15	passed	pass	VERB
ihlr-16498	462	16	,	,	PUNCT
ihlr-16498	462	17	debate	debate	NOUN
ihlr-16498	462	18	surrounded	surround	VERB
ihlr-16498	462	19	the	the	DET
ihlr-16498	462	20	voluntary	voluntary	ADJ
ihlr-16498	462	21	incen106	incen106	PROPN
ihlr-16498	462	22	hearing	hear	VERB
ihlr-16498	462	23	on	on	ADP
ihlr-16498	462	24	antidepressant	antidepressant	ADJ
ihlr-16498	462	25	pediatric	pediatric	ADJ
ihlr-16498	462	26	trials	trial	NOUN
ihlr-16498	462	27	,	,	PUNCT
ihlr-16498	462	28	supra	supra	PROPN
ihlr-16498	462	29	note	note	VERB
ihlr-16498	462	30	87	87	NUM
ihlr-16498	462	31	,	,	PUNCT
ihlr-16498	462	32	at	at	ADP
ihlr-16498	462	33	35	35	NUM
ihlr-16498	462	34	(	(	PUNCT
ihlr-16498	462	35	statement	statement	NOUN
ihlr-16498	462	36	ofu.s	ofu.s	PROPN
ihlr-16498	462	37	.	.	PUNCT
ihlr-16498	462	38	rep	rep	PROPN
ihlr-16498	462	39	.	.	PROPN
ihlr-16498	462	40	henry	henry	PROPN
ihlr-16498	462	41	waxman	waxman	PROPN
ihlr-16498	462	42	of	of	ADP
ihlr-16498	462	43	california	california	PROPN
ihlr-16498	462	44	)	)	PUNCT
ihlr-16498	462	45	(	(	PUNCT
ihlr-16498	462	46	discussing	discuss	VERB
ihlr-16498	462	47	a	a	DET
ihlr-16498	462	48	new	new	ADJ
ihlr-16498	462	49	bill	bill	NOUN
ihlr-16498	462	50	that	that	PRON
ihlr-16498	462	51	would	would	AUX
ihlr-16498	462	52	establish	establish	VERB
ihlr-16498	462	53	a	a	DET
ihlr-16498	462	54	registry	registry	NOUN
ihlr-16498	462	55	of	of	ADP
ihlr-16498	462	56	in­	in­	NOUN
ihlr-16498	462	57	formation	formation	NOUN
ihlr-16498	462	58	about	about	ADP
ihlr-16498	462	59	all	all	DET
ihlr-16498	462	60	the	the	DET
ihlr-16498	462	61	studies	study	NOUN
ihlr-16498	462	62	performed	perform	VERB
ihlr-16498	462	63	that	that	PRON
ihlr-16498	462	64	would	would	AUX
ihlr-16498	462	65	include	include	VERB
ihlr-16498	462	66	positive	positive	ADJ
ihlr-16498	462	67	,	,	PUNCT
ihlr-16498	462	68	negative	negative	ADJ
ihlr-16498	462	69	,	,	PUNCT
ihlr-16498	462	70	and	and	CCONJ
ihlr-16498	462	71	inconclu­	inconclu­	PROPN
ihlr-16498	462	72	sive	sive	ADJ
ihlr-16498	462	73	studies	study	NOUN
ihlr-16498	462	74	)	)	PUNCT
ihlr-16498	462	75	.	.	PUNCT
ihlr-16498	463	1	107	107	NUM
ihlr-16498	463	2	legal	legal	ADJ
ihlr-16498	463	3	status	status	NOUN
ihlr-16498	463	4	of	of	ADP
ihlr-16498	463	5	approved	approve	VERB
ihlr-16498	463	6	labeling	labeling	NOUN
ihlr-16498	463	7	for	for	ADP
ihlr-16498	463	8	prescription	prescription	NOUN
ihlr-16498	463	9	drugs	drug	NOUN
ihlr-16498	463	10	;	;	PUNCT
ihlr-16498	463	11	prescribing	prescribe	VERB
ihlr-16498	463	12	for	for	ADP
ihlr-16498	463	13	uses	use	NOUN
ihlr-16498	463	14	un­	un­	PROPN
ihlr-16498	463	15	approved	approve	VERB
ihlr-16498	463	16	by	by	ADP
ihlr-16498	463	17	the	the	DET
ihlr-16498	463	18	food	food	NOUN
ihlr-16498	463	19	and	and	CCONJ
ihlr-16498	463	20	drug	drug	NOUN
ihlr-16498	463	21	administration	administration	NOUN
ihlr-16498	463	22	,	,	PUNCT
ihlr-16498	463	23	37	37	NUM
ihlr-16498	463	24	fed	fed	PROPN
ihlr-16498	463	25	.	.	PUNCT
ihlr-16498	464	1	reg	reg	PROPN
ihlr-16498	464	2	.	.	PROPN
ihlr-16498	464	3	16,503	16,503	NUM
ihlr-16498	464	4	,	,	PUNCT
ihlr-16498	464	5	16,503	16,503	NUM
ihlr-16498	464	6	-	-	SYM
ihlr-16498	464	7	04	04	NUM
ihlr-16498	464	8	(	(	PUNCT
ihlr-16498	464	9	aug	aug	PROPN
ihlr-16498	464	10	.	.	PROPN
ihlr-16498	464	11	15	15	NUM
ihlr-16498	464	12	,	,	PUNCT
ihlr-16498	464	13	1972)(to	1972)(to	NOUN
ihlr-16498	464	14	be	be	AUX
ihlr-16498	464	15	codifiedat21	codifiedat21	NOUN
ihlr-16498	464	16	c.f.r	c.f.r	NOUN
ihlr-16498	464	17	.	.	PUNCT
ihlr-16498	465	1	pt	pt	PROPN
ihlr-16498	465	2	.	.	PROPN
ihlr-16498	465	3	130);seebreslow	130);seebreslow	NUM
ihlr-16498	465	4	,	,	PUNCT
ihlr-16498	465	5	supranote22,at	supranote22,at	NOUN
ihlr-16498	465	6	145	145	NUM
ihlr-16498	465	7	(	(	PUNCT
ihlr-16498	465	8	discussing	discuss	VERB
ihlr-16498	465	9	off­	off­	NOUN
ihlr-16498	465	10	label	label	NOUN
ihlr-16498	465	11	practice	practice	NOUN
ihlr-16498	465	12	)	)	PUNCT
ihlr-16498	465	13	.	.	PUNCT
ihlr-16498	466	1	108	108	NUM
ihlr-16498	466	2	hearing	hear	VERB
ihlr-16498	466	3	on	on	ADP
ihlr-16498	466	4	antidepressant	antidepressant	ADJ
ihlr-16498	466	5	pediatric	pediatric	ADJ
ihlr-16498	466	6	trials	trial	NOUN
ihlr-16498	466	7	,	,	PUNCT
ihlr-16498	466	8	supra	supra	PROPN
ihlr-16498	466	9	note	note	VERB
ihlr-16498	466	10	87	87	NUM
ihlr-16498	466	11	,	,	PUNCT
ihlr-16498	466	12	at	at	ADP
ihlr-16498	466	13	36	36	NUM
ihlr-16498	466	14	(	(	PUNCT
ihlr-16498	466	15	statement	statement	NOUN
ihlr-16498	466	16	ofu.s	ofu.s	PROPN
ihlr-16498	466	17	.	.	PUNCT
ihlr-16498	466	18	rep	rep	PROPN
ihlr-16498	466	19	.	.	PROPN
ihlr-16498	466	20	henry	henry	PROPN
ihlr-16498	466	21	waxman	waxman	PROPN
ihlr-16498	466	22	of	of	ADP
ihlr-16498	466	23	california	california	PROPN
ihlr-16498	466	24	)	)	PUNCT
ihlr-16498	466	25	(	(	PUNCT
ihlr-16498	466	26	stating	state	VERB
ihlr-16498	466	27	that	that	SCONJ
ihlr-16498	466	28	congress	congress	PROPN
ihlr-16498	466	29	is	be	AUX
ihlr-16498	466	30	going	go	VERB
ihlr-16498	466	31	to	to	PART
ihlr-16498	466	32	hear	hear	VERB
ihlr-16498	466	33	that	that	SCONJ
ihlr-16498	466	34	drug	drug	NOUN
ihlr-16498	466	35	companies	company	NOUN
ihlr-16498	466	36	are	be	AUX
ihlr-16498	466	37	willing	willing	ADJ
ihlr-16498	466	38	to	to	PART
ihlr-16498	466	39	set	set	VERB
ihlr-16498	466	40	up	up	ADP
ihlr-16498	466	41	a	a	DET
ihlr-16498	466	42	registry	registry	NOUN
ihlr-16498	466	43	voluntarily	voluntarily	ADV
ihlr-16498	466	44	)	)	PUNCT
ihlr-16498	466	45	.	.	PUNCT
ihlr-16498	467	1	2007j	2007j	NOUN
ihlr-16498	467	2	reforming	reform	VERB
ihlr-16498	467	3	fda	fda	PROPN
ihlr-16498	467	4	policy	policy	NOUN
ihlr-16498	467	5	for	for	ADP
ihlr-16498	467	6	pediatric	pediatric	ADJ
ihlr-16498	467	7	testing	testing	NOUN
ihlr-16498	467	8	79	79	NUM
ihlr-16498	467	9	tive	tive	NOUN
ihlr-16498	467	10	structure	structure	NOUN
ihlr-16498	467	11	for	for	ADP
ihlr-16498	467	12	pediatric	pediatric	ADJ
ihlr-16498	467	13	testing	testing	NOUN
ihlr-16498	467	14	.	.	PUNCT
ihlr-16498	468	1	proponents	proponent	NOUN
ihlr-16498	468	2	argued	argue	VERB
ihlr-16498	468	3	that	that	SCONJ
ihlr-16498	468	4	this	this	DET
ihlr-16498	468	5	legislative	legislative	ADJ
ihlr-16498	468	6	ac­	ac­	PROPN
ihlr-16498	468	7	tion	tion	NOUN
ihlr-16498	468	8	,	,	PUNCT
ihlr-16498	468	9	including	include	VERB
ihlr-16498	468	10	the	the	DET
ihlr-16498	468	11	exclusionary	exclusionary	ADJ
ihlr-16498	468	12	provision	provision	NOUN
ihlr-16498	468	13	,	,	PUNCT
ihlr-16498	468	14	provides	provide	VERB
ihlr-16498	468	15	important	important	ADJ
ihlr-16498	468	16	incentives	incentive	NOUN
ihlr-16498	468	17	to	to	ADP
ihlr-16498	468	18	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	468	19	companies	company	NOUN
ihlr-16498	468	20	resulting	result	VERB
ihlr-16498	468	21	in	in	ADP
ihlr-16498	468	22	pediatric	pediatric	ADJ
ihlr-16498	468	23	testing	testing	NOUN
ihlr-16498	468	24	.	.	PUNCT
ihlr-16498	469	1	109	109	NUM
ihlr-16498	469	2	other	other	ADJ
ihlr-16498	469	3	supporters	supporter	NOUN
ihlr-16498	469	4	like	like	ADP
ihlr-16498	469	5	the	the	DET
ihlr-16498	469	6	voluntary	voluntary	ADJ
ihlr-16498	469	7	structure	structure	NOUN
ihlr-16498	469	8	because	because	SCONJ
ihlr-16498	469	9	they	they	PRON
ihlr-16498	469	10	favor	favor	VERB
ihlr-16498	469	11	the	the	DET
ihlr-16498	469	12	incentive	incentive	NOUN
ihlr-16498	469	13	process	process	NOUN
ihlr-16498	469	14	over	over	ADP
ihlr-16498	469	15	man­	man­	NOUN
ihlr-16498	469	16	datory	datory	ADJ
ihlr-16498	469	17	pediatric	pediatric	ADJ
ihlr-16498	469	18	testing	testing	NOUN
ihlr-16498	469	19	.	.	PUNCT
ihlr-16498	470	1	110	110	NUM
ihlr-16498	470	2	as	as	SCONJ
ihlr-16498	470	3	discussed	discuss	VERB
ihlr-16498	470	4	below	below	ADV
ihlr-16498	470	5	,	,	PUNCT
ihlr-16498	470	6	to	to	ADP
ihlr-16498	470	7	date	date	NOUN
ihlr-16498	470	8	,	,	PUNCT
ihlr-16498	470	9	as	as	ADV
ihlr-16498	470	10	long	long	ADV
ihlr-16498	470	11	as	as	SCONJ
ihlr-16498	470	12	the	the	DET
ihlr-16498	470	13	manufac­	manufac­	PROPN
ihlr-16498	470	14	turer	turer	PROPN
ihlr-16498	470	15	conducts	conduct	VERB
ihlr-16498	470	16	the	the	DET
ihlr-16498	470	17	studies	study	NOUN
ihlr-16498	470	18	and	and	CCONJ
ihlr-16498	470	19	submits	submit	VERB
ihlr-16498	470	20	the	the	DET
ihlr-16498	470	21	results	result	NOUN
ihlr-16498	470	22	to	to	ADP
ihlr-16498	470	23	the	the	DET
ihlr-16498	470	24	fda	fda	PROPN
ihlr-16498	470	25	,	,	PUNCT
ihlr-16498	470	26	the	the	DET
ihlr-16498	470	27	manufacturer	manufacturer	NOUN
ihlr-16498	470	28	receives	receive	VERB
ihlr-16498	470	29	the	the	DET
ihlr-16498	470	30	market	market	NOUN
ihlr-16498	470	31	exclusivity	exclusivity	NOUN
ihlr-16498	470	32	extension	extension	NOUN
ihlr-16498	470	33	.	.	PUNCT
ihlr-16498	471	1	that	that	PRON
ihlr-16498	471	2	is	be	AUX
ihlr-16498	471	3	,	,	PUNCT
ihlr-16498	471	4	even	even	ADV
ihlr-16498	471	5	if	if	SCONJ
ihlr-16498	471	6	the	the	DET
ihlr-16498	471	7	results	result	NOUN
ihlr-16498	471	8	of	of	ADP
ihlr-16498	471	9	the	the	DET
ihlr-16498	471	10	studies	study	NOUN
ihlr-16498	471	11	are	be	AUX
ihlr-16498	471	12	negative	negative	ADJ
ihlr-16498	471	13	,	,	PUNCT
ihlr-16498	471	14	the	the	DET
ihlr-16498	471	15	manufacturer	manufacturer	NOUN
ihlr-16498	471	16	will	will	AUX
ihlr-16498	471	17	be	be	AUX
ihlr-16498	471	18	granted	grant	VERB
ihlr-16498	471	19	the	the	DET
ihlr-16498	471	20	six	six	NUM
ihlr-16498	471	21	-	-	PUNCT
ihlr-16498	471	22	month	month	NOUN
ihlr-16498	471	23	patent	patent	NOUN
ihlr-16498	471	24	ex­	ex­	NOUN
ihlr-16498	471	25	tension	tension	NOUN
ihlr-16498	471	26	.	.	PUNCT
ihlr-16498	472	1	opponents	opponent	NOUN
ihlr-16498	472	2	ofthe	ofthe	VERB
ihlr-16498	472	3	voluntary	voluntary	ADJ
ihlr-16498	472	4	incentive	incentive	NOUN
ihlr-16498	472	5	structure	structure	NOUN
ihlr-16498	472	6	argued	argue	VERB
ihlr-16498	472	7	that	that	SCONJ
ihlr-16498	472	8	some	some	DET
ihlr-16498	472	9	pediatric	pediatric	ADJ
ihlr-16498	472	10	testing	testing	NOUN
ihlr-16498	472	11	should	should	AUX
ihlr-16498	472	12	be	be	AUX
ihlr-16498	472	13	mandatory	mandatory	ADJ
ihlr-16498	472	14	.	.	PUNCT
ihlr-16498	473	1	111	111	NUM
ihlr-16498	474	1	moreover	moreover	ADV
ihlr-16498	474	2	,	,	PUNCT
ihlr-16498	474	3	the	the	DET
ihlr-16498	474	4	exclusivity	exclusivity	NOUN
ihlr-16498	474	5	provision	provision	NOUN
ihlr-16498	474	6	costs	cost	VERB
ihlr-16498	474	7	con­	con­	NOUN
ihlr-16498	474	8	sumers	sumer	VERB
ihlr-16498	474	9	enormous	enormous	ADJ
ihlr-16498	474	10	amounts	amount	NOUN
ihlr-16498	474	11	of	of	ADP
ihlr-16498	474	12	money	money	NOUN
ihlr-16498	474	13	in	in	ADP
ihlr-16498	474	14	subsidizing	subsidize	VERB
ihlr-16498	474	15	the	the	DET
ihlr-16498	474	16	research	research	NOUN
ihlr-16498	474	17	because	because	SCONJ
ihlr-16498	474	18	the	the	DET
ihlr-16498	474	19	cost	cost	NOUN
ihlr-16498	474	20	of	of	ADP
ihlr-16498	474	21	the	the	DET
ihlr-16498	474	22	trials	trial	NOUN
ihlr-16498	474	23	and	and	CCONJ
ihlr-16498	474	24	exclusionary	exclusionary	ADJ
ihlr-16498	474	25	period	period	NOUN
ihlr-16498	474	26	are	be	AUX
ihlr-16498	474	27	passed	pass	VERB
ihlr-16498	474	28	along	along	ADP
ihlr-16498	474	29	to	to	ADP
ihlr-16498	474	30	the	the	DET
ihlr-16498	474	31	consumer	consumer	NOUN
ihlr-16498	474	32	.	.	PUNCT
ihlr-16498	475	1	112	112	NUM
ihlr-16498	475	2	first	first	ADV
ihlr-16498	475	3	,	,	PUNCT
ihlr-16498	475	4	a	a	DET
ihlr-16498	475	5	manufacturer	manufacturer	NOUN
ihlr-16498	475	6	may	may	AUX
ihlr-16498	475	7	raise	raise	VERB
ihlr-16498	475	8	the	the	DET
ihlr-16498	475	9	price	price	NOUN
ihlr-16498	475	10	of	of	ADP
ihlr-16498	475	11	a	a	DET
ihlr-16498	475	12	drug	drug	NOUN
ihlr-16498	475	13	to	to	PART
ihlr-16498	475	14	pay	pay	VERB
ihlr-16498	475	15	for	for	ADP
ihlr-16498	475	16	the	the	DET
ihlr-16498	475	17	clinical	clinical	ADJ
ihlr-16498	475	18	trials	trial	NOUN
ihlr-16498	475	19	.	.	PUNCT
ihlr-16498	476	1	second	second	ADJ
ihlr-16498	476	2	,	,	PUNCT
ihlr-16498	476	3	consumers	consumer	NOUN
ihlr-16498	476	4	have	have	VERB
ihlr-16498	476	5	access	access	NOUN
ihlr-16498	476	6	only	only	ADV
ihlr-16498	476	7	to	to	ADP
ihlr-16498	476	8	the	the	DET
ihlr-16498	476	9	one	one	NUM
ihlr-16498	476	10	drug	drug	NOUN
ihlr-16498	476	11	during	during	ADP
ihlr-16498	476	12	the	the	DET
ihlr-16498	476	13	six	six	NUM
ihlr-16498	476	14	-	-	PUNCT
ihlr-16498	476	15	month	month	NOUN
ihlr-16498	476	16	ex­	ex­	NOUN
ihlr-16498	476	17	clusivity	clusivity	NOUN
ihlr-16498	476	18	period	period	NOUN
ihlr-16498	476	19	even	even	ADV
ihlr-16498	476	20	if	if	SCONJ
ihlr-16498	476	21	the	the	DET
ihlr-16498	476	22	results	result	NOUN
ihlr-16498	476	23	of	of	ADP
ihlr-16498	476	24	the	the	DET
ihlr-16498	476	25	pediatric	pediatric	ADJ
ihlr-16498	476	26	trial	trial	NOUN
ihlr-16498	476	27	are	be	AUX
ihlr-16498	476	28	negative	negative	ADJ
ihlr-16498	476	29	.	.	PUNCT
ihlr-16498	477	1	hence	hence	ADV
ihlr-16498	477	2	,	,	PUNCT
ihlr-16498	477	3	the	the	DET
ihlr-16498	477	4	consumers	consumer	NOUN
ihlr-16498	477	5	pay	pay	VERB
ihlr-16498	477	6	on	on	ADP
ihlr-16498	477	7	both	both	DET
ihlr-16498	477	8	ends	end	NOUN
ihlr-16498	477	9	for	for	ADP
ihlr-16498	477	10	the	the	DET
ihlr-16498	477	11	clinical	clinical	ADJ
ihlr-16498	477	12	studies	study	NOUN
ihlr-16498	477	13	.	.	PUNCT
ihlr-16498	478	1	in	in	ADP
ihlr-16498	478	2	some	some	DET
ihlr-16498	478	3	situations	situation	NOUN
ihlr-16498	478	4	where	where	SCONJ
ihlr-16498	478	5	the	the	DET
ihlr-16498	478	6	manufacturer	manufacturer	NOUN
ihlr-16498	478	7	does	do	AUX
ihlr-16498	478	8	not	not	PART
ihlr-16498	478	9	conduct	conduct	VERB
ihlr-16498	478	10	a	a	DET
ihlr-16498	478	11	required	require	VERB
ihlr-16498	478	12	pediatric	pediatric	ADJ
ihlr-16498	478	13	trial	trial	NOUN
ihlr-16498	478	14	for	for	ADP
ihlr-16498	478	15	already	already	ADV
ihlr-16498	478	16	ap­	ap­	NOUN
ihlr-16498	478	17	proved	prove	VERB
ihlr-16498	478	18	drugs	drug	NOUN
ihlr-16498	478	19	,	,	PUNCT
ihlr-16498	478	20	tax	tax	NOUN
ihlr-16498	478	21	money	money	NOUN
ihlr-16498	478	22	may	may	AUX
ihlr-16498	478	23	be	be	AUX
ihlr-16498	478	24	used	use	VERB
ihlr-16498	478	25	to	to	PART
ihlr-16498	478	26	conduct	conduct	VERB
ihlr-16498	478	27	the	the	DET
ihlr-16498	478	28	study	study	NOUN
ihlr-16498	478	29	.	.	PUNCT
ihlr-16498	479	1	therefore	therefore	ADV
ihlr-16498	479	2	,	,	PUNCT
ihlr-16498	479	3	it	it	PRON
ihlr-16498	479	4	costs	cost	VERB
ihlr-16498	479	5	the	the	DET
ihlr-16498	479	6	citizen	citizen	NOUN
ihlr-16498	479	7	money	money	NOUN
ihlr-16498	479	8	either	either	CCONJ
ihlr-16498	479	9	as	as	ADP
ihlr-16498	479	10	a	a	DET
ihlr-16498	479	11	consumer	consumer	NOUN
ihlr-16498	479	12	or	or	CCONJ
ihlr-16498	479	13	as	as	ADP
ihlr-16498	479	14	a	a	DET
ihlr-16498	479	15	taxpayer	taxpayer	NOUN
ihlr-16498	479	16	.	.	PUNCT
ihlr-16498	480	1	the	the	DET
ihlr-16498	480	2	prea	prea	PROPN
ihlr-16498	480	3	addressed	address	VERB
ihlr-16498	480	4	the	the	DET
ihlr-16498	480	5	opponents	opponent	NOUN
ihlr-16498	480	6	'	'	PART
ihlr-16498	480	7	concerns	concern	NOUN
ihlr-16498	480	8	to	to	ADP
ihlr-16498	480	9	some	some	DET
ihlr-16498	480	10	extent	extent	NOUN
ihlr-16498	480	11	,	,	PUNCT
ihlr-16498	480	12	but	but	CCONJ
ihlr-16498	480	13	it	it	PRON
ihlr-16498	480	14	did	do	AUX
ihlr-16498	480	15	not	not	PART
ihlr-16498	480	16	go	go	VERB
ihlr-16498	480	17	far	far	ADV
ihlr-16498	480	18	enough	enough	ADV
ihlr-16498	480	19	.	.	PUNCT
ihlr-16498	481	1	the	the	DET
ihlr-16498	481	2	prea	prea	PROPN
ihlr-16498	481	3	recognized	recognize	VERB
ihlr-16498	481	4	the	the	DET
ihlr-16498	481	5	exclusivity	exclusivity	NOUN
ihlr-16498	481	6	provision	provision	NOUN
ihlr-16498	481	7	in	in	ADP
ihlr-16498	481	8	the	the	DET
ihlr-16498	481	9	bpca	bpca	NOUN
ihlr-16498	481	10	,	,	PUNCT
ihlr-16498	481	11	but	but	CCONJ
ihlr-16498	481	12	it	it	PRON
ihlr-16498	481	13	changed	change	VERB
ihlr-16498	481	14	the	the	DET
ihlr-16498	481	15	voluntary	voluntary	ADJ
ihlr-16498	481	16	incentive	incentive	NOUN
ihlr-16498	481	17	structure	structure	NOUN
ihlr-16498	481	18	.	.	PUNCT
ihlr-16498	482	1	as	as	SCONJ
ihlr-16498	482	2	described	describe	VERB
ihlr-16498	482	3	in	in	ADP
ihlr-16498	482	4	part	part	NOUN
ihlr-16498	482	5	m	m	PROPN
ihlr-16498	482	6	,	,	PUNCT
ihlr-16498	482	7	the	the	DET
ihlr-16498	482	8	fda	fda	PROPN
ihlr-16498	482	9	established	establish	VERB
ihlr-16498	482	10	a	a	DET
ihlr-16498	482	11	list	list	NOUN
ihlr-16498	482	12	of	of	ADP
ihlr-16498	482	13	drugs	drug	NOUN
ihlr-16498	482	14	requiring	require	VERB
ihlr-16498	482	15	pediatric	pediatric	ADJ
ihlr-16498	482	16	testing	testing	NOUN
ihlr-16498	482	17	.	.	PUNCT
ihlr-16498	483	1	113	113	NUM
ihlr-16498	483	2	for	for	ADP
ihlr-16498	483	3	fda­	fda­	NOUN
ihlr-16498	483	4	approved	approve	VERB
ihlr-16498	483	5	drugs	drug	NOUN
ihlr-16498	483	6	,	,	PUNCT
ihlr-16498	483	7	the	the	DET
ihlr-16498	483	8	fda	fda	PROPN
ihlr-16498	483	9	gave	give	VERB
ihlr-16498	483	10	an	an	DET
ihlr-16498	483	11	option	option	NOUN
ihlr-16498	483	12	to	to	ADP
ihlr-16498	483	13	the	the	DET
ihlr-16498	483	14	manufacturer	manufacturer	NOUN
ihlr-16498	483	15	to	to	PART
ihlr-16498	483	16	test	test	VERB
ihlr-16498	483	17	the	the	DET
ihlr-16498	483	18	drug	drug	NOUN
ihlr-16498	483	19	.	.	PUNCT
ihlr-16498	484	1	if	if	SCONJ
ihlr-16498	484	2	the	the	DET
ihlr-16498	484	3	manufacturer	manufacturer	NOUN
ihlr-16498	484	4	did	do	AUX
ihlr-16498	484	5	not	not	PART
ihlr-16498	484	6	want	want	VERB
ihlr-16498	484	7	to	to	PART
ihlr-16498	484	8	test	test	VERB
ihlr-16498	484	9	the	the	DET
ihlr-16498	484	10	drug	drug	NOUN
ihlr-16498	484	11	,	,	PUNCT
ihlr-16498	484	12	then	then	ADV
ihlr-16498	484	13	the	the	DET
ihlr-16498	484	14	fda	fda	PROPN
ihlr-16498	484	15	could	could	AUX
ihlr-16498	484	16	contract	contract	VERB
ihlr-16498	484	17	with	with	ADP
ihlr-16498	484	18	a	a	DET
ihlr-16498	484	19	third	third	ADJ
ihlr-16498	484	20	party	party	NOUN
ihlr-16498	484	21	to	to	PART
ihlr-16498	484	22	conduct	conduct	VERB
ihlr-16498	484	23	the	the	DET
ihlr-16498	484	24	test	test	NOUN
ihlr-16498	484	25	.	.	PUNCT
ihlr-16498	485	1	114	114	NUM
ihlr-16498	485	2	for	for	ADP
ihlr-16498	485	3	new	new	ADJ
ihlr-16498	485	4	drugs	drug	NOUN
ihlr-16498	485	5	,	,	PUNCT
ihlr-16498	485	6	the	the	DET
ihlr-16498	485	7	fda	fda	PROPN
ihlr-16498	485	8	could	could	AUX
ihlr-16498	485	9	require	require	VERB
ihlr-16498	485	10	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	485	11	companies	company	NOUN
ihlr-16498	485	12	to	to	PART
ihlr-16498	485	13	either	either	CCONJ
ihlr-16498	485	14	conduct	conduct	VERB
ihlr-16498	485	15	a	a	DET
ihlr-16498	485	16	pediatric	pediatric	ADJ
ihlr-16498	485	17	clinical	clinical	ADJ
ihlr-16498	485	18	trial	trial	NOUN
ihlr-16498	485	19	or	or	CCONJ
ihlr-16498	485	20	apply	apply	VERB
ihlr-16498	485	21	for	for	ADP
ihlr-16498	485	22	a	a	DET
ihlr-16498	485	23	waiver	waiver	NOUN
ihlr-16498	485	24	.	.	PUNCT
ihlr-16498	486	1	the	the	DET
ihlr-16498	486	2	revision	revision	NOUN
ihlr-16498	486	3	in	in	ADP
ihlr-16498	486	4	the	the	DET
ihlr-16498	486	5	prea	prea	PROPN
ihlr-16498	486	6	,	,	PUNCT
ihlr-16498	486	7	however	however	ADV
ihlr-16498	486	8	,	,	PUNCT
ihlr-16498	486	9	did	do	AUX
ihlr-16498	486	10	not	not	PART
ihlr-16498	486	11	address	address	VERB
ihlr-16498	486	12	the	the	DET
ihlr-16498	486	13	cost	cost	NOUN
ihlr-16498	486	14	to	to	ADP
ihlr-16498	486	15	the	the	DET
ihlr-16498	486	16	consumer	consumer	NOUN
ihlr-16498	486	17	and	and	CCONJ
ihlr-16498	486	18	taxpayer	taxpayer	NOUN
ihlr-16498	486	19	.	.	PUNCT
ihlr-16498	487	1	as	as	ADP
ihlr-16498	487	2	policy	policy	NOUN
ihlr-16498	487	3	considerations	consideration	NOUN
ihlr-16498	487	4	,	,	PUNCT
ihlr-16498	487	5	the	the	DET
ihlr-16498	487	6	patent	patent	NOUN
ihlr-16498	487	7	extension	extension	NOUN
ihlr-16498	487	8	should	should	AUX
ihlr-16498	487	9	be	be	AUX
ihlr-16498	487	10	conditioned	condition	VERB
ihlr-16498	487	11	on	on	ADP
ihlr-16498	487	12	the	the	DET
ihlr-16498	487	13	following	follow	VERB
ihlr-16498	487	14	two	two	NUM
ihlr-16498	487	15	criteria	criterion	NOUN
ihlr-16498	487	16	.	.	PUNCT
ihlr-16498	488	1	first	first	ADV
ihlr-16498	488	2	,	,	PUNCT
ihlr-16498	488	3	the	the	DET
ihlr-16498	488	4	drug	drug	NOUN
ihlr-16498	488	5	must	must	AUX
ihlr-16498	488	6	be	be	AUX
ihlr-16498	488	7	shown	show	VERB
ihlr-16498	488	8	to	to	PART
ihlr-16498	488	9	be	be	AUX
ihlr-16498	488	10	safe	safe	ADJ
ihlr-16498	488	11	and	and	CCONJ
ihlr-16498	488	12	effec­	effec­	PRON
ihlr-16498	488	13	tive	tive	NOUN
ihlr-16498	488	14	in	in	ADP
ihlr-16498	488	15	the	the	DET
ihlr-16498	488	16	approved	approve	VERB
ihlr-16498	488	17	pediatric	pediatric	ADJ
ihlr-16498	488	18	trials	trial	NOUN
ihlr-16498	488	19	.	.	PUNCT
ihlr-16498	489	1	that	that	PRON
ihlr-16498	489	2	is	is	ADV
ihlr-16498	489	3	,	,	PUNCT
ihlr-16498	489	4	the	the	DET
ihlr-16498	489	5	exclusivity	exclusivity	NOUN
ihlr-16498	489	6	provision	provision	NOUN
ihlr-16498	489	7	should	should	AUX
ihlr-16498	489	8	apply	apply	VERB
ihlr-16498	489	9	only	only	ADV
ihlr-16498	489	10	to	to	ADP
ihlr-16498	489	11	drugs	drug	NOUN
ihlr-16498	489	12	that	that	PRON
ihlr-16498	489	13	will	will	AUX
ihlr-16498	489	14	be	be	AUX
ihlr-16498	489	15	approved	approve	VERB
ihlr-16498	489	16	for	for	ADP
ihlr-16498	489	17	use	use	NOUN
ihlr-16498	489	18	in	in	ADP
ihlr-16498	489	19	pediatric	pediatric	ADJ
ihlr-16498	489	20	populations	population	NOUN
ihlr-16498	489	21	.	.	PUNCT
ihlr-16498	490	1	to	to	ADP
ihlr-16498	490	2	date	date	NOUN
ihlr-16498	490	3	,	,	PUNCT
ihlr-16498	490	4	if	if	SCONJ
ihlr-16498	490	5	a	a	DET
ihlr-16498	490	6	manufacturer	manufacturer	NOUN
ihlr-16498	490	7	conducts	conduct	VERB
ihlr-16498	490	8	a	a	DET
ihlr-16498	490	9	pediatric	pediatric	ADJ
ihlr-16498	490	10	trial	trial	NOUN
ihlr-16498	490	11	,	,	PUNCT
ihlr-16498	490	12	but	but	CCONJ
ihlr-16498	490	13	the	the	DET
ihlr-16498	490	14	drug	drug	NOUN
ihlr-16498	490	15	is	be	AUX
ihlr-16498	490	16	shown	show	VERB
ihlr-16498	490	17	to	to	PART
ihlr-16498	490	18	be	be	AUX
ihlr-16498	490	19	109	109	NUM
ihlr-16498	490	20	breslow	breslow	ADJ
ihlr-16498	490	21	,	,	PUNCT
ihlr-16498	490	22	supra	supra	PROPN
ihlr-16498	490	23	note	note	NOUN
ihlr-16498	490	24	22	22	NUM
ihlr-16498	490	25	,	,	PUNCT
ihlr-16498	490	26	at	at	ADP
ihlr-16498	490	27	182	182	NUM
ihlr-16498	490	28	-	-	SYM
ihlr-16498	490	29	83	83	NUM
ihlr-16498	490	30	(	(	PUNCT
ihlr-16498	490	31	citing	cite	VERB
ihlr-16498	490	32	congressional	congressional	ADJ
ihlr-16498	490	33	records	record	NOUN
ihlr-16498	490	34	regarding	regard	VERB
ihlr-16498	490	35	the	the	DET
ihlr-16498	490	36	bpca	bpca	PROPN
ihlr-16498	490	37	)	)	PUNCT
ihlr-16498	490	38	.	.	PUNCT
ihlr-16498	491	1	110	110	NUM
ihlr-16498	491	2	i	i	NOUN
ihlr-16498	491	3	d	d	PROPN
ihlr-16498	491	4	at	at	ADP
ihlr-16498	491	5	183	183	NUM
ihlr-16498	491	6	(	(	PUNCT
ihlr-16498	491	7	noting	note	VERB
ihlr-16498	491	8	proponents	proponent	NOUN
ihlr-16498	491	9	'	'	PART
ihlr-16498	491	10	positions	position	NOUN
ihlr-16498	491	11	)	)	PUNCT
ihlr-16498	491	12	.	.	PUNCT
ihlr-16498	492	1	111	111	NUM
ihlr-16498	492	2	/d	/d	PUNCT
ihlr-16498	492	3	.	.	PUNCT
ihlr-16498	493	1	(	(	PUNCT
ihlr-16498	493	2	citing	cite	VERB
ihlr-16498	493	3	congressional	congressional	ADJ
ihlr-16498	493	4	records	record	NOUN
ihlr-16498	493	5	regarding	regard	VERB
ihlr-16498	493	6	the	the	DET
ihlr-16498	493	7	bpca	bpca	PROPN
ihlr-16498	493	8	)	)	PUNCT
ihlr-16498	493	9	.	.	PUNCT
ihlr-16498	494	1	112	112	NUM
ihlr-16498	494	2	!	!	PUNCT
ihlr-16498	494	3	d.	d.	PROPN
ihlr-16498	494	4	at	at	ADP
ihlr-16498	494	5	183	183	NUM
ihlr-16498	494	6	,	,	PUNCT
ihlr-16498	494	7	189	189	NUM
ihlr-16498	494	8	(	(	PUNCT
ihlr-16498	494	9	discussing	discuss	VERB
ihlr-16498	494	10	costs	cost	NOUN
ihlr-16498	494	11	passed	pass	VERB
ihlr-16498	494	12	onto	onto	ADP
ihlr-16498	494	13	the	the	DET
ihlr-16498	494	14	consumer	consumer	NOUN
ihlr-16498	494	15	directly	directly	ADV
ihlr-16498	494	16	or	or	CCONJ
ihlr-16498	494	17	indirectly	indirectly	ADV
ihlr-16498	494	18	)	)	PUNCT
ihlr-16498	494	19	.	.	PUNCT
ihlr-16498	495	1	113	113	NUM
ihlr-16498	495	2	program	program	NOUN
ihlr-16498	495	3	for	for	ADP
ihlr-16498	495	4	pediatric	pediatric	ADJ
ihlr-16498	495	5	studies	study	NOUN
ihlr-16498	495	6	of	of	ADP
ihlr-16498	495	7	drugs	drug	NOUN
ihlr-16498	495	8	,	,	PUNCT
ihlr-16498	495	9	42	42	NUM
ihlr-16498	495	10	u.s.c	u.s.c	ADJ
ihlr-16498	495	11	.	.	PUNCT
ihlr-16498	496	1	§	§	PROPN
ihlr-16498	496	2	284m(axl	284m(axl	NUM
ihlr-16498	496	3	)	)	PUNCT
ihlr-16498	496	4	(	(	PUNCT
ihlr-16498	496	5	supp	supp	PROPN
ihlr-16498	496	6	.	.	PUNCT
ihlr-16498	497	1	iii	iii	NUM
ihlr-16498	497	2	2003	2003	NUM
ihlr-16498	497	3	)	)	PUNCT
ihlr-16498	497	4	;	;	PUNCT
ihlr-16498	497	5	list	list	NOUN
ihlr-16498	497	6	of	of	ADP
ihlr-16498	497	7	drugs	drug	NOUN
ihlr-16498	497	8	for	for	ADP
ihlr-16498	497	9	which	which	PRON
ihlr-16498	497	10	additional	additional	ADJ
ihlr-16498	497	11	pediatric	pediatric	ADJ
ihlr-16498	497	12	information	information	NOUN
ihlr-16498	497	13	may	may	AUX
ihlr-16498	497	14	produce	produce	VERB
ihlr-16498	497	15	health	health	NOUN
ihlr-16498	497	16	benefits	benefit	NOUN
ihlr-16498	497	17	in	in	ADP
ihlr-16498	497	18	the	the	DET
ihlr-16498	497	19	pediatric	pediatric	ADJ
ihlr-16498	497	20	population	population	NOUN
ihlr-16498	497	21	,	,	PUNCT
ihlr-16498	497	22	63	63	NUM
ihlr-16498	497	23	fed	feed	VERB
ihlr-16498	497	24	.	.	PUNCT
ihlr-16498	498	1	reg	reg	PROPN
ihlr-16498	498	2	.	.	PUNCT
ihlr-16498	499	1	27,733	27,733	NUM
ihlr-16498	499	2	,	,	PUNCT
ihlr-16498	499	3	27,734	27,734	NUM
ihlr-16498	499	4	(	(	PUNCT
ihlr-16498	499	5	may	may	PROPN
ihlr-16498	499	6	20	20	NUM
ihlr-16498	499	7	,	,	PUNCT
ihlr-16498	499	8	1998	1998	NUM
ihlr-16498	499	9	)	)	PUNCT
ihlr-16498	499	10	.	.	PUNCT
ihlr-16498	500	1	114	114	NUM
ihlr-16498	500	2	42	42	NUM
ihlr-16498	500	3	u.s.c	u.s.c	ADJ
ihlr-16498	500	4	.	.	PUNCT
ihlr-16498	501	1	§	§	PROPN
ihlr-16498	501	2	284m(b)-(c	284m(b)-(c	NUM
ihlr-16498	501	3	)	)	PUNCT
ihlr-16498	501	4	.	.	PUNCT
ihlr-16498	502	1	80	80	NUM
ihlr-16498	502	2	indiana	indiana	PROPN
ihlr-16498	502	3	health	health	PROPN
ihlr-16498	502	4	law	law	NOUN
ihlr-16498	502	5	review	review	NOUN
ihlr-16498	502	6	[	[	X
ihlr-16498	502	7	vol	vol	NOUN
ihlr-16498	502	8	.	.	PUNCT
ihlr-16498	503	1	4:59	4:59	NUM
ihlr-16498	503	2	unsafe	unsafe	ADJ
ihlr-16498	503	3	or	or	CCONJ
ihlr-16498	503	4	ineffective	ineffective	ADJ
ihlr-16498	503	5	,	,	PUNCT
ihlr-16498	503	6	the	the	DET
ihlr-16498	503	7	manufacturer	manufacturer	NOUN
ihlr-16498	503	8	still	still	ADV
ihlr-16498	503	9	receives	receive	VERB
ihlr-16498	503	10	the	the	DET
ihlr-16498	503	11	market	market	NOUN
ihlr-16498	503	12	exclusion	exclusion	NOUN
ihlr-16498	503	13	.	.	PUNCT
ihlr-16498	504	1	115	115	NUM
ihlr-16498	504	2	opponents	opponent	NOUN
ihlr-16498	504	3	of	of	ADP
ihlr-16498	504	4	this	this	DET
ihlr-16498	504	5	idea	idea	NOUN
ihlr-16498	504	6	may	may	AUX
ihlr-16498	504	7	argue	argue	VERB
ihlr-16498	504	8	that	that	SCONJ
ihlr-16498	504	9	the	the	DET
ihlr-16498	504	10	high	high	ADJ
ihlr-16498	504	11	cost	cost	NOUN
ihlr-16498	504	12	of	of	ADP
ihlr-16498	504	13	clinical	clinical	ADJ
ihlr-16498	504	14	trials	trial	NOUN
ihlr-16498	504	15	will	will	AUX
ihlr-16498	504	16	create	create	VERB
ihlr-16498	504	17	disincentives	disincentive	NOUN
ihlr-16498	504	18	for	for	SCONJ
ihlr-16498	504	19	manufacturers	manufacturer	NOUN
ihlr-16498	504	20	to	to	PART
ihlr-16498	504	21	conduct	conduct	VERB
ihlr-16498	504	22	the	the	DET
ihlr-16498	504	23	trials	trial	NOUN
ihlr-16498	504	24	without	without	ADP
ihlr-16498	504	25	the	the	DET
ihlr-16498	504	26	guarantee	guarantee	NOUN
ihlr-16498	504	27	of	of	ADP
ihlr-16498	504	28	receiving	receive	VERB
ihlr-16498	504	29	the	the	DET
ihlr-16498	504	30	market	market	NOUN
ihlr-16498	504	31	exclusion	exclusion	NOUN
ihlr-16498	504	32	.	.	PUNCT
ihlr-16498	505	1	this	this	PRON
ihlr-16498	505	2	is	be	AUX
ihlr-16498	505	3	because	because	SCONJ
ihlr-16498	505	4	the	the	DET
ihlr-16498	505	5	manufacturers	manufacturer	NOUN
ihlr-16498	505	6	become	become	VERB
ihlr-16498	505	7	fa­	fa­	VERB
ihlr-16498	505	8	miliar	miliar	ADJ
ihlr-16498	505	9	with	with	ADP
ihlr-16498	505	10	the	the	DET
ihlr-16498	505	11	six	six	NUM
ihlr-16498	505	12	-	-	PUNCT
ihlr-16498	505	13	month	month	NOUN
ihlr-16498	505	14	extension	extension	NOUN
ihlr-16498	505	15	.	.	PUNCT
ihlr-16498	506	1	if	if	SCONJ
ihlr-16498	506	2	,	,	PUNCT
ihlr-16498	506	3	however	however	ADV
ihlr-16498	506	4	,	,	PUNCT
ihlr-16498	506	5	the	the	DET
ihlr-16498	506	6	market	market	NOUN
ihlr-16498	506	7	extension	extension	NOUN
ihlr-16498	506	8	was	be	AUX
ihlr-16498	506	9	changed	change	VERB
ihlr-16498	506	10	to	to	ADP
ihlr-16498	506	11	an	an	DET
ihlr-16498	506	12	"	"	PUNCT
ihlr-16498	506	13	icing	ice	VERB
ihlr-16498	506	14	on	on	ADP
ihlr-16498	506	15	the	the	DET
ihlr-16498	506	16	cake	cake	NOUN
ihlr-16498	506	17	"	"	PUNCT
ihlr-16498	506	18	benefit	benefit	NOUN
ihlr-16498	506	19	for	for	ADP
ihlr-16498	506	20	the	the	DET
ihlr-16498	506	21	required	require	VERB
ihlr-16498	506	22	testing	testing	NOUN
ihlr-16498	506	23	,	,	PUNCT
ihlr-16498	506	24	then	then	ADV
ihlr-16498	506	25	manu­	manu­	ADJ
ihlr-16498	506	26	facturers	facturer	NOUN
ihlr-16498	506	27	would	would	AUX
ihlr-16498	506	28	be	be	AUX
ihlr-16498	506	29	required	require	VERB
ihlr-16498	506	30	to	to	PART
ihlr-16498	506	31	conduct	conduct	VERB
ihlr-16498	506	32	the	the	DET
ihlr-16498	506	33	trials	trial	NOUN
ihlr-16498	506	34	and	and	CCONJ
ihlr-16498	506	35	receive	receive	VERB
ihlr-16498	506	36	a	a	DET
ihlr-16498	506	37	benefit	benefit	NOUN
ihlr-16498	506	38	only	only	ADV
ihlr-16498	506	39	if	if	SCONJ
ihlr-16498	506	40	the	the	DET
ihlr-16498	506	41	drug	drug	NOUN
ihlr-16498	506	42	is	be	AUX
ihlr-16498	506	43	safe	safe	ADJ
ihlr-16498	506	44	and	and	CCONJ
ihlr-16498	506	45	effective	effective	ADJ
ihlr-16498	506	46	in	in	ADP
ihlr-16498	506	47	pediatric	pediatric	ADJ
ihlr-16498	506	48	populations	population	NOUN
ihlr-16498	506	49	.	.	PUNCT
ihlr-16498	507	1	thus	thus	ADV
ihlr-16498	507	2	,	,	PUNCT
ihlr-16498	507	3	consumers	consumer	NOUN
ihlr-16498	507	4	will	will	AUX
ihlr-16498	507	5	bear	bear	VERB
ihlr-16498	507	6	the	the	DET
ihlr-16498	507	7	cost	cost	NOUN
ihlr-16498	507	8	only	only	ADV
ihlr-16498	507	9	for	for	ADP
ihlr-16498	507	10	drugs	drug	NOUN
ihlr-16498	507	11	that	that	PRON
ihlr-16498	507	12	will	will	AUX
ihlr-16498	507	13	be	be	AUX
ihlr-16498	507	14	used	use	VERB
ihlr-16498	507	15	in	in	ADP
ihlr-16498	507	16	pediatric	pediatric	ADJ
ihlr-16498	507	17	populations	population	NOUN
ihlr-16498	507	18	and	and	CCONJ
ihlr-16498	507	19	not	not	PART
ihlr-16498	507	20	for	for	ADP
ihlr-16498	507	21	all	all	DET
ihlr-16498	507	22	drugs	drug	NOUN
ihlr-16498	507	23	tested	test	VERB
ihlr-16498	507	24	on	on	ADP
ihlr-16498	507	25	children	child	NOUN
ihlr-16498	507	26	.	.	PUNCT
ihlr-16498	508	1	for	for	ADP
ihlr-16498	508	2	new	new	ADJ
ihlr-16498	508	3	drug	drug	NOUN
ihlr-16498	508	4	applications	application	NOUN
ihlr-16498	508	5	,	,	PUNCT
ihlr-16498	508	6	the	the	DET
ihlr-16498	508	7	six	six	NUM
ihlr-16498	508	8	-	-	PUNCT
ihlr-16498	508	9	month	month	NOUN
ihlr-16498	508	10	mar­	mar­	NOUN
ihlr-16498	508	11	ket	ket	NOUN
ihlr-16498	508	12	exclusion	exclusion	NOUN
ihlr-16498	508	13	could	could	AUX
ihlr-16498	508	14	be	be	AUX
ihlr-16498	508	15	tacked	tack	VERB
ihlr-16498	508	16	on	on	ADP
ihlr-16498	508	17	to	to	ADP
ihlr-16498	508	18	the	the	DET
ihlr-16498	508	19	patent	patent	NOUN
ihlr-16498	508	20	extension	extension	NOUN
ihlr-16498	508	21	granted	grant	VERB
ihlr-16498	508	22	under	under	ADP
ihlr-16498	508	23	the	the	DET
ihlr-16498	508	24	hatch	hatch	NOUN
ihlr-16498	508	25	-	-	PUNCT
ihlr-16498	508	26	waxman	waxman	PROPN
ihlr-16498	508	27	act	act	PROPN
ihlr-16498	508	28	.	.	PUNCT
ihlr-16498	509	1	second	second	ADV
ihlr-16498	509	2	,	,	PUNCT
ihlr-16498	509	3	the	the	DET
ihlr-16498	509	4	patent	patent	NOUN
ihlr-16498	509	5	extension	extension	NOUN
ihlr-16498	509	6	should	should	AUX
ihlr-16498	509	7	occur	occur	VERB
ihlr-16498	509	8	only	only	ADV
ihlr-16498	509	9	after	after	SCONJ
ihlr-16498	509	10	the	the	DET
ihlr-16498	509	11	label	label	NOUN
ihlr-16498	509	12	changes	change	NOUN
ihlr-16498	509	13	are	be	AUX
ihlr-16498	509	14	fully	fully	ADV
ihlr-16498	509	15	implemented.116	implemented.116	ADJ
ihlr-16498	509	16	as	as	SCONJ
ihlr-16498	509	17	described	describe	VERB
ihlr-16498	509	18	below	below	ADV
ihlr-16498	509	19	,	,	PUNCT
ihlr-16498	509	20	the	the	DET
ihlr-16498	509	21	average	average	ADJ
ihlr-16498	509	22	time	time	NOUN
ihlr-16498	509	23	for	for	ADP
ihlr-16498	509	24	a	a	DET
ihlr-16498	509	25	label	label	NOUN
ihlr-16498	509	26	change	change	NOUN
ihlr-16498	509	27	is	be	AUX
ihlr-16498	509	28	five	five	NUM
ihlr-16498	509	29	months	month	NOUN
ihlr-16498	509	30	,	,	PUNCT
ihlr-16498	509	31	and	and	CCONJ
ihlr-16498	509	32	in	in	ADP
ihlr-16498	509	33	some	some	DET
ihlr-16498	509	34	cases	case	NOUN
ihlr-16498	509	35	it	it	PRON
ihlr-16498	509	36	occurs	occur	VERB
ihlr-16498	509	37	after	after	SCONJ
ihlr-16498	509	38	one	one	NUM
ihlr-16498	509	39	year.117	year.117	NOUN
ihlr-16498	509	40	physicians	physician	NOUN
ihlr-16498	509	41	need	need	VERB
ihlr-16498	509	42	to	to	PART
ihlr-16498	509	43	know	know	VERB
ihlr-16498	509	44	how	how	SCONJ
ihlr-16498	509	45	to	to	PART
ihlr-16498	509	46	appropriately	appropriately	ADV
ihlr-16498	509	47	prescribe	prescribe	VERB
ihlr-16498	509	48	medications	medication	NOUN
ihlr-16498	509	49	to	to	ADP
ihlr-16498	509	50	pediatric	pediatric	ADJ
ihlr-16498	509	51	populations	population	NOUN
ihlr-16498	509	52	,	,	PUNCT
ihlr-16498	509	53	and	and	CCONJ
ihlr-16498	509	54	the	the	DET
ihlr-16498	509	55	patent	patent	NOUN
ihlr-16498	509	56	extension	extension	NOUN
ihlr-16498	509	57	should	should	AUX
ihlr-16498	509	58	not	not	PART
ihlr-16498	509	59	begin	begin	VERB
ihlr-16498	509	60	until	until	SCONJ
ihlr-16498	509	61	the	the	DET
ihlr-16498	509	62	appropriate	appropriate	ADJ
ihlr-16498	509	63	label	label	NOUN
ihlr-16498	509	64	changes	change	NOUN
ihlr-16498	509	65	are	be	AUX
ihlr-16498	509	66	made	make	VERB
ihlr-16498	509	67	.	.	PUNCT
ihlr-16498	510	1	c.	c.	NOUN
ihlr-16498	511	1	the	the	DET
ihlr-16498	511	2	new	new	ADJ
ihlr-16498	511	3	policy	policy	NOUN
ihlr-16498	511	4	should	should	AUX
ihlr-16498	511	5	address	address	VERB
ihlr-16498	511	6	labeling	labeling	NOUN
ihlr-16498	511	7	changes	change	NOUN
ihlr-16498	511	8	the	the	DET
ihlr-16498	511	9	results	result	NOUN
ihlr-16498	511	10	of	of	ADP
ihlr-16498	511	11	all	all	DET
ihlr-16498	511	12	pediatric	pediatric	ADJ
ihlr-16498	511	13	clinical	clinical	ADJ
ihlr-16498	511	14	trials	trial	NOUN
ihlr-16498	511	15	should	should	AUX
ihlr-16498	511	16	follow	follow	VERB
ihlr-16498	511	17	a	a	DET
ihlr-16498	511	18	more	more	ADV
ihlr-16498	511	19	rigid	rigid	ADJ
ihlr-16498	511	20	time	time	NOUN
ihlr-16498	511	21	frame	frame	NOUN
ihlr-16498	511	22	.	.	PUNCT
ihlr-16498	512	1	the	the	DET
ihlr-16498	512	2	antidepressant	antidepressant	ADJ
ihlr-16498	512	3	cases	case	NOUN
ihlr-16498	512	4	highlight	highlight	VERB
ihlr-16498	512	5	the	the	DET
ihlr-16498	512	6	importance	importance	NOUN
ihlr-16498	512	7	of	of	ADP
ihlr-16498	512	8	disseminating	disseminate	VERB
ihlr-16498	512	9	all	all	DET
ihlr-16498	512	10	known	know	VERB
ihlr-16498	512	11	information	information	NOUN
ihlr-16498	512	12	to	to	ADP
ihlr-16498	512	13	physicians	physician	NOUN
ihlr-16498	512	14	so	so	SCONJ
ihlr-16498	512	15	they	they	PRON
ihlr-16498	512	16	can	can	AUX
ihlr-16498	512	17	prescribe	prescribe	VERB
ihlr-16498	512	18	the	the	DET
ihlr-16498	512	19	correct	correct	ADJ
ihlr-16498	512	20	drug	drug	NOUN
ihlr-16498	512	21	to	to	ADP
ihlr-16498	512	22	their	their	PRON
ihlr-16498	512	23	patients	patient	NOUN
ihlr-16498	512	24	.	.	PUNCT
ihlr-16498	513	1	the	the	DET
ihlr-16498	513	2	bpca	bpca	PROPN
ihlr-16498	513	3	strengthened	strengthen	VERB
ihlr-16498	513	4	labeling	labeling	NOUN
ihlr-16498	513	5	requirements	requirement	NOUN
ihlr-16498	513	6	,	,	PUNCT
ihlr-16498	513	7	but	but	CCONJ
ihlr-16498	513	8	it	it	PRON
ihlr-16498	513	9	did	do	AUX
ihlr-16498	513	10	not	not	PART
ihlr-16498	513	11	mandate	mandate	VERB
ihlr-16498	513	12	proper	proper	ADJ
ihlr-16498	513	13	labeling	labeling	NOUN
ihlr-16498	513	14	of	of	ADP
ihlr-16498	513	15	drugs	drug	NOUN
ihlr-16498	513	16	before	before	ADP
ihlr-16498	513	17	marketing	marketing	NOUN
ihlr-16498	513	18	.	.	PUNCT
ihlr-16498	514	1	118	118	NUM
ihlr-16498	514	2	in	in	ADP
ihlr-16498	514	3	1979	1979	NUM
ihlr-16498	514	4	,	,	PUNCT
ihlr-16498	514	5	the	the	DET
ihlr-16498	514	6	fda	fda	PROPN
ihlr-16498	514	7	changed	change	VERB
ihlr-16498	514	8	the	the	DET
ihlr-16498	514	9	labeling	labeling	NOUN
ihlr-16498	514	10	requirements	requirement	NOUN
ihlr-16498	514	11	to	to	PART
ihlr-16498	514	12	include	include	VERB
ihlr-16498	514	13	a	a	DET
ihlr-16498	514	14	pediatric	pediatric	ADJ
ihlr-16498	514	15	use	use	NOUN
ihlr-16498	514	16	subsection.119	subsection.119	NOUN
ihlr-16498	514	17	under	under	ADP
ihlr-16498	514	18	this	this	DET
ihlr-16498	514	19	rule	rule	NOUN
ihlr-16498	514	20	,	,	PUNCT
ihlr-16498	514	21	if	if	SCONJ
ihlr-16498	514	22	a	a	DET
ihlr-16498	514	23	manufacturer	manufacturer	NOUN
ihlr-16498	514	24	completed	complete	VERB
ihlr-16498	514	25	pediatric	pediatric	ADJ
ihlr-16498	514	26	trials	trial	NOUN
ihlr-16498	514	27	and	and	CCONJ
ihlr-16498	514	28	the	the	DET
ihlr-16498	514	29	drugs	drug	NOUN
ihlr-16498	514	30	were	be	AUX
ihlr-16498	514	31	approved	approve	VERB
ihlr-16498	514	32	for	for	ADP
ihlr-16498	514	33	use	use	NOUN
ihlr-16498	514	34	in	in	ADP
ihlr-16498	514	35	pediatric	pediatric	ADJ
ihlr-16498	514	36	populations	population	NOUN
ihlr-16498	514	37	,	,	PUNCT
ihlr-16498	514	38	then	then	ADV
ihlr-16498	514	39	both	both	CCONJ
ihlr-16498	514	40	the	the	DET
ihlr-16498	514	41	in­	in­	NOUN
ihlr-16498	514	42	dication	dication	NOUN
ihlr-16498	514	43	and	and	CCONJ
ihlr-16498	514	44	dose	dose	NOUN
ihlr-16498	514	45	would	would	AUX
ihlr-16498	514	46	be	be	AUX
ihlr-16498	514	47	described	describe	VERB
ihlr-16498	514	48	under	under	ADP
ihlr-16498	514	49	the	the	DET
ihlr-16498	514	50	appropriate	appropriate	ADJ
ihlr-16498	514	51	labeling	labeling	NOUN
ihlr-16498	514	52	sections	section	NOUN
ihlr-16498	514	53	.	.	PUNCT
ihlr-16498	515	1	if	if	SCONJ
ihlr-16498	515	2	a	a	DET
ihlr-16498	515	3	drug	drug	NOUN
ihlr-16498	515	4	had	have	AUX
ihlr-16498	515	5	not	not	PART
ihlr-16498	515	6	been	be	AUX
ihlr-16498	515	7	tested	test	VERB
ihlr-16498	515	8	for	for	ADP
ihlr-16498	515	9	use	use	NOUN
ihlr-16498	515	10	in	in	ADP
ihlr-16498	515	11	children	child	NOUN
ihlr-16498	515	12	,	,	PUNCT
ihlr-16498	515	13	then	then	ADV
ihlr-16498	515	14	the	the	DET
ihlr-16498	515	15	label	label	NOUN
ihlr-16498	515	16	reflected	reflect	VERB
ihlr-16498	515	17	that	that	SCONJ
ihlr-16498	515	18	by	by	ADP
ihlr-16498	515	19	saying	say	VERB
ihlr-16498	515	20	either	either	CCONJ
ihlr-16498	515	21	"	"	PUNCT
ihlr-16498	515	22	safety	safety	NOUN
ihlr-16498	515	23	and	and	CCONJ
ihlr-16498	515	24	effectiveness	effectiveness	NOUN
ihlr-16498	515	25	in	in	ADP
ihlr-16498	515	26	pediatric	pediatric	ADJ
ihlr-16498	515	27	patients	patient	NOUN
ihlr-16498	515	28	below	below	ADP
ihlr-16498	515	29	the	the	DET
ihlr-16498	515	30	age	age	NOUN
ihlr-16498	515	31	of	of	ADP
ihlr-16498	515	32	115	115	NUM
ihlr-16498	515	33	hearing	hearing	NOUN
ihlr-16498	515	34	on	on	ADP
ihlr-16498	515	35	antidepressant	antidepressant	ADJ
ihlr-16498	515	36	pediatric	pediatric	ADJ
ihlr-16498	515	37	trials	trial	NOUN
ihlr-16498	515	38	,	,	PUNCT
ihlr-16498	515	39	supra	supra	PROPN
ihlr-16498	515	40	note	note	VERB
ihlr-16498	515	41	87	87	NUM
ihlr-16498	515	42	,	,	PUNCT
ihlr-16498	515	43	at	at	ADP
ihlr-16498	515	44	17	17	NUM
ihlr-16498	515	45	(	(	PUNCT
ihlr-16498	515	46	statement	statement	NOUN
ihlr-16498	515	47	ofu.s	ofu.s	PROPN
ihlr-16498	515	48	.	.	PUNCT
ihlr-16498	515	49	rep	rep	PROPN
ihlr-16498	515	50	.	.	PROPN
ihlr-16498	515	51	bart	bart	PROPN
ihlr-16498	515	52	stupack	stupack	PROPN
ihlr-16498	515	53	of	of	ADP
ihlr-16498	515	54	michigan	michigan	PROPN
ihlr-16498	515	55	)	)	PUNCT
ihlr-16498	515	56	.	.	PUNCT
ihlr-16498	516	1	116	116	NUM
ihlr-16498	517	1	i	i	PRON
ihlr-16498	517	2	d.	d.	PROPN
ihlr-16498	517	3	(	(	PUNCT
ihlr-16498	517	4	"	"	PUNCT
ihlr-16498	517	5	we	we	PRON
ihlr-16498	517	6	have	have	VERB
ihlr-16498	517	7	it	it	PRON
ihlr-16498	517	8	backwards	backwards	ADV
ihlr-16498	517	9	.	.	PUNCT
ihlr-16498	518	1	the	the	DET
ihlr-16498	518	2	patent	patent	NOUN
ihlr-16498	518	3	extension	extension	NOUN
ihlr-16498	518	4	should	should	AUX
ihlr-16498	518	5	only	only	ADV
ihlr-16498	518	6	occur	occur	VERB
ihlr-16498	518	7	if	if	SCONJ
ihlr-16498	518	8	the	the	DET
ihlr-16498	518	9	drug	drug	NOUN
ihlr-16498	518	10	is	be	AUX
ihlr-16498	518	11	safe	safe	ADJ
ihlr-16498	518	12	,	,	PUNCT
ihlr-16498	518	13	effective	effective	ADJ
ihlr-16498	518	14	and	and	CCONJ
ihlr-16498	518	15	after	after	SCONJ
ihlr-16498	518	16	the	the	DET
ihlr-16498	518	17	necessary	necessary	ADJ
ihlr-16498	518	18	label	label	NOUN
ihlr-16498	518	19	changes	change	NOUN
ihlr-16498	518	20	are	be	AUX
ihlr-16498	518	21	fully	fully	ADV
ihlr-16498	518	22	implemented	implement	VERB
ihlr-16498	518	23	.	.	PUNCT
ihlr-16498	519	1	then	then	ADV
ihlr-16498	519	2	,	,	PUNCT
ihlr-16498	519	3	and	and	CCONJ
ihlr-16498	519	4	only	only	ADV
ihlr-16498	519	5	then	then	ADV
ihlr-16498	519	6	,	,	PUNCT
ihlr-16498	519	7	should	should	AUX
ihlr-16498	519	8	a	a	DET
ihlr-16498	519	9	patent	patent	NOUN
ihlr-16498	519	10	extension	extension	NOUN
ihlr-16498	519	11	be	be	AUX
ihlr-16498	519	12	granted	grant	VERB
ihlr-16498	519	13	.	.	PUNCT
ihlr-16498	519	14	"	"	PUNCT
ihlr-16498	519	15	)	)	PUNCT
ihlr-16498	519	16	.	.	PUNCT
ihlr-16498	520	1	117	117	NUM
ihlr-16498	520	2	149	149	NUM
ihlr-16498	520	3	cong	cong	NOUN
ihlr-16498	520	4	.	.	PUNCT
ihlr-16498	521	1	rec	rec	PROPN
ihlr-16498	521	2	.	.	PUNCT
ihlr-16498	522	1	hll567	hll567	PROPN
ihlr-16498	522	2	,	,	PUNCT
ihlr-16498	522	3	hll57l	hll57l	PROPN
ihlr-16498	522	4	(	(	PUNCT
ihlr-16498	522	5	2003	2003	NUM
ihlr-16498	522	6	)	)	PUNCT
ihlr-16498	522	7	(	(	PUNCT
ihlr-16498	522	8	statement	statement	NOUN
ihlr-16498	522	9	ofu.s	ofu.s	PROPN
ihlr-16498	522	10	.	.	PUNCT
ihlr-16498	522	11	rep	rep	PROPN
ihlr-16498	522	12	.	.	PROPN
ihlr-16498	522	13	bart	bart	PROPN
ihlr-16498	522	14	stupack	stupack	PROPN
ihlr-16498	522	15	of	of	ADP
ihlr-16498	522	16	michigan	michigan	PROPN
ihlr-16498	522	17	)	)	PUNCT
ihlr-16498	522	18	.	.	PUNCT
ihlr-16498	523	1	118	118	NUM
ihlr-16498	523	2	i	i	NOUN
ihlr-16498	523	3	d	d	PROPN
ihlr-16498	523	4	(	(	PUNCT
ihlr-16498	523	5	"	"	PUNCT
ihlr-16498	523	6	as	as	SCONJ
ihlr-16498	523	7	we	we	PRON
ihlr-16498	523	8	said	say	VERB
ihlr-16498	523	9	earlier	early	ADV
ihlr-16498	523	10	,	,	PUNCT
ihlr-16498	523	11	the	the	DET
ihlr-16498	523	12	best	good	ADJ
ihlr-16498	523	13	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	523	14	act	act	NOUN
ihlr-16498	523	15	of2002	of2002	NOUN
ihlr-16498	523	16	did	do	AUX
ihlr-16498	523	17	require	require	VERB
ihlr-16498	523	18	a	a	DET
ihlr-16498	523	19	strengthen­	strengthen­	PROPN
ihlr-16498	523	20	ing	ing	ADJ
ihlr-16498	523	21	oflabeling	oflabeling	NOUN
ihlr-16498	523	22	requirements	requirement	NOUN
ihlr-16498	523	23	,	,	PUNCT
ihlr-16498	523	24	but	but	CCONJ
ihlr-16498	523	25	it	it	PRON
ihlr-16498	523	26	did	do	AUX
ihlr-16498	523	27	not	not	PART
ihlr-16498	523	28	mandate	mandate	VERB
ihlr-16498	523	29	proper	proper	ADJ
ihlr-16498	523	30	labeling	labeling	NOUN
ihlr-16498	523	31	before	before	ADP
ihlr-16498	523	32	marketing	market	VERB
ihlr-16498	523	33	ofthese	ofthese	ADJ
ihlr-16498	523	34	drugs	drug	NOUN
ihlr-16498	523	35	.	.	PUNCT
ihlr-16498	523	36	"	"	PUNCT
ihlr-16498	523	37	)	)	PUNCT
ihlr-16498	523	38	.	.	PUNCT
ihlr-16498	524	1	119	119	NUM
ihlr-16498	524	2	21	21	NUM
ihlr-16498	524	3	c.f.r	c.f.r	NOUN
ihlr-16498	524	4	.	.	PUNCT
ihlr-16498	525	1	§	§	PROPN
ihlr-16498	525	2	§	§	PROPN
ihlr-16498	525	3	201	201	NUM
ihlr-16498	525	4	-	-	SYM
ihlr-16498	525	5	202	202	NUM
ihlr-16498	525	6	(	(	PUNCT
ihlr-16498	525	7	2002	2002	NUM
ihlr-16498	525	8	)	)	PUNCT
ihlr-16498	525	9	;	;	PUNCT
ihlr-16498	525	10	see	see	VERB
ihlr-16498	525	11	labson	labson	NOUN
ihlr-16498	525	12	,	,	PUNCT
ihlr-16498	525	13	supra	supra	PROPN
ihlr-16498	525	14	note	note	NOUN
ihlr-16498	525	15	39	39	NUM
ihlr-16498	525	16	,	,	PUNCT
ihlr-16498	525	17	at	at	ADP
ihlr-16498	525	18	39	39	NUM
ihlr-16498	525	19	-	-	SYM
ihlr-16498	525	20	41	41	NUM
ihlr-16498	525	21	(	(	PUNCT
ihlr-16498	525	22	describing	describe	VERB
ihlr-16498	525	23	the	the	DET
ihlr-16498	525	24	labeling	labeling	NOUN
ihlr-16498	525	25	requirements	requirement	NOUN
ihlr-16498	525	26	)	)	PUNCT
ihlr-16498	525	27	.	.	PUNCT
ihlr-16498	526	1	2007	2007	NUM
ihlr-16498	526	2	]	]	PUNCT
ihlr-16498	526	3	reforming	reform	VERB
ihlr-16498	526	4	fda	fda	PROPN
ihlr-16498	526	5	policy	policy	NOUN
ihlr-16498	526	6	for	for	ADP
ihlr-16498	526	7	pediatric	pediatric	ADJ
ihlr-16498	526	8	testing	testing	NOUN
ihlr-16498	526	9	81	81	NUM
ihlr-16498	526	10	u	u	NOUN
ihlr-16498	526	11	have	have	AUX
ihlr-16498	526	12	not	not	PART
ihlr-16498	526	13	been	be	AUX
ihlr-16498	526	14	established"120	established"120	ADJ
ihlr-16498	526	15	or	or	CCONJ
ihlr-16498	526	16	"	"	PUNCT
ihlr-16498	526	17	safety	safety	NOUN
ihlr-16498	526	18	and	and	CCONJ
ihlr-16498	526	19	effectiveness	effectiveness	NOUN
ihlr-16498	526	20	in	in	ADP
ihlr-16498	526	21	pediatric	pediatric	ADJ
ihlr-16498	526	22	pa­	pa­	ADJ
ihlr-16498	526	23	tients	tient	NOUN
ihlr-16498	526	24	have	have	AUX
ihlr-16498	526	25	not	not	PART
ihlr-16498	526	26	been	be	AUX
ihlr-16498	526	27	established	establish	VERB
ihlr-16498	526	28	.	.	PUNCT
ihlr-16498	527	1	"121	"121	PROPN
ihlr-16498	527	2	the	the	DET
ihlr-16498	527	3	prea	prea	PROPN
ihlr-16498	527	4	does	do	AUX
ihlr-16498	527	5	not	not	PART
ihlr-16498	527	6	contain	contain	VERB
ihlr-16498	527	7	a	a	DET
ihlr-16498	527	8	provision	provision	NOUN
ihlr-16498	527	9	addressing	address	VERB
ihlr-16498	527	10	proper	proper	ADJ
ihlr-16498	527	11	use	use	NOUN
ihlr-16498	527	12	and	and	CCONJ
ihlr-16498	527	13	label­	label­	PRON
ihlr-16498	527	14	ing	ing	NOUN
ihlr-16498	527	15	prior	prior	ADV
ihlr-16498	527	16	to	to	ADP
ihlr-16498	527	17	marketing	marketing	NOUN
ihlr-16498	527	18	and	and	CCONJ
ihlr-16498	527	19	use	use	NOUN
ihlr-16498	527	20	in	in	ADP
ihlr-16498	527	21	children	child	NOUN
ihlr-16498	527	22	.	.	PUNCT
ihlr-16498	528	1	during	during	ADP
ihlr-16498	528	2	the	the	DET
ihlr-16498	528	3	congressional	congressional	ADJ
ihlr-16498	528	4	hearings	hearing	NOUN
ihlr-16498	528	5	for	for	ADP
ihlr-16498	528	6	the	the	DET
ihlr-16498	528	7	passage	passage	NOUN
ihlr-16498	528	8	of	of	ADP
ihlr-16498	528	9	the	the	DET
ihlr-16498	528	10	prea	prea	PROPN
ihlr-16498	528	11	,	,	PUNCT
ihlr-16498	528	12	representative	representative	ADJ
ihlr-16498	528	13	bart	bart	PROPN
ihlr-16498	528	14	stupack	stupack	PROPN
ihlr-16498	528	15	ofmichigan	ofmichigan	NOUN
ihlr-16498	528	16	stated	state	VERB
ihlr-16498	528	17	:	:	PUNCT
ihlr-16498	528	18	so	so	CCONJ
ihlr-16498	528	19	before	before	SCONJ
ihlr-16498	528	20	a	a	DET
ihlr-16498	528	21	drug	drug	NOUN
ihlr-16498	528	22	is	be	AUX
ihlr-16498	528	23	marketed	market	VERB
ihlr-16498	528	24	,	,	PUNCT
ihlr-16498	528	25	it	it	PRON
ihlr-16498	528	26	should	should	AUX
ihlr-16498	528	27	be	be	AUX
ihlr-16498	528	28	properly	properly	ADV
ihlr-16498	528	29	labeled	label	VERB
ihlr-16498	528	30	with	with	ADP
ihlr-16498	528	31	all	all	DET
ihlr-16498	528	32	the	the	DET
ihlr-16498	528	33	necessary	necessary	ADJ
ihlr-16498	528	34	information	information	NOUN
ihlr-16498	528	35	to	to	PART
ihlr-16498	528	36	be	be	AUX
ihlr-16498	528	37	used	use	VERB
ihlr-16498	528	38	in	in	ADP
ihlr-16498	528	39	pediatric	pediatric	ADJ
ihlr-16498	528	40	pa­	pa­	ADJ
ihlr-16498	528	41	tients	tient	NOUN
ihlr-16498	528	42	.	.	PUNCT
ihlr-16498	529	1	doctors	doctor	NOUN
ihlr-16498	529	2	and	and	CCONJ
ihlr-16498	529	3	patients	patient	NOUN
ihlr-16498	529	4	and	and	CCONJ
ihlr-16498	529	5	families	family	NOUN
ihlr-16498	529	6	have	have	VERB
ihlr-16498	529	7	no	no	DET
ihlr-16498	529	8	idea	idea	NOUN
ihlr-16498	529	9	on	on	ADP
ihlr-16498	529	10	how	how	SCONJ
ihlr-16498	529	11	to	to	PART
ihlr-16498	529	12	administer	administer	VERB
ihlr-16498	529	13	drugs	drug	NOUN
ihlr-16498	529	14	or	or	CCONJ
ihlr-16498	529	15	what	what	PRON
ihlr-16498	529	16	the	the	DET
ihlr-16498	529	17	effect	effect	NOUN
ihlr-16498	529	18	will	will	AUX
ihlr-16498	529	19	be	be	AUX
ihlr-16498	529	20	on	on	ADP
ihlr-16498	529	21	young	young	ADJ
ihlr-16498	529	22	people	people	NOUN
ihlr-16498	529	23	without	without	ADP
ihlr-16498	529	24	proper	proper	ADJ
ihlr-16498	529	25	labeling	labeling	NOUN
ihlr-16498	529	26	.	.	PUNCT
ihlr-16498	530	1	all	all	PRON
ihlr-16498	530	2	i	i	PRON
ihlr-16498	530	3	am	be	AUX
ihlr-16498	530	4	saying	say	VERB
ihlr-16498	530	5	is	be	AUX
ihlr-16498	530	6	we	we	PRON
ihlr-16498	530	7	should	should	AUX
ihlr-16498	530	8	have	have	AUX
ihlr-16498	530	9	had	have	VERB
ihlr-16498	530	10	an	an	DET
ihlr-16498	530	11	opportunity	opportunity	NOUN
ihlr-16498	530	12	to	to	PART
ihlr-16498	530	13	amend	amend	VERB
ihlr-16498	530	14	this	this	DET
ihlr-16498	530	15	legislation	legislation	NOUN
ihlr-16498	530	16	to	to	PART
ihlr-16498	530	17	make	make	VERB
ihlr-16498	530	18	sure	sure	ADJ
ihlr-16498	530	19	be­	be­	PUNCT
ihlr-16498	530	20	fore	fore	NOUN
ihlr-16498	530	21	a	a	DET
ihlr-16498	530	22	patent	patent	NOUN
ihlr-16498	530	23	is	be	AUX
ihlr-16498	530	24	extended	extend	VERB
ihlr-16498	530	25	,	,	PUNCT
ihlr-16498	530	26	before	before	SCONJ
ihlr-16498	530	27	a	a	DET
ihlr-16498	530	28	drug	drug	NOUN
ihlr-16498	530	29	is	be	AUX
ihlr-16498	530	30	given	give	VERB
ihlr-16498	530	31	for	for	ADP
ihlr-16498	530	32	pediatric	pediatric	ADJ
ihlr-16498	530	33	patients	patient	NOUN
ihlr-16498	530	34	,	,	PUNCT
ihlr-16498	530	35	that	that	SCONJ
ihlr-16498	530	36	the	the	DET
ihlr-16498	530	37	proper	proper	ADJ
ihlr-16498	530	38	labeling	labeling	NOUN
ihlr-16498	530	39	is	be	AUX
ihlr-16498	530	40	done	do	VERB
ihlr-16498	530	41	and	and	CCONJ
ihlr-16498	530	42	made	make	VERB
ihlr-16498	530	43	available	available	ADJ
ihlr-16498	530	44	to	to	ADP
ihlr-16498	530	45	doctors	doctor	NOUN
ihlr-16498	530	46	,	,	PUNCT
ihlr-16498	530	47	patients	patient	NOUN
ihlr-16498	530	48	,	,	PUNCT
ihlr-16498	530	49	and	and	CCONJ
ihlr-16498	530	50	their	their	PRON
ihlr-16498	530	51	families	family	NOUN
ihlr-16498	530	52	.	.	PUNCT
ihlr-16498	531	1	it	it	PRON
ihlr-16498	531	2	is	be	AUX
ihlr-16498	531	3	marketed	market	VERB
ihlr-16498	531	4	and	and	CCONJ
ihlr-16498	531	5	given	give	VERB
ihlr-16498	531	6	to	to	ADP
ihlr-16498	531	7	children	child	NOUN
ihlr-16498	531	8	before	before	SCONJ
ihlr-16498	531	9	we	we	PRON
ihlr-16498	531	10	know	know	VERB
ihlr-16498	531	11	what	what	PRON
ihlr-16498	531	12	the	the	DET
ihlr-16498	531	13	effects	effect	NOUN
ihlr-16498	531	14	are	be	AUX
ihlr-16498	531	15	on	on	ADP
ihlr-16498	531	16	young	young	ADJ
ihlr-16498	531	17	people	people	NOUN
ihlr-16498	531	18	.	.	PUNCT
ihlr-16498	532	1	122	122	NUM
ihlr-16498	532	2	one	one	NUM
ihlr-16498	532	3	of	of	ADP
ihlr-16498	532	4	the	the	DET
ihlr-16498	532	5	main	main	ADJ
ihlr-16498	532	6	reasons	reason	NOUN
ihlr-16498	532	7	for	for	ADP
ihlr-16498	532	8	the	the	DET
ihlr-16498	532	9	need	need	NOUN
ihlr-16498	532	10	for	for	ADP
ihlr-16498	532	11	pediatric	pediatric	ADJ
ihlr-16498	532	12	testing	testing	NOUN
ihlr-16498	532	13	is	be	AUX
ihlr-16498	532	14	that	that	SCONJ
ihlr-16498	532	15	physi­	physi­	PROPN
ihlr-16498	532	16	cians	cian	NOUN
ihlr-16498	532	17	were	be	AUX
ihlr-16498	532	18	"	"	PUNCT
ihlr-16498	532	19	dosing	dose	VERB
ihlr-16498	532	20	down	down	ADP
ihlr-16498	532	21	"	"	PUNCT
ihlr-16498	532	22	prescriptions	prescription	NOUN
ihlr-16498	532	23	for	for	ADP
ihlr-16498	532	24	children	child	NOUN
ihlr-16498	532	25	based	base	VERB
ihlr-16498	532	26	on	on	ADP
ihlr-16498	532	27	body	body	NOUN
ihlr-16498	532	28	weight.123	weight.123	PROPN
ihlr-16498	532	29	but	but	CCONJ
ihlr-16498	532	30	"	"	PUNCT
ihlr-16498	532	31	dosing	dose	VERB
ihlr-16498	532	32	down	down	ADP
ihlr-16498	532	33	"	"	PUNCT
ihlr-16498	532	34	from	from	ADP
ihlr-16498	532	35	a	a	DET
ihlr-16498	532	36	whole	whole	ADJ
ihlr-16498	532	37	tablet	tablet	NOUN
ihlr-16498	532	38	to	to	ADP
ihlr-16498	532	39	a	a	DET
ihlr-16498	532	40	half	half	NOUN
ihlr-16498	532	41	a	a	DET
ihlr-16498	532	42	tablet	tablet	NOUN
ihlr-16498	532	43	,	,	PUNCT
ihlr-16498	532	44	for	for	ADP
ihlr-16498	532	45	example	example	NOUN
ihlr-16498	532	46	,	,	PUNCT
ihlr-16498	532	47	may	may	AUX
ihlr-16498	532	48	not	not	PART
ihlr-16498	532	49	be	be	AUX
ihlr-16498	532	50	the	the	DET
ihlr-16498	532	51	appropriate	appropriate	ADJ
ihlr-16498	532	52	dosageor	dosageor	NOUN
ihlr-16498	532	53	even	even	ADV
ihlr-16498	532	54	a	a	DET
ihlr-16498	532	55	safe	safe	ADJ
ihlr-16498	532	56	medication	medication	NOUN
ihlr-16498	532	57	for	for	ADP
ihlr-16498	532	58	a	a	DET
ihlr-16498	532	59	child	child	NOUN
ihlr-16498	532	60	.	.	PUNCT
ihlr-16498	533	1	indeed	indeed	ADV
ihlr-16498	533	2	,	,	PUNCT
ihlr-16498	533	3	the	the	DET
ihlr-16498	533	4	reason	reason	NOUN
ihlr-16498	533	5	for	for	ADP
ihlr-16498	533	6	this	this	PRON
ihlr-16498	533	7	is	be	AUX
ihlr-16498	533	8	that	that	SCONJ
ihlr-16498	533	9	children	child	NOUN
ihlr-16498	533	10	are	be	AUX
ihlr-16498	533	11	still	still	ADV
ihlr-16498	533	12	developing	develop	VERB
ihlr-16498	533	13	and	and	CCONJ
ihlr-16498	533	14	may	may	AUX
ihlr-16498	533	15	have	have	VERB
ihlr-16498	533	16	different	different	ADJ
ihlr-16498	533	17	bio­	bio­	NOUN
ihlr-16498	533	18	chemical	chemical	NOUN
ihlr-16498	533	19	reactions	reaction	NOUN
ihlr-16498	533	20	to	to	ADP
ihlr-16498	533	21	any	any	DET
ihlr-16498	533	22	particular	particular	ADJ
ihlr-16498	533	23	drug	drug	NOUN
ihlr-16498	533	24	,	,	PUNCT
ihlr-16498	533	25	whether	whether	SCONJ
ihlr-16498	533	26	it	it	PRON
ihlr-16498	533	27	is	be	AUX
ihlr-16498	533	28	a	a	DET
ihlr-16498	533	29	full	full	ADJ
ihlr-16498	533	30	dose	dose	NOUN
ihlr-16498	533	31	or	or	CCONJ
ihlr-16498	533	32	a	a	DET
ihlr-16498	533	33	partial	partial	ADJ
ihlr-16498	533	34	dose	dose	NOUN
ihlr-16498	533	35	,	,	PUNCT
ihlr-16498	533	36	and	and	CCONJ
ihlr-16498	533	37	"	"	PUNCT
ihlr-16498	533	38	dosing	dose	VERB
ihlr-16498	533	39	down	down	ADP
ihlr-16498	533	40	"	"	PUNCT
ihlr-16498	533	41	may	may	AUX
ihlr-16498	533	42	be	be	AUX
ihlr-16498	533	43	ineffective	ineffective	ADJ
ihlr-16498	533	44	or	or	CCONJ
ihlr-16498	533	45	potentially	potentially	ADV
ihlr-16498	533	46	harmful	harmful	ADJ
ihlr-16498	533	47	.	.	PUNCT
ihlr-16498	534	1	a	a	DET
ihlr-16498	534	2	pediatric	pediatric	ADJ
ihlr-16498	534	3	clinical	clinical	ADJ
ihlr-16498	534	4	trial	trial	NOUN
ihlr-16498	534	5	should	should	AUX
ihlr-16498	534	6	determine	determine	VERB
ihlr-16498	534	7	both	both	DET
ihlr-16498	534	8	the	the	DET
ihlr-16498	534	9	safety	safety	NOUN
ihlr-16498	534	10	of	of	ADP
ihlr-16498	534	11	the	the	DET
ihlr-16498	534	12	drug	drug	NOUN
ihlr-16498	534	13	and	and	CCONJ
ihlr-16498	534	14	the	the	DET
ihlr-16498	534	15	optimal	optimal	ADJ
ihlr-16498	534	16	dose	dose	NOUN
ihlr-16498	534	17	and	and	CCONJ
ihlr-16498	534	18	these	these	PRON
ihlr-16498	534	19	should	should	AUX
ihlr-16498	534	20	be	be	AUX
ihlr-16498	534	21	reflected	reflect	VERB
ihlr-16498	534	22	on	on	ADP
ihlr-16498	534	23	the	the	DET
ihlr-16498	534	24	label	label	NOUN
ihlr-16498	534	25	so	so	SCONJ
ihlr-16498	534	26	a	a	DET
ihlr-16498	534	27	physician	physician	NOUN
ihlr-16498	534	28	can	can	AUX
ihlr-16498	534	29	prescribe	prescribe	VERB
ihlr-16498	534	30	a	a	DET
ihlr-16498	534	31	drug	drug	NOUN
ihlr-16498	534	32	correctly	correctly	ADV
ihlr-16498	534	33	.	.	PUNCT
ihlr-16498	535	1	to	to	PART
ihlr-16498	535	2	address	address	VERB
ihlr-16498	535	3	this	this	DET
ihlr-16498	535	4	problem	problem	NOUN
ihlr-16498	535	5	,	,	PUNCT
ihlr-16498	535	6	a	a	DET
ihlr-16498	535	7	stricter	strict	ADJ
ihlr-16498	535	8	time	time	NOUN
ihlr-16498	535	9	frame	frame	NOUN
ihlr-16498	535	10	for	for	ADP
ihlr-16498	535	11	safe	safe	ADJ
ihlr-16498	535	12	and	and	CCONJ
ihlr-16498	535	13	effective	effective	ADJ
ihlr-16498	535	14	drugs	drug	NOUN
ihlr-16498	535	15	should	should	AUX
ihlr-16498	535	16	be	be	AUX
ihlr-16498	535	17	implemented	implement	VERB
ihlr-16498	535	18	to	to	PART
ihlr-16498	535	19	comply	comply	VERB
ihlr-16498	535	20	with	with	ADP
ihlr-16498	535	21	labeling	labeling	NOUN
ihlr-16498	535	22	requirements	requirement	NOUN
ihlr-16498	535	23	.	.	PUNCT
ihlr-16498	536	1	moreover	moreover	ADV
ihlr-16498	536	2	,	,	PUNCT
ihlr-16498	536	3	if	if	SCONJ
ihlr-16498	536	4	the	the	DET
ihlr-16498	536	5	results	result	NOUN
ihlr-16498	536	6	of	of	ADP
ihlr-16498	536	7	a	a	DET
ihlr-16498	536	8	clinical	clinical	ADJ
ihlr-16498	536	9	trial	trial	NOUN
ihlr-16498	536	10	are	be	AUX
ihlr-16498	536	11	inconclusive	inconclusive	ADJ
ihlr-16498	536	12	or	or	CCONJ
ihlr-16498	536	13	negative	negative	ADJ
ihlr-16498	536	14	,	,	PUNCT
ihlr-16498	536	15	the	the	DET
ihlr-16498	536	16	labeling	labeling	NOUN
ihlr-16498	536	17	changes	change	NOUN
ihlr-16498	536	18	should	should	AUX
ihlr-16498	536	19	reflect	reflect	VERB
ihlr-16498	536	20	these	these	DET
ihlr-16498	536	21	results	result	NOUN
ihlr-16498	536	22	immediately	immediately	ADV
ihlr-16498	536	23	.	.	PUNCT
ihlr-16498	537	1	for	for	ADP
ihlr-16498	537	2	example	example	NOUN
ihlr-16498	537	3	,	,	PUNCT
ihlr-16498	537	4	if	if	SCONJ
ihlr-16498	537	5	a	a	DET
ihlr-16498	537	6	clinical	clinical	ADJ
ihlr-16498	537	7	trial	trial	NOUN
ihlr-16498	537	8	is	be	AUX
ihlr-16498	537	9	conducted	conduct	VERB
ihlr-16498	537	10	for	for	ADP
ihlr-16498	537	11	an	an	DET
ihlr-16498	537	12	antidepressant	antidepressant	ADJ
ihlr-16498	537	13	drug	drug	NOUN
ihlr-16498	537	14	and	and	CCONJ
ihlr-16498	537	15	the	the	DET
ihlr-16498	537	16	results	result	NOUN
ihlr-16498	537	17	show	show	VERB
ihlr-16498	537	18	the	the	DET
ihlr-16498	537	19	drug	drug	NOUN
ihlr-16498	537	20	is	be	AUX
ihlr-16498	537	21	safe	safe	ADJ
ihlr-16498	537	22	but	but	CCONJ
ihlr-16498	537	23	not	not	PART
ihlr-16498	537	24	effective	effective	ADJ
ihlr-16498	537	25	,	,	PUNCT
ihlr-16498	537	26	the	the	DET
ihlr-16498	537	27	label	label	NOUN
ihlr-16498	537	28	should	should	AUX
ihlr-16498	537	29	reflect	reflect	VERB
ihlr-16498	537	30	this	this	DET
ihlr-16498	537	31	result	result	NOUN
ihlr-16498	537	32	.	.	PUNCT
ihlr-16498	538	1	124	124	NUM
ihlr-16498	538	2	the	the	DET
ihlr-16498	538	3	label	label	NOUN
ihlr-16498	538	4	120	120	NUM
ihlr-16498	538	5	specific	specific	ADJ
ihlr-16498	538	6	requirements	requirement	NOUN
ihlr-16498	538	7	on	on	ADP
ihlr-16498	538	8	content	content	NOUN
ihlr-16498	538	9	and	and	CCONJ
ihlr-16498	538	10	fonnat	fonnat	NOUN
ihlr-16498	538	11	of	of	ADP
ihlr-16498	538	12	labeling	labeling	NOUN
ihlr-16498	538	13	for	for	ADP
ihlr-16498	538	14	human	human	ADJ
ihlr-16498	538	15	prescription	prescription	NOUN
ihlr-16498	538	16	drugs	drug	NOUN
ihlr-16498	538	17	,	,	PUNCT
ihlr-16498	538	18	21	21	NUM
ihlr-16498	538	19	c.f.r	c.f.r	NOUN
ihlr-16498	538	20	.	.	PUNCT
ihlr-16498	539	1	§	§	PROPN
ihlr-16498	539	2	201.57(t)(9)(v	201.57(t)(9)(v	NUM
ihlr-16498	539	3	)	)	PUNCT
ihlr-16498	539	4	(	(	PUNCT
ihlr-16498	539	5	2002	2002	NUM
ihlr-16498	539	6	)	)	PUNCT
ihlr-16498	539	7	;	;	PUNCT
ihlr-16498	539	8	see	see	VERB
ihlr-16498	539	9	labson	labson	NOUN
ihlr-16498	539	10	,	,	PUNCT
ihlr-16498	539	11	supra	supra	PROPN
ihlr-16498	539	12	note	note	NOUN
ihlr-16498	539	13	39	39	NUM
ihlr-16498	539	14	,	,	PUNCT
ihlr-16498	539	15	at	at	ADP
ihlr-16498	539	16	40	40	NUM
ihlr-16498	539	17	.	.	PUNCT
ihlr-16498	540	1	121	121	NUM
ihlr-16498	540	2	21	21	NUM
ihlr-16498	540	3	c.p.r.§	c.p.r.§	NOUN
ihlr-16498	540	4	201.57(t)(9)(vi	201.57(t)(9)(vi	NUM
ihlr-16498	540	5	)	)	PUNCT
ihlr-16498	540	6	;	;	PUNCT
ihlr-16498	540	7	see	see	VERB
ihlr-16498	540	8	labson	labson	NOUN
ihlr-16498	540	9	,	,	PUNCT
ihlr-16498	540	10	supra	supra	PROPN
ihlr-16498	540	11	note	note	NOUN
ihlr-16498	540	12	39	39	NUM
ihlr-16498	540	13	,	,	PUNCT
ihlr-16498	540	14	at	at	ADP
ihlr-16498	540	15	40	40	NUM
ihlr-16498	540	16	.	.	PUNCT
ihlr-16498	541	1	122	122	NUM
ihlr-16498	541	2	149	149	NUM
ihlr-16498	541	3	cong	cong	NOUN
ihlr-16498	541	4	.	.	PUNCT
ihlr-16498	542	1	r.ec	r.ec	PROPN
ihlr-16498	542	2	.	.	PROPN
ihlr-16498	542	3	hl1567	hl1567	PROPN
ihlr-16498	542	4	,	,	PUNCT
ihlr-16498	542	5	hl157l	hl157l	PROPN
ihlr-16498	542	6	(	(	PUNCT
ihlr-16498	542	7	2003	2003	NUM
ihlr-16498	542	8	)	)	PUNCT
ihlr-16498	542	9	(	(	PUNCT
ihlr-16498	542	10	statement	statement	NOUN
ihlr-16498	542	11	of	of	ADP
ihlr-16498	542	12	u.s	u.s	PROPN
ihlr-16498	542	13	.	.	PROPN
ihlr-16498	542	14	rep	rep	PROPN
ihlr-16498	542	15	.	.	PROPN
ihlr-16498	542	16	bart	bart	PROPN
ihlr-16498	542	17	stupack	stupack	PROPN
ihlr-16498	542	18	of	of	ADP
ihlr-16498	542	19	michigan	michigan	PROPN
ihlr-16498	542	20	)	)	PUNCT
ihlr-16498	542	21	.	.	PUNCT
ihlr-16498	543	1	123	123	NUM
ihlr-16498	543	2	groopman	groopman	NOUN
ihlr-16498	543	3	,	,	PUNCT
ihlr-16498	543	4	supra	supra	PROPN
ihlr-16498	543	5	note	note	NOUN
ihlr-16498	543	6	1	1	NUM
ihlr-16498	543	7	.	.	X
ihlr-16498	543	8	124	124	NUM
ihlr-16498	543	9	hearing	hearing	NOUN
ihlr-16498	543	10	on	on	ADP
ihlr-16498	543	11	antidepressant	antidepressant	ADJ
ihlr-16498	543	12	pediatric	pediatric	ADJ
ihlr-16498	543	13	trials	trial	NOUN
ihlr-16498	543	14	,	,	PUNCT
ihlr-16498	543	15	supra	supra	PROPN
ihlr-16498	543	16	note	note	VERB
ihlr-16498	543	17	87	87	NUM
ihlr-16498	543	18	,	,	PUNCT
ihlr-16498	543	19	at	at	ADP
ihlr-16498	543	20	17	17	NUM
ihlr-16498	543	21	(	(	PUNCT
ihlr-16498	543	22	statement	statement	NOUN
ihlr-16498	543	23	ofu.s	ofu.s	PROPN
ihlr-16498	543	24	.	.	PUNCT
ihlr-16498	543	25	rep	rep	PROPN
ihlr-16498	543	26	.	.	PROPN
ihlr-16498	543	27	bart	bart	PROPN
ihlr-16498	543	28	stupack	stupack	PROPN
ihlr-16498	543	29	of	of	ADP
ihlr-16498	543	30	michigan	michigan	PROPN
ihlr-16498	543	31	)	)	PUNCT
ihlr-16498	543	32	(	(	PUNCT
ihlr-16498	543	33	"	"	PUNCT
ihlr-16498	543	34	remember	remember	VERB
ihlr-16498	543	35	,	,	PUNCT
ihlr-16498	543	36	each	each	DET
ihlr-16498	543	37	patent	patent	NOUN
ihlr-16498	543	38	extension	extension	NOUN
ihlr-16498	543	39	often	often	ADV
ihlr-16498	543	40	means	mean	VERB
ihlr-16498	543	41	hundreds	hundred	NOUN
ihlr-16498	543	42	of	of	ADP
ihlr-16498	543	43	millions	million	NOUN
ihlr-16498	543	44	of	of	ADP
ihlr-16498	543	45	dollars	dollar	NOUN
ihlr-16498	543	46	to	to	ADP
ihlr-16498	543	47	the	the	DET
ihlr-16498	543	48	drug	drug	NOUN
ihlr-16498	543	49	companies	company	NOUN
ihlr-16498	543	50	.	.	PUNCT
ihlr-16498	544	1	this	this	DET
ihlr-16498	544	2	systematic	systematic	ADJ
ihlr-16498	544	3	flaw	flaw	NOUN
ihlr-16498	544	4	that	that	PRON
ihlr-16498	544	5	rewards	reward	VERB
ihlr-16498	544	6	companies	company	NOUN
ihlr-16498	544	7	for	for	ADP
ihlr-16498	544	8	do­	do­	VERB
ihlr-16498	544	9	ing	e	VERB
ihlr-16498	544	10	a	a	DET
ihlr-16498	544	11	study	study	NOUN
ihlr-16498	544	12	,	,	PUNCT
ihlr-16498	544	13	the	the	DET
ihlr-16498	544	14	results	result	NOUN
ihlr-16498	544	15	of	of	ADP
ihlr-16498	544	16	which	which	PRON
ihlr-16498	544	17	are	be	AUX
ihlr-16498	544	18	not	not	PART
ihlr-16498	544	19	made	make	VERB
ihlr-16498	544	20	public	public	ADJ
ihlr-16498	544	21	,	,	PUNCT
ihlr-16498	544	22	which	which	PRON
ihlr-16498	544	23	may	may	AUX
ihlr-16498	544	24	show	show	VERB
ihlr-16498	544	25	the	the	DET
ihlr-16498	544	26	drug	drug	NOUN
ihlr-16498	544	27	is	be	AUX
ihlr-16498	544	28	not	not	PART
ihlr-16498	544	29	effective	effective	ADJ
ihlr-16498	544	30	and	and	CCONJ
ihlr-16498	544	31	actually	actually	ADV
ihlr-16498	544	32	may	may	AUX
ihlr-16498	544	33	harm	harm	VERB
ihlr-16498	544	34	young	young	ADJ
ihlr-16498	544	35	people	people	NOUN
ihlr-16498	544	36	and	and	CCONJ
ihlr-16498	544	37	the	the	DET
ihlr-16498	544	38	consumers	consumer	NOUN
ihlr-16498	544	39	'	'	PART
ihlr-16498	544	40	notice	notice	NOUN
ihlr-16498	544	41	,	,	PUNCT
ihlr-16498	544	42	the	the	DET
ihlr-16498	544	43	package	package	NOUN
ihlr-16498	544	44	labeling	labeling	NOUN
ihlr-16498	544	45	is	be	AUX
ihlr-16498	544	46	not	not	PART
ihlr-16498	544	47	inlmediately	inlmediately	ADV
ihlr-16498	544	48	changed	change	VERB
ihlr-16498	544	49	.	.	PUNCT
ihlr-16498	544	50	"	"	PUNCT
ihlr-16498	544	51	)	)	PUNCT
ihlr-16498	545	1	82	82	NUM
ihlr-16498	545	2	indiana	indiana	PROPN
ihlr-16498	545	3	health	health	PROPN
ihlr-16498	545	4	law	law	PROPN
ihlr-16498	545	5	review	review	NOUN
ihlr-16498	545	6	[	[	X
ihlr-16498	545	7	vol	vol	NOUN
ihlr-16498	545	8	.	.	PUNCT
ihlr-16498	545	9	4:59	4:59	NUM
ihlr-16498	545	10	could	could	AUX
ihlr-16498	545	11	say	say	VERB
ihlr-16498	545	12	;	;	PUNCT
ihlr-16498	545	13	"	"	PUNCT
ihlr-16498	545	14	the	the	DET
ihlr-16498	545	15	results	result	NOUN
ihlr-16498	545	16	of	of	ADP
ihlr-16498	545	17	a	a	DET
ihlr-16498	545	18	clinical	clinical	ADJ
ihlr-16498	545	19	trial	trial	NOUN
ihlr-16498	545	20	show	show	VERB
ihlr-16498	545	21	that	that	SCONJ
ihlr-16498	545	22	this	this	DET
ihlr-16498	545	23	drug	drug	NOUN
ihlr-16498	545	24	may	may	AUX
ihlr-16498	545	25	be	be	AUX
ihlr-16498	545	26	safe	safe	ADJ
ihlr-16498	545	27	,	,	PUNCT
ihlr-16498	545	28	but	but	CCONJ
ihlr-16498	545	29	not	not	PART
ihlr-16498	545	30	effective	effective	ADJ
ihlr-16498	545	31	,	,	PUNCT
ihlr-16498	545	32	for	for	ADP
ihlr-16498	545	33	use	use	NOUN
ihlr-16498	545	34	in	in	ADP
ihlr-16498	545	35	pediatric	pediatric	ADJ
ihlr-16498	545	36	populations	population	NOUN
ihlr-16498	545	37	.	.	PUNCT
ihlr-16498	545	38	"	"	PUNCT
ihlr-16498	546	1	in	in	ADP
ihlr-16498	546	2	this	this	DET
ihlr-16498	546	3	way	way	NOUN
ihlr-16498	546	4	,	,	PUNCT
ihlr-16498	546	5	the	the	DET
ihlr-16498	546	6	physician	physician	NOUN
ihlr-16498	546	7	is	be	AUX
ihlr-16498	546	8	edu­	edu­	VERB
ihlr-16498	546	9	cated	cat	VERB
ihlr-16498	546	10	about	about	ADP
ihlr-16498	546	11	the	the	DET
ihlr-16498	546	12	drug	drug	NOUN
ihlr-16498	546	13	's	's	PART
ihlr-16498	546	14	potential	potential	ADJ
ihlr-16498	546	15	benefits	benefit	NOUN
ihlr-16498	546	16	or.lack	or.lack	ADV
ihlr-16498	546	17	thereof	thereof	ADV
ihlr-16498	546	18	.	.	PUNCT
ihlr-16498	547	1	this	this	PRON
ihlr-16498	547	2	will	will	AUX
ihlr-16498	547	3	give	give	VERB
ihlr-16498	547	4	phar­	phar­	NOUN
ihlr-16498	547	5	maceutical	maceutical	ADJ
ihlr-16498	547	6	companies	company	NOUN
ihlr-16498	547	7	an	an	DET
ihlr-16498	547	8	incentive	incentive	NOUN
ihlr-16498	547	9	to	to	PART
ihlr-16498	547	10	conduct	conduct	VERB
ihlr-16498	547	11	additional	additional	ADJ
ihlr-16498	547	12	clinical	clinical	ADJ
ihlr-16498	547	13	trials	trial	NOUN
ihlr-16498	547	14	to	to	PART
ihlr-16498	547	15	determine	determine	VERB
ihlr-16498	547	16	effectiveness	effectiveness	NOUN
ihlr-16498	547	17	and	and	CCONJ
ihlr-16498	547	18	thereby	thereby	ADV
ihlr-16498	547	19	use	use	VERB
ihlr-16498	547	20	in	in	ADP
ihlr-16498	547	21	pediatric	pediatric	ADJ
ihlr-16498	547	22	populations	population	NOUN
ihlr-16498	547	23	.	.	PUNCT
ihlr-16498	548	1	alternatively	alternatively	ADV
ihlr-16498	548	2	,	,	PUNCT
ihlr-16498	548	3	pharmaceutical	pharmaceutical	ADJ
ihlr-16498	548	4	companies	company	NOUN
ihlr-16498	548	5	may	may	AUX
ihlr-16498	548	6	not	not	PART
ihlr-16498	548	7	want	want	VERB
ihlr-16498	548	8	to	to	PART
ihlr-16498	548	9	conduct	conduct	VERB
ihlr-16498	548	10	pediatric	pediatric	ADJ
ihlr-16498	548	11	trials	trial	NOUN
ihlr-16498	548	12	due	due	ADP
ihlr-16498	548	13	to	to	ADP
ihlr-16498	548	14	their	their	PRON
ihlr-16498	548	15	high	high	ADJ
ihlr-16498	548	16	cost	cost	NOUN
ihlr-16498	548	17	and	and	CCONJ
ihlr-16498	548	18	the	the	DET
ihlr-16498	548	19	possibility	possibility	NOUN
ihlr-16498	548	20	of	of	ADP
ihlr-16498	548	21	negative	negative	ADJ
ihlr-16498	548	22	results	result	NOUN
ihlr-16498	548	23	.	.	PUNCT
ihlr-16498	549	1	but	but	CCONJ
ihlr-16498	549	2	,	,	PUNCT
ihlr-16498	549	3	if	if	SCONJ
ihlr-16498	549	4	the	the	DET
ihlr-16498	549	5	fda	fda	PROPN
ihlr-16498	549	6	determines	determine	VERB
ihlr-16498	549	7	that	that	SCONJ
ihlr-16498	549	8	the	the	DET
ihlr-16498	549	9	drug	drug	NOUN
ihlr-16498	549	10	is	be	AUX
ihlr-16498	549	11	important	important	ADJ
ihlr-16498	549	12	for	for	ADP
ihlr-16498	549	13	use	use	NOUN
ihlr-16498	549	14	in	in	ADP
ihlr-16498	549	15	children	child	NOUN
ihlr-16498	549	16	,	,	PUNCT
ihlr-16498	549	17	then	then	ADV
ihlr-16498	549	18	the	the	DET
ihlr-16498	549	19	drug	drug	NOUN
ihlr-16498	549	20	company	company	NOUN
ihlr-16498	549	21	may	may	AUX
ihlr-16498	549	22	be	be	AUX
ihlr-16498	549	23	required	require	VERB
ihlr-16498	549	24	to	to	PART
ihlr-16498	549	25	conduct	conduct	VERB
ihlr-16498	549	26	the	the	DET
ihlr-16498	549	27	tests	test	NOUN
ihlr-16498	549	28	.	.	PUNCT
ihlr-16498	550	1	d.	d.	PROPN
ihlr-16498	550	2	the	the	DET
ihlr-16498	550	3	fda	fda	PROPN
ihlr-16498	550	4	should	should	AUX
ihlr-16498	550	5	implement	implement	VERB
ihlr-16498	550	6	additional	additional	ADJ
ihlr-16498	550	7	post	post	ADJ
ihlr-16498	550	8	-	-	ADJ
ihlr-16498	550	9	approval	approval	ADJ
ihlr-16498	550	10	surveillance	surveillance	NOUN
ihlr-16498	550	11	mechanisms	mechanism	NOUN
ihlr-16498	550	12	the	the	DET
ihlr-16498	550	13	fda	fda	PROPN
ihlr-16498	550	14	can	can	AUX
ihlr-16498	550	15	approve	approve	VERB
ihlr-16498	550	16	the	the	DET
ihlr-16498	550	17	use	use	NOUN
ihlr-16498	550	18	of	of	ADP
ihlr-16498	550	19	a	a	DET
ihlr-16498	550	20	drug	drug	NOUN
ihlr-16498	550	21	for	for	ADP
ihlr-16498	550	22	children	child	NOUN
ihlr-16498	550	23	based	base	VERB
ihlr-16498	550	24	on	on	ADP
ihlr-16498	550	25	the	the	DET
ihlr-16498	550	26	results	result	NOUN
ihlr-16498	550	27	of	of	ADP
ihlr-16498	550	28	a	a	DET
ihlr-16498	550	29	pediatric	pediatric	ADJ
ihlr-16498	550	30	clinical	clinical	ADJ
ihlr-16498	550	31	trial	trial	NOUN
ihlr-16498	550	32	,	,	PUNCT
ihlr-16498	550	33	but	but	CCONJ
ihlr-16498	550	34	the	the	DET
ihlr-16498	550	35	clinical	clinical	ADJ
ihlr-16498	550	36	trials	trial	NOUN
ihlr-16498	550	37	may	may	AUX
ihlr-16498	550	38	not	not	PART
ihlr-16498	550	39	cover	cover	VERB
ihlr-16498	550	40	all	all	DET
ihlr-16498	550	41	age	age	NOUN
ihlr-16498	550	42	groups	group	NOUN
ihlr-16498	550	43	or	or	CCONJ
ihlr-16498	550	44	reveal	reveal	VERB
ihlr-16498	550	45	long	long	ADJ
ihlr-16498	550	46	-	-	PUNCT
ihlr-16498	550	47	term	term	NOUN
ihlr-16498	550	48	side	side	NOUN
ihlr-16498	550	49	effects	effect	NOUN
ihlr-16498	550	50	.	.	PUNCT
ihlr-16498	551	1	one	one	NUM
ihlr-16498	551	2	of	of	ADP
ihlr-16498	551	3	the	the	DET
ihlr-16498	551	4	biggest	big	ADJ
ihlr-16498	551	5	challenges	challenge	NOUN
ihlr-16498	551	6	in	in	ADP
ihlr-16498	551	7	evaluating	evaluate	VERB
ihlr-16498	551	8	pedi­	pedi­	NOUN
ihlr-16498	551	9	atric	atric	ADJ
ihlr-16498	551	10	populations	population	NOUN
ihlr-16498	551	11	is	be	AUX
ihlr-16498	551	12	the	the	DET
ihlr-16498	551	13	biological	biological	ADJ
ihlr-16498	551	14	immaturity	immaturity	NOUN
ihlr-16498	551	15	of	of	ADP
ihlr-16498	551	16	organs	organ	NOUN
ihlr-16498	551	17	.	.	PUNCT
ihlr-16498	552	1	adolescents	adolescent	NOUN
ihlr-16498	552	2	may	may	AUX
ihlr-16498	552	3	have	have	VERB
ihlr-16498	552	4	very	very	ADV
ihlr-16498	552	5	different	different	ADJ
ihlr-16498	552	6	biological	biological	ADJ
ihlr-16498	552	7	reactions	reaction	NOUN
ihlr-16498	552	8	than	than	ADP
ihlr-16498	552	9	toddlers	toddler	NOUN
ihlr-16498	552	10	.	.	PUNCT
ihlr-16498	553	1	in	in	ADP
ihlr-16498	553	2	addition	addition	NOUN
ihlr-16498	553	3	,	,	PUNCT
ihlr-16498	553	4	finding	find	VERB
ihlr-16498	553	5	large	large	ADJ
ihlr-16498	553	6	sample	sample	NOUN
ihlr-16498	553	7	sizes	size	NOUN
ihlr-16498	553	8	of	of	ADP
ihlr-16498	553	9	children	child	NOUN
ihlr-16498	553	10	in	in	ADP
ihlr-16498	553	11	a	a	DET
ihlr-16498	553	12	variety	variety	NOUN
ihlr-16498	553	13	of	of	ADP
ihlr-16498	553	14	age	age	NOUN
ihlr-16498	553	15	ranges	range	VERB
ihlr-16498	553	16	makes	make	VERB
ihlr-16498	553	17	conducting	conduct	VERB
ihlr-16498	553	18	clinical	clinical	ADJ
ihlr-16498	553	19	trials	trial	NOUN
ihlr-16498	553	20	across	across	ADP
ihlr-16498	553	21	an	an	DET
ihlr-16498	553	22	eighteen	eighteen	NUM
ihlr-16498	553	23	-	-	PUNCT
ihlr-16498	553	24	plus	plus	CCONJ
ihlr-16498	553	25	year	year	NOUN
ihlr-16498	553	26	age	age	NOUN
ihlr-16498	553	27	span	span	VERB
ihlr-16498	553	28	extremely	extremely	ADV
ihlr-16498	553	29	challenging	challenging	ADJ
ihlr-16498	553	30	.	.	PUNCT
ihlr-16498	554	1	thus	thus	ADV
ihlr-16498	554	2	,	,	PUNCT
ihlr-16498	554	3	post­	post­	NOUN
ihlr-16498	554	4	approval	approval	NOUN
ihlr-16498	554	5	surveillance	surveillance	NOUN
ihlr-16498	554	6	in	in	ADP
ihlr-16498	554	7	pediatric	pediatric	ADJ
ihlr-16498	554	8	populations	population	NOUN
ihlr-16498	554	9	will	will	AUX
ihlr-16498	554	10	be	be	AUX
ihlr-16498	554	11	a	a	DET
ihlr-16498	554	12	critical	critical	ADJ
ihlr-16498	554	13	source	source	NOUN
ihlr-16498	554	14	of	of	ADP
ihlr-16498	554	15	safety	safety	NOUN
ihlr-16498	554	16	and	and	CCONJ
ihlr-16498	554	17	efficacy	efficacy	NOUN
ihlr-16498	554	18	information	information	NOUN
ihlr-16498	554	19	.	.	PUNCT
ihlr-16498	555	1	the	the	DET
ihlr-16498	555	2	prea	prea	PROPN
ihlr-16498	555	3	is	be	AUX
ihlr-16498	555	4	a	a	DET
ihlr-16498	555	5	step	step	NOUN
ihlr-16498	555	6	in	in	ADP
ihlr-16498	555	7	the	the	DET
ihlr-16498	555	8	right	right	ADJ
ihlr-16498	555	9	direction	direction	NOUN
ihlr-16498	555	10	for	for	ADP
ihlr-16498	555	11	follow	follow	VERB
ihlr-16498	555	12	-	-	PUNCT
ihlr-16498	555	13	up	up	ADP
ihlr-16498	555	14	studies	study	NOUN
ihlr-16498	555	15	in	in	ADP
ihlr-16498	555	16	pediatric	pediatric	ADJ
ihlr-16498	555	17	populations	population	NOUN
ihlr-16498	555	18	;	;	PUNCT
ihlr-16498	555	19	however	however	ADV
ihlr-16498	555	20	,	,	PUNCT
ihlr-16498	555	21	it	it	PRON
ihlr-16498	555	22	still	still	ADV
ihlr-16498	555	23	suffers	suffer	VERB
ihlr-16498	555	24	from	from	ADP
ihlr-16498	555	25	some	some	PRON
ihlr-16498	555	26	of	of	ADP
ihlr-16498	555	27	the	the	DET
ihlr-16498	555	28	same	same	ADJ
ihlr-16498	555	29	flaws	flaw	NOUN
ihlr-16498	555	30	seen	see	VERB
ihlr-16498	555	31	in	in	ADP
ihlr-16498	555	32	the	the	DET
ihlr-16498	555	33	complete	complete	ADJ
ihlr-16498	555	34	fda	fda	PROPN
ihlr-16498	555	35	post	post	PROPN
ihlr-16498	555	36	-	-	ADJ
ihlr-16498	555	37	approval	approval	ADJ
ihlr-16498	555	38	regulatory	regulatory	ADJ
ihlr-16498	555	39	scheme	scheme	NOUN
ihlr-16498	555	40	.	.	PUNCT
ihlr-16498	556	1	first	first	ADV
ihlr-16498	556	2	,	,	PUNCT
ihlr-16498	556	3	medwatch	medwatch	PROPN
ihlr-16498	556	4	is	be	AUX
ihlr-16498	556	5	a	a	DET
ihlr-16498	556	6	volun­	volun­	PROPN
ihlr-16498	556	7	tary	tary	ADJ
ihlr-16498	556	8	reporting	reporting	NOUN
ihlr-16498	556	9	system	system	NOUN
ihlr-16498	556	10	that	that	PRON
ihlr-16498	556	11	allows	allow	VERB
ihlr-16498	556	12	physicians	physician	NOUN
ihlr-16498	556	13	to	to	PART
ihlr-16498	556	14	report	report	VERB
ihlr-16498	556	15	anecdotal	anecdotal	ADJ
ihlr-16498	556	16	information	information	NOUN
ihlr-16498	556	17	about	about	ADP
ihlr-16498	556	18	a	a	DET
ihlr-16498	556	19	particular	particular	ADJ
ihlr-16498	556	20	drug	drug	NOUN
ihlr-16498	556	21	.	.	PUNCT
ihlr-16498	557	1	125	125	NUM
ihlr-16498	557	2	medw	medw	NOUN
ihlr-16498	557	3	atch	atch	NOUN
ihlr-16498	557	4	is	be	AUX
ihlr-16498	557	5	a	a	DET
ihlr-16498	557	6	passive	passive	ADJ
ihlr-16498	557	7	system	system	NOUN
ihlr-16498	557	8	for	for	ADP
ihlr-16498	557	9	physician	physician	NOUN
ihlr-16498	557	10	report­	report­	PART
ihlr-16498	557	11	ing	ing	NOUN
ihlr-16498	557	12	,	,	PUNCT
ihlr-16498	557	13	and	and	CCONJ
ihlr-16498	557	14	it	it	PRON
ihlr-16498	557	15	is	be	AUX
ihlr-16498	557	16	unclear	unclear	ADJ
ihlr-16498	557	17	whether	whether	SCONJ
ihlr-16498	557	18	it	it	PRON
ihlr-16498	557	19	provides	provide	VERB
ihlr-16498	557	20	the	the	DET
ihlr-16498	557	21	appropriate	appropriate	ADJ
ihlr-16498	557	22	breadth	breadth	NOUN
ihlr-16498	557	23	of	of	ADP
ihlr-16498	557	24	information	information	NOUN
ihlr-16498	557	25	for	for	ADP
ihlr-16498	557	26	the	the	DET
ihlr-16498	557	27	fda	fda	PROPN
ihlr-16498	557	28	to	to	PART
ihlr-16498	557	29	determine	determine	VERB
ihlr-16498	557	30	the	the	DET
ihlr-16498	557	31	potentially	potentially	ADV
ihlr-16498	557	32	deleterious	deleterious	ADJ
ihlr-16498	557	33	safety	safety	NOUN
ihlr-16498	557	34	and	and	CCONJ
ihlr-16498	557	35	efficacy	efficacy	NOUN
ihlr-16498	557	36	prob­	prob­	NOUN
ihlr-16498	557	37	lems	lem	NOUN
ihlr-16498	557	38	of	of	ADP
ihlr-16498	557	39	approved	approve	VERB
ihlr-16498	557	40	drugs	drug	NOUN
ihlr-16498	557	41	.	.	PUNCT
ihlr-16498	558	1	126	126	NUM
ihlr-16498	558	2	second	second	ADJ
ihlr-16498	558	3	,	,	PUNCT
ihlr-16498	558	4	the	the	DET
ihlr-16498	558	5	fda	fda	PROPN
ihlr-16498	558	6	suffers	suffer	VERB
ihlr-16498	558	7	from	from	ADP
ihlr-16498	558	8	an	an	DET
ihlr-16498	558	9	internal	internal	ADJ
ihlr-16498	558	10	structural	structural	ADJ
ihlr-16498	558	11	dilemma	dilemma	NOUN
ihlr-16498	558	12	.	.	PUNCT
ihlr-16498	559	1	the	the	DET
ihlr-16498	559	2	center	center	NOUN
ihlr-16498	559	3	for	for	ADP
ihlr-16498	559	4	drug	drug	NOUN
ihlr-16498	559	5	evaluation	evaluation	NOUN
ihlr-16498	559	6	and	and	CCONJ
ihlr-16498	559	7	research	research	NOUN
ihlr-16498	559	8	(	(	PUNCT
ihlr-16498	559	9	"	"	PUNCT
ihlr-16498	559	10	cder	cder	NOUN
ihlr-16498	559	11	"	"	PUNCT
ihlr-16498	559	12	)	)	PUNCT
ihlr-16498	559	13	is	be	AUX
ihlr-16498	559	14	the	the	DET
ihlr-16498	559	15	part	part	NOUN
ihlr-16498	559	16	of	of	ADP
ihlr-16498	559	17	the	the	DET
ihlr-16498	559	18	agency	agency	NOUN
ihlr-16498	559	19	responsible	responsible	ADJ
ihlr-16498	559	20	for	for	ADP
ihlr-16498	559	21	drug	drug	NOUN
ihlr-16498	559	22	approval	approval	NOUN
ihlr-16498	559	23	.	.	PUNCT
ihlr-16498	560	1	sitting	sit	VERB
ihlr-16498	560	2	below	below	ADP
ihlr-16498	560	3	the	the	DET
ihlr-16498	560	4	coer	coer	NOUN
ihlr-16498	560	5	is	be	AUX
ihlr-16498	560	6	the	the	DET
ihlr-16498	560	7	office	office	NOUN
ihlr-16498	560	8	of	of	ADP
ihlr-16498	560	9	drug	drug	NOUN
ihlr-16498	560	10	safety	safety	NOUN
ihlr-16498	560	11	.	.	PUNCT
ihlr-16498	561	1	once	once	SCONJ
ihlr-16498	561	2	the	the	DET
ihlr-16498	561	3	cder	cder	NOUN
ihlr-16498	561	4	approves	approve	VERB
ihlr-16498	561	5	a	a	DET
ihlr-16498	561	6	drug	drug	NOUN
ihlr-16498	561	7	,	,	PUNCT
ihlr-16498	561	8	some	some	PRON
ihlr-16498	561	9	hypothesize	hypothesize	NOUN
ihlr-16498	561	10	that	that	SCONJ
ihlr-16498	561	11	tension	tension	NOUN
ihlr-16498	561	12	exists	exist	VERB
ihlr-16498	561	13	,	,	PUNCT
ihlr-16498	561	14	based	base	VERB
ihlr-16498	561	15	on	on	ADP
ihlr-16498	561	16	the	the	DET
ihlr-16498	561	17	hierarchy	hierarchy	NOUN
ihlr-16498	561	18	,	,	PUNCT
ihlr-16498	561	19	and	and	CCONJ
ihlr-16498	561	20	it	it	PRON
ihlr-16498	561	21	may	may	AUX
ihlr-16498	561	22	be	be	AUX
ihlr-16498	561	23	difficult	difficult	ADJ
ihlr-16498	561	24	for	for	SCONJ
ihlr-16498	561	25	the	the	DET
ihlr-16498	561	26	office	office	NOUN
ihlr-16498	561	27	of	of	ADP
ihlr-16498	561	28	drug	drug	NOUN
ihlr-16498	561	29	safety	safety	NOUN
ihlr-16498	561	30	to	to	PART
ihlr-16498	561	31	invalidate	invalidate	VERB
ihlr-16498	561	32	the	the	DET
ihlr-16498	561	33	previous	previous	ADJ
ihlr-16498	561	34	approval.127	approval.127	NOUN
ihlr-16498	561	35	finally	finally	ADV
ihlr-16498	561	36	,	,	PUNCT
ihlr-16498	561	37	the	the	DET
ihlr-16498	561	38	drug	drug	NOUN
ihlr-16498	561	39	companies	company	NOUN
ihlr-16498	561	40	125	125	NUM
ihlr-16498	561	41	see	see	VERB
ihlr-16498	561	42	u.s	u.s	PROPN
ihlr-16498	561	43	.	.	PROPN
ihlr-16498	561	44	dep't	dep't	PROPN
ihlr-16498	561	45	health	health	PROPN
ihlr-16498	561	46	&	&	CCONJ
ihlr-16498	561	47	human	human	PROPN
ihlr-16498	561	48	servs	servs	PROPN
ihlr-16498	561	49	.	.	PUNCT
ihlr-16498	561	50	,	,	PUNCT
ihlr-16498	561	51	medwatch	medwatch	ADJ
ihlr-16498	561	52	:	:	PUNCT
ihlr-16498	561	53	the	the	DET
ihlr-16498	561	54	fda	fda	PROPN
ihlr-16498	561	55	safety	safety	NOUN
ihlr-16498	561	56	information	information	NOUN
ihlr-16498	561	57	and	and	CCONJ
ihlr-16498	561	58	adverse	adverse	ADJ
ihlr-16498	561	59	event	event	NOUN
ihlr-16498	561	60	reporting	reporting	NOUN
ihlr-16498	561	61	program	program	NOUN
ihlr-16498	561	62	,	,	PUNCT
ihlr-16498	561	63	form	form	VERB
ihlr-16498	561	64	fda	fda	PROPN
ihlr-16498	561	65	3500	3500	NUM
ihlr-16498	561	66	(	(	PUNCT
ihlr-16498	561	67	oct	oct	PROPN
ihlr-16498	561	68	.	.	PROPN
ihlr-16498	561	69	2005	2005	NUM
ihlr-16498	561	70	)	)	PUNCT
ihlr-16498	561	71	available	available	ADJ
ihlr-16498	561	72	at	at	ADP
ihlr-16498	561	73	http://www.fda.gov/medwatch/safety/3500.pdf(form	http://www.fda.gov/medwatch/safety/3500.pdf(form	NOUN
ihlr-16498	561	74	used	use	VERB
ihlr-16498	561	75	to	to	PART
ihlr-16498	561	76	voluntarily	voluntarily	ADV
ihlr-16498	561	77	report	report	VERB
ihlr-16498	561	78	adverse	adverse	ADJ
ihlr-16498	561	79	events	event	NOUN
ihlr-16498	561	80	and	and	CCONJ
ihlr-16498	561	81	product	product	NOUN
ihlr-16498	561	82	problems	problem	NOUN
ihlr-16498	561	83	under	under	ADP
ihlr-16498	561	84	the	the	DET
ihlr-16498	561	85	medwatch	medwatch	ADJ
ihlr-16498	561	86	program	program	NOUN
ihlr-16498	561	87	)	)	PUNCT
ihlr-16498	561	88	.	.	PUNCT
ihlr-16498	562	1	126	126	NUM
ihlr-16498	562	2	phil	phil	PROPN
ihlr-16498	562	3	b.	b.	PROPN
ihlr-16498	562	4	fontanarosa	fontanarosa	PROPN
ihlr-16498	562	5	,	,	PUNCT
ihlr-16498	562	6	drummond	drummond	PROPN
ihlr-16498	562	7	rennie	rennie	PROPN
ihlr-16498	562	8	&	&	CCONJ
ihlr-16498	562	9	catherine	catherine	PROPN
ihlr-16498	562	10	d.	d.	PROPN
ihlr-16498	562	11	deangelis	deangelis	PROPN
ihlr-16498	562	12	,	,	PUNCT
ihlr-16498	562	13	postmarketing	postmarkete	VERB
ihlr-16498	562	14	surveillancelack	surveillancelack	NOUN
ihlr-16498	562	15	of	of	ADP
ihlr-16498	562	16	vigilance	vigilance	NOUN
ihlr-16498	562	17	,	,	PUNCT
ihlr-16498	562	18	lack	lack	NOUN
ihlr-16498	562	19	of	of	ADP
ihlr-16498	562	20	trust	trust	NOUN
ihlr-16498	562	21	,	,	PUNCT
ihlr-16498	562	22	292	292	NUM
ihlr-16498	562	23	j.	j.	PROPN
ihlr-16498	562	24	am	am	PROPN
ihlr-16498	562	25	.	.	PUNCT
ihlr-16498	562	26	med	med	PROPN
ihlr-16498	562	27	.	.	PUNCT
ihlr-16498	563	1	ass'n	ass'n	ADP
ihlr-16498	563	2	2647	2647	NUM
ihlr-16498	563	3	,	,	PUNCT
ihlr-16498	563	4	2647	2647	NUM
ihlr-16498	563	5	,	,	PUNCT
ihlr-16498	563	6	2649	2649	NUM
ihlr-16498	563	7	(	(	PUNCT
ihlr-16498	563	8	2004	2004	NUM
ihlr-16498	563	9	)	)	PUNCT
ihlr-16498	563	10	(	(	PUNCT
ihlr-16498	563	11	describing	describe	VERB
ihlr-16498	563	12	medwatch	medwatch	NOUN
ihlr-16498	563	13	as	as	ADP
ihlr-16498	563	14	a	a	DET
ihlr-16498	563	15	passive	passive	ADJ
ihlr-16498	563	16	collection	collection	NOUN
ihlr-16498	563	17	system	system	NOUN
ihlr-16498	563	18	)	)	PUNCT
ihlr-16498	563	19	;	;	PUNCT
ihlr-16498	563	20	see	see	VERB
ihlr-16498	563	21	also	also	ADV
ihlr-16498	563	22	groopman	groopman	NOUN
ihlr-16498	563	23	,	,	PUNCT
ihlr-16498	563	24	supra	supra	PROPN
ihlr-16498	563	25	note	note	NOUN
ihlr-16498	563	26	1	1	NUM
ihlr-16498	563	27	,	,	PUNCT
ihlr-16498	563	28	at35	at35	PROPN
ihlr-16498	563	29	-	-	PUNCT
ihlr-16498	563	30	6	6	NUM
ihlr-16498	563	31	.	.	X
ihlr-16498	563	32	127	127	NUM
ihlr-16498	563	33	richard	richard	PROPN
ihlr-16498	563	34	horton	horton	PROPN
ihlr-16498	563	35	,	,	PUNCT
ihlr-16498	563	36	vioxx	vioxx	PROPN
ihlr-16498	563	37	,	,	PUNCT
ihlr-16498	563	38	the	the	DET
ihlr-16498	563	39	implosion	implosion	NOUN
ihlr-16498	563	40	of	of	ADP
ihlr-16498	563	41	merck	merck	NOUN
ihlr-16498	563	42	,	,	PUNCT
ihlr-16498	563	43	and	and	CCONJ
ihlr-16498	563	44	aftershocks	aftershock	NOUN
ihlr-16498	563	45	at	at	ADP
ihlr-16498	563	46	the	the	DET
ihlr-16498	563	47	fda	fda	PROPN
ihlr-16498	563	48	,	,	PUNCT
ihlr-16498	563	49	3641im	3641im	PROPN
ihlr-16498	563	50	lancet	lancet	VERB
ihlr-16498	563	51	1995	1995	NUM
ihlr-16498	563	52	,	,	PUNCT
ihlr-16498	563	53	1995	1995	NUM
ihlr-16498	563	54	(	(	PUNCT
ihlr-16498	563	55	2004	2004	NUM
ihlr-16498	563	56	)	)	PUNCT
ihlr-16498	563	57	(	(	PUNCT
ihlr-16498	563	58	describing	describe	VERB
ihlr-16498	563	59	the	the	DET
ihlr-16498	563	60	inherent	inherent	ADJ
ihlr-16498	563	61	flaws	flaw	NOUN
ihlr-16498	563	62	in	in	ADP
ihlr-16498	563	63	the	the	DET
ihlr-16498	563	64	fda	fda	PROPN
ihlr-16498	563	65	regulatory	regulatory	ADJ
ihlr-16498	563	66	scheme	scheme	NOUN
ihlr-16498	563	67	)	)	PUNCT
ihlr-16498	563	68	.	.	PUNCT
ihlr-16498	564	1	2007	2007	NUM
ihlr-16498	564	2	)	)	PUNCT
ihlr-16498	564	3	reforming	reform	VERB
ihlr-16498	564	4	fda	fda	PROPN
ihlr-16498	564	5	poucy	poucy	NOUN
ihlr-16498	564	6	for	for	ADP
ihlr-16498	564	7	pedia1ric	pedia1ric	ADV
ihlr-16498	564	8	testing	test	VERB
ihlr-16498	564	9	83	83	NUM
ihlr-16498	564	10	have	have	VERB
ihlr-16498	564	11	little	little	ADJ
ihlr-16498	564	12	incentive	incentive	NOUN
ihlr-16498	564	13	to	to	PART
ihlr-16498	564	14	conduct	conduct	VERB
ihlr-16498	564	15	and	and	CCONJ
ihlr-16498	564	16	report	report	VERB
ihlr-16498	564	17	clinical	clinical	ADJ
ihlr-16498	564	18	trials	trial	NOUN
ihlr-16498	564	19	that	that	PRON
ihlr-16498	564	20	would	would	AUX
ihlr-16498	564	21	show	show	VERB
ihlr-16498	564	22	ad­	ad­	ADJ
ihlr-16498	564	23	verse	verse	NOUN
ihlr-16498	564	24	drug	drug	NOUN
ihlr-16498	564	25	reactions	reaction	NOUN
ihlr-16498	564	26	.	.	PUNCT
ihlr-16498	565	1	in	in	ADP
ihlr-16498	565	2	order	order	NOUN
ihlr-16498	565	3	to	to	PART
ihlr-16498	565	4	protect	protect	VERB
ihlr-16498	565	5	their	their	PRON
ihlr-16498	565	6	economic	economic	ADJ
ihlr-16498	565	7	interests	interest	NOUN
ihlr-16498	565	8	,	,	PUNCT
ihlr-16498	565	9	drug	drug	NOUN
ihlr-16498	565	10	compa­	compa­	NOUN
ihlr-16498	565	11	nies	ny	NOUN
ihlr-16498	565	12	may	may	AUX
ihlr-16498	565	13	either	either	CCONJ
ihlr-16498	565	14	not	not	PART
ihlr-16498	565	15	conduct	conduct	VERB
ihlr-16498	565	16	additional	additional	ADJ
ihlr-16498	565	17	clinical	clinical	ADJ
ihlr-16498	565	18	trials	trial	NOUN
ihlr-16498	565	19	or	or	CCONJ
ihlr-16498	565	20	use	use	VERB
ihlr-16498	565	21	subversive	subversive	ADJ
ihlr-16498	565	22	tactics	tactic	NOUN
ihlr-16498	565	23	to	to	PART
ihlr-16498	565	24	cover	cover	VERB
ihlr-16498	565	25	up	up	ADP
ihlr-16498	565	26	negative	negative	ADJ
ihlr-16498	565	27	information.128	information.128	ADP
ihlr-16498	565	28	the	the	DET
ihlr-16498	565	29	specific	specific	ADJ
ihlr-16498	565	30	pediatric	pediatric	ADJ
ihlr-16498	565	31	problems	problem	NOUN
ihlr-16498	565	32	must	must	AUX
ihlr-16498	565	33	be	be	AUX
ihlr-16498	565	34	addressed	address	VERB
ihlr-16498	565	35	by	by	ADP
ihlr-16498	565	36	the	the	DET
ihlr-16498	565	37	fda	fda	PROPN
ihlr-16498	565	38	.	.	PUNCT
ihlr-16498	566	1	specifi­	specifi­	PROPN
ihlr-16498	566	2	cally	cally	ADV
ihlr-16498	566	3	,	,	PUNCT
ihlr-16498	566	4	the	the	DET
ihlr-16498	566	5	fda	fda	PROPN
ihlr-16498	566	6	should	should	AUX
ihlr-16498	566	7	establish	establish	VERB
ihlr-16498	566	8	a	a	DET
ihlr-16498	566	9	post	post	ADJ
ihlr-16498	566	10	-	-	ADJ
ihlr-16498	566	11	approval	approval	ADJ
ihlr-16498	566	12	surveillance	surveillance	NOUN
ihlr-16498	566	13	mechanism	mechanism	NOUN
ihlr-16498	566	14	that	that	PRON
ihlr-16498	566	15	requires	require	VERB
ihlr-16498	566	16	additional	additional	ADJ
ihlr-16498	566	17	pediatric	pediatric	ADJ
ihlr-16498	566	18	testing	testing	NOUN
ihlr-16498	566	19	,	,	PUNCT
ihlr-16498	566	20	follows	follow	VERB
ihlr-16498	566	21	anecdotal	anecdotal	ADJ
ihlr-16498	566	22	information	information	NOUN
ihlr-16498	566	23	,	,	PUNCT
ihlr-16498	566	24	and	and	CCONJ
ihlr-16498	566	25	uses	use	VERB
ihlr-16498	566	26	information	information	NOUN
ihlr-16498	566	27	gathered	gather	VERB
ihlr-16498	566	28	from	from	ADP
ihlr-16498	566	29	similar	similar	ADJ
ihlr-16498	566	30	agencies	agency	NOUN
ihlr-16498	566	31	in	in	ADP
ihlr-16498	566	32	other	other	ADJ
ihlr-16498	566	33	countries	country	NOUN
ihlr-16498	566	34	.	.	PUNCT
ihlr-16498	567	1	as	as	SCONJ
ihlr-16498	567	2	suggested	suggest	VERB
ihlr-16498	567	3	for	for	ADP
ihlr-16498	567	4	the	the	DET
ihlr-16498	567	5	fda	fda	PROPN
ihlr-16498	567	6	in	in	ADP
ihlr-16498	567	7	general	general	ADJ
ihlr-16498	567	8	,	,	PUNCT
ihlr-16498	567	9	an	an	DET
ihlr-16498	567	10	independent	independent	ADJ
ihlr-16498	567	11	body	body	NOUN
ihlr-16498	567	12	should	should	AUX
ihlr-16498	567	13	exist	exist	VERB
ihlr-16498	567	14	to	to	PART
ihlr-16498	567	15	regulate	regulate	VERB
ihlr-16498	567	16	and	and	CCONJ
ihlr-16498	567	17	monitor	monitor	VERB
ihlr-16498	567	18	post	post	ADJ
ihlr-16498	567	19	-	-	ADJ
ihlr-16498	567	20	approval	approval	ADJ
ihlr-16498	567	21	safety	safety	NOUN
ihlr-16498	567	22	and	and	CCONJ
ihlr-16498	567	23	efficacy	efficacy	NOUN
ihlr-16498	567	24	of	of	ADP
ihlr-16498	567	25	drugs	drug	NOUN
ihlr-16498	567	26	.	.	PUNCT
ihlr-16498	568	1	129	129	NUM
ihlr-16498	568	2	due	due	ADP
ihlr-16498	568	3	to	to	ADP
ihlr-16498	568	4	the	the	DET
ihlr-16498	568	5	recognized	recognize	VERB
ihlr-16498	568	6	niche	niche	NOUN
ihlr-16498	568	7	of	of	ADP
ihlr-16498	568	8	pediatric	pediatric	ADJ
ihlr-16498	568	9	populations	population	NOUN
ihlr-16498	568	10	,	,	PUNCT
ihlr-16498	568	11	an	an	DET
ihlr-16498	568	12	independent	independent	ADJ
ihlr-16498	568	13	"	"	PUNCT
ihlr-16498	568	14	pediatric	pediatric	ADJ
ihlr-16498	568	15	post	post	NOUN
ihlr-16498	568	16	-	-	ADJ
ihlr-16498	568	17	approval	approval	ADJ
ihlr-16498	568	18	surveillance	surveillance	NOUN
ihlr-16498	568	19	safety	safety	NOUN
ihlr-16498	568	20	and	and	CCONJ
ihlr-16498	568	21	efficacy	efficacy	NOUN
ihlr-16498	568	22	office	office	NOUN
ihlr-16498	568	23	"	"	PUNCT
ihlr-16498	568	24	should	should	AUX
ihlr-16498	568	25	be	be	AUX
ihlr-16498	568	26	established	establish	VERB
ihlr-16498	568	27	.	.	PUNCT
ihlr-16498	569	1	this	this	DET
ihlr-16498	569	2	new	new	ADJ
ihlr-16498	569	3	office	office	NOUN
ihlr-16498	569	4	could	could	AUX
ihlr-16498	569	5	address	address	VERB
ihlr-16498	569	6	many	many	ADJ
ihlr-16498	569	7	of	of	ADP
ihlr-16498	569	8	the	the	DET
ihlr-16498	569	9	problems	problem	NOUN
ihlr-16498	569	10	described	describe	VERB
ihlr-16498	569	11	above.130	above.130	NOUN
ihlr-16498	569	12	first	first	ADV
ihlr-16498	569	13	,	,	PUNCT
ihlr-16498	569	14	it	it	PRON
ihlr-16498	569	15	could	could	AUX
ihlr-16498	569	16	specifically	specifically	ADV
ihlr-16498	569	17	enforce	enforce	VERB
ihlr-16498	569	18	post	post	ADJ
ihlr-16498	569	19	-	-	ADJ
ihlr-16498	569	20	approval	approval	ADJ
ihlr-16498	569	21	clinical	clinical	ADJ
ihlr-16498	569	22	trials	trial	NOUN
ihlr-16498	569	23	needed	need	VERB
ihlr-16498	569	24	for	for	ADP
ihlr-16498	569	25	addi­	addi­	ADV
ihlr-16498	569	26	tional	tional	ADJ
ihlr-16498	569	27	age	age	NOUN
ihlr-16498	569	28	groups	group	NOUN
ihlr-16498	569	29	or	or	CCONJ
ihlr-16498	569	30	population	population	NOUN
ihlr-16498	569	31	sizes	size	NOUN
ihlr-16498	569	32	,	,	PUNCT
ihlr-16498	569	33	and	and	CCONJ
ihlr-16498	569	34	congress	congress	PROPN
ihlr-16498	569	35	could	could	AUX
ihlr-16498	569	36	grant	grant	VERB
ihlr-16498	569	37	the	the	DET
ihlr-16498	569	38	new	new	ADJ
ihlr-16498	569	39	office	office	NOUN
ihlr-16498	569	40	the	the	DET
ihlr-16498	569	41	ability	ability	NOUN
ihlr-16498	569	42	to	to	PART
ihlr-16498	569	43	bring	bring	VERB
ihlr-16498	569	44	legal	legal	ADJ
ihlr-16498	569	45	sanctions	sanction	NOUN
ihlr-16498	569	46	against	against	ADP
ihlr-16498	569	47	manufacturers	manufacturer	NOUN
ihlr-16498	569	48	who	who	PRON
ihlr-16498	569	49	fail	fail	VERB
ihlr-16498	569	50	to	to	PART
ihlr-16498	569	51	comply	comply	VERB
ihlr-16498	569	52	with	with	ADP
ihlr-16498	569	53	the	the	DET
ihlr-16498	569	54	mandatory	mandatory	ADJ
ihlr-16498	569	55	post	post	NOUN
ihlr-16498	569	56	-	-	NOUN
ihlr-16498	569	57	approval	approval	NOUN
ihlr-16498	569	58	testing.131	testing.131	NUM
ihlr-16498	569	59	second	second	NOUN
ihlr-16498	569	60	,	,	PUNCT
ihlr-16498	569	61	the	the	DET
ihlr-16498	569	62	office	office	NOUN
ihlr-16498	569	63	could	could	AUX
ihlr-16498	569	64	evaluate	evaluate	VERB
ihlr-16498	569	65	whether	whether	SCONJ
ihlr-16498	569	66	the	the	DET
ihlr-16498	569	67	voluntary	voluntary	ADJ
ihlr-16498	569	68	medwatch	medwatch	NOUN
ihlr-16498	569	69	system	system	NOUN
ihlr-16498	569	70	is	be	AUX
ihlr-16498	569	71	an	an	DET
ihlr-16498	569	72	effective	effective	ADJ
ihlr-16498	569	73	means	mean	NOUN
ihlr-16498	569	74	to	to	PART
ihlr-16498	569	75	monitor	monitor	VERB
ihlr-16498	569	76	post­	post­	NOUN
ihlr-16498	569	77	approval	approval	NOUN
ihlr-16498	569	78	adverse	adverse	ADJ
ihlr-16498	569	79	drug	drug	NOUN
ihlr-16498	569	80	effects	effect	NOUN
ihlr-16498	569	81	.	.	PUNCT
ihlr-16498	570	1	the	the	DET
ihlr-16498	570	2	agency	agency	NOUN
ihlr-16498	570	3	could	could	AUX
ihlr-16498	570	4	also	also	ADV
ihlr-16498	570	5	give	give	VERB
ihlr-16498	570	6	the	the	DET
ihlr-16498	570	7	medwatch	medwatch	ADJ
ihlr-16498	570	8	pro­	pro­	NOUN
ihlr-16498	570	9	gram	gram	NOUN
ihlr-16498	570	10	a	a	DET
ihlr-16498	570	11	"	"	PUNCT
ihlr-16498	570	12	face	face	NOUN
ihlr-16498	570	13	-	-	PUNCT
ihlr-16498	570	14	lift	lift	NOUN
ihlr-16498	570	15	"	"	PUNCT
ihlr-16498	570	16	to	to	PART
ihlr-16498	570	17	allow	allow	VERB
ihlr-16498	570	18	it	it	PRON
ihlr-16498	570	19	to	to	PART
ihlr-16498	570	20	effectively	effectively	ADV
ihlr-16498	570	21	follow	follow	VERB
ihlr-16498	570	22	anecdotal	anecdotal	ADJ
ihlr-16498	570	23	information	information	NOUN
ihlr-16498	570	24	.	.	PUNCT
ihlr-16498	571	1	fi­	fi­	NOUN
ihlr-16498	571	2	nally	nally	ADV
ihlr-16498	571	3	,	,	PUNCT
ihlr-16498	571	4	the	the	DET
ihlr-16498	571	5	new	new	ADJ
ihlr-16498	571	6	office	office	NOUN
ihlr-16498	571	7	could	could	AUX
ihlr-16498	571	8	collaborate	collaborate	VERB
ihlr-16498	571	9	more	more	ADV
ihlr-16498	571	10	closely	closely	ADV
ihlr-16498	571	11	with	with	ADP
ihlr-16498	571	12	its	its	PRON
ihlr-16498	571	13	sister	sister	NOUN
ihlr-16498	571	14	organizations	organization	NOUN
ihlr-16498	571	15	in	in	ADP
ihlr-16498	571	16	other	other	ADJ
ihlr-16498	571	17	countries	country	NOUN
ihlr-16498	571	18	.	.	PUNCT
ihlr-16498	572	1	under	under	ADP
ihlr-16498	572	2	this	this	DET
ihlr-16498	572	3	approach	approach	NOUN
ihlr-16498	572	4	,	,	PUNCT
ihlr-16498	572	5	the	the	DET
ihlr-16498	572	6	fda	fda	PROPN
ihlr-16498	572	7	may	may	AUX
ihlr-16498	572	8	have	have	AUX
ihlr-16498	572	9	reacted	react	VERB
ihlr-16498	572	10	faster	fast	ADV
ihlr-16498	572	11	to	to	ADP
ihlr-16498	572	12	the	the	DET
ihlr-16498	572	13	·	·	PUNCT
ihlr-16498	572	14	needed	need	VERB
ihlr-16498	572	15	ban	ban	NOUN
ihlr-16498	572	16	on	on	ADP
ihlr-16498	572	17	ssris	ssris	NOUN
ihlr-16498	572	18	prescribed	prescribe	VERB
ihlr-16498	572	19	to	to	ADP
ihlr-16498	572	20	pediatric	pediatric	ADJ
ihlr-16498	572	21	populations	population	NOUN
ihlr-16498	572	22	.	.	PUNCT
ihlr-16498	573	1	vi	vi	X
ihlr-16498	573	2	.	.	NOUN
ihlr-16498	573	3	conclusion	conclusion	VERB
ihlr-16498	573	4	the	the	DET
ihlr-16498	573	5	testing	testing	NOUN
ihlr-16498	573	6	of	of	ADP
ihlr-16498	573	7	drugs	drug	NOUN
ihlr-16498	573	8	in	in	ADP
ihlr-16498	573	9	pediatric	pediatric	ADJ
ihlr-16498	573	10	populations	population	NOUN
ihlr-16498	573	11	runs	run	VERB
ihlr-16498	573	12	along	along	ADP
ihlr-16498	573	13	a	a	DET
ihlr-16498	573	14	regulation	regulation	NOUN
ihlr-16498	573	15	con­	con­	NOUN
ihlr-16498	573	16	tinuum	tinuum	NOUN
ihlr-16498	573	17	.	.	PUNCT
ihlr-16498	574	1	first	first	ADV
ihlr-16498	574	2	,	,	PUNCT
ihlr-16498	574	3	drugs	drug	NOUN
ihlr-16498	574	4	that	that	PRON
ihlr-16498	574	5	will	will	AUX
ihlr-16498	574	6	be	be	AUX
ihlr-16498	574	7	used	use	VERB
ihlr-16498	574	8	in	in	ADP
ihlr-16498	574	9	pediatric	pediatric	ADJ
ihlr-16498	574	10	populations	population	NOUN
ihlr-16498	574	11	must	must	AUX
ihlr-16498	574	12	be	be	AUX
ihlr-16498	574	13	identi­	identi­	AUX
ihlr-16498	574	14	fied	fie	VERB
ihlr-16498	574	15	.	.	PUNCT
ihlr-16498	575	1	second	second	ADV
ihlr-16498	575	2	,	,	PUNCT
ihlr-16498	575	3	carefully	carefully	ADV
ihlr-16498	575	4	planned	plan	VERB
ihlr-16498	575	5	and	and	CCONJ
ihlr-16498	575	6	ethical	ethical	ADJ
ihlr-16498	575	7	clinical	clinical	ADJ
ihlr-16498	575	8	trials	trial	NOUN
ihlr-16498	575	9	must	must	AUX
ihlr-16498	575	10	be	be	AUX
ihlr-16498	575	11	conducted	conduct	VERB
ihlr-16498	575	12	.	.	PUNCT
ihlr-16498	576	1	finally	finally	ADV
ihlr-16498	576	2	,	,	PUNCT
ihlr-16498	576	3	post	post	ADJ
ihlr-16498	576	4	-	-	ADJ
ihlr-16498	576	5	approval	approval	ADJ
ihlr-16498	576	6	surveillance	surveillance	NOUN
ihlr-16498	576	7	systems	system	NOUN
ihlr-16498	576	8	should	should	AUX
ihlr-16498	576	9	monitor	monitor	VERB
ihlr-16498	576	10	additional	additional	ADJ
ihlr-16498	576	11	informa­	informa­	PROPN
ihlr-16498	576	12	tion	tion	NOUN
ihlr-16498	576	13	learned	learn	VERB
ihlr-16498	576	14	about	about	ADP
ihlr-16498	576	15	a	a	DET
ihlr-16498	576	16	particular	particular	ADJ
ihlr-16498	576	17	drug	drug	NOUN
ihlr-16498	576	18	.	.	PUNCT
ihlr-16498	577	1	the	the	DET
ihlr-16498	577	2	current	current	ADJ
ihlr-16498	577	3	regulatory	regulatory	ADJ
ihlr-16498	577	4	and	and	CCONJ
ihlr-16498	577	5	legislative	legislative	ADJ
ihlr-16498	577	6	schemes	scheme	NOUN
ihlr-16498	577	7	address	address	VERB
ihlr-16498	577	8	only	only	ADV
ihlr-16498	577	9	parts	part	NOUN
ihlr-16498	577	10	of	of	ADP
ihlr-16498	577	11	the	the	DET
ihlr-16498	577	12	continuum	continuum	NOUN
ihlr-16498	577	13	for	for	ADP
ihlr-16498	577	14	safe	safe	ADJ
ihlr-16498	577	15	and	and	CCONJ
ihlr-16498	577	16	effective	effective	ADJ
ihlr-16498	577	17	drug	drug	NOUN
ihlr-16498	577	18	use	use	NOUN
ihlr-16498	577	19	in	in	ADP
ihlr-16498	577	20	pediatric	pediatric	ADJ
ihlr-16498	577	21	populations	population	NOUN
ihlr-16498	577	22	.	.	PUNCT
ihlr-16498	578	1	new	new	ADJ
ihlr-16498	578	2	policy	policy	NOUN
ihlr-16498	578	3	changes	change	NOUN
ihlr-16498	578	4	must	must	AUX
ihlr-16498	578	5	be	be	AUX
ihlr-16498	578	6	implemented	implement	VERB
ihlr-16498	578	7	to	to	PART
ihlr-16498	578	8	remedy	remedy	VERB
ihlr-16498	578	9	the	the	DET
ihlr-16498	578	10	identified	identify	VERB
ihlr-16498	578	11	deficiencies	deficiency	NOUN
ihlr-16498	578	12	.	.	PUNCT
ihlr-16498	579	1	the	the	DET
ihlr-16498	579	2	policy	policy	NOUN
ihlr-16498	579	3	suggestions	suggestion	NOUN
ihlr-16498	579	4	described	describe	VERB
ihlr-16498	579	5	above	above	ADP
ihlr-16498	579	6	incorporate	incorporate	VERB
ihlr-16498	579	7	suggestions	suggestion	NOUN
ihlr-16498	579	8	made	make	VERB
ihlr-16498	579	9	by	by	ADP
ihlr-16498	579	10	others	other	NOUN
ihlr-16498	579	11	and	and	CCONJ
ihlr-16498	579	12	offer	offer	VERB
ihlr-16498	579	13	important	important	ADJ
ihlr-16498	579	14	improvements	improvement	NOUN
ihlr-16498	579	15	.	.	PUNCT
ihlr-16498	580	1	first	first	ADV
ihlr-16498	580	2	,	,	PUNCT
ihlr-16498	580	3	the	the	DET
ihlr-16498	580	4	dissemination	dissemination	NOUN
ihlr-16498	580	5	of	of	ADP
ihlr-16498	580	6	informa­	informa­	PROPN
ihlr-16498	580	7	tion	tion	NOUN
ihlr-16498	580	8	through	through	ADP
ihlr-16498	580	9	public	public	ADJ
ihlr-16498	580	10	databases	database	NOUN
ihlr-16498	580	11	will	will	AUX
ihlr-16498	580	12	provide	provide	VERB
ihlr-16498	580	13	the	the	DET
ihlr-16498	580	14	medical	medical	ADJ
ihlr-16498	580	15	community	community	NOUN
ihlr-16498	580	16	with	with	ADP
ihlr-16498	580	17	impor128	impor128	PROPN
ihlr-16498	580	18	fontanarosa	fontanarosa	PROPN
ihlr-16498	580	19	,	,	PUNCT
ihlr-16498	580	20	rennie	rennie	PROPN
ihlr-16498	580	21	&	&	CCONJ
ihlr-16498	580	22	deangelis	deangelis	PROPN
ihlr-16498	580	23	,	,	PUNCT
ihlr-16498	580	24	supra	supra	PROPN
ihlr-16498	580	25	note	note	PROPN
ihlr-16498	580	26	126	126	NUM
ihlr-16498	580	27	,	,	PUNCT
ihlr-16498	580	28	at	at	ADP
ihlr-16498	580	29	2649	2649	NUM
ihlr-16498	580	30	(	(	PUNCT
ihlr-16498	580	31	noting	note	VERB
ihlr-16498	580	32	the	the	DET
ihlr-16498	580	33	industry	industry	NOUN
ihlr-16498	580	34	's	's	PART
ihlr-16498	580	35	for­	for­	PROPN
ihlr-16498	580	36	profit	profit	NOUN
ihlr-16498	580	37	motivations	motivation	NOUN
ihlr-16498	580	38	)	)	PUNCT
ihlr-16498	580	39	.	.	PUNCT
ihlr-16498	581	1	129	129	NUM
ihlr-16498	581	2	!	!	PUNCT
ihlr-16498	582	1	d.	d.	PROPN
ihlr-16498	582	2	(	(	PUNCT
ihlr-16498	582	3	discussing	discuss	VERB
ihlr-16498	582	4	the	the	DET
ihlr-16498	582	5	establishment	establishment	NOUN
ihlr-16498	582	6	of	of	ADP
ihlr-16498	582	7	an	an	DET
ihlr-16498	582	8	independent	independent	ADJ
ihlr-16498	582	9	agency	agency	NOUN
ihlr-16498	582	10	for	for	ADP
ihlr-16498	582	11	drug	drug	NOUN
ihlr-16498	582	12	safety	safety	NOUN
ihlr-16498	582	13	)	)	PUNCT
ihlr-16498	582	14	.	.	PUNCT
ihlr-16498	583	1	130	130	NUM
ihlr-16498	583	2	i	i	NOUN
ihlr-16498	583	3	d	d	PROPN
ihlr-16498	583	4	at	at	ADP
ihlr-16498	583	5	2649	2649	NUM
ihlr-16498	583	6	-	-	SYM
ihlr-16498	583	7	50	50	NUM
ihlr-16498	583	8	(	(	PUNCT
ihlr-16498	583	9	proposing	propose	VERB
ihlr-16498	583	10	the	the	DET
ihlr-16498	583	11	establishment	establishment	NOUN
ihlr-16498	583	12	of	of	ADP
ihlr-16498	583	13	an	an	DET
ihlr-16498	583	14	independent	independent	ADJ
ihlr-16498	583	15	agency	agency	NOUN
ihlr-16498	583	16	''	''	PUNCT
ihlr-16498	583	17	to	to	PART
ihlr-16498	583	18	oversee	oversee	VERB
ihlr-16498	583	19	postmarketing	postmarkete	VERB
ihlr-16498	583	20	surveillance	surveillance	NOUN
ihlr-16498	583	21	for	for	ADP
ihlr-16498	583	22	drugs	drug	NOUN
ihlr-16498	583	23	and	and	CCONJ
ihlr-16498	583	24	devices	device	NOUN
ihlr-16498	583	25	"	"	PUNCT
ihlr-16498	583	26	and	and	CCONJ
ihlr-16498	583	27	referencing	reference	VERB
ihlr-16498	583	28	other	other	ADJ
ihlr-16498	583	29	people	people	NOUN
ihlr-16498	583	30	's	's	PART
ihlr-16498	583	31	suggestions	suggestion	NOUN
ihlr-16498	583	32	for	for	ADP
ihlr-16498	583	33	a	a	DET
ihlr-16498	583	34	surveillance	surveillance	NOUN
ihlr-16498	583	35	system	system	NOUN
ihlr-16498	583	36	)	)	PUNCT
ihlr-16498	583	37	.	.	PUNCT
ihlr-16498	584	1	131	131	NUM
ihlr-16498	584	2	i	i	NOUN
ihlr-16498	584	3	d	d	PROPN
ihlr-16498	584	4	(	(	PUNCT
ihlr-16498	584	5	discussing	discuss	VERB
ihlr-16498	584	6	post	post	ADJ
ihlr-16498	584	7	-	-	ADJ
ihlr-16498	584	8	marketing	marketing	ADJ
ihlr-16498	584	9	studies	study	NOUN
ihlr-16498	584	10	and	and	CCONJ
ihlr-16498	584	11	legal	legal	ADJ
ihlr-16498	584	12	penalties	penalty	NOUN
ihlr-16498	584	13	)	)	PUNCT
ihlr-16498	584	14	.	.	PUNCT
ihlr-16498	585	1	84	84	NUM
ihlr-16498	585	2	indiana	indiana	PROPN
ihlr-16498	585	3	health	health	PROPN
ihlr-16498	585	4	law	law	PROPN
ihlr-16498	585	5	review	review	NOUN
ihlr-16498	585	6	[	[	X
ihlr-16498	585	7	vol	vol	NOUN
ihlr-16498	585	8	.	.	PUNCT
ihlr-16498	585	9	4:59	4:59	NUM
ihlr-16498	585	10	tant	tant	ADJ
ihlr-16498	585	11	information	information	NOUN
ihlr-16498	585	12	when	when	SCONJ
ihlr-16498	585	13	prescribing	prescribe	VERB
ihlr-16498	585	14	drugs	drug	NOUN
ihlr-16498	585	15	to	to	ADP
ihlr-16498	585	16	their	their	PRON
ihlr-16498	585	17	patients	patient	NOUN
ihlr-16498	585	18	.	.	PUNCT
ihlr-16498	586	1	it	it	PRON
ihlr-16498	586	2	will	will	AUX
ihlr-16498	586	3	also	also	ADV
ihlr-16498	586	4	hold	hold	VERB
ihlr-16498	586	5	the	the	DET
ihlr-16498	586	6	manufacturers	manufacturer	NOUN
ihlr-16498	586	7	accountable	accountable	ADJ
ihlr-16498	586	8	for	for	ADP
ihlr-16498	586	9	supplying	supply	VERB
ihlr-16498	586	10	the	the	DET
ihlr-16498	586	11	public	public	NOUN
ihlr-16498	586	12	with	with	ADP
ihlr-16498	586	13	the	the	DET
ihlr-16498	586	14	results	result	NOUN
ihlr-16498	586	15	of	of	ADP
ihlr-16498	586	16	their	their	PRON
ihlr-16498	586	17	tri­	tri­	NOUN
ihlr-16498	586	18	als	als	NOUN
ihlr-16498	586	19	.	.	PUNCT
ihlr-16498	587	1	second	second	ADJ
ihlr-16498	587	2	,	,	PUNCT
ihlr-16498	587	3	the	the	DET
ihlr-16498	587	4	market	market	NOUN
ihlr-16498	587	5	exclusivity	exclusivity	NOUN
ihlr-16498	587	6	provision	provision	NOUN
ihlr-16498	587	7	should	should	AUX
ihlr-16498	587	8	only	only	ADV
ihlr-16498	587	9	apply	apply	VERB
ihlr-16498	587	10	to	to	ADP
ihlr-16498	587	11	drugs	drug	NOUN
ihlr-16498	587	12	that	that	PRON
ihlr-16498	587	13	are	be	AUX
ihlr-16498	587	14	shown	show	VERB
ihlr-16498	587	15	to	to	PART
ihlr-16498	587	16	be	be	AUX
ihlr-16498	587	17	safe	safe	ADJ
ihlr-16498	587	18	and	and	CCONJ
ihlr-16498	587	19	effective	effective	ADJ
ihlr-16498	587	20	in	in	ADP
ihlr-16498	587	21	pediatric	pediatric	ADJ
ihlr-16498	587	22	populations	population	NOUN
ihlr-16498	587	23	.	.	PUNCT
ihlr-16498	588	1	third	third	ADJ
ihlr-16498	588	2	,	,	PUNCT
ihlr-16498	588	3	stricter	strict	ADJ
ihlr-16498	588	4	time	time	NOUN
ihlr-16498	588	5	frames	frame	NOUN
ihlr-16498	588	6	for	for	ADP
ihlr-16498	588	7	labeling	labeling	NOUN
ihlr-16498	588	8	changes	change	NOUN
ihlr-16498	588	9	should	should	AUX
ihlr-16498	588	10	occur	occur	VERB
ihlr-16498	588	11	with	with	ADP
ihlr-16498	588	12	the	the	DET
ihlr-16498	588	13	results	result	NOUN
ihlr-16498	588	14	of	of	ADP
ihlr-16498	588	15	pediatric	pediatric	ADJ
ihlr-16498	588	16	trials	trial	NOUN
ihlr-16498	588	17	to	to	PART
ihlr-16498	588	18	provide	provide	VERB
ihlr-16498	588	19	physicians	physician	NOUN
ihlr-16498	588	20	and	and	CCONJ
ihlr-16498	588	21	patients	patient	NOUN
ihlr-16498	588	22	with	with	ADP
ihlr-16498	588	23	reliable	reliable	ADJ
ihlr-16498	588	24	information	information	NOUN
ihlr-16498	588	25	.	.	PUNCT
ihlr-16498	589	1	finally	finally	ADV
ihlr-16498	589	2	,	,	PUNCT
ihlr-16498	589	3	to	to	PART
ihlr-16498	589	4	address	address	VERB
ihlr-16498	589	5	the	the	DET
ihlr-16498	589	6	post	post	ADJ
ihlr-16498	589	7	-	-	ADJ
ihlr-16498	589	8	approval	approval	ADJ
ihlr-16498	589	9	surveillance	surveillance	NOUN
ihlr-16498	589	10	problems	problem	NOUN
ihlr-16498	589	11	,	,	PUNCT
ihlr-16498	589	12	congress	congress	PROPN
ihlr-16498	589	13	could	could	AUX
ihlr-16498	589	14	grant	grant	VERB
ihlr-16498	589	15	the	the	DET
ihlr-16498	589	16	fda	fda	PROPN
ihlr-16498	589	17	the	the	DET
ihlr-16498	589	18	authority	authority	NOUN
ihlr-16498	589	19	to	to	PART
ihlr-16498	589	20	establish	establish	VERB
ihlr-16498	589	21	an	an	DET
ihlr-16498	589	22	independent	independent	ADJ
ihlr-16498	589	23	office	office	NOUN
ihlr-16498	589	24	to	to	PART
ihlr-16498	589	25	monitor	monitor	VERB
ihlr-16498	589	26	safe	safe	ADJ
ihlr-16498	589	27	and	and	CCONJ
ihlr-16498	589	28	effective	effective	ADJ
ihlr-16498	589	29	drug	drug	NOUN
ihlr-16498	589	30	use	use	NOUN
ihlr-16498	589	31	in	in	ADP
ihlr-16498	589	32	pediatric	pediatric	ADJ
ihlr-16498	589	33	populations	population	NOUN
ihlr-16498	589	34	,	,	PUNCT
ihlr-16498	589	35	evaluate	evaluate	VERB
ihlr-16498	589	36	the	the	DET
ihlr-16498	589	37	effectiveness	effectiveness	NOUN
ihlr-16498	589	38	of	of	ADP
ihlr-16498	589	39	the	the	DET
ihlr-16498	589	40	voluntary	voluntary	ADJ
ihlr-16498	589	41	med­	med­	PROPN
ihlr-16498	589	42	watch	watch	NOUN
ihlr-16498	589	43	system	system	NOUN
ihlr-16498	589	44	,	,	PUNCT
ihlr-16498	589	45	assess	assess	VERB
ihlr-16498	589	46	the	the	DET
ihlr-16498	589	47	current	current	ADJ
ihlr-16498	589	48	pediatric	pediatric	ADJ
ihlr-16498	589	49	age	age	NOUN
ihlr-16498	589	50	group	group	NOUN
ihlr-16498	589	51	guidelines	guideline	NOUN
ihlr-16498	589	52	,	,	PUNCT
ihlr-16498	589	53	and	and	CCONJ
ihlr-16498	589	54	work	work	VERB
ihlr-16498	589	55	closely	closely	ADV
ihlr-16498	589	56	to	to	PART
ihlr-16498	589	57	share	share	VERB
ihlr-16498	589	58	information	information	NOUN
ihlr-16498	589	59	with	with	ADP
ihlr-16498	589	60	sister	sister	NOUN
ihlr-16498	589	61	organizations	organization	NOUN
ihlr-16498	589	62	in	in	ADP
ihlr-16498	589	63	other	other	ADJ
ihlr-16498	589	64	countries	country	NOUN
ihlr-16498	589	65	.	.	PUNCT
ihlr-16498	590	1	a	a	DET
ihlr-16498	590	2	great	great	ADJ
ihlr-16498	590	3	many	many	ADJ
ihlr-16498	590	4	lessons	lesson	NOUN
ihlr-16498	590	5	are	be	AUX
ihlr-16498	590	6	learned	learn	VERB
ihlr-16498	590	7	from	from	ADP
ihlr-16498	590	8	evaluating	evaluate	VERB
ihlr-16498	590	9	the	the	DET
ihlr-16498	590	10	deficiencies	deficiency	NOUN
ihlr-16498	590	11	in	in	ADP
ihlr-16498	590	12	the	the	DET
ihlr-16498	590	13	fdama	fdama	NOUN
ihlr-16498	590	14	,	,	PUNCT
ihlr-16498	590	15	bpca	bpca	PROPN
ihlr-16498	590	16	,	,	PUNCT
ihlr-16498	590	17	and	and	CCONJ
ihlr-16498	590	18	prea	prea	PROPN
ihlr-16498	590	19	.	.	PUNCT
ihlr-16498	591	1	due	due	ADP
ihlr-16498	591	2	to	to	ADP
ihlr-16498	591	3	the	the	DET
ihlr-16498	591	4	special	special	ADJ
ihlr-16498	591	5	nature	nature	NOUN
ihlr-16498	591	6	of	of	ADP
ihlr-16498	591	7	pediatric	pediatric	ADJ
ihlr-16498	591	8	popula­	popula­	ADJ
ihlr-16498	591	9	tions	tion	NOUN
ihlr-16498	591	10	,	,	PUNCT
ihlr-16498	591	11	they	they	PRON
ihlr-16498	591	12	require	require	VERB
ihlr-16498	591	13	heightened	heighten	VERB
ihlr-16498	591	14	regulatory	regulatory	ADJ
ihlr-16498	591	15	measures	measure	NOUN
ihlr-16498	591	16	to	to	PART
ihlr-16498	591	17	provide	provide	VERB
ihlr-16498	591	18	them	they	PRON
ihlr-16498	591	19	with	with	ADP
ihlr-16498	591	20	safe	safe	ADJ
ihlr-16498	591	21	and	and	CCONJ
ihlr-16498	591	22	effective	effective	ADJ
ihlr-16498	591	23	drugs	drug	NOUN
ihlr-16498	591	24	.	.	PUNCT
ihlr-16498	592	1	because	because	SCONJ
ihlr-16498	592	2	the	the	DET
ihlr-16498	592	3	bpca	bpca	PROPN
ihlr-16498	592	4	and	and	CCONJ
ihlr-16498	592	5	the	the	DET
ihlr-16498	592	6	prea	prea	PROPN
ihlr-16498	592	7	will	will	AUX
ihlr-16498	592	8	sunset	sunset	VERB
ihlr-16498	592	9	in	in	ADP
ihlr-16498	592	10	2007	2007	NUM
ihlr-16498	592	11	,	,	PUNCT
ihlr-16498	592	12	many	many	ADJ
ihlr-16498	592	13	of	of	ADP
ihlr-16498	592	14	the	the	DET
ihlr-16498	592	15	regulatory	regulatory	ADJ
ihlr-16498	592	16	deficiencies	deficiency	NOUN
ihlr-16498	592	17	can	can	AUX
ihlr-16498	592	18	be	be	AUX
ihlr-16498	592	19	addressed	address	VERB
ihlr-16498	592	20	with	with	ADP
ihlr-16498	592	21	new	new	ADJ
ihlr-16498	592	22	legislation	legislation	NOUN
ihlr-16498	592	23	and	and	CCONJ
ihlr-16498	592	24	regulatory	regulatory	ADJ
ihlr-16498	592	25	schemes	scheme	NOUN
ihlr-16498	592	26	.	.	PUNCT